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Abstract 
Meticillin-resistant Staphylococcus aureus (MRSA) is one of the major human pathogens and is 
a common cause of hospital-associated infection in immunocompromised patients and 
individuals with open wounds. However, infections affecting the healthy and young have 
increased in the past few decades and are a rising clinical concern. Understanding the 
genetic diversity of S. aureus can therefore result in a better understanding of the 
pathogenesis, spread and evolution of S. aureus, which in turn can lead to the development 
of effective infection control measures. In the present study, molecular methods were 
utilised to investigate differences in the distribution and variability of bacterial genes present 
between successful and unsuccessful lineages of MRSA. Lineages were assigned based on 
multilocus sequence typing (MLST) clonal complexes and successful lineages were defined as 
those lineages that have given rise to multiple epidemic MRSA clones. In addition to 
well-established molecular methods such as MLST and staphylococcal cassette chromosome 
mec typing, a novel fluorescent amplified fragment length polymorphism assay was developed 
to identify regions of genetic heterogeneity between and within lineages. These differences 
were attributed to lineage-specific sequence variation and differences in the distribution of 
mobile genetic elements (MGEs) between lineages. These genetic differences were 
investigated in relation to functional differences within the bacterium, to explore the role of 
cell functions encoded by these regions in the emergence and prevalence (or spread) of 
dominant genetic lineages. This study indicates a combination of factors play a role in the 
success of major MRSA lineages. The genetic diversity amongst core regions and MGEs 
appear to alter antimicrobial resistance and virulence factors that are vital to their success, as 
they enable the rapid adaption of lineages to their environment. 
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CHAPTER 1 
1. Introduction 
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1.1. The genus Staphylococcus 
1.1.1. The history of Staphylococcus 
Alexander Ogston was the first to detail the characteristic grape-like clusters of staphylococci 
in 1882. He named the genus Staphylococcus, based on the Greek word 'staphyle' meaning 
bunch of grapes (Ogston, 1880). Subsequent cultivation by Rosenbach provided evidence 
that the microorganism could cause wound infections, which in the pre-antimicrobial era 
often endangered life (Rosenbach, 1884). Rosenbach distinguished two strains of 
Staphylococcus which he named on the basis of colony pigmentation: Staphylococcus aureus 
based on the Latin word 'aurum' for gold and Staphylococcus albus based on the Latin word 
'albus' for white. 
Staphylococci were initially grouped into the family Micrococcaceae with micrococci into the 
genus Micrococcus (Macdonald and Smith, 1981). However, studies based either on single 
biochemical characteristics or on multiple characteristics using numerical taxonomy 
displayed both genera were distinct (Evans et aL, 1955; Hill, 1959). Analysis of the 
percentage G+C content further supported this distinction. Staphylococcus displayed a low 
G+C content of 31·37 % whilst Micrococcus exhibited a higher G+C content of 69-75 % 
(Silvestri and Hill, 1965). 16S ribosomal RNA (rRNA) gene sequence analysis also identified 
staphylococci were distinct from Micrococcus and the other genus in the family, Planococcus 
(Stackebrandt and Woese, 1979). Kloos et aL (1998) have subsequently shown that 
Staphylococcus is closely related to the more recently described genus Macrococcus. Since then, 
the genus Staphylococcus has been assigned to the family Staphylococcaceae along with 
Macrococcus. This genus is monophyletic (descended from a single common ancestor). Over 
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40 species and 20 subspecies within the genus Staphylococcus have been described to date (de 
Vos et al, 2009). 
1.1.2. Characteristics of Staphylococcus aureus 
Staphylococci are Gram-positive bacteria which commonly form part of the human and 
animal microbiota. Species such as S. aureus and S. epidermidis are colonisers of human skin 
and mucosa, and are a common cause of human infections. S. aureus exists in two forms: 
planktonic cells (free living cells) or within biofilms (aggregation of cells to a surface). The 
cells have a diameter of 0.5-1.5 pm and grow in characteristic grape.like clusters as they 
divide along three planes. The colonies can appear golden yellow due to the synthesis of a 
carotenoid pigment but are more commonly cream, white or non-pigmented. It is a non-
spore forming, non-motile and facultative anaerobic bacterium. Cells have an optimum 
growth temperature of between 30 to 37°C and they can tolerate a pH ranging from 4 to 10. 
S. aureus is catalase- and coagulase-positive; the latter enables clotting of blood plasma and 
enables it to be distinguished from the approximately 40 coagulase-negative staphylococci 
(CoNS) species such as S. epidermidis (Harris et al, 2002). S. aureus can utilise various carbon 
sources and are capable of growth in vitro on a variety of media. When grown on blood agar, 
some colonies show a zone of ~-haemolysis due to the production of haemolysin, which 
results in the lysis of erythrocytes (Singleton, 2004). 
S. aureus possesses a plasma membrane surrounded by a cell wall which is 20-50 nm thick. 
The cell wall maintains the cell shape and protects the cell against osmotic forces. 
Approximately 40 % of the cell wall is composed of peptidoglycan also known as murein (see 
penicillin-resistant S. aureus: section 1.4.2) and other polymers such as teichoic acid (Figure 
1) (Shockman & Barrett, 1983). The peptidoglycan and teichoic acid compose 90 % of the 
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cell wall. The remaining component is made up of surface proteins and exoproteins which 
may play a role in virulence (Harris et aL., 2002). In addition, around 90 % of S. aureus 
isolates produce capsular polysaccharides which may enhance the virulence of the organism 
(Thakker et al., 1998). 
Figure 1. Cross-sectional view of a Gram-positive bacterium cell wall 
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The cell membrane depicts membrane proteins and a lipid bilayer, the latter anchors 
lipoteichoic acid. Lipoteichoic acid and teichoic acid are found within the peptidoglycan 
layer. 
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1.2. Clinical significance of S. aureus 
1.2.1. Colonisation 
S. aureus causes infections in humans and a variety of animal hosts. S. aureus carriage has 
been described in reptiles, birds and mammals, the latter of which include livestock and 
domestic pets. There is no consensus between studies for the rate of carriage in canines and 
felines but prevalence rates range from 0 to 4 % (Weese, 2010). Risk factors include open 
wounds, previous antimicrobial treatment and contact with colonised individuals 
(Thompson et al, 1982). S. aureus is ubiquitous in nature and around 20 % of humans are 
thought to be permanent carriers and are colonised continuously with a single strain. 
However, a turnover of strains has been reported in permanent carriers. Around 60 % are 
thought to be intermittent carriers where the strains are variable and around 20 % are not 
carriers (Sakwinska et al, 2009; Singleton, 2004; Whitt & Salyers, 2002; Williams, 1963). 
Colonisation has recently been reclassified into two types, persistent and other carriers (van 
Belkum et al, 2009). The most common reservoir of S. aureus in humans is the nostrils but 
they can also be found in areas of moist skin such as the axillae and perineum. Nasal 
colonisation has been associated as a risk factor for S. aureus infections in the 
immunocompromised, the elderly and the very young, as well as those recovering from open 
surgery (Frank et al., 1999). In infections such as bacteraemia, the majority of patients are 
infected by the same strain they are colonised with (von Eiff et al, 2001; Wertheim et al, 
2004). Similarly, a higher proportion of children are persistently colonised as compared with 
adults. The causes of this are as yet unknown, although bacterial cell surface and adhesion 
proteins are thought to play a role in colonisation (Armstrong-Esther & Smith, 1976; 
Kluytmans et al., 1997; Nouwen et al., 2004). 
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1.2.2. Types of disease 
Staphylococci are a common cause of skin and soft tissue infections and bacteraemia in 
humans. In the broad term bacteraemia refers to the any presence of bacteria in the blood. 
However, overtime it has become used to refer to the presence of bacteria in the blood 
which result in clinical symptoms. This latter definition has been utilised in this thesis here 
after. Symptoms associated with infection vary depending on the site of infection. Most 
common superficial infections develop in hair follicles and present as boils (or furuncles) 
which are pus-filled cavities. Deeper penetration can result in internal abscess formation 
(Ogston, 1880) and penetration of the organism into the bloodstream which can seed 
infections at other body sites and lead to arthritis, meningitis and pneumonia. This is 
common in patients with predispositions such as existing illness and old age. Intravenous 
lines and open wounds also increase chances of bacteraemia (Flu it & Schmitz, 2003). 
s. aureus can encode acquired toxins which act as superantigens and cause toxigenic diseases. 
Clinical symptoms that are associated with toxigenic staphylococcal disease include food 
poisoning, staphylococcal scalded skin syndrome, toxic shock syndrome and necrotising 
fasciitis, amongst others. Toxic shock syndrome is caused by the invasion of a toxin into the 
bloodstream which can result in toxic shock and multi-organ failure (Lappin & Ferguson, 
2009). Staphylococcal food poisoning is caused by consuming foods products that contain 
one or more staphylococcal emetic toxins. Toxins cause symptoms ranging from nausea to 
severe dehydration and changes in blood pressure. Infections also manifest as the contagious 
condition, bullous impetigo, which is found to spread rapidly between infants and close 
contacts. This is characterised by the formation of blisters containing large numbers of 
bacteria in the top layers of skin (Flu it & Schmitz, 2003). 
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1.2.3. Burden of disease 
Meticillin-resistant S. aureus (MRSA) (see MRSA: section 1.4.3) is among the most common 
antimicrobial-resistant pathogen identified among hospitals around the world, although the 
incidence of MRSA varies between countries (European Antimicrobial Resistance 
Surveillance System annual report 2008). The UK continued to show a decreasing trend in 
prevalence down to 31 % in 2008. The European Antimicrobial Resistance Surveillance 
Network attributed 1 % of S. aureus infections in Northern European countries to MRSA 
and 50 % to MRSA in Southern European countries (European Antimicrobial Resistance 
Surveillance System annual report 2008). This included the first case of MRSA reported in 
Iceland between 1999 and 2008. Countries such as Belgium, Poland and France reported a 
continued decrease whilst others such as Portugal and Switzerland reported an increase. In 
2005, over half of hospitalisations due to S. aureus infections in the USA were due to MRSA 
(Klein et aL, 2007). During the period 2005 to 2008, a 9.4 % decrease in hospital-associated 
(HA) infections and a 5.7 % decrease in community-associated (CA) infections was observed 
in the USA (Kallen et aL, 2010). 
Throughout 2001 to 2006, the proportion of S. aureus bacteraemia attributable to MRSA 
was around 42 % in the UK and Ireland and these strains often displayed multiple 
resistances (Hope et aL, 2008). Although the proportion of MRSA bacteraemia in 2009 and 
2010 dropped to 23 % and 19 % respectively, the rate of decline has slowed since 2006 
(Martin et al., 2011). Despite the overall decrease, the proportion of bacteraemia whose 
source of infection was attributed to skin and soft tissue infections has increased (Pearson et 
al., 2009; Wilson et al., 2011). A study of nosocomial bacteraemia during the period 1996 to 
2006 from more than 16 countries suggested that 60.2 % of infections were caused by 
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epidemic MRSA (EMRSA)..15 and 35.4 % by EMRSA-16 (Johnson et al, 2001). These two 
strains have continuously accounted for the majority of MRSA bacteraemia throughout 
2001 to 2007 (Ellington et al., 2010), despite an overall reduction of 56 % in MRSA 
bacteraemia between 2004 and 2008 (Johnson et al, 2012). In the last decade, a decline in 
EMRSA-16 in the UK was observed which was compensated by a proportionate increase in 
the prevalence of EMRSA-15. EMRSA-16 declined dramatically from 21.4 to 9 % during the 
period 2001 to 2007 whilst the proportion attributable to EMRSA-15 increased 
correspondingly (Ellington et aL, 2010). EMRSA-16 may however have been in natural 
decline before the implementation of enhanced infection control measures (Rao et al, 2011; 
Wyllie et aL, 2011). 
1.3. Virulence and pathogenicity factors 
Virulence factors assist the organism to adhere to host tissue, evade the host immune system 
and to disseminate and invade tissue (Projan & Novick, 1997). Virulence factors also affect 
the degree of pathogenicity, which is the ability of an organism to cause disease (van Belkum 
et al, 2007). The production of virulence factors varies between growth stages (Figure 2) 
(Schlievert et aL, 2010). The presence of S. aureus infections proves that this organism can 
become established and transmit affectively between hosts. The production of virulence and 
pathogenicity factors often found on mobile genetic elements (MGEs) such as 
bacteriophages and S. aureus pathogenicity islands (SaPIs) are also contributing factors. 
1.3.1. Factors which aid tissue adhesion 
Fibronectin-binding proteins enable adhesion of bacterial cells to fibronectin (plasma 
protein) (Jonsson et al, 1991) and subsequently bind to the fibronectin receptor (integrin 
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a5~1). This facilitates the uptake of bacteria into host cells (Schwarz..Linek et al. , 2003; Sinha 
et al., 1999). Mutations within the proteins reduce the binding capacity of S. aureus to 
fibrinogen and its ability to invade host cells (Grundmeier et al., 2004). Clumping factors 
Cif A and ClfB enable adhesion of S. aureus to fibronectin and cytokeratin, which results in 
the aggregation of platelets and protects the bacteria against phagocytosis by host leukocytes 
(Bayer et al. , 1995; Palmqvist et al., 2004). The above proteins are examples of microbial 
surface components recognising adhesive matrix molecules (MSCRAMM) (Holden et al., 
2008). 
Figure 2. S. aureus virulence factors produced during different bacterial growth stages 
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Cell surface virulence factors are produced during the exponential growth stage whilst 
secreted factors are produced during the stationary phase (obtained from Schlievert et al., 
2010). MSCRAMM, Microbial surface components recognising adhesive matrix molecule; 
PVL, Panton-Valentine leucocidin; SE, staphylococcal enterotoxin; SEl, staphylococcal 
enterotoxin-like protein; TSST-l, toxic shock syndrome toxin-to 
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The extracellular adherence protein (Eap) and extracellular fibrinogen-binding protein (Efb) 
are S. aureus secreted proteins that facilitate their adhesion to fibrinogen (Palm a et aL, 1999). 
Eap decreases the migration of neutrophils to the site of infection (Chavakis et aL, 2002) and 
prevents extravasation (movement from capillaries to tissue) of leukocytes (Harraghy et aL, 
2003) whilst Efb prevents complement activation ofT-cells (Lee et aL, 2004a; 2004b). Sortase 
A (enzyme anchoring surface adhesion proteins) mutants display a decrease in virulence, 
thus highlighting the importance of cell adhesion to the pathogenesis of S. aureus (Fluit & 
Schmitz, 2003). 
1.3.2. Factors which aid immune system evasion 
Staphylococcal protein A is anchored within the cell wall and prevents phagocytosis and 
initiates apoptosis (programmed cell death) of host leukocytes (Goodyear & Silverman, 
2004). The chemotaxis inhibitory protein of S. aureus is a secreted protein that binds to the 
C5a receptor on leukocytes and prevents their induction (de Haas et al, 2004; Wright et aL, 
2007). Various S. aureus strains produce a capsule layer and the majority of strains causing 
infection have been shown to belong to capsule serotype 5 or 8. The capsule and other 
secreted molecules such as the staphylococcal complement inhibitor and staphylokinase 
protein prevent the binding of antibodies to the bacterial cell surface preventing recognition 
and phagocytosis by host leukocytes (Karakawa et al, 1988; Rooijakkers et aL, 2005aj 2005b; 
van Wamel et aL, 2006). S. aureus produce proteases such as the cysteine protease staphopain 
B and the metalloprotease aureolysin (Massimi et al, 2002) which degrade host tissue (Lowy, 
2000) and plasma proteins (Potempa et al, 1986; 1991). 
S. aureus produces superantigens that are presented on the major histocompatibility complex 
class Il (MHC II) molecules at the cell surface of antigen-presenting cells during an infection. 
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These MHe II molecules interact with receptors on T-leukocytes which generate an increase 
in cytokine production, a surge in immune cells and the inflammatory response. 
Superantigens can be encoded on MGEs such as bacteriophages and SaPIs (Betley & 
Mekalanos, 1985). Superantigens include the enterotoxins (types A to E, G to Rand U) and 
the production of certain variants of these toxins cause staphylococcal food poisoning 
(Jarraud et al., 2001; Letertre et al., 2003; Omoe et al., 2003; Orwin et al., 2001; 2003). The 
egc toxin gene cluster, which encodes the toxins, is found in specific staphylococcal lineages 
(Fluit & Schmitz, 2003). Lineages are assigned based on multilocus sequence typing (MLSn 
clonal complexes. Enterotoxin production has been shown to differ between colonising and 
bacteraemia isolates (Peck et al., 2009). Other S. aureus toxins such as toxic shock syndrome 
toxin-I (TSST-l) which plays a role in the apoptosis of host cells, can lead to toxic shock 
syndrome (Hofer et al., 1996; Kreiswirth, 1989; Lowy, 2000), whilst staphylococcal scalded-
skin syndrome is associated with exfoliative toxin A (Ladhani, 2003). 
1.3.3. Factors which aid tissue invasion 
Cytotoxins secreted by S. aureus lyse host leukocytes and erythrocytes (Song et al., 1996). 
Three forms of haemolysins: a, ~ and 'Y are produced by S. aureus. Alpha-haemolysin forms 
pores in the cell membrane of erythrocytes (Bhakdi & Tranum-Jensen, 1991; Bohach & 
Foster, 2000) whilst ~haemolysin degrades sphingomyelin in the cytoplasmic membrane to 
cause cell lysis (Bohach & Foster, 2000). The third form, 'Y-haemolysin, works synergistically 
with leukocidins such as Panton-Valentine leukocidin (PVL) to form pores in leukocytes 
(Jayasinghe & Bayley, 2005; Joubert et al., 2006). Strains with mutations in the gene 
encoding 'Y-haemolysin have been associated with persistent bacteraemia (Fowler et al., 2004) 
whilst PVL is thought to play a role in necrotising pneumonia (Labandeira-Rey et al., 2007). 
PVL is a toxin composed of two subunits encoded by the genes lukS-PV and lukF-PV 
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(Rahman et aL, 1992). It is detected to a greater extent in clinical isolates as compared to 
colonising isolates (Chiu et aL, 2011). There has been a rise from 2 to 15 % in clinical 
isolates that are PVL-positive (Prevost et aL, 1995; Wannet et aL, 2005). 
Invasive and carriage isolates have been shown to be genetically similar and occur in similar 
lineages (Lindsay et aL, 2006; Melles et aL, 2004). However, variation among virulence 
factors such as surface proteins is greater between lineages than within lineages. This 
variation is lineage-specific, although variation among protein domains is conserved across 
unrelated lineages (McCarthy & Lindsay, 2010). The absence of certain virulence factors in 
lineages associated with invasive strains questions the role of individual factors in virulence 
and suggests combinations of proteins are required to confer increased virulence. Despite 
this, virulence genes do differ between strains and some of these are important for a change 
from colonisation to an invasive pathogen (Peacock et aL, 2002). Whether virulence genes 
differ between MRSA and meticillin-susceptible S. aureus (MSSA) is controversial, although 
factors such as enterotoxins do differ between genetic backgrounds (Liu et aL, 2010; Peck et 
aL, 2009; Varshney et aL, 2009). 
1.3.4. Survival mechanisms of S. aureus 
S. aureus virulence factors are regulated by global regulators, which help the bacterium to 
adapt to its environment and survive. The accessory gene regulator (agr) locus regulates the 
transcription of the protein A (spa), f3-haemolysin (hlb) and toxic shock syndrome toxin-1 (tst) 
genes (Recsei et aL, 1986). The agr system plays a role in quorum sensing, which is when 
bacteria detect the bacterial population density in their vicinity by signalling molecules that 
cause changes in gene expression of exoproteins and proteins associated with cell walls 
(Cassat et aL, 2006; Ji et aL, 1995). agr groups I, II and Ill, which are defined based on their 
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sequence, are present in each lineage and are part of the variable genes (Lindsay et aL, 2006; 
Peacock et aL, 2002). These groups are specific to genetic background and may play a role in 
colonisation and pathogenesis (Goerke et aL, 2003; Schwan et aL, 2003). The system is 
involved in the interaction of S. aureus with the host cell surface and plays a role in the 
induction of apoptosis of host cells (Schnaith et aL, 2007) and the shedding of extracellular 
proteins from host cells. Other regulators such as the staphylococcal accessory element 
system is important in the adhesion to host cells and in the induction of apoptosis of host 
cells (Liang et al., 2006a; 2006b) whilst the staphylococcal accessory gene regulatory locus is 
involved in the regulation ofbiofilm formation (Cucarella et al., 2001). 
S. aureus can form biofilms, an aggregation of cells that have adhered to a surface which are 
associated with persistent infections as antimicrobials cannot penetrate the cells (Costerton 
et al., 1999). Strains within biofilms are often resistant to multiple (~2) antimicrobials (Kwon 
et al., 2008). Cells in biofilms display differential gene expression patterns, a reduced growth 
rate and altered metabolic state (Beenken et aL, 2004; Stewart & Costerton, 2001). S. aureus 
also produces bacteriocins (also known as lantibiotics), small molecules encoded by the bsa 
genes, which kill other species. Bacteriocins are encoded on MGEs and chromosome and are 
variable between lineages. Such molecules confer a selective advantage in a mixed population 
or under conditions of selection due to environmental stress. 
1.4. Antimicrobial resistance in S. aureus 
An antimicrobial is a substance of microbial or synthetic origin which kills or inhibits the 
growth of microbes. They have specific targets and are even active at low concentrations 
(Waksman, 1947). There are two types of antimicrobials: those displaying bactericidal 
35 
activity (kill bacteria) and those that are bacteriostatic (prevent growth). Antimicrobials are 
categorised as broad spectrum if they act on Gram-positive and Gram-negative bacteria or 
narrow spectrum if they are affective against a smaller group of bacteria. 
1.4.1. Mechanisms of antimicrobial resistance 
Various mechanisms confer antimicrobial resistance in bacteria (Figure 3). Some of these are 
always active, while others are induced in the presence of an antimicrobial (Singleton, 2004). 
Figure 3. Mechanisms of antimicrobial resistance 
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The figure depicts four mechanisms of antimicrobial resistance. One mechanism involves 
the inactivation or modification of the antimicrobial molecules whilst another is the 
prevention of antimicrobial molecules penetrating into the cell or the removal of 
antimicrobial molecules via efflux pumps. Another mechanism involves modification of 
the target site that prevents the action of the antimicrobial. The cell can also 'bypass' the 
effect of the antimicrobial by production of an alternative target (obtained from Hawkey, 
1998). 
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Two major mechanisms of resistance to f3-lactam antimicrobials have been extensively 
studied in S. aureus. The first is the production of f3-lactamases, which hydrolyse the f3-lactam 
ring of the antimicrobial molecules. The second is the modification of the f3-lactam targets 
known as penicillin-binding-proteins (PBPs) (Malouin & Bryan, 1986). Other mechanisms of 
resistance include the removal of antimicrobial molecules once they have penetrated the cell 
via efflux pumps embedded in the bacterial cell envelope (Figure 3). Resistance can also be 
conferred by changing the cell envelope composition, thus preventing the molecules from 
penetrating the bacterium or modification of the antimicrobial molecules (Wilke et al, 
2005). Further mechanisms involve production of an alternative target or the removal of the 
antimicrobial target. 
1.4.2. Penicil1in~resistant S. aureus 
Penicillin was introduced clinically in 1941, however, its overuse may have driven or 
contributed to the selective pressure responsible for emergence of penicillin-resistant 
bacteria. Bacteria were identified prior to the introduction of penicillin which could produce 
proteins that conferred resistance to penicillin (Abraham & Chain, 1940). f3-lactam 
molecules including penicillin contain a four member ring, one member of which is 
nitrogen. This class of antimicrobials prevent the synthesis of the cell envelope in growing 
cells. The cell wall is composed of many layers of peptidoglycan, a unique bacterial polymer 
comprising a glycan backbone made of alternating units of N-acetyl glucosamine and N-
acetyl muramic acid, with short peptides cross-linking the N-acetyl muramic acid residues 
(Figure 4). The precise structure of the peptide cross-bridges can differ between bacterial 
species but always contain both D- and J..,.amino acids. Peptidoglycan is unique as it contains 
amino acids in the D-isomer form which help protect the cell from peptidases. Antimicrobial 
molecules saturate PBPs found in the cytoplasmic membrane by covalently binding to the 
37 
se rine residue at the active site. PBPs catalyse the transglycosylation and transpeptidase 
reactions which form glycosidic and peptide bonds respectively of the peptide cross-bridges. 
The PBPs are therefore required in the synthesis of the peptidoglycan layer (Ghuysen, 1991; 
Malouin & Bryan, 1986). Meticillin thus results in a weakened peptidoglycan layer, 
pred isposing the cell to lysis (Witke et al., 2005). 
Figure 4. Structure of peptidoglycan 
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Peptidoglycan is a component of the bacterial cell wall. It is made of alternating units of 
N-acetyl glucosamine and N-acetyl muramic acid, with short pep tides cross-linking the N-
acetyl muramic acid residues (reproduced with permission from John Heritage, University 
of Leeds, UK). 
The first mode of ~-lactam resistance is conferred by the production of ~-lactamases, which 
hydrolyse the amide bond in the ~-lactam ring, thus inactivating antirnicrobials such as 
pen icillin (Figure 5) (Wilke et al., 2005). In staphylococci, ~lactamases are encoded on 
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plasmids, which can transfer between strains thereby increasing the spread of resistance. B-
lactamase production is encoded by the blaZ gene. Transcription of the gene is induced by 
the presence of B-Iactam molecules and is regulated by the blaI repressor and blaRl receptor. 
B-Iactamases are not affective against some J3-lactam antimicrobials including meticillin 
(Singleton, 2004). 
Figure 5. Structure of penicillin 
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The figure depicts the structure of penicillin. The red arrow indicates the IJ-lactamase 
target in the IJ-lactam ring. 
1.4.3. Meticillin,resistant S. aureus (MRSA) 
By the late 1950s, up to 80 % of S. aureus strains causing infections were resistant to 
penicillin. This increased the pressure to develop and discover novel antimicrobials. The 
semi-synthetic B-lactam antimicrobial meticillin was derived from penicillin and was 
introduced into Europe in 1959 for the treatment of infections due to penicillin-resistant 
S. aureus. However, the first MRSA were reported shortly after the introduction of meticillin 
(Jevons et al., 1961). MRSA can express heterogeneous resistance, characteristic of strains 
from the 1980s or homogeneous resistance. Heterogeneous MRSA exhibit low or borderline 
minimum inhibitory concentrations (MICs) of meticillin, as low as 1.5 mg/L, whilst 
homogeneous MRSA exhibit higher MICs, >400 mg/L (Resende and Figueiredo, 1997). 
Heterogeneous MRSA often express resistance at low temperatures such as 30°C. However, 
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as cultures in current practice are incubated at 37°C, such strains may generally be identified 
as MSSA (Cooks on, 2011). 
The second mode of (3-lactam resistance in S. aureus is conferred by a modified PBP. MRSA 
express four native PBPs in addition to a modified PBP2' or 2A Although MRSA display 
reduced levels of peptidoglycan cros~linking, PBP2A is still able to catalyse the 
transpeptidation reaction for the cros~linking of the peptidoglycan layer and is therefore 
essential for cell wall assembly in the presence of (3-lactams (Wyke et al, 1982). PBP2A is 
encoded by the mecA gene found on the staphylococcal cassette chromosome mec (SCCmec; 
see MGEs: section 1.5.2) (Fluit & Schmitz, 2003). This protein (78 kDa) is only expressed in 
MRSA and has been modified and exhibits a lower affinity for meticillin. This reduced 
affinity lowers the rate at which the fj-Iactam molecules covalently bind to PBP2A Cells 
therefore require higher concentrations of meticillin to saturate the PBP2A (Hartman & 
Tomasz, 1981; 1984). 
The mecA gene is regulated by meeRl and mecl found on the SCCmee, although additional 
mechanisms are needed to regulate mecA (Oliveira & de Lencastre, 2011). The blaRl and 
blaI regulate the expression of the blaZ gene; purifying selection on the bla locus maintains 
its function even in MRSA. This correlates with the findings that bla regulatory genes can 
also regulate mecA (Milheiri<;:o et al, 2011). Apart from the mecA gene, the aux (auxiliary) and 
fern (factor essential for meticillin resistance) genes are essential for complete meticillin 
resistance (de Lencastre & Tomasz, 1994; de Lencastre et al, 1999). 
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1.4.4. Vancomycin~resistant S. aureus (VRSA) 
While glycopeptides such as vancomycin remain affective against the majority of S. aureus, 
where resistance occurs, it causes utmost concern due to the widespread use of the 
compounds as anti-M RSA agents. Glycopeptides bind to the end amino acids of 
peptidoglycan precursors, thus preventing the transpeptidase activity of PBPs and 
cross-linking of the peptidoglycan layer (Frere, 1995). The first S. aureus strains that displayed 
increased vancomycin MICs emerged in 1997 in Japan and were termed vancomycin-
intermediate S. aureus (VISA) (Hiramatsu et aL, 1997). The mechanism that confers 
intermediate vancomycin resistance is still not understood (McA1eese et al., 2006). However, 
VISA have been demonstrated to have a thickened cell wall which prevents the antimicrobial 
molecules from penetrating further (Cui et al, 2000). It has also been suggested that 
glycopeptides inhibit the transglycosylation reaction of PBPs (Ge et aL, 1999). On the 
contrary, heterogeneous vancomycin-intermediate S aureus (h VISA) give rise to some cells 
partially resistant to vancomycin (Hiramatsu et al, 1997). CoNS are reported to act as a 
reservoir for vancomycin resistance (Nouwen et aL, 2005). Whilst such strains remain a 
concern, their true prevalence and impact on clinical care remain a matter of debate. There 
are concerns that these strains have been reported as being significantly associated with 
persistent bacteraemia and heart failure. Genotypes of these strains do not differ from 
strains not displaying heterogeneous vancomycin resistance. 
In 2002, the first strains were reported that displayed high-level vancomycin resistance (MIC 
> 256 mg/L). Fortunately these resistant strains have not spread widely. There have only been 
reports of sporadic incidents, including 11 vancomycin-resistant S. aureus (VRSA) cases in 
the USA in 2009 (Perichon & Courvalin, 2009). This resistance is thought to be conferred 
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by the vanA cluster found on the transposon Tn1546. Genes in this cluster cause structural 
changes in the peptidoglycan precursors which lowers the affinity of the vancomycin 
molecules to the precursors (Figure 6) (Bugg et al. , 1991). The vanA cluster may have been 
transferred from Enterococcus faecalis (Noble et al., 1992). However, the plasmid harbouring 
Tn1546 has varied between VRSA, indicating multiple insertions into S. aureus. Strains 
harbouring both the mecA and vanA gene have been reported and these can exhibit 
resistance to meticillin and vancomycin. However, such strains cannot grow in the presence 
of both antimicrobials as one resistance mechanism hinders the other (Sever in et al., 2004). 
Figure 6. Mechanism of resistance to vancomycin 
Vancomycin-susceptible staphylococci 
Vancomycin 
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Tripeptide containing intermediates 
in cell-wall synthesis 
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Inhibition of 
cell·wall synthesis 
Cell-wall 
synthesis 
In the presence of vancomycin, the vanA operon enables the synthesis of a cell wall 
precursor ending in D-Ala-D-Lac dipeptide rather than D-Ala-D-Ala. The D-Ala-D-Lac 
dipeptide displays reduced affinity for vancomycin (obtained from Murray, 2000). 
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1.4.5. Evolution of antimicrobial resistance 
Antimicrobial resistance mechanisms such as efflux pumps and enzymes that degrade or alter 
the antimicrobial may be encoded on the chromosome (intrinsic resistance). Conversely, 
resistance can arise via mutations in the genome or through the acquisition of MGEs via 
horizontal gene transfer (HGT; acquired resistance). In the latter case, these genes are 
thought to originate from environmental bacteria within which intrinsic resistance has been 
described since before the introduction of antimicrobials (D'Costa et al, 2011). These genes 
are thought to have integrated into existing MGEs and transferred into pathogenic 
organisms, although various bottlenecks are thought to restrict this (Datta & Hughes, 1983; 
Martinez, 2011). 
These environmental bacteria may act as reservoirs for resistance genes or mechanisms 
(AlIen et al, 2010; Cant6n, 2009; Wright. 2010). Environmental bacteria are exposed to 
chemicals which may drive natural selection of such traits. In addition, resistance 
determinants have been shown to play a role in other cell functions of environmental 
bacteria (Martinez, 2009). Since the advent of the antimicrobial era, bacteria acquired 
resistance to newly introduced antimicrobials through HOT of MOEs such as plasmids (lto 
et al, 1999). Their natural selection appears in part to be driven by the Widespread use and 
over-prescription of antimicrobials. Greater antimicrobial use enables those bacteria that 
harbour mutations or genes that confer antimicrobial resistance to survive and spread. 
However, the evolutionary processes driving resistance in environmental bacteria and hence, 
in part, in clinical pathogens are still largely unknown. 
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1.5. Genome of S. aureus 
1.5.1. Mobile genetic elements (MGEs) 
MOEs help drive the evolution of S. aureus by generating genetic variations between strains, 
thus enabling them to adapt to changing environments for survival. MOEs were first 
discovered in the 1940s (McClintock, 1950) and have since been found to be ubiquitous in 
both eukaryotes and prokaryotes. MOEs are segments of DNA that are capable of inter- and 
intra-cellular movement and may encode mechanisms of insertion into the bacterial 
chromosome or plasmid. Up to 20 % of the S. aureus genome is composed of MOEs which 
forms part of the accessory genome. MOEs also encode virulence and antimicrobial 
resistance factors, which may aid in the onset of disease, carriage or may cause complications 
in the treatment of infections (Holden et al, 2008). The HOT of foreign DNA or genetic 
recombination in bacteria occurs via transformation, conjugation or transduction. HOT into 
S. aureus occurs predominantly from within the same species (Figure 7). This is partially due 
to bacteriophages being species-specific and due to mechanisms that minimise the transfer of 
DNA from other species (Holden et al, 2008). 
44 
Figure 7. Methods of bacterial genetic transfer 
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a) Transduction is the incorporation of DNA from a bacterial genome into a 
bacteriophage, resulting in lysis of the donor cell. This incorporation may include random 
bacterial genes (generalised transduction) or specific bacterial genes (specialised 
transduction). This bacteriophage infects another recipient host and transfers this DNA 
fragment into the new host chromosome or plasmid. b) Conjugation involves the direct 
exchange of DNA between two cells via a pilus (Becker et al., 2006). c) Transformation is 
the uptake of free DNA into the chromosome. This free DNA can be in the linear form 
however, the majority of successful transformations require circular DNA. Factors 
required for the competence of S. aureus however are as yet unknown (obtained from 
Redfield,2001). 
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1.5.1.1. Bacteriopha2es 
Bacteriophages are viruses and in S. aureus, most harbour a genome of approximately 45 kb. 
They can exist in the lytic state but most S. aureus bacteriophages exist in the lysogenic state 
where DNA is integrated into the chromosome and remains in a dormant state known as a 
prophage. They harbour short inverted repeats at the terminal ends and encode an integrase 
which specifies the insertion site and enables site-specific insertion into the chromosome 
(Carroll et aL, 1995). S. aureus genomes harbour up to four prophages which can either be 
common to all lineages or be lineage-specific. The spread of bacteriophages may be 
controlled by the host Saul Restriction-Modification (R-M) system (see R-M system: section 
1.6.3). In addition, some others such as the bacteriophage cp42 encodes its own R-M system 
such as the Sau42I R-M system (Dempsey et at, 2005). Bacteriophages may convey a selective 
advantage as they can encode virulence factors and toxins such as PVL (Rahman et al, 1992). 
Bacteriophages have been utilised for decades to type S. aureus strains based on their 
susceptibility pattern to a particular set of bacteriophages. They are also utilised to genetically 
manipulate S. aureus in vivo. Host DNA has been shown to integrate into prophages in the 
chromosome and prevent the formation of bacteriophage particles. This mechanism is 
thought to form SaPIs and may play a role in the co-evolution of bacteriophages and bacteria 
(Wirtz et at, 2010; Yarwood et al, 2002). 
1.5.1.2. S. aureus patho2enicity islands (SaPIs) 
SaPIs are approximately 15 kb and do not encode bacteriophage structural proteins, but use 
proteins encoded by bacteriophages present in the bacterium to excise from the 
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chromosome. SaPIs integrate into specific sites using an integrase and terminal inverted 
repeats under environmental conditions of stress (Lindsay et al, 1998; Tallent et al, 2007). 
S. aureus strains harbour up to two SaPIs which can be packaged into small phage head·like 
particles, released via cell lysis and can integrate into other cells (T ormo et al, 2008). Like 
bacteriophages, SaPIs are thought to be species-specific and transfer is thought to be 
regulated by the Saul R-M system. However, interspecies transfer has also been reported 
(Maiques et al, 2007). As in bacteriophages, variations in SaPI integrases correlate with 
different insertion sites. Similarly, some SaPIs are relatively common and others are 
lineage-specific. SaPIs also display a mosaic structure, suggesting rearrangements with other 
SaPIs. SaPIs harbour R·M system proteins and virulence genes which can aid in the onset of 
disease (Baba et al., 2008). Superantigens such as TSST·1, exotoxins and leukocidin 
components can be found on SaPIs, as can various enterotoxins and haemolysins (Baba et 
al, 2008; Diep et al, 2006; Fitzgerald et al, 2001; Lindsay et al, 1998). 
1.5.1.3. Plasmids 
Plasmids are circular sections of DNA up to 150 kb in size, which undergo autonomous 
replication. As S. aureus are less competent than other bacteria such as Streptococcus 
pneumoniae, plasmids are thought to be transferred by conjugation or transduction (Holden 
et al, 2008). Strains of S. aureus harbour up to three plasmids which can either be free or 
integrated into the chromosome at sites such as the SCCmec. Plasmids from other species 
can be transferred into S. aureus and often carry antimicrobial resistance determinants and 
virulence factors. The plasmid pAM830 containing the tlanA transposon (Tn1456-like 
element} is thought to have transferred via conjugation from enterococci to form VRSA 
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(Flannagan et al., 2003; Weigel et al., 2003). High-level mupirocin resistance is associated 
with strains where the mupA gene, which encodes mupirocin resistance, is found on a 
plasmid (Ramsey et al., 1996). Virulence factors such as enterotoxin B (Yamaguchi et al., 
2001) and exotoxins are also encoded on plasmids (Omoe et al., 2003). Genes conferring 
resistance to bacteriocins have also been described on plasmids which may confer an 
advantage in mixed populations or under environmental stress (Navaratna et al., 1999). In 
addition, point mutations in promoter regions can result in changes in gene expression that 
provide a selective advantage under conditions of selection due to antimicrobial therapy 
(Holden et al., 2008; Nakaminami et al., 2008). 
1.5.1.4. Transposons 
T ransposons, sized up to 60 kb, are fragments of DNA that encode a transposase. This 
allows relocation of its related transposon to sites in the genome with which the transposon 
has no sequence homology. This can cause polar mutations (changes in gene expression 
downstream of the site of integration) and generate knockout mutations. Most S. aureus 
strains harbour one or two different transposons. T ransposons harbouring antimicrobial 
resistance determinants for penicillin, erythromycin, tetracycline, aminoglycosides and 
vancomycin have been described in S. aureus (Holden et al., 2008; Nakaminami et al., 2008). 
1.5.1.4.1. Insertion sequences (ISs) 
ISs are a type of transposon which are relatively small in size (less than 2.5 kb) and only 
encode proteins required for transposition such as a transposase. They are found in most 
48 
bacterial species and over 1500 types are described to date in Eubacteria and Archaea 
(Siguier et al., 2006). Most ISs harbour terminal inverted repeats. In S. aureus, ISs have been 
associated with individual lineages (Lindsay et al., 2006). Multiple copies of an IS can be 
present throughout the chromosome and within plasmids. ISs flanking a piece of DNA can 
excise and transport it around the chromosome (composite transposon) (Mahillon & 
Chandler, 1998). This mechanism enables the exchange and recombination of DNA 
between plasmids and chromosomes. These may induce rapid rearrangement of the S. aureus 
chromosome and enable the bacterium to adapt to its environment. Integration of ISs in 
genes can disrupt cell functions, for example the integration of ISs into the lytic enzyme gene 
LytH results in increased meticillin resistance (Fujimura & Murakami, 2008). ISs have been 
utilised with other techniques to type S. aureus strains (Symms et al., 1998). 
Figure S. Genetic inversion between USAJOO and USASOO strains identified by whole-
genome mapping (WGM) 
The inverted region is highlighted in yellow and with purple lines between two optical 
maps (generated using whole-genome mapping, WGM) whilst the blue regions and black 
lines indicate homogeneous regions. White regions indicate those regions unique to each 
map (obtained from Shukla et al., 2009). 
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Inversions in S. aureus are also rare and they are thought to occur when ISs flanking a region 
of DNA excise and reintegrate into the chromosome in the opposite orientation (Watanabe 
et aL, 2007). Only one large-scale inversion of approximately 500 kb has been described 
between S. aureus strains of USA300 and USA800 (Figure 8). This region was flanked by 
ISl181 and harboured inverted repeats 73 bp in length (Shukla et aL, 2009). Inversions 
could alter the expression order and level of genes (Henderson et aL, 1999). 
1.5.1.5. Genomic islands (GIs) 
GIs are clusters of genes that can be transferred into the same S. aureus strain on multiple 
occasions from the same host (Roos & van Passel, 2011). Pathogenicity islands are those Gls 
that carry genes that encode functions that enhance virulence. All S. aureus strains harbour 
the pathogenicity islands, GIa and GIp. These do not encode their own replication, excision 
and mobility and are thought to be transferred via transduction (Holden et aL, 2008). 
Virulence factors such as multiple toxin genes, leukocidins and bacteriocin biosynthesis 
genes have been described on these Gls (Gravat et aL, 1998; Jarraud et al., 2001; Navaratna 
et aL, 1999). Although not all GIs encode virulence factors, differences in pathogenicity 
between S. aureus and S. epidermidis may be due to toxins encoded on these GIs (Gill et aL, 
2005). 
1.5.2. Staphylococcal cassette chromosome mec (SCCmed 
The mecA gene, which encodes PBP2A, is found on a large G1 section known as the 
staphylococcal cassette chromosome (SCC) which is absent in MSSA (Beck et aL, 1986). This 
Gl inserts in the chromosome at the attB site (bacterial chromosomal attachment site), the 
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sequence of which differs between MRSA and MSSA (Noto et al, 2008). The attB site is 
located at the 3' end of an open reading frame which encodes an rRNA methyltransferase, 
orfX, located near the origin of replication of the chromosome; the orfX is conserved 
between strains (Boundy et al, 2013; Ito et aL, 2001). SCC harbouring the mecA gene 
(SCCmec) and those that lack the mecA have been described. This GI can harbour other 
virulence factors and antimicrobial resistance determinants but lacks bacteriophage 
structural proteins and conjugative transfer (tra) genes. However, the mechanism of transfer 
of the SCCmec is still unknown (Hanssen & SoUid, 2006). Unless otherwise stated, the 
following information was obtained from the International Working Group on the 
classification of Staphylococcal Cassette Chromosome elements (IWG-SCC, 2009). 
The SCCmec is composed of a mec complex, cer complex and three joining regions Q regions) 
which surround the mec and cer complexes. The left and right junctions of the SCCmec with 
the chromosome are known as the attL and attR respectively (Ito et aL, 1999). All SCCmec 
harbour direct repeats found next to the attL and within the SCCmec right terminal end. In 
addition, all SCCmec harbour inverted terminal repeats IR·L and IR·R (27 bp) found at the 
termini of the GI. 
1.5.2.1. mec complex 
The mec complex harbours the mecA gene, the associated regulatory genes (med, repressor 
and mecRl, transducer) and a variety of ISs (Ito et al, 1999; Katayama et al, 2000). The mecl 
and mecR 1 genes can be present in the functional or truncated form or can be absent. The 
mec gene complex is assigned to a class A to E based on the presence of genes and ISs 
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(Figure 9). mec complex class E is a recently described complex with the composition 
blaZ-mecALGA251-mecR 1LGA25rmeclLGA25 1. The sequences of the mec and regulatory genes are 
divergent from those previously described and as a consequence, the mec gene has been 
designated mecC (Garcia-Alvarez et al. , 201 1). 
Figure 9. Composition of meccomplex: class A to D 
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The figure depicts m ecA, its associated regulatory genes and insertion sequences which 
form the mec complex of the SCCmec. Class A composition: IS431-mecA-mecRl-mecl; 
class B composition: IS431-mecA-AmecRI-lSI272; class Cl: IS431-mecA-AmecRI-lS431 
(both IS 431s are arranged in the same direction); class CZ: composition 
IS431-mecA-AmecRI-lS431 (both IS431s are arranged in the opposite direction); class D: 
composition IS431-mecA-AmecRI. A, truncated sequence; IS, insertion sequence; mecA, 
meticillin resistant determinant; mecI, repressor; mecRl, transducer (obtained from 
Hiramatsu et al., ZOOl). 
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1.5.2.2. eer complex 
The eer gene complex encodes DNA recombinases (invertase-resolvase family) 
(Katayama et al, 2000). Three recombinases have been described: cerA and eerB genes are 
found in the same eer complex whilst ecrC is found in others. Both cerA and eerB are 
required for the site-specific integration and excision of SCCmee (Wang & Archer, 2010). 
The eerB displays specificity for a 14 bp sequence (CGTATCATAAGTAA) at the terminal of 
or{X (Wang et al., 2012). Based on the variations of these gene sequences, the genes are 
classified into one of eight allotypes (Table 1). 
Table 1. Types of ccrcomplex 
ccr complex cer genes 
Type 1 eerAl & eerBl 
Type 2 ccrA2 & cerB2 
Type 3 cerA3 & eerB3 
Type 4 eerA4 & eerB4 
Type 5 cerCI 
Type 6 eerA5 & eerB3 
Type 7 cerAl & ccrB6 
Type 8 eerAl & eerB3 
Allotypes of cerA and cerE or ccrC only which constitute ccr complex types 1 to 8 of the 
SCCmec. 
1.5.2.3. Joinin~ re~ions a regions) 
The J regions can harbour additional ISs and plasmid sequences which may carry 
antimicrobial resistance determinants. The majority of SCCmee types harbour three J 
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regions. The J 1 region is between the right chromosomal junction and the cer complex, J2 is 
the region between the cC'r and mec complex and J3 is the region between the mec complex 
and the left chromosomal junction. J regions also harbour pis, a sequence which encodes a 
plasmin-sensitive surface protein, des, a downstream constant segment and kdp a sequence 
encoding for an adenosine triphosphate (ATP)-dependent potassium transport protein. The 
SCCmec site is a transposition hot spot where different plasmids and transposons have 
integrated or recombined (Diep et at, 2006; Noto et at, 2008). This has led to the emergence 
and dissemination of multiple antimicrobial resistant strains. 
1.5.2.4. SCCmec types 
The first SCCmec structure was described by Ito et aL (1999) and within two years, two more 
structures were identified (Ito et aL, 2001). By 2008, eight structurally diverse SCCmec types 
were described (Figure to). Classification criteria for SCCmec types were established by the 
IWG-SCC in 2009. The classification of SCCmec is based on the class of mec complex and 
the type of ccr complex whilst variations in the J regions are used to define subtypes. The 
recombination of SCCmec types may occur and generate new SCCmec types (Zhang et aL, 
2009). To date, 11 SCCmec types have been described (Table 2). 
SCCmec types can be classified further into subtypes based on variations in their J regions. 
Differences in the Jl region are denoted as small letters after the SCCmec type e.g. IVa to 
IVh subtypes (Berglund et aL, 2009; Ito et aL, 2003; Ma et aL, 2002; Milheiri<;:o et aL, 2007; 
Shore et aL, 2005). Variations due to the acquisition of MGEs are denoted by capital letters 
e.g. HA and IVA whilst differences in the Jl, J2 and J3 regions are denoted as numbers e.g. 
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11.1.1.1 and 1l.2.1.1. Composite SCCmee types that harbour two eer complexes have also 
been reported (Heusser et aL, 2007; Higuchi et aL., 2008). 
Figure 10. Staphylococcal Cassette Chromosome mec (SCCmec) types I to VIII 
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Schematic diagram depicting mec and ccr complex and features identified in the J1, J2 
and J3 regions which constitute SCCmec types I to VIII (obtained fromDavid & Daum, 
2010). 
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Table 2. Types of Staphylococcal Cassette Chromosome mec (SCCmec) 
SCCmec type ccrcomplex mec complex Reference 
. 
I 1 B (Ito et al, 2001) 
II 2 A (Ito et al, 1999) 
III 3 A (Ito et al, 2001) 
IV 2 B (Ma et al, 2002) 
V 5 C2 (Ito et al, 2004) 
VI 4 B (Oliveira et al, 2006) 
VII 5 Cl (Berglund et aL, 2008) 
VIII 4 A (Zhang et al, 2009) 
IX 1 C2 (Li et al, 2011) 
X 7 Cl (Li et al, 2011) 
XI 8 E (Garcia,Alvarez et al, 2011) 
Combination of mecand ccrcomplex found in SCCmectypes I to XI. 
"References indicate the first study to describe each type. 
1.5.2.5. SCCnon-mec 
Different SCC elements that lack the mecA gene but harbour other resistance or virulence 
factors have been described. The SCCcap 1 lacks mecA and harbours the cap 1 operon which 
confers resistance to phagocytosis, indicating this element may confer a selective advantage 
(Luong et al, 2002). Further elements such as the SCC[U'I' and SCCHg (Figure 10) have been 
described which confer resistance to fusidic acid and mercury. 
1.5.3. Determining the sequence of the S. aureusgenome 
Genome sequences enable greater understanding of the biological processes of the cell. They 
enable us to shed new light on bacterial growth, replication, survival and adapt ion as well as 
aiding in the development of new typing techniques. Sanger and his colleagues proposed the 
di,deoxynucleotide (ddNTP) sequence determination method in 1975, which is now utilised 
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globally (Sanger & Coulson, 1975). This method involves amplification of target DNA using 
a mixture of deoxynucleotides (dNTP) and ddNTPs. The latter of which terminates chain 
elongation. This reaction is repeated four times, once for each ddNTP (A, T, C or G). Each 
reaction is separated by gel electrophoresis in individual wells and the size of the fragments 
determined by the distance travelled in the gel. The recent developments of next-generation 
sequencing (NGS) technologies are based on sequencing-by-synthesis method, which reduces 
the speed and cost and could lead to NOS being utilised in routine laboratories in the 
future. 
As a major human pathogen, S. aureus has been a focus for NOS studies. Over 180 fully 
annotated genomes have been sequenced to date and are available on the NCBI database 
(http://www.ncbLnlm.nih.gov). The S. aureus genome is composed typically of a 2.7-3.0 Mb 
chromosome and one or more plasmids and has a O+C content between 30 and 39 % (Dale 
& Park, 2004; Takeuchi et al., 2005). Approximately 82-90 % of the chromosome is coding 
DNA, forming 2500-2900 protein coding sequences (Baba et aL, 2008; Lindsay et aL, 2008). 
The sequenced strains belong to approximately 15 clonal complexes (CCs) which are based 
on MlST (see MLST: section 1.8). Comparative studies have revealed approximately 75 % 
of the genome is conserved between strains. These regions encode essential cell functions 
such as growth and metabolism. A large proportion of the variable part of the genome is 
composed of transposons, ISs, SaPIs and bacteriophages which play a role in antimicrobial 
resistance, virulence and pathogenicity (Table 3) (Fitzgerald et aL, 2001). 
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Table 3. Basic features of whole-genome sequences of S. aureus 
Strain designation 
~ ~ Z C Z ~ ::0 Z s::: ~ ~ (f) 8 (f) n> ""- '-v.> -= ~ c: ~ 'Tl ;r::. ;r:: ...... ..... \Jt t""' El 00 N ..... 'C) \Jt 0 N 0 I'> N \Jt -.J 0 
=' 
v.> 
N 0- N VI 
Length of 2814816 2878040 2820462 2902619 2799802 2809422 2872769 2878897 2821361 2742531 2906507 2906700 sequence {bp} 
G + Ccontent 32.8% 32.9% 32.8% 32.8% 32.9% 32.8% 32.8% 32.9% 32.9% 32.8% 33.0% 33.0% 
Protein coding 2593 2714 2632 2671 2565 2673 2560 2614 2892 2589 2747 2697 regions 
IS' 20 23 6 30 5 10 12 12 8 11 17 17 
Transposon 5 2 0 3 0 0 0 0 0 0 2 2 Tn554 
Bacteriophage 1 2 2 2 2 1 2 4 3 1 4 4 
SaPlt 3 4 4 1 0 5 6 4 4 5 3 3 
Plasmid 1 1 1 0 1 
-
3 
- - - - -
Reference (Baba et aL, 2002; Kuroda et al., (Holden et al., (Baba et al., 2008) 2001) 2004) 
------ --
This table displays size and G+C content of the genome, number of protein coding regions and mobile genetic elements. 
'Is, insertion sequence. 
tsapl, S. aureus pathogenicity island. 
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1.6. Evolution of S. aureus 
1.6 1. Processes of evolution 
Bacteria evolve via the action of natural selection upon genetic variation. Oenetic variations 
can arise via random point mutations or via the HOT of foreign DNA Over time, we expect 
mutations that are advantageous to increase in frequency via natural selection, thus enabling 
the bacteria to adapt to their environment. Point mutations can result in changes in 
virulence and antimicrobial resistance. Studies have shown, for example, that mutations in 
the isoleucyl-transfer RNA synthetase and [usA gene result in increased mupirocin and 
fusidic acid resistance respectively (Antonio et aL, 2002; Besier et aL, 2003). In addition, 
mutations upstream of parE result in a change in gene expression of topoisomerase IV which 
is associated with quinolone resistance Once & Hooper, 2003). Natural selection may 
maintain the sequence of genes encoding essential cell functions such as those utilised in 
MLST (see MLST: section 1.8). 
1.6.2. Restriction-Modification (R-M) systems 
The presence of genes encoding surface-associated proteins and regulators of virulence genes 
have been shown to vary between lineages but are relatively stable within a lineage (Lindsay 
et al., 2006). This suggests mechanisms within S. aureus enable the HOT of DNA within a 
lineage at a higher frequency than between lineages. The hypothesis that HOT is restricted 
between lineages supports the evolutionary model for the emergence of MRSA The 
insertion of the SCCmec transforms MSSA strains into MRSA (lto et aL, 1999). There have 
been limited insertions of the SCCmec into MSSA lineages (Robinson & Enright, 2003). 
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MRSA therefore display a highly clonal population structure and the majority of isolates 
therefore belong to a limited number of closely related genotypes or ecs. 
One such mechanism, R-M systems, has been highlighted as an important factor probably 
influencing its evolution. R-M systems are thought to control the uptake of foreign DNA 
from other S. aureus lineages or species by minimising the uptake of DNA such as that of 
bacteriophage. R-M enzymes recognise host-specific sequences and carry out modifications 
such as methylation; the unmodified foreign sequences are then digested by a restriction 
endonuclease. Restriction endonucleases cleave the DNA at a specific sequence usually 
between 4 to 8 bp long. Four types of R-M systems have been identified in bacteria (Waldron 
& Lindsay, 2006). Type I saul R-M system has been identified in all sequenced strains of 
S. aureus. This system is composed of three types of genes: one copy of a restriction enzyme 
subunit saulhsdR, two copies each of a modification enzyme subunit saulhsdMl and 
saulhsdM2 and two copies each of a specificity enzyme subunit saulhsdSl and saulhsdS2. The 
genes encoding for each of the corresponding modification and sequence specificity subunits 
are found on operons on GIa and GIp. 
A study by Waldron and Lindsay (2006) identified a stop codon in the saulhsdR gene that 
enabled the uptake of E. coli plasmids. The saulhsdR and both saulhsdM genes are highly 
conserved between different strains. However, two highly variable DNA binding regions 
named TRDI and TRD2 were identified within the conserved regions of the saulhsdS; five 
and nine subtypes of these regions were identified respectively. Different combinations of 
each of the two subtypes correlated with an S. aureus lineage (CC8, 12, 15, 22, 25, 39,45 or 
51). This indicates isolates of different lineages recognise and modify a different sequence 
which may explain why HGT occurs at a higher frequency within lineages than between 
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lineages. Variation in these genes may therefore be involved in the establishment of new 
lineages (Waldron & Lindsay, 2006). A study by Veiga and Pinho (2009) showed deletion of 
the saulhsdR gene resulted in no increase in the ability of S. aureus to take up plasmids or 
bacteriophages. This implies additional factors such as a second R-M system contributing to 
the acceptance of foreign DNA into S. aureus. Other R-M systems such as the Sau421 R-M 
system have been described in S. aureus. They display restriction endonuclease activity but 
further work is needed to identify their specific recognition sequence (Dempsey et aL, 2005). 
1.6.3. Evolution of MRSA lineages 
1.6.3.1. Origin ofSCCmec 
The origin of SCCmec is unknown. Archer et al (I996) proposed the integration of mecA 
into the ancestral SCCmec occurred from Enterococcus hirae via S. haemolyticus and S. 
epidermidis. A mecA homologue has been described in S. sciuri, which is thought to be the 
most ancient Staphylococcus species. However, isolates with this gene show little meticillin 
resistance (Couto et al, 2000). A proportion of S. sciuri isolates (46 %) harbour a mecA gene 
that encodes PBP2A identical to that found in MRSA and confers meticillin resistance. It is 
thought to be the ancestor of the mecA in MRSA (Couto et al, 2000). Before the 
introduction of meticillin, the ancestral form of SCCmec lacked mecA (Fluit & Schmitz, 
2003). Shore et aL (2008) supports this theory and states that the function of such elements 
may have been the transfer of DNA between staphylococci under conditions of selection due 
to environmental stress, apart from antimicrobial pressure (Katayama et al, 2003a). Since the 
acquisition of mecA however, the transfer of the SCCmec may be driven by meticillin 
selective pressure. Although the exact origin of SCCmec is unknown, there is evidence that 
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CoNS such as S. epidermidis act as a reservoir and can transfer the SCCmec to S. aureus 
(Hanssen & Sollid, 2006; Tulinski et al., 2012). 
1.6.3.2. Insertion of SCCmec 
Two theories postulate the insertion of the SCCmec into MSSA to form MRSA. One theory 
is a single insertion event whereby all MRSA have evolved from a single origin or clone (a 
collection of organisms derived asexually from a single individual and with a common 
genotype) (Kreiswirth et al., 1993; lacey & Grinsted, 1973; van Belkum et al., 2007). Based 
on the genetic diversity of MRSA exhibited by multilocus enzyme electrophoresis, Musser 
and Kapur (1992) proposed the second theory that multiple independent insertions of the 
SCCmec element have occurred. Whole-genome variation in MRSA has also been 
investigated by DNA microarrays which cover approximately 90 % of the genome (Fitzgerald 
et al., 2001). This revealed evolution of five genotypically divergent groups that did not share 
a common ancestor, indicating independent acquisitions of the SCCmec into MSSA. This 
has led to the wide-spread acceptance of this multi-done theory. 
1.6.3.3. Evolutionary models for the ori~in of ma'jor MRSA linea~es 
MlST has revealed that human MRSA belong to one of 11 major clones or 5 CCs, based on 
their sequence type (Sn and SCCmec type (Enright et al., 2002). Enright et aL (2002) 
observed that with the exception of ST5 and ST8, the majority of STs were associated with 
one SCCmec type. They were able to propose evolutionary models for the five major MRSA 
CCs associated with HA infections: CC5, 8, 22, 30 and 45. MSSA ST5, 8, 30 and 45 isolates 
were present in the 1960s prior to the emergence of EMRSA clones, indicating these 
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lineages were successful colonisers and causes of invasive disease prior to their acquisition of 
the SCCmec (Oliveira et aL, 2001). In contrast, community-associated MRSA (CA-M RSA) 
belong to distinct combinations of genetic background and SCCmec type. The origin of CA-
MRSA has been postu lated to be the transfer of mecA from a HA-M RSA strain into a 
susceptible strain of a divergent genetic background (Chambers, 2001). CA-MRSA with PVL 
has been described in six main genetic backgrounds: ST1, 8, 30, 59, 80 and 93. 
Figure 11. Evolutionary model for the origin of CC5 and CC30 
A 2MslsLV . .7 ST5·MRSA·1 
ST5-MSSA 2 MRSA SLY. 
sccmllCl sccmocl ~lyc~c ST5-MtSA-II~ST5-GISA'1I 
Iype III type IV pe 
B 
ST5-MRSA·1I1 ST5-MRSA-IV 
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ST3O-MSSA ~. (ST36-MSSA) ~ST36.MRSA'1! 
sccmec! 
typolV 
poInI mutation 
ST3O-MRSA·1V 
(A) Proposed evolutionary origin of major epidemic MRSA (EMRSA) clones of ST5. 
SCCmec types I to IV have inserted into ST5 and the majority of 
glycopeptide-intermediate S. aureus (GISA) isolates have emerged from the ST5-MRSA-II 
clone. (B) Proposed evolutionary origin of major EMRSA clone of ST36. ST36-MRSA·II 
(EMRSA-16) evolved from an ST36-MSSA progenitor within which the SCCmec type II 
has inserted. ST36 is a single-locus-variant (SL V) (point mutation in pta locus) of 
ST30-MSSA. The SCCmec type IV has also been acquired once into ST30 (obtained from 
Enright et al., 2002). 
All five major hospital-associated MRSA (HA-MRSA) clones were derived from the insertion 
of the SCCmec into their MSSA progenitors. Multiple insertions of the SCCmec have been 
proposed within CC5 and 30 (Figure 11). A single insertion event of SCCmec type IV into 
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ST22 (EMRSA-15) has led to the emergence of a successful MRSA clone. The term 
successful clone refers to a clone that has given rise to epidemics in the past. Conversely, 
SCCmec type IV and SCCmec type II has been acquired by ST45 on four and one occasion 
respectively. The pandemic 80/ 81 clone epidemic in the 1950s evolved from ST30-MSSA 
and subsequently acquired the PVL toxin (Feil & Enright, 2004). 
Figure 12. Evolutionary model for the origin of CCS 
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Early MRSA isolates 
ST2S0 with SCCmec type I evolved from an STS-MSSA progenitor within which a single 
point mutation in the yqiL locus gave rise to ST2SO-MSSA. Independent insertions of 
SCCmec type I, ll, III and IV have occurred within ST8-MSSA of which ST8-MRSA·ll 
and IV have subsequently given rise to successful MRSA clones. ST8-MRSA·III rather 
than ST8-MSSA was proposed to be the ancestor of ST239·MRSA-III (previously Brazilian 
clone) as all ST239 isolates were MRSA {obtained from Enright et al., 2002}. 
CC8 was found to include the original MRSA clone (Archaic clone) ST250 with SCCmec 
type I (Enright et al., 2002). The evolutionary model of CC8 was proposed by Robinson and 
Enright (2003) (Figure 12). ST250-MSSA isolates were reported in Denmark from the 1960s 
(Crisostomo et al., 2001). ST247·MRSA-I (previously Iberian clone) was proposed to have 
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evolved from ST250·MRSA-I via a point mutation at the gmk locus. ST257·MRSA-I, another 
early MRSA clone, also arose from ST250·MRSA-I via a point mutation at the glpF locus 
(Robinson & Enright, 2003), whilst ST254·MRSA-I (EMRSA-lO) is thought to have arisen 
directly from ST8·MSSA. 
Certain CCs such as ST25 and STl21 are composed predominantly of MSSA while others 
are predominated by strain types that include important MRSA strains such as ST36 
(notable for including EMRSA-16 isolates) (Enright et al, 2002). This implies that either 
certain lineages such as STl21 have a genetic background within which acquisition of the 
SCCmec is not stable or the combination of genetic lineage and SCCmec element is not 
successful. However, these CCs may encode factors associated with growth or survival which 
make it more transmissible or persistent (Gomes et al, 2006). The SCCmec type present in 
strains was specific to the genetic background of the clone (Oliveira et al, 2001). SCCmec 
type I and III were found in strains from the same genetic background and SCCmec type II 
was found in strains from a different genetic background. However, SCCmec type IV was 
found in strains from both backgrounds. The latter type may be acquired frequently as its 
small size makes the transfer more efficient or it may have a lower fitness cost on the strain, 
making its transfer more favourable (Ma et al, 2002). Once SCCmec is acquired within an 
MSSA ST, it is retained and is rarely replaced by another SCCmec type (Robinson & 
Enright, 2003). Studies have suggested that SCCmec was only stable in certain genetic 
backgrounds and was limited in its acquisition which could explain the clonal nature of 
MRSA (Katayama et al., 2003bj 2005). Further research in this area is needed to provide an 
insight on the regulation of other M GE insertions and the limited spread of vancomycin 
resistance. 
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1.6.3 .4. La rge-sca le insertions 
Large-sca le insertions into S. aure us genomes are relatively rare. Based on the sequences of 
seven MLST loci and surface proteins, a large-scale recombination event between the 
progenitors of ST8 and ST30 has been predicted to form ST239, which displays a longer cell 
cycle (Figure 13) (Robinson & Enright, 2003). O f 41 surface protein genes, 22 genes 
(approximately 557 kb) were similar to ST30 whilst 19 genes (approximately 2220 kb) were 
similar to ST8. 
Figure 13. Evolutionary relationships of sequence types involved in large chromosomal 
replacements 
A B 
The black and white sections represent the approximate chromosome contributions from 
each parent to form the mosaic chromosome. A) ST239 has descended from ST8 and 
ST30 progenitors. B) ST34 has descended from ST30 and STlO and ST145 progenitors. 
ST42 has descended from ST39 and STIO and ST145 progenitors (obtained from 
Robinson & Enright, 2004). 
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A second large-scale rearrangement of ST30 and ST39 with ST10 and ST145 has also been 
described (Figure 13). Approximately 244 kb and 256 kb from STlO and ST145 have been 
exchanged into ST30 and ST39 to form ST34 and ST 42 respectively. As these 
rearrangements have only been observed in CC30, this implies lineage-specific genes may be 
essential (Robinson & Enright, 2004). In addition, due to the large nature of the DNA 
exchange, this transfer is likely to occur by conjugation. 
1.6.4. Hospital and Community-associated MRSA 
The first outbreak of MRSA was reported in 1963. However, it was not until the 1980s that 
the pandemic of MRSA truly began. The spread of MRSA mirrors that of penicillin-resistant 
S. aureus decades previously, with cases initially emerging in hospitals and later in the 
community (Chambers, 2001). The incidence of MRSA infections vary worldwide. MRSA 
infections are however associated with up to 50 % higher mortality rate as compared to 
MSSA infections (Cosgrove et aL, 2003; Hanberger et al., 2011; Yoon et al., 2005). This may 
be due to the limited antimicrobial therapy available for MRSA, rather than increased 
virulence (Lowy, 2003). 
MRSA infections have historically been HA. However, in the last two decades 
MRSA-associated infections in the community have risen dramatically. These CA-M RSA 
strains are not associated with the same risk factors as HA-MRSA strains and often affect all 
individuals, irrespective of age or health (Zetola et al., 2005). The risk factors associated with 
CA-M RSA strains are intravenous drug use (Qi et aL, 2005), men who have sex with other 
men (Sztramko et aL, 2007) and members of contact sport teams (Centers for Disease 
Control and Prevention, 2003). HA-MRSA infections are defined as those that present 
symptoms 48 h after admission to the hospital, whereas CA-M RSA infections are those that 
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present symptoms within 48 h and are acquired from settings unrelated to hospitals such as 
schools and gyms (Buck et aL, 2005). This definition is widely accepted despite the fact that 
CA-MRSA strains have been noted to show symptoms >48 h after hospital admission, 
particularly amongst patients with a history of exposure to the hospital (Wilson et aL, 2011). 
CAM RSA strains differ from HA-MRSA in the diseases they cause, their antimicrobial 
susceptibilities as well as their genetic background (Cooke & Brown, 2010). Respiratory 
tract, urinary tract and wound infections tend to be due to HA-MRSA whilst CA·MRSA 
infections often present as severe skin and soft tissue infections, necrotising pneumonia and 
bacteraemia. HA-MRSA strains are often resistant to J3-lactams and multiple classes of 
antimicrobials whilst CAM RSA strains tend to be susceptible to most classes of 
antimicrobials excluding the J3-lactams. This may be attributed to lower antimicrobial 
selective pressure in the community compared to the healthcare environment. A higher 
proportion of community strains are also PVlrpositive and belong to distinct genetic 
backgrounds (Chambers, 2001). SCCmec types IV and V tend to be attributed to community 
strains whilst types I, II and III are traditionally associated with HA·MRSA Whether 
community strains are more virulent is debatable; however studies have suggested patients 
with infections as a result of community strains are more likely to develop severe sepsis 
(Kreisel et aL, 2011). Colonisation by CA-MRSA strains can replace the existing colonising 
MSSA strains. MSSA however still account for the majority of S. aureus infections and are 
still a major clinical concern (Mostofsky et aL, 2011). 
1.6.5. Waves of epidemic S. aureus 
After the emergence of MRSA in 1961, strains resistant to multiple antimicrobials were 
reported throughout the 1960s (Fluit & Schmitz, 2003). This coincided with the decline of 
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penicillin-resistant strains such as bacteriophage type 80/81 that were prevalent in the 1950s. 
In the 1970s, resistance to aminoglycosides such as gentamicin was also reported. MRSA 
re-emerged simultaneously as strains that express multiple resistance phenotypes in the USA 
during the 1980s. In the UK, the first EMRSA strain (EMRSA-l), defined by the ability to 
spread rapidly amongst patients (Hospital Infection Society and British Society for 
Antimicrobial Chemotherapy, 1990), was isolated in 1986 (Marples et al., 1986). Thirteen 
further epidemic strains, EMRSA-2 to EMRSA-14, were defined by Staphylococcal Reference 
Laboratory (SRL) at Public Health England, PHE, London, (previously known as Public 
Health Laboratory Service and Health Protection Agency) based on strains received over a 
six month period from 1987 to 1988 (Kerr et al., 1990). 
EMRSA-15 was first isolated in the Midlands and South East of England and EMRSA-16 
was detected a year later, between 1991 and 1992, in outbreaks at three Northampton 
hospitals (Cox et al., 1995; Richardson & Reith, 1993). EMRSA-15 and EMRSA-16 are the 
predominant strains in the UK This is in accordance with studies that suggest one or two 
MRSA lineages dominate in one geographical area (Figure 14) (Cockfield et al., 2007). These 
two strains have subsequently spread widely in the UK and have been reported in other 
European countries (Cookson, 2011; Gould et al., 2008), Australia (Pearman et al., 2001), 
Asia (Hsu et al., 2007) and USA (McDougal et al., 2003). EMRSA-15 and EMRSA-16 are 
commonly resistant to erythromycin, ciprofloxacin and to (3-lactams (Ellington et al., 2010). 
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Figure 14. Emergence and waves of epidemics of antimicrobial resistant S. aureus 
1950s 
Pandemic 
of 2000 
penicillin- 1961 1986 1990 1997 USA300 
resista nt S. First MRSA EMRSA-1 EMRSA-15 First VISA strain 
aureus reported reported reported reported reported 
1959 1960s 1987-1988 1991-1992 1997-2000 2002 
Production Multiple EMRSA-2 EMRSA-16 EMRSA-17 First VRSA 
of resistant to 14 reported reported reported 
meticillin strains reported 
emerge 
Hospital,associated MRSA emerged in 1961 since then, numerous epidemic MRSA (EMRSA) strains have been a major clinical concern in the UK. 
Community-associated MRSA, vancomycin-intermediate S. aureus MSA) and vancomycin-resistant S. aureus (VRSA) have emerged in the past few 
decades and continues to increase in prevalence. 
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By the late 1980s and 1990s, a number of pandemic clones defined by pulsed-field gel 
electrophoresis (PFGE) were circulating around the world. These included the Brazilian, 
Hungarian, Iberian, New York/Japan and Pediatric clones. The Iberian clone is closely 
related to the Archaic clone, thought to be the earliest MRSA clone in Europe, which is now 
extinct (de Lencastre et al., 2000). At the beginning of the 21st century, EMRSA-17 emerged 
as a multi-resistant strain isolated predominantly from the south coast of the UK and 
London (Aucken et al., 2002). This period also saw the emergence of PVL-positive strains 
such as USA300 which has spread rapidly amongst the community and in hospital settings 
in North America (Reyes et al, 2009). Recent cause for concern has been the transmission of 
strains into humans from livestock which are thought to be a reservoir for MRSA Cases of 
skin and soft tissue as well as joint infections have been reported in people with close 
contact to pigs. Isolated infections in patients with no identifiable link to livestock have also 
been reported (Krziwanek et al, 2009; Mammina et al, 2010). Despite the emergence of 
these clones, a limited number of MRSA clones have spread in Europe (Grundmann et al, 
2010). 
1.7. Bacterial identification and typing 
1.7.1. Concepts of bacterial typing 
Bacterial typing techniques use phenotypic or genotypic characteristics to discriminate 
between isolates of the same species. Typing is useful in bacterial epidemiology, infection 
control measures and in the surveillance of infectious diseases on a local and global scale. 
Surveillance can warn us of emerging strains and clones that may cause future outbreaks. On 
a global scale, typing isolates from different origins may enable the population structure of 
the species to be determined and the significance of the diversity understood. Genetic typing 
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methods are therefore commonly utilised in the identification of markers and mechanisms 
related to virulence, which could be utilised in diagnostics or as future drug targets (Flu it & 
Schmitz, 2003; Trindade et al, 2003; van Belkum et al, 2007). 
In this context, an isolate is defined as a population of bacterial cells in pure culture derived 
from a single colony. A strain is defined as descendants of a single isolation from a pure 
culture which is distinguished from other bacteria of the same species by their phenotypic or 
genotypic characteristics. A clone is defined as a collection of organisms derived asexually 
from a single individual and with a common genotype (van Belkum et al, 2007). However, 
individual members of a clone may vary through spontaneous mutations. Prompt detection 
and identification of bacteria from clinical samples often requires a pure culture. The 
effectiveness of a typing technique is evaluated and validated against two types of criteria: 
performance criteria, which survey the efficacy of the technique and convenience criteria, 
which explore the efficiency. Performance criteria include stability of the marker, typeability, 
discriminatory power which is the ability of the technique to distinguish between two 
unrelated isolates and reprodUcibility, which is the ability to assign an isolate to the same 
type on independent occasions. Convenience criteria include the rapidity and flexibility of 
the technique, accessibility of the technique to laboratories, cost and the ease of the 
interpretation, comparison and the geographical and temporal portability of data (Trindade 
et al., 2003; van Belkum et al, 2007). 
1.7.2. Identification of S. aureus 
The differentiation between microorganisms from clinical samples includes determination of 
phenotypic and genotypic characteristics and recently the characteristics of proteins in 
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bacteria such as antimicrobial susceptibility testing through to 16S rRNA gene sequence 
determination and mass spectrometry. 
1.7.2.1. Antimicrobial susceptibility testin~ 
Antimicrobial susceptibility testing can have direct uses in clinical therapy. Isolates are tested 
against a range of anti microbials forming an antimicrobial resistance pattern or antibiogram. 
Lineages of S. aureus can exhibit susceptibilities to different antimicrobials (Holden et al, 
2008). The stability and discriminatory power of this technique is variable, in part due to the 
resistance determinants being encoded on MGEs. Thus the discriminatory power of the 
susceptibility profiling for typing purposes is limited (van Belkum et al, 2007). 
1.7.2.2. Bacteriophage typing 
Bacteriophages, which were discovered in 1915 (Twort, 1915), have been utilised for the 
typing of bacteria. Bacteriophages are restricted to the organisms they are able to infect and 
can differ between the genus and strain level (Dale & Park, 2004). Typing is based on the 
susceptibility patterns generated when cultures are exposed to a diverse set of bacteriophages 
(Holden et al, 2008). Bacteriophage typing specific for staphylococci was proposed in the 
early 1950s and since then, this technique has become popular in reference centres due to 
the low cost and ease of use. However, this does not account for the cost of the curation and 
maintenance of the bacteriophage collection (Blair & Williams, 1961; Singleton, 2004). The 
technique however has low resolution, displays poor reproducibility and cannot distinguish 
73 
between strains. In addition, the quality control of bacteriophages is time-consuming and 
laborious (van Belkum et al., 2007). 
1.7.2.3. Multilocus enzyme electrophoresis (MLEE) 
Multilocus enzyme electrophoresis (MLEE) utilises differences in the electrophoretic 
mobility of 15 to 25 housekeeping enzymes. The mobility varies, depending on the protein 
size and charge which are caused by polymorphisms in the genes encoding the housekeeping 
proteins. The mobility of the enzyme is directly related to the allele at the locus that encodes 
the enzyme (Selander et al., 1986). The reproducibility of the technique is variable as 
different enzymes can have the same electrophoretic mobility. MLEE has been particularly 
useful for studies investigating the population structure of MRSA and have revealed multiple 
insertions of the SCCmec into S. aureus (Musser & Kapur, 1992). However, some 
polymorphisms do not cause changes in the amino acid sequence, especially in housekeeping 
genes, where the majority of mutations are neutral. In addition, post-translational 
modifications of enzymes may bias the level of variation estimated (Selander et al., 1986). 
1.7.2.4. Determininl: the sequence of the 16S ribosomal RNA (rRNA) I:ene 
Determining the sequence of the 16S rRNA gene is a powerful identification technique for 
most bacteria and was first discovered by Carl Woese (Woese et al., 1975). The gene is 
composed of highly conserved regions alternating with hypervariable regions. Sequence 
determination of the hypervariable regions is possible by deSigning primers complementary 
to the highly conserved flanking regions (Dale & Park, 2004). The rRNA genes are ideal as 
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genetic markers because they are ubiquitous and their function is conserved over time and 
can also be used as a measure of evolution. The number of differences can therefore infer 
evolutionary distance and relationships between species via the construction of phylogenetic 
trees. The 16S rRNA gene has been used for bacterial identification but there is no universal 
agreement on what percentage similarity constitutes a species. Almost all isolates can be 
assigned to the genus level and up to 83 % to the species level Oanda & Abbott, 2007). 
Problems arise due to similar sequences between species, poor sequences deposited in 
nucleotide databases and novel sequences (Ashelford et al, 2005). 
1.7.2.5. Mass spectrometry 
The genome of an organism is considered to be stable. In contrast, the proteome changes in 
response to the organism's environment and proteomics identifies proteins expressed under 
specific growth conditions or at a particular growth stage (Holden et al, 2008). Mass 
spectrometry is used to determine the molecular composition of a sample or mixture. The 
principle of time-of-fight mass spectrometer was first described by William Stephens in 1946. 
However, it was two years later when the first spectrometer was designed and spectra were 
published (Cameron & Eggers, 1948; Stephens, 1946). Matrix-assisted laser desorption 
ionization-time-of-flight mass spectrometry (MALDI-TOF MS; will be referred to as MALDI 
here on) is a technique that enables the analysis of biomolecules such as DNA and proteins. 
The basic principle of MALDI involves overlaying the sample (target spot) with a matrix 
solution and subjecting it to an intense laser. The matrix solution initially absorbs this 
energy and is ionised. This aids in the ionisation of the sample by acting as a proton acceptor 
or donator to or from the molecules. The vaporised sample (formed of ions) are directed 
into a flight tube which is under vacuum and is subjected to an electromagnetic field. This 
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accelerates and deflects the ions, based on their mass-to-charge ratio. Smaller ions are 
distorted to a greater extent than larger ions and reach the detector (at the end of the flight 
tube) first. A signal is generated when an ion reaches the detector giving rise to a spectrum. 
MALDI is used routinely in hospital laboratories as it produces spectra that provide a 
molecular fingerprint for the detection of bacterial species. MALDI can identify the 
staphylococci down to the species level as it is based on the identification of ribosomal 
peptides (Carbonnelle et aL, 2007). A more recent study has utilised MALDl to discriminate 
between MRSA belonging to five major CCs (CC5, 8, 22, 30 and 45) associated with 
HAM RSA infections (Wolters et aL, 2011). In addition, MAiDl has been utilised to 
identify isolates producing the PVL toxin and delta-toxin (Bittar et aL, 2009; Gagnaire et aL, 
2012). In both these cases, the assignment is based on the detection of a specific 
mass-to-charge peak. This technique is rapid and reproducible and can be utilised for the 
rapid assignment of MRSA lineages. Current topics of research include using MALDI to 
identify antimicrobial resistance (Wieser et aL, 2012). 
1.8. Genotyping of S. aureus 
Advances in molecular biology have led to the development of DNA-based typing techniques 
which are rapid and generally reproducible. These techniques can provide additional 
information about the population structure and genetic diversity between isolates. These 
techniques are less prone to changes due to environmental influences and genotypic markers 
represent stable targets that enable the application of molecular techniques to all strains. 
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1.8.1. Plasmid profiling 
Plasmid profiling was the first molecular technique used for MRSA typing (Trindade et al, 
2003). This technique involves extraction of plasmid DNA, which mayor may not be 
digested with restriction endonucleases and separation on an agarose gel to obtain a profile. 
However, as plasmids can be lost and acquired, related isolates can display different profiles. 
In addition, plasmids can harbour transposons or ISs which can be excised and enter the 
chromosome, thus altering the plasmid (Hartstein et al., 1995). It is therefore difficult to 
ascertain whether dissemination of the clone or the plasmid is occurring (T enover et al, 
1994). The reproducibility and discriminatory power are variable due to the limited number 
of plasmids, the stability of the plasmid and that fact that it exists in different forms 
(supercoiled, nicked and linear). As some strains lack a plasmid, the typeability is partial 
(Hartstein et al., 1995; Weller, 2000). 
1.8.2. Southern hybridisation 
DNA is first digested with a restriction endonuclease and the restriction fragments are 
separated by gel electrophoresis and single-stranded DNA fragments are immobilised on to a 
nitrocellulose or nylon membrane. DNA molecules specific to certain sequences (probes) are 
hybridised to these fragments (Southern, 1992), thus reducing the number of fragments and 
aiding interpretation (Busch & Nitschko, 1999). Changing the specificity of the probes has 
led to the development of different typing techniques. Binary typing utilises up to 15 probes 
specific to MRSA. Based on hybridisation with each probe, each isolate is given a binary 
code. This technique is specific, easy to perform, reproducible and displays a high 
discriminatory power, but is time-consuming (van Leeuwen et al, 1999; 2001). Ribotyping 
uses probes for the 16S rRNA gene which is present in multiple copies and positions on the 
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genome and is highly conserved within a species. It has been shown to be useful in outbreak 
situations and displays good reproducibility and discriminatory power, although it is less 
than that of other techniques such as PFGE (Bingen et al, 1994; Prevost et al., 1992; 
Tenover et al, 1994; Yoshida et al, 1997). 
1.8.3. Pulsed~field gel electrophoresis (PFGE) 
PFGE was developed by Schwartz and Cantor (1984) and is considered to be the present 
gold standard typing technique for S. aureus outbreaks (Bannerman et al, 1995). It is able to 
rapidly detect accumulating variations and some movement of MGEs (T rindade et al, 2003). 
The technique requires relatively unsheared DNA that is restricted with a 'rare~utting' 
endonuclease. The endonuclease SmaI demonstrates the best performance for S. aureus 
(Carle~Nurit et al, 1992; lchiyama et al, 1991; Prevost et al., 1992). Thirty or less fragments 
ranging in size from 20 to 600 kb result in good discriminatory power (van Belkum et al, 
2007). Gel-based methods use a standard size ladder, thus limiting the accuracy of fragment 
sizing. Small differences in electrophoresis conditions can alter the banding pattern, thus 
making it difficult to standardise the technique between laboratories. This reduces the inter-
laboratory reproducibility and makes data exchange and interpretation difficult; this has 
been overcome by the creation of international databases (van Belkum et al, 2007). Data 
therefore needs careful analysis and quality control and standard interpretation of PFGE 
profiles has been proposed (Tenover et aL, 1995). Profiles differing by up to three bands are 
considered to be related whilst six or more band differences are thought to be exhibited 
between unrelated isolates. These criteria however only hold for isolates collected over a 
short period of time. The technique requires 2-4 days to obtain results and has high reagent 
and equipment costs. Despite this, PFGE has been useful in identifying and differentiating 
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MRSA (Carles-Nurit et al, 1992). PFGE data in outbreak situations for example has helped 
identify the source and transmission events of MRSA (Ichiyama et al, 1991). 
1.8.4. Variable-number tandem-repeats NNTRs) 
Variable-number tandem-repeats (VNTRs, also known as minisatellites) are short nucleotide 
sequences that are repeated sequentially in the genome and are present in the same 
orientation. On average, the repeat unit lengths range from 9 to 65 bp and contain a short 
sequence known as a 'core' sequence (Jeffreys et al, 1985; Wright, 1994). The distribution of 
these loci in the genome is not completely random and highly clustered in particular regions 
(Nakamura et al., 1987). Polymorphisms are caused by the differing number of repeat units 
found at each locus. This variability is thought to result from unequal crossovers during 
chromosome replication, which occurs at a higher rate in minisatellites or slipped strand 
mispairing (van Belkum et al, 1998). These are thought to be caused by problems with DNA 
repair during or after replication or with the enzyme DNA polymerase (van Belkum, 1999). 
VNTRs are thought to help the organism to adapt to environmental factors by accumulating 
factors providing a selective advantage (van Belkum et al, 1998). Whether all VNTRs have a 
function within the genome is still debatable. VNTRs can be found within gene coding 
regions (Nakamura et al, 1998) and variation probably can affect factors such as virulence in 
bacteria (van Belkum et al., 1998). 
VNTRs in S. aureus have been identified and are designated as staphylococcal interspersed 
repeat units (SIRUs). Seven SIRUs are common to all strains, although the number of 
repeats and their location vary between strains. These repeats contain similar flanking 
regions at the 3' and 5' end and lengths range from 48 to 159 bp. Three of the SIRUs are 
found multiple times in the genome. The sequences and numbers of repeat units differed 
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between each of the loci in regard to these SIRUs (Hardy et aL, 2004). SIRUs can 
discriminate both between EMRSA and endemic MRSA and results are concordant with 
MLST (Concei<;ao et aL, 2009; Hardy et al, 2004; 2006). PCR of multiple well characterised 
VNTRs can be utilised to differentiate between isolates. This method is technically simple 
and accessible to most healthcare facilities .. However, VNTR typing displays a discriminatory 
power lower than that of PFGE. In addition, the evolution of repetitive DNA is rapid, 
therefore care is needed to ensure related isolates in an outbreak are not discriminated. 
(Holmes et al, 2010; van Belkum et al, 2007). 
1.8.5. Protein A (spa) typing 
This technique is based on sequence determination of a VNTR unit found in the 
polymorphic X region at the 3' end of the spa locus (Figure 15). Protein A is found at the cell 
surface and is anchored into the cell wall. It is thought to play a role in the virulence of 
s. aureus (Shops in et al, 1999). This gene is under purifying selection (removal of deleterious 
variants therefore most mutations are synonymous) and therefore it is ideal for pandemic 
studies (Koreen et aL, 2004). The VNTR is composed of a 24 bp repeating unit (21 bp 
variant detected). Deletions, duplications and point mutations result in a PCR product 
ranging in size from 250 to 650 bp, which is detected by primers targeting the conserved 
flanking regions (Shops in et aL, 1999). The data are largely concordant with MLST and 
although it has been shown to be useful in evolutionary and population genetic studies, this 
technique is limited in displaying chromosomal diversity (Koreen et al, 2004). As spa typing 
is based on sequence data, it is unambiguous and data are stored on a spa database. More 
than 10, 000 spa types from over 90 countries have been deposited in the database (Rid om 
GmbH, 2012). Novel repeats can be submitted to the curated database for assignment to a 
spa type. The technique is applicable to all strains but is unable to detect chromosomal 
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changes outside this locus. However, spa typing shows good discriminatory power compared 
to bacteriophage typing (Shopsi n et al., 1999). 
Figure 15. Structural composition of protein A gene 
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Boxes represent segments of the gene encoding for the signal sequence (S), the 
immunoglobulin G-binding regions (AD), region homologous to A-D (E) and the carboxyl 
terminus (X). The terminus includes the short sequence repeat region ~) and the cell 
wall attachment sequence (XJ The annealing sites for the forward (F) and reverse (R) 
primers are indicated by arrows and base pair position on the gene represented by 
numbers (obtained from Shopsin et al., 1999). 
1.8.6. Direct repeat units (dru) typing 
This is a recent method based on the PCR and sequence determination of the dru locus 
found next to lS431 in SCCmec. These sequences consist of 40 bp units and are found in 
the same location, regardless of the SCCmec type of the isolate. A study by Goering et al. 
(2008) utilised dru typing to track EMRSA15 and EMRSA16 isolates which present 
indistinguishable PFGE types. They showed the number of nucleotide changes in the units 
varied from one to seven; this variation in the sequence of the repeat units and the order of 
the units were designated a dru type. They distinguished 13 and 12 different dru types among 
the 47 EMRSA15 and 57 EMRSA16 isolates respectively. Other studies have shown that 
dru typing exhibit a Simpson index of diversity of 77 .83 which was between that of spa typing 
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(66.9) and PFGE (81.34) (Shore et aL, 2010). Although these repeats are absent in a few 
MRSA strains, the sequences were found to be stable for use in strain determination. 
1.8.7. Multilocus sequence typing (MLSTI 
The MLST scheme for S. aureus involves determining the sequence of approximately 450 bp 
of seven housekeeping genes encoding for proteins involved in central metabolism. These 
are carbamate kinase, shikimate dehydrogenase, glycerol kinase, guanylate kinase, phosphate 
acetyltransferase, triose phosphate isomerase and acetyl coenzyme A acetyltransferase (Enright 
et al, 2000). Variations in these sequences are assigned as different alleles of the genes and 
are designated an allele number. The combination of the seven genes constitute the allelic 
profile of the strain, which constitutes an ST. These differences are not weighted and hence 
single or several sequence variations still result in a single change in allele and hence ST 
(Table 4). Up to 30 variants at each locus have been identified, which combines to a possible 
two million allelic profiles. This method is therefore highly discriminatory. 
An online curated MLST database (http://www.mlst.net) has enabled the standardisation of 
MLST across the globe. The MLST website provides the eBURST software version 3 which 
displays the evolutionary relationship between isolates of a species. Closely related isolates 
are displayed as clusters known as CCs that aggregate around the 'founder' type which is the 
most closely related to all of the types within the cluster. Descendants of the founder are 
known as single-locus-variants (SLVs) if their allelic profile differs from the founding 
genotype at one allele and double-locus-variants (DLVs) if they differ at two. Each CC is 
thought to represent a different S. aureus lineage (Figure 16: Table 4) (Feil et al, 2004). Ten 
major CCs of clinical relevance have been identified in S. aureus (Feil et al, 2003). Those STs 
that are not assigned to a CC are known as singletons. 
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Table 4. Correlation betw'een S. aureuscharacterisation methods and nomenclature 
Characterisation method Correlation 
Lineage Based on a single MLST' CCt which can be composed of 
multiple clones 
CC A lineage composed of closely related STs* based on MLST 
ST A subset of a CC, based on an allelic profile of seven 
housekeeping genes used for MLST 
SCCmec§ types Based on composition of genes present at a 01 ". Multiple 
SCCmec types are found in a lineage or CC 
Clone A subset of a lineage based on the combination of CC and 
SCCmec type 
spa type Based on protein A sequence, each spa type belongs to a 
subset of isolates in a single lineage 
Displays nomenclature used in molecular techniques used to characterise isolates and 
correlations betw'een the nomenclature terms. 
·MLST, multilocus sequence type. 
tcc, clonal complex. 
*ST, sequence type. 
§SCCmet; staphylococcus cassette chromosome mec. 
11 GI, genomic island. 
The variation in housekeeping genes is accumulated slowly. As isolates in an outbreak are 
likely to originate from a common ancestor, these isolates are unlikely to exhibit differences 
in these genes. Therefore MLST is not useful in epidemiology or outbreak studies. In 
addition, few lineages are found in one geographic area (Cockfield et al, 2007). Despite its 
uses for studying the population structure, emergence and spread of clones, MLST remains 
expensive for routine hospital laboratories (van Belkum et al, 2007). Nevertheless, MLST 
together with SCCmec typing has provided possible evolutionary models for MRSA. 
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Figure 16. eBURST diagram depicting population structure of the entire multilocus sequence typing (MLST) database for S. aureus 
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A 'population snapshot' of the entire MLST database (http://www.mlst.net) presented as an eBURST diagram (http://eburst.mlst.net) showing 
clusters of linked and unlinked STs (indicated by blue arrows and purple labels). The blue circles indicate the founder ST of a group and the yellow 
indicate subgroup founder STs. The size of the circle indicates the abundance of that ST in the database; larger circles indicate the presence of a 
greater number of isolates and vice versa. 
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1.8.8. SCCmectyping 
Characterisation of MRSA clones by SCCmec typing provides insights into prevalent clones. 
Numerous assays for the detection of specific SCCmec types and subtypes have been 
described (Table 5). In addition to assigning isolates to MRSA clones, SCCmec typing helps 
our understanding of the virulence of MRSA. SCCmec-associated virulence factors for 
example are thought to play a role in the clinical outcome of bacteraemia (Ganga et al., 
2009). Other studies have shown HA-MRSA are significantly associated with SCCmec type 
lI, ag;r group II and higher vancomycin MIC whilst CA-M RSA is associated with SCCmec 
type IV, ag;r group I and lower vancomycin MIC (Chua et al., 2008; Moise et al., 2009). 
Table 5. Assays designed for SCCmectyping 
SCCmec typing 
SCCmec target Type of assay Reference 
method 
1 Types I to V Multiplex PCR (Oliveira & de Lencastre, 2002) 
2 Types I to V Multiplex PCR (Kondo et al., 2007) 
3 Types I to V Multiplex PCR (Zhang et al., 2012) 
4 Types I to V Multiplex PCR (Milheirico et al., 2007) 
5 Subtypes IVa to IVh Multiplex PCR (Milheirico et al., 2007) 
6 Types I to V Multiplex PCR and (Cai et al., 2009) DNA hybridisation 
7 Type VII Multiplex PCR and (Higuchi et al., 2008) 
real-time PCR 
8 Types I to VI and Multiplex real-time (Chen et al., 2009) VIII PCR 
9 Type VIII Multiplex PCR (McClure et al., 2010) 
10 Type XI Multiplex PCR (Stegger et al., 2012a) 
The table displays published studies that describe assays designed to detect specific 
SCCmectypes and subtypes. 
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1.8.9. Pyroseguencing™ 
Pyrosequencing™ is an alternative sequencing-by-synthesis methodology to ddNTP 
termination technology. The method involves amplification of the template by peR with a 
biotinylated primer. Biotinylated peR products are captured on to streptavidin-coated 
magnetic beads to wash away primers, nucleotides and salts from the peR reaction, which 
interfere with Pyrosequencing™ (Figure 17) (Gharizadeh et aL, 2002; Ronaghi et al., 1998; 
Ronaghi, 2001). Pyrosequencing™ has a limited read length of around 100 bp and it is 
difficult to determine the number of nucleotides incorporated in regions composed of a 
series of identical nucleotides. 
Pyrosequencing™ has been used in combination with Sanger sequence determination to 
obtain the whole-genome sequence (WGS) of a USA300 strain of S. aureus (Highlander et aL, 
2007). It has been a useful tool in identifying S. aureus by targeting the bacterial16S rRNA 
gene (Masoud et aL, 2012) and the DEFB4 and DEFB103 genes in humans, which have been 
investigated for associations with S. aureus bacteraemia (Fode et aL, 2012). It is also a useful 
tool for single-nucleotide-polymorphism (SNP) detection and analysis. Here, each sequence 
will produce a distinct Pyrogram TM enabling the easy assignment of alleles (Ahmadian et aL, 
2000; Fakhrai-Rad et aL, 2002). This methodology is accurate, rapid and results can be 
obtained in real-time. 
86 
Figure 17. Principle of Pyrosequencing™ 
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The figure depicts the principle of Pyrosequencing™ and an example of the output 
Pyrogram TM. During Pyrosequencing™, each nucleotide is added into the reaction in 
succession. Incorporation of a nucleotide into the nucleic acid chain is catalysed by the 
polymerase. This step releases pyrophosphate (PPi) which is converted to ATP by 
sulfurylase present in the reaction. The ATP is used by luciferase to produce light which is 
detected by a camera. The intensity of the light is proportional to the number of 
nucleotides added, enabling sequence determination. Apyrase degrades unincorporated 
nucleotides. Incorporation of a single nucleotide is indicated by the lower height peaks 
whilst incorporation of two nucleotides is indicated by a double peak height (obtained 
from England & Pettersson, 2005). 
1.8.10. Microarrays 
Microarrays for S. aureus genes have been developed from up to seven WGSs (Witney et aL., 
2005). DNA samples hybrid ise to complementary labelled sequences on the array, 
identifying the presence of this sequence in the sample. This enables comparative genomic 
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studies as the presence and absence of genes can be identified in isolates. In addition, as 
messenger RNA can be reverse transcribed into complementary DNA, transcription studies 
can also be performed (Holden et al, 2008). 
Comparative studies of S. aureus using microarrays have revealed genetic variation between 
isolates causing similar clinical symptoms. A proportion of this variation was due to large-
scale deletions, some of which were found at loci with MOEs (Fitzgerald et al, 2001). Other 
studies have also identified variations in MOEs; however this variation was not correlated 
with isolates causing invasive disease. This study therefore concluded colonising isolates 
(presence of bacteria on a body surface without displaying clinical symptoms of an infection) 
and those causing disease can be genetically similar (Lindsay et al, 2006). Microarray studies, 
along with MLST, have also revealed the population structure of human S. aureus which 
belong to ten dominant lineages and several minor lineages. Excluding core genes present in 
every lineage, a combination of genes amongst the variable region of the genome are unique 
to each lineage. These genes encode a variety of toxins, proteases and superantigens, with a 
large proportion encoding for surface proteins. These unique combinations of proteins in 
each lineage may increase our understanding of the predominance of one or two lineages in 
a geographical location (Cockfield et al, 2007; Feil et al, 2003; Lindsay et al, 2006). 
Microarrays have also revealed some MOEs are lineage-specific whilst others are variable 
within a lineage or are found between multiple lineages. 
1.8.11. Whole:genome mapping (wGM) 
Whole-genome mapping (WOM, formerly optical mapping) is a technique that utilises a 
restriction endonuclease to produce an ordered whole-genome restriction map (optical map) 
with high-resolution. The technique involves gentle lysis of cells to isolate high molecular 
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weight DNA. The fragmented DNA (approximately 200 kb) is restricted with a rare-cutting 
endonuclease and optical maps are generated (Figure 18). These can be aligned in WGM 
software to perform genome comparisons. In addition, in silico maps can be generated from 
National Center for Biotechnology Information (NCBI) database sequences to enable 
comparative genomics and strain typing. 
Comparative genomics of strain maps enables the detection of insertions, deletions and 
large-scale rearrangements. It has been successfully utilised to identify a large inversion in an 
s. aureus strain (Shukla et al, 2009). The alignment of maps can also be used for 
epidemiological studies and outbreaks and can differentiate between strains. In S. aureus, 
optical maps enable the differentiation between strains harbouring different SCCmec 
cassettes. Similarity clustering data of S. aureus strains was concordant with those obtained by 
PFGE (Shukla et al, 2012). In addition, MRSA-specific motifs associated with virulence were 
identified. To date, optical maps have helped close gaps in multiple S. aureus genomes (Chua 
et al, 2010; Huang et al, 2012; Stegger et al, 2012b). At present, the cost and rapidity of 
optical maps do not make it feasible for routine diagnostics. 
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Figure 18. WGM protocol 
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For whole-genome mapping (WGM) DNA is captured along parallel arrays on a 
microfluidics device by capillary action and held electrostatically to the surface. The DNA 
molecules are restricted with a rare-cutting endonuclease and fragments are fluorescently 
labelled. Software scans the restricted molecules in each lane and assigns the fragments a 
size and order; these generate a digital single molecule restriction map. The single 
molecule restriction maps are aligned to produce a map covering the entire genome. This 
alignment provides deep coverage which improves accuracy and allows for incomplete 
digestion or random breaks in the DNA. A consensus map is generated from this 
alignment (obtained from Fitzpatrick & Burggrave, 2009). 
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1.8.12. Next-generation sequencing (NGS) 
WOSs have been utilised for the development of microarrays which have been useful in 
comparative genomics. Since the advent of NOS technologies, the cost and time to sequence 
a genome have fallen dramatically. These improvements could lead to NOS being utilised in 
routine laboratories in the future. In a clinical setting, NOS can identify strains associated 
with an outbreak and distinguish them from background strains. Furthermore, NOS can 
identify transmission events associated with the outbreak, including those within the 
community setting. Such timely insights can identify the source of an outbreak and enable 
the implementation of affective infection control measures. However, use of NOS as a 
routine diagnostic tool still requires the development of WOS databases for comparisons 
and an automated analysis method (Harris et al, 2013; Koser et al, 2012). 
1.8.13. Fluorescent amplified fragment length polymorphism (FAFLP) 
Fluorescent amplified fragment length polymorphism (FAFLP) is a PCR·based DNA 
fingerprinting technique which detects polymorphisms in primer annealing sites and 
restriction endonuclease recognition sequences. In addition, it also detects insertions and 
deletions within core conserved regions and variable genomic regions Nos et al, 1995). 
FAFLP utilises two restriction endonucleases and ligation of restricted fragments to 
double-stranded adaptors (Figure 19). PCR using selective or non-selective primers, one of 
which is labelled with a fluorescent dye, results in amplification of a subset of fragments. 
Selective primer sequences comprise additional nucleotides (up to four) on the 3' end of the 
sequence; each additional nucleotide (+X) reduces the number of fragments amplified by 
four·fold. 
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Figure 19. Diagram of fluorescent amplified fragment length polymorphism (FAFLP) 
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Genomic DNA is restricted using two endonucleases, a 'rare-cutter' (blue: BgllI) which 
recognises a 6 bp sequence and a 'frequent-cutter' (red: Gp6I) which recognises a 4 bp 
sequence. The majority of resultant fragments are restricted at both ends with the 
frequent-cutter, a minority are restricted with the rare-cutter and a moderate number are 
restricted with both endonucleases. The latter are the fragments of interest. 
Double-stranded adaptor sequences composed of a core sequence and a sequence 
complementary to the restriction endonuclease recognition sequence are ligated to the 
ends of the restricted fragments. peR is performed using primers with sequences 
complementary to the adaptor sequences. One of the primers is fluorescendy labelled at 
the 5' end (blue sequence). The amplified fragments are run on an automated capillary 
sequencer along with a size standard in each lane (obtained from Desai, 1999). 
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Fragments are run on an automated capillary sequencer along with an internal size standard 
labelled with a different fluorescent dye. This enables accurate sizing of the fragments to 
within ±0.5 bp, thus improving the reproducibility between laboratories (Arnold et al, 1999; 
Desai et al., 1998). FAFLP analysis can be performed in silico on WGSs using software and 
online tools to determine the sequences of fragments of interest (Bikandi et al., 2004; 
Underwood, 2008). 
Utilising two endonucleases ensures small fragments are generated which can be resolved 
well by capillary gel electrophoresis. Simultaneously, use of a rare-cutting endonuclease limits 
the number of fragments generated. Utilising two endonucleases also enables one strand of 
the fragment to be fluorescently labelled. As only one strand is detected, the analysis is not 
compromised by unequal mobility of the two strands. The use of two endonucleases 
provides greater flexibility in the number of fragments and profiles generated (Vos et al., 
1995). 
FAFLP is a robust and high-resolution methodology used for the analysis of genetic diversity 
within bacterial genomes, without prior knowledge of the genome sequence. This technique 
covers a large proportion of the genome and exhibits a high discriminatory power. Altering 
the primers and restriction endonucleases can increase or decrease the discriminatory power, 
as different regions of the genome are sampled. As the amplified fragments (AFs) are selected 
randomly, the technique is representative of the whole genome. It has drawbacks in that 
variations outside of the restriction enzyme sites are not detected, although it can, to an 
extent, detect transposition events (Vela et al, 2011). The results are reproducible within the 
same laboratory if the same capillary sequencer is used. FAFLP can distinguish between 
isolates that are indistinguishable from one another by other methods such as restriction 
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fragment length polymorphism, PFGE and serotyping (Desai et al., 1999; Hookey et al., 
1999). It displays greater reproducibility than PFGE but less so than MLST for S. aureus 
(Melles et al., 2007). Isolate clusters based on VNTRs however, are similar to those obtained 
by AFLP (Melles et al., 2009). 
The application of FAFLP has enabled the discrimination of genetically related bacterial 
strains and has helped in outbreak analysis and epidemiological studies for varied bacterial 
genera (Desai et al., 1998; Grady et al., 1999; Janssen et al., 1996; Kober et al., 2011). In 
addition, FAFLP has been applied to population structure studies and bacterial taxonomy 
(Janssen et al., 1996; Melles et al., 2008) and can detect transposition (Vela et al., 2011). 
FAFLP has been adapted to target IS6110 in Mycobacterium tuberculosis to provide insights 
into its evolution. This involves the identification and amplification of the IS present in 
variable copy numbers and at variable positions in the genome between different strains 
(Thorne et al., 2007). Epidemiologically unrelated but genetically related isolates can be 
distinguished using this method (Borrell et al., 2009). In addition, FAFLP has assisted the 
identification of hypervirulent lineages (Goulding et al., 2000). Isolates in the same FAFLP 
cluster of organisms share a number of common AFs but also display additional differential 
fragments highlighting the discriminatory power of FAFLP (Desai et al., 2001). 
FAFLP studies on S. aureus have enabled differentiation between various bacteriophage types 
and has revealed the genetic heterogeneity within EMRSA-15 (Grady et al., 1999; 2000). 
FAFLP cluster analysis does not separate MRSA from MSSA isolates but AFs exclusive to 
MRSA and MSSA have been identified. Comparative studies of invasive and colonising 
clinical isolates using amplified fragment length polymorphism (AFLP) have identified that 
both types of isolates belong to similar genetic backgrounds as multiresistant isolates. 
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However, invasive isolates are overrepresented in some genetic clusters (Melles et aL, 2004). 
This correlates with the later findings of Lindsay et aL (2006) who found no association of 
lineages with the severity of infection or with any single virulence or pathogenicity factor. 
AFLP can highlight the genetic heterogeneity within major lineages of S. aureus. AFLP 
genetic clusters and sub-clusters correlate with MLST CCs. Previous studies have shown that 
whilst isolates of the same lineage shared a greater number of fragments compared to isolates 
from different lineages, unique AFLP markers could be identified amongst isolates of a 
specific cluster. AFLP has been applied to short-term epidemiological studies and population 
structure studies of S. aureus (Melles et aL, 2004; 2007; 2009). 
S. aureus typing techniques that target single or multiple loci detect genetic variation at these 
loci. Inferences based on this variation can be made about the genetic diversity amongst this 
species. Molecular tools may target core regions of the genome (MLSTI, variable regions 
(VNTR and SCCmec typing) or may target regions throughout the genome (microarrays, 
WGM and FAFLP). Each molecular method displays a number of advantages and 
disadvantages and the choice of molecular method will depend on the focus of the study, 
whether that be in the investigation of population structure, an outbreak or genetic diversity. 
Studies investigating the genetic diversity amongst a species may utilise molecular methods 
which target a large number of loci, core and variable regions of the genome and regions 
throughout the genome. This would present an overview of the genetic variation present 
across the genome. Thus molecular tools such as FAFLP and WGM present an advantage as 
they require no prior sequence knowledge. 
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1.9. Aims and objectives of this study 
The aim of this study was to investigate the genetic diversity between and within 
predominant hospital-associated MRSA lineages in the United Kingdom. This study 
hypothesised that distinct genetic differences are present between successful and 
unsuccessful lineages of MRSA Regions of genetic variation were identified between and 
within lineages. Sequence data of regions of genetic heterogeneity between major MRSA 
lineages was mapped to the genome and linked to their cell functions. This study explored 
the role of these cell functions in the emergence and prevalence (or spread) of dominant 
genetic lineages. These mechanisms may confer a fitness advantage by altering the virulence or 
pathogenicity between lineages. 
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CHAPTER 2 
2. Materials and Methods 
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2.1. Bacterial culture collection 
A total of 302 S. aureus isolates were included in this study; arbitrary numbers, DB HT 1 to 
DBHT 302, were given to the isolates. The isolates were obtained from five collections. The 
five collections included 50 isolates from SRL (henceforth referred as SRL collection), six 
strains obtained from the National Collection of Type Cultures were used as reference 
strains (henceforth referred as Reference collection), 34 isolates obtained from Glasgow, 
Public Health Scotland (henceforth referred as Glasgow collection), 202 isolates from the 
2009 British Society for Antimicrobial Chemotherapy bacteraemia resistance surveillance 
programme (henceforth referred as BSAC collection) (British Society for Antimicrobial 
Chemotherapy, 2010) and 10 isolates obtained from the Clinical Microbiology and Public 
Health Laboratory, PHE, Cambridge (henceforth referred as CMPHL collection). 
The first collection of 50 isolates from SRL was sent to the laboratory for identification and 
characterisation during 2007 to 2009 from geographically diverse centres throughout 
England and Wales. Bacteriophage typing and PFGE were performed by SRL. Bacteriophage 
typing identified four isolates as EMRSA-15, five belonged to bacteriophage type A, one was 
a wide-spread sporadic strain, 11 displayed previously unrecognised distinct bacteriophage 
patterns, nine were non,typeable and no data were available for the remaining 20 isolates. 
PFOE identified 15 isolates as EMRSA-15, four displayed pattern A, pattern Band C were 
displayed by one isolate each, five displayed distinct PFOE patterns and no data were 
available for the remaining 24 isolates. Of the 50 isolates, 25 were obtained from eight 
hospitals and no data on the origin of the remaining 25 isolates was available. Eight isolates 
from a single hospital were obtained from a single patient. Bacteriophage typing results were 
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available for seven of the eight isolates; two were identified as EMRSA-15 whilst five were 
non-typeable. PFGE results were available for seven of the eight isolates; six were identified 
as EMRSA-15 whilst one exhibited pattern A. Each of the four isolates from a single ward 
displayed a distinct bacteriophage pattern. 
WGSs for all of the six Reference collection strains were available on the NCBI database 
(http://www.ncbLnlm.nih.gov) {Table 6}. STs for these strains have been previously 
described, based on their WGS (Saunders et al, 2004). Of the six strains, DBHT 54 and 
DBHT 59 belonged to ST5 whilst DBHT 79 and DBHT 84 were assigned to STl. The two 
remaining strains, DBHT 51 and DBHT 75, belonged to ST36 and ST250 respectively. 
Table 6. Characteristics of six strains from the Reference collection 
Isolate Isolation Antimicrobial Strain Comments Accession 
number numbers . year resistance 
DBHT 51 NDt M RSA MRSA252 HA* Ne 002952 
DBHT54 1982 MRSA N315 HA NC 002745 
DB HT 59 1996 VISA Mu50 HA NC 002758 
DB HT 75 ND M RSA COL ND NC 002951 
DBHT79 1998 M RSA MW2 High virulence CA§ NC 003923 
DBHT84 ND MSSA MSSA476 High virulence CA NC 002953 
Displays year of isolation, meticillin or vancomycin resistance, and origin of six reference 
strains with whole-genome sequence (WGS) data. 
'Accession numbers obtained from the NCBI database for WGS data for each strain. 
~, no data. 
*HA, hospital-associated. 
§CA, community-associated. 
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The Glasgow collection of 34 isolates was previously characterised using bacteriophage 
typing, PFGE, oxacillin MICs, and m.ecA and mupA PCRs at SRL, PHE (Appendix 1). 
Bacteriophage typing was performed on 27 isolates; five were non-typeable, two belonged to 
the same distinct type and the remaining 20 isolates displayed a unique bacteriophage 
pattern each. Based on PFGE results, three and four isolates were assigned to EMRSA 15 
and -16 respectively. Of the remaining 27 isolates, 26 isolates were assigned to 26 unique 
PFGE profiles each and no datum was available for one isolate. Oxacillin MIC was 
performed on 32 isolates. The majority of isolates were resistant (n=23) or displayed 
borderline resistance (n"'7); the remaining two isolates were susceptible to oxacillin. T wenty-
three of the 27 isolates tested positive for the m.ecA PCR and the remaining four isolates 
were negative. Of the 18 isolates analysed for the mupA gene, the majority (n-15) were 
negative. 
The BSAC collection consisted of 99 MRSA and 103 MSSA isolates. The MRSA and MSSA 
isolates were contributed from a total of 25 and 24 centres respectively throughout England 
and Ireland (Appendix 11) (Reynolds et al, 2008). Each centre was able to contribute up to 
20 consecutive isolates. The MICs of six antimicrobials, including oxacillin and vancomycin, 
were determined by the BSAC agar dilution method (Appendix 11). PCRs for the m.ecA and 
mupA genes were performed at the Antimicrobial Resistance and Healthcare Associated 
Infections Reference Unit (PHE, London; Appendix 11) (Andrews, 2001). 
Of the 202 BSAC isolates, MLST data (see materials and methods: section 2.4.1) from a 
subset of 71 isolates was analysed further with antimicrobial MICs (Appendix II) and 
SCCm.ec data (see materials and methods: section 2.4.2). These 71 isolates included one 
representative of a specific lineage selected randomly from each centre to ensure each isolate 
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was independent. The percentage resistance amongst isolates of each lineage was calculated 
using Stata software version 12 (StataCorp LP, USA) for each of the six antimicrobials along 
with the 95 % Cl. The percentage of isolates of a specific lineage belonging to each of the 
SCCmec types amongst isolates of each lineage was also calculated along with the 95 % Cl. 
The CMPHL collection of 10 isolates consisted of six isolates from an outbreak in the 
intensive care unit (lCU) and were collected in December 2009. Of these, five isolates were 
EMRSA-15 by bacteriophage typing and! or PFGE (Table 7). Antimicrobial susceptibility 
testing was performed on the six isolates from ICU patients for eight antimicrobials 
(Appendix Ill). The remaining four isolates were collected over June to December 2009. 
Table 7. Characteristics of the 10 S. aureus isolates obtained from the Clinical 
Microbiology and Public Health Laboratory 
Isolate number Isolation Bacteriophage typing PFGE result Comments year result 
DBHT293 2009 EMRSA-15· EMRSA-15 ICU
t 
outbreak 
DBHT294 2009 EMRSA·15 EMRSA-15 ICU outbreak 
DBHT295 2009 ND* NO 
DBHT296 2009 ND ND ICU outbreak 
DBHT297 2009 NO ND 
DBHT298 2009 ND NO 
DBHT299 2009 ND ND 
DBHT300 2009 NO EMRSA-15 ICU outbreak 
DBHT 301 2009 EMRSA-15 EMRSA-15 ICU outbreak 
DBHT302 2009 EMRSA-15 EMRSA-15 ICU outbreak 
The year and ward of isolation, bacteriophage and PFGE type of each isolate is displayed. 
·EMRSA, Epidemic MRSA. 
fJcu, intensive care unit. 
*Nu, no data. 
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The SRL collection provided multiple isolates from the same centre including those 
obtained from a single patient. The SRL collection was utilised as a test panel of isolates to 
develop and optimise a novel FAFLP method. This collection was analysed using FAFLP to 
identify whether FAFLP could identify genetic heterogeneity within isolates from a single 
patient. The Reference collection facilitated in silico analysis on strains and a direct 
comparison with experimental data for the same strains. The Glasgow collection provided a 
well-characterised isolate collection from Scotland to ensure the study represented isolates 
from different regions of the UK. The BSAC collection provided a well-characterised set of 
isolates to assess the genetic diversity between lineages using FAFLP. The CMPHL collection 
provided a collection of invasive and carriage isolates associated with an outbreak. FAFLP 
was used to assess whether FAFLP could identify genetic heterogeneity within these isolates. 
2.2. Bacterial cultures and DNA extraction 
Isolates were inoculated on Columbia agar plates supplemented with horse blood (CBA) 
(Oxoid, Thermo Scientific, UK), incubated overnight at 37°C in air and were stored on 
Microbank lM preservation beads (Pro-lab diagnostics, UK) at -80°C. Two MagNA Pure 
systems (Roche, UK), a compact and a high,throughput system, were utilised for DNA 
extraction. 
2.2.1. MagNA Pure compact 
Genomic DNA from a subset of isolates was extracted using the MagNA Pure compact 
system (Roche, UI<). Cell lysis was performed by selecting up to five single colonies from 24 
h cultures with a 1)11 loop and re,guspending in 180)11 of lysis buffer. Lysis buffer was 
composed of 2x Trig,EDTA buffer, 1.2 % TritonlM X-lOO, 0.3 mg/mllysozyme, 0.03 mg/ml 
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lysostaphin (Sigma.A1drich, UK) and nuclease free water (hereafter referred to only as water) 
(Promega, UK). The tubes were incubated for 1·2 h at 37°C and the final volume was made 
up to 400 pI with water. DNA was extracted using the MagNA Pure compact system and the 
MagNA Pure compact nucleic acid isolation kit I (Roche, UK) according to the 
manufacturer's recommendations. 
2.2.2. MagNA Pure Le 
Genomic DNA for the remaining isolates was extracted using the MagNA Pure LC (Roche, 
UK). Isolates from CBA plates were re-suspended in lysis buffer, as instructed in the MagNA 
Pure LC DNA isolation kit III {Bacteria, Fungi} (Roche, UK). The inoculated lysis buffer was 
incubated at 65°C for 4 h. DNA was extracted using the MagNA Pure LC system and 
MagNA Pure LC DNA isolation kit III according to the manufacturer's recommendations. 
With both extractions, DNA was eluted into 100 pI of elution buffer. Stock DNA solution 
was quantified using the NanoDrop~ 8-sample spectrophotometer ND-8000 (Labtech 
international, UK). A 1:10 diluted stock solution was used for further experiments, unless 
otherwise stated. 
2.3. S. aureus identification 
2.3.1. 16S ribosomal RNA (rRNA) gene amplification and sequence 
determination 
A subset of isolates was identified to species level by 16S rRNA gene PCR and sequence 
determination. Confirmatory identification was required for those isolates from a single 
patient which were not identical based on MLST and SCCmec typing. PCR was performed 
under standard conditions using an annealing temperature of 56°C (described below) using 
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the universal16S rRNA gene primers ANTIF and 1392R (MWG Eurofins, UK) (Appendix 
IV). Sequences were determined using the standard sequence determination protocol 
(described below), and using 16S rRNA gene sequencing primer 357F or 3R (MWG 
Eurofins) (Appendix IV). The resultant chromatograms of the 16S rRNA gene sequences 
were assembled into a contig using BioEdit software version 7.0.9.0. The consensus 
sequence was searched against the NCBI database using Basic Local Alignment Search Tool 
(BLASn. Isolates were assigned to a genus and species based on the consensus of the top 
search results and percentage homology. 
2.3 .1.1. Standard PCR conditions 
PCR was performed in a 50 J.lI PCR reaction containing Ix PCR reaction buffer, 2.5 mM 
MgCI2, 0.2 mM each deoxynucleotide triphosphate (dNTP), 1.25 U Taq DNA polymerase 
recombinant (Life Technologies, UK), 0.2 J.lM of each primer and 50 ng of DNA 
Thermocycling was performed on GeneAmp® PCR system 9700 (Life Technologies) and 
cycling conditions used were as follows: 95°C for 2 min; followed by 35 cycles of 95°C for 
45 s, XoC for 45 s (where X is an annealing temperature specific to each primer pair) and 
noc for 1 min and a final extension at 72°C for 5 min with a hold cycle at 4°C. PCR 
products (5 J.ll) were confirmed on a 2 % agarose gel (Bioline, UK) pre-stained with 
Ix GelRedlM nucleic acid stain (Biotium, UK) and separated by electrophoresis at 80 V for 2 
h. Products were run with I J.lI of Ix BlueJuicelM gel loading buffer and sized using I J.lI of 
100 bp ladder (Life Technologies). DNA within gels was visualised under ultraviolet light 
using the Gel Doc 2000 (Bio-Rad, UI<). 
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2.3.1.2. Standard sequence determination protocol 
peR reaction mixtures were 'cleaned up' to remove unincorporated dNTPs, primers and 
other salts or contaminants using the Agencourt® AMPure® reagent and the Biomek NXP 
robot (Beckman Coulter, UK) following the manufacturer's protocol. Bidirectional 
sequencing was performed using a forward and reverse primer. Sequencing PCR reactions 
were performed according to the ddNTP termination method by Sanger (Sanger et al., 1977) 
using the BigDye® Terminator version 1.1 cycle sequencing chemistry (Life Technologies). 
Each 10 pI sequencing reaction contained 1 J.lM of sequencing primer, 1.5 J.lI of 5x 
sequencing buffer, 1.0 J.lI ready reaction dye-mix, 5.5 J.lI of water and 1 J.lI of PCR template. 
The thermocycling conditions used were as follows: 96°C for 1 min, followed by 25 cycles of 
96°C for 10 s, 50°C for 5 s, 60°C for 1.15 min and a hold of 4°C. Sequencing reaction 
mixtures were cleaned up using the Agencourt® cleanSEQ® reagent (Beckman Coulter, 
UK) and the Biomek NXP robot following the manufacturer's protocol. This process 
eliminates dye-terminators and other sequencing reaction components such as primers, salts 
and contaminants. Sequences were then analysed using the ABI 3730 Genetic Analyzer (Life 
Technologies). Performance Optimized Polymer (POP_7Thi) (Life Technologies) was used for 
capillary electrophoresis at 13.4 kV with a 3 s injection time and 1.5 kV injection voltage. A 
48-capillary array with a length of 50 cm was utilised. Negative sequencing controls with no 
PCR template were included in each run. Positive sequencing control included an E. coli 
plasmid vector, plasmid DNA pOEM® 3Zf {+}, which was a~plified using the M13 (-21) 
sequencing primer (Life Technologies). Samples with ambiguous bases in the forward and 
reverse chromatograms were repeated. 
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2.3.2. Mat~assisted laser desorption ionization~time-of~flight mass 
spectrometry (MALDI-TOF MS) 
Thirty~two isolates chosen at random from amongst the SRL, Reference, Glasgow and BSAC 
collections were identified to the species level by MALDI and spectra differences were 
analysed, as previously described (W olters et aL, 2011). Protein extraction was performed 
using an ethanol and formic acid protocol developed by Bruker Daltonics (Coventry, UK). 
One bacterial colony was resuspended in 300 pI of water, mixed well and 900 pI of absolute 
ethanol was added. The solution was centrifuged at 12 000 x g for 2 min and the 
supernatant was decanted; this process was repeated to form a pellet. Fifty pI of 70 % formic 
acid was added to the pellet and mixed thoroughly. To this solution, 50 pI of acetonitrile was 
added and centrifuged for 2 min at 12 000 x g. One pI of the supernatant was spotted three 
times on an MSP 96 polished steel target plate. Samples were air dried and 1 pI of saturated 
a-cyan04-hydroxycinnamic acid (HCCA) matrix solution (matrix crystals were dissolved in 
water containing 50 % acetonitrile and 2.5 % trifluoroacetic acid, TFA) was spotted onto 
each sample and left to dry in air. A bacterial test standard (BTS) (Bruker Daltonics) 
composed of E. coli K12 protein extract and two additional higher mass range proteins 
(RNAse A and myoglobin) were used for calibration of the mass spectrometer. The BTS 
covered a mass range from 4 to 17 kDa and was used as a positive control; H CCA matrix 
was used as a negative control. The controls and test samples were spotted in duplicate on to 
the target plate. All reagents were obtained from Sigma Aldrich unless otherwise stated. 
The target plate was cleaned using a protocol developed by Bruker Daltonics. In brief, the 
target plate was overlaid with 70 % ethanol and incubated for 5 min. After rinsing the target 
plate with water, it was wiped with 70 % ethanol and a Kimwipe®. The target plate was 
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rinsed with water and wiped dry with another Kimwipe®. After overlaying the target plate 
with 80 % TFA in a fume hood, it was wiped vigorously with another Kimwipe®. The target 
plate was rinsed with deionised water, wiped, left to dry for 15 min and stored in a box. 
Samples were analysed using the Bruker microflexlM mass spectrometer software. The 
samples were subjected to a laser frequency of 60 Hz; a mean spectrum was generated from 
240 spectra for each spot. The spectra detected peaks between 1960 to 20137 m/ Z; proteins 
within this range are mainly ribosomal proteins. The spectra were compared using Biotyper 
software version 3.0 (Bruker Daltonics) against a database curated by Bruker Daltonics, 
which contains quality controlled spectra for >2000 microbial species. Peaks that match 
against the spectra in the database are given a positive value whilst those that are different 
are assigned negative values. A score is given to the top matches against the database and 
depending on the score, a species and/or genus identification is obtained. The isolates were 
analysed by MALDI in replicate at both CMPHL and at Colindale, PHE, London. 
The mean spectrum for each isolate was analysed manually using FlexAnalysis software 
version 3.0 (Bruker Daltonics, UI<). Each spectrum was analysed for the presence or absence 
of 13 m/z peaks; the combination of the presence and absence of these 13 peaks constituted 
the MALDI type. Based on this analysis, the isolates were assigned to one of 15 MALDI, 
types. These corresponded to one of the following CCs: CC5, 8, 22, 30 or 45 (Wolters et al, 
2011). Isolates that did not belong to any of the 15 types were presumed to belong to a CC 
not identifiable by the presence or absence of these 13 peaks. 
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2.4. Molecular tools for characterising strains 
2.4.1. Multilocus sequence typing (MLST) 
MLST of S. aureus was performed on all 302 isolates. PCR was performed under standard 
conditions (see materials and methods: section 2.3.1) using an annealing temperature of 
55°C (Enright et al., 2000). Sequences from the seven housekeeping genes arcC, aroE, glpF, 
gmk, pta, tpi and yqiL were amplified using seven primer pairs (Appendix IV). Sequencing 
reactions using the PCR primers were performed using the standard sequence determination 
protocol described (see materials and methods: section 2.3.1). Chromatograms were 
assembled into contigs using BioNumerics software version 6.1 (Applied Maths, Belgium). 
The sequence of each amplicon was assigned to an allele by comparison with the MLST 
database using BioNumerics (Platt et al., 2006). Isolates were assigned to a CC based on an 
eBURST diagram produced from the entire MLST database (Feil et al., 2004). The eBURST 
diagram was generated using the definition of a group as those ST s that shared five or more 
alleles with one another. 
Novel sequences that did not correspond to a known allele were submitted to the MLST 
database for confirmation. Sequences submitted to the database require good quality 
forward and reverse chromatograms which span the entire target region. Chromatograms for 
those isolates that displayed a novel sequence at one of the six loci (arcC, aroE, glpF, pta, tpi 
or yqiL) were submitted to the S. aureus MLST database curator for allele assignment. 
Redesigning the existing gmk reverse primer was required to enable submission of 
chromatograms for those isolates displaying a novel allele at the gmk locus. Sequencing 
reactions start downstream of the primer sequence. However, as the gmk reverse primer is 
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complementary to a sequence within the target region, chromatograms spanning the entire 
gmk region could not be obtained using the original primer. Fifteen gmk gene sequences were 
downloaded from S. aureus WGSs from the NCBI database (Appendix V: Group A) into 
BioEdit software. A consensus sequence was generated with gaps at polymorphic sites. 
Primers were designed utilising Primer3 software (Rozen & Skaletsky, 1999) and the 
consensus sequence. The gmk primers thus designed and used for amplification were: 
5'GGATAATGAAAAAGGATTGTTAATCG 3' and 
5' CGCGCTCTCI I I I lAAGTGC 3' (gmkF _R2). The discriminatory power (D) based on 
the Simpson index of diversity and the 95 % confidence interval (Cl) (95 % confidence the 
true D value lies within this range) were calculated for MLST data from all isolates 
(Grundmann et al, 2001; Hunter & Gaston, 1988; Simpson, 1949). The D value and Cl 
amongst isolates from each collection and amongst BSAC MRSA and MSSA isolates was 
also calculated. 
2.4.2. Staphylococcal cassette chromosome mec (SCCmed typing 
Typing of all isolates was performed based on SCCmec sequences via the analysis of SCCmec 
PCR amplifications. A multiplex SCCmec PCR using 10 primer pairs was performed on all 
isolates under standard conditions (see materials and methods: section 2.3.1) with an 
annealing temperature of 53°C (Milheiri~o et al, 2007). Isolates belonging to SCCmec types 
I-V were detected by this PCR. PCR products (10 I.t!) were separated by electrophoresis on a 
2 % agarose gel (see materials and methods: section 2.3.1) and the amplicon sizes were used 
to infer the SCCmec type as previously described (Milheiri~o et al, 2007). 
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2.4.2.1. SCCmec type IV subtypin~ 
Isolates belonging to SCCmec type IV identified above were further typed into subtypes IVa 
to IVh (Milheiri~o et al, 2007). A multiplex PCR using seven primer pairs was performed on 
a subset of isolates under standard conditions (see materials and methods: section 2.3.1) 
with an annealing temperature of 48°C (Milheiri<ro et al, 2007). PCR products (10 pI) were 
separated by electrophoresis on a 2 % agarose gel (see materials and methods: section 2.3.1) 
and the amplicon sizes were used to infer the SCCmec type IV subtype as previously 
described (Milheiri<ro et al, 2007). Isolates that could not be assigned to SCCmec types I to V 
via the described protocol (Milheiri<;o et al, 2007) were typed using one or more of the 
methods described in the sub-sections that follow. PCR products in each method were 
separated by electrophoresis as previously described (see materials and methods: section 
2.3.1). 
2.4.2.2. SCCmec-orfX junction observation 
The junction between the SCCmec and or{X region was sequenced in a subset of isolates. 
PCR primers were designed by performing a multiple alignment of SCCmec type IV 
sequences obtained from the NCBI database (Appendix V: Group B) using MegAlign™ 
software version 8 (Lasergene®, DNAST AR, USA) using the clustalW method. A consensus 
sequence of approximately 1500 bp was generated and used to design PCR primers using 
Primer3 software. The resultant primer sequences were BLAST searched against the NCBI 
database and the primer pair with the highest similarity score with SCCmec type IV 
sequences (described above) was selected. The designed primers SCCmec-orfXF and SCCmec-
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cnjXR (MWG Eurofins) (Appendix IV) were utilised in a PCR performed under standard 
conditions. PCR products (15 J.1l) were separated by electrophoresis on a 2 % agarose gel (see 
materials and methods: section 2.3.1) and the amplicon sizes were used to infer the presence 
of the SCCmec. 
PCR products were sequenced as described in the standard sequence determination protocol 
(see materials and methods: section 2.3.1). Two PCR primers were used initially and 
subsequently three nested sequencing primers were used to determine whether longer 
sequence reads could be obtained. These included one forward primer SCCmec'07tx2F and 
two reverse primers SCCmec"07tx2R and SCCmec-<njX3R (MWG Eurofins) (Appendix IV). 
Primers were designed using the SCCmec-otfX junction consensus sequence with the primer 
walking feature of SeqMan ProlM software version 8 (Lasergene®). Contigs were assembled 
using SeqMan ProlM software, aligned to the 1500 bp consensus sequence in MegAlign and 
BlAST searched against the NCBI database to determine the presence of the otfX region 
and SCCmec type .. 
2.4.2.3. orfX amplification 
Amplification of the cnjX region was performed for a subset of isolates. PCR primers were 
designed by performing a multiple alignment of cnjX sequences associated with SCCmec type 
I·V obtained from the NCBI database (Appendix V: Group C) using BioEdit software and 
the clustalW method. A consensus sequence of approximately 480 bp was generated. The 
primers cnjXF and otfXR (MWG Eurofins) (Appendix IV) were designed manually after no 
appropriate primers were obtained using Primer3 software. An annealing temperature of 
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50°C was used to amplify the PCR products. peR products (10 pI) were separated by 
electrophoresis on a 2 % agarose gel (see materials and methods: section 2.3.1) and the 
amplicon sizes were used to infer the presence of the orfX. 
2.4.2.4. SCCmec type VI PCR 
Two PCRs were performed on a subset of isolates for the detection of isolates assigned to 
SCCmec type VI. Two primer pairs IS1272J·F with IS 1272J·R and ccrB4-F with ccrB4-R were 
utilised from a previous study (Chen et al., 2009) (Appendix IV). These primers amplify mec 
class Band ccrB4 found in SCCmec type VI. An annealing temperature of 50°C was used to 
amplify the PCR products. PCR products (10 J.ll) were separated by electrophoresis on a 2 % 
agarose gel (see materials and methods: section 2.3.1) and the amplicon sizes were used to 
infer the presence of SCCmec type VI as previously described (Chen et aL, 2009). 
2.4.2.5. SCCmec type VII PCR 
A multiplex PCR using two primer pairs (ccrC2·F2 with ccrC2·R2 and ccrC8-F with ccrC8·R), 
targeting ccrc allotypes 2 and 8 respectively, was used on a subset of isolates. A second PCR 
using the primer pair mecC2·F with mecC2-R was utilised to target mec class C2 (Higuchi et 
aL, 2008) (Appendix IV). The annealing temperature for both PCRs was 50°C. PCR 
products (10 pI) were separated by electrophoresis on a 2 % agarose gel (see materials and 
methods: section 2.3.1) and the amplicon sizes were used to infer the presence of SCCmec 
type VII as previously described (Higuchi et aL, 2008). 
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2.4.2.6. SCCmec type VIII PCR 
A subset of isolates belonging to SCCmec type VIII was identified by a previously described 
multiplex PCR (McClure et al., 2010). The three primer pairs (mecl,F with mecl,R, cer4Fd 
with cer4R2 and VIII,F3 with VIII,R3) (Appendix IV) targeting the mecl, cer complex type 4 
and the recombination junction of SCCmec respectively were used. The multiplex PCR was 
performed using an annealing temperature of 52°C. PCR products (10 pI) were separated by 
electrophoresis on a 2 % agarose gel (see materials and methods: section 2.3.1) and the 
amplicon sizes were used to infer the presence of SCCmec type VIII as previously described 
(McClure et al., 2010). 
2.4.2.7. Investigation ofSCCmec non,typeable isolates 
Two multiplex PCRs were performed on isolates that were non,typeable by the above 
methods. Ten primer pairs were utilised from a previous study (Kondo et al., 2007) 
(Appendix IV). The primers targeted the mecA. cerAl to cerA4. cerBl to cerB4 and ccrC to 
enable assignment of the cer complex type in each SCCmec. Four primer pairs in the second 
multiplex PCR targeted the mecA. mecl, IS1272 and IS431 to enable the assignment of the 
mec class. The multiplex PCRs were performed using an annealing temperature of 57°C and 
60°C in the cer type and mec class PCR respectively. PCR products (10 pI) were separated by 
electrophoresis on a 2 % agarose gel (see materials and methods: section 2.3.1) and the 
amplicon sizes were used to infer the presence of the above SCCmec features as previously 
described (Kondo et al., 2007). The D value and the 95 % Cl as previously proposed were 
calculated for SCCmec data from all isolates (Grundmann et al., 2001; Hunter & Gaston, 
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1988; Simpson, 1949). The D value and Cl were also calculated amongst isolates from each 
collection and amongst isolates belonging to each of the CCs: CCI, 5, 8,22,30 and 45. 
2.4.3. spa typing 
spa typing was performed on a subset of isolates, representative of 15 CCS, by determining 
the sequence of the polymorphic X region of protein A as described previously (Shops in et 
al., 1999). PCR was performed using an annealing temperature of 60°C and PCR products 
(5 J.lI) were separated by electrophoresis on a 2 % agarose gel and sequenced as described 
previously (see materials and methods: section 2.3.1). Chromatograms were assembled into 
contigs using BioNumerics software. The sequence of each amplicon was assigned to a spa 
type by comparison to the Ridom SpaServer database (http://spa.ridom.de) using 
BioNumerics software. Novel spa types were submitted to the Ridom SpaServer database. 
The spa type of each isolate was compared with MLST data and cluster analysis was 
performed on spa sequences using the Unweighted Pair Group Method with Arithmetic 
mean (UPGMA) method and BioNumerics software. The D and Cl value were calculated for 
spa data from isolates belonging to CC1, 5, 8, 22, 30 and 45 (Grundmann et al, 2001; 
Hunter & Gaston, 1988; Simpson, 1949). 
2.5. Genetic diversity throughout the genome 
2.5.1. Preliminary fluorescent amplified fragment length polymorphism 
(FAFLP) 
FAFLP was performed empirically on a subset of isolates using four endonuclease 
combinations: EeoRI with MseI, HindIII with HhaI, EeoRI with HhaI and BglII with Csp6I. 
An E. eoli K12 strain was used as a positive control in each FAFLP reaction. The 
114 
endonuclease digestion and adaptor ligation reactions for each combination are described 
below. Unless otherwise stated, the reagents for the digestion and ligation reactions were 
obtained from New England Biolabs, UK. 
2.5.1.1. EeoRI with MseI digestion 
Genomic DNA (500 ng) was digested at 37°C for 3 h in a final reaction volume of 20.5 pI 
consisting of 10 U MseI, 2 pl10x NEBuffer 2, 0.2 pI bovine serum albumin (BSA, 10 g/mL) 
and 0.5 pI RNase A (30 mg/mL, Sigma,Aldrich). Five units of EeoRI (Fermentas, Thermo 
Scientific, UK) was subsequently added to each reaction mixture and incubated for a further 
3 h at 37°C. Reactions were subsequently heated to 65°C for 10 min to inactivate the 
endonucleases and cooled to 4°C. Ligation was performed as described below (see ligation 
protocol: section 2.5.1). 
2.5.1.2. HindIII with HhaI digestion 
Genomic DNA (500 ng) was digested at 37°C for 2 h in a final reaction volume of 29 pI 
consisting of 6 U HindIII, 3 pI lOx NEBuffer 2 and 0.5 pI RNase A 
(30 mg/mL, Sigma,Aldrich). One pL master,mix containing six units of HhaI and 
0.3 pI BSA (10 mg/mL) was subsequently added to each reaction mixture and incubated for 
a further 2 h at 37°C. Reactions were subsequently heated to 65°C for 10 min to inactivate 
the endonucleases and cooled to 4°C. Ligation was performed as described below (see 
ligation protocol: section 2.5.1). 
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2.5.1.3. EeoRI with HhaI dieestion 
Genomic DNA (500 ng) was digested at 37°C for 2 h in a final reaction volume of 22.5 pI 
consisting of 6 U HhaI, 3 pI lOx NEBuffer 2, 0.3 pI BSA (10 mg/mL) and 0.5 pI RNase A 
(30 mg/mL, Sigma-Aldrich). Six units of EeoRI was subsequently added to each reaction 
mixture and incubated for a further 2 h at 37°C. Reactions were subsequently heated to 
65°C for 10 min to inactivate the endonucleases and cooled to 4°C. Ligation was performed 
as described below (see ligation protocol: section 2.5.1). 
2.5.1.4. Csp6I with BglII dieestion 
Genomic DNA (500 ng) was digested at 37°C for 2 h in a final reaction volume of 15 pi 
consisting of 10 U Csp6I, 2 pI lOx Y+ITango™ and 0.3 pi RNase A (30 mg/mL, 
Sigma-Aldrich). Three pL master-mix containing five units of BglII and 2.5 pI IOx 
Y + IT ango TM was subsequently added to each reaction mixture and incubated for a further 2 
h at 37°C. Reactions were subsequently heated to 65°C for 10 min to inactivate the 
endonucleases and cooled to 4°C. Ligation was performed as described below (see ligation 
protocol: section 2.5.1). 
2.5.1.5. Lieation protocol 
Ligation was performed by adding 25 pI of master-mix containing 5 pi IOx T4 DNA-ligase 
buffer, 80 U T4 DNA ligase, 0.5 pI of each adaptor (MWG Eurofins) to the EeoRI with MseI, 
HindIII with HhaI and EcoRI with HhaI double-digested DNA Ligation was performed by 
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adding 27 pI of the above mastermix to the Csp6I with Bglll digestion (Table 8). The reaction 
was incubated at 12°C for 16-18 h, heated to 65°C for 10 min to inactivate the ligase and 
cooled to 4°C. The ligation reactions were used as FAFLP PCR templates. 
Table 8. Fluorescent Amplified Fragment Length Polymorphism (FAFLP) adaptors and 
sequences 
Adaptor name Adaptor sequence (5' to 3') Concentration (pM) 
EeoRI CTCGTAGACTGCGTACC 2 MTTGGTACGCAGTC 2 
MseI TACTCAGGACTCATC 20 GACGATGAGTCCTGAG 20 
HindUI CTCGTAGACTGCGTACC 2 AGCTGGTACGCAGTC 2 
HhaI GACGATGAGTCCTGATCG 20 ATCAGGACTCATCG 20 
BglII CGGACTAGAGTACACTGTC 2 GATCGACAGTGTACTCTAGTC 2 
Csp6I MTTCCMGAGCTCTCCAGTAC 20 TAGTACTGGAGAGCTCTTGG 20 
The table displays double-stranded adaptor sequences and concentration utilised in 
F AFLP ligation reaction. 
2.5.1.6. FAFLP PCR 
A touchdown PCR (Desai et aL, 1998) was performed in 25 pI PCR reaction containing 
2.5 pI of the ligated sample, Ix PCR reaction buffer, 2.5 mM MgCI2, 0.2 mM each dNTP, 
0.8 pM of each primer (Table 9) and 1.25 U Taq DNA polymerase recombinant. For each 
pair of primers, the forward primer was labelled at the 5'-end with one of the four 
fluorescent dyes 5' -carboxyfluorescein 
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2' -chloro-T ,phenyl, 1, 4-dichloro-6-carboxyfluorescein (VI C®), 
1 ',2',benz0-4"fluoro-7'-chloro-6-carboxy4, 7 -dichlorofluorescein (NEDTM) and 
N,Dimethylaminoethylene) amino-N,allyl,1,8.naphthalimide (PET®) whilst the reverse 
primer was unlabelled (Life Technologies). 
Table 9. FAFLP PCR primers and sequences 
Primers Sequence (5' to 3') 
BgllI+X· GAGTACACTGTCGATCTX 
Csp6I+X GAGCTCTCCAGTACTACX 
HindIII+X GACTGCGTACCAGCTTX 
HhaI+X GATGAGTCCTGATCGCX 
EcoRI+X GACTGCGTACCAATTCX 
MseI+X GATGAGTCCTGAGTAAX 
·x represents a selective base: either nucleotide A, T, Cor G. 
The primer sequences utilised on each double digest are described in Table 9. PCRs were 
performed with the primer pairs FAM,EcoRI+O and MseI+C (on EcoRI and MseI digestions), 
FAM,HindIU+A and HhaI+T (on HindUI and HhaI digestions) and FAM,EcoRI+O and 
Hhal+A (on EcoRI and HhaI digestions). PCRs using primers BgllI+X (where X is nucleotide 
A, T, Cor G labelled with FAM, PET, VIC and NED respectively) (Life technologies) and 
Csp6I+O, FAM,BglII+A and Csp61+T, and FAM,BgllI+O and Csp6I+X were performed on 
Csp61 and BglII digestions. Unless otherwise stated the primers for FAFLP PCRs were 
obtained from MWG Eurofins. 
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The thermocycling conditions used were as follows: 
Denaturation -+ 94°C -+ 2 min ::r 1 cycle 
Denaturation -+ 94°C -+ 20 s 
Annealing -+ 1 cycle -+ 66°C -+ 30 s 
-+ 9 cycles -+ decrease by 1°C increments -+30 s -+ 30 cycles 
-+ 20 cycles -+ 56°C -+ 30 s 
Extension -+ 72°C -+ 2 min 
Final extension -+ 60°C -+ 30 min ]-1 cycle 
FAFLP PCR reaction mixtures were cleaned up using the Agencourt® cleanSEQ® reagent 
as described previously (see materials and methods: section 2.3.1). One pL of cleaned 
product was added to 10 pI of Hi-Di formamide (Life technologies) and 0.5 pI of 
GeneScan TM-600 LIZ® size standard (Life technologies). The size standard was labelled with 
a fifth proprietary fluorescent dye (LIZ). The reaction was heated at 95°C for 5 min and 
cooled to 4°C. Fragments were separated using the AB! 3730 Genetic Analyzer. POP-7™ 
was used for capillary electrophoresis which was run at 15 kV with a 15 s injection time and 
1.6 kV injection voltage. A 48-capillary array with a length of 50 cm was utilised. 
2.5.1.7. Preliminary FAFLP analysis 
FAFLP AFs were separated on an AB! 3730 sequencer and the set of fragments generated for 
each sample were sized using GeneMapper software version 4.0 (Life Technologies). Based 
on the collective peaks from all samples, automatic bin assignment was performed. Process 
Quality Value tests were performed using the default peak quality settings. The size calling 
algorithm measures the similarity between the fragment pattern expected depending on the 
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size standard used and the actual peaks. Fragments ranging in size from 50 to 600 bp with a 
peak height of 50 relative fluorescent units (RFU) or above constituted the FAFLP profile of 
each isolate. Manual scoring of the fragments was then performed. Based on the collective 
AFs obtained from all samples, amplicon size categories (bins) greater than ±0.5 bp of one 
another were defined. Each bin represented an FAFLP locus and for each locus, the 
presence or absence of an AF was recorded in a binary format (1 and 0 for presence and 
absence respectively). The number of AFs in each profile and the number of common and 
polymorphic AFs between all profiles and those belonging to the same CC were analysed 
using the binary table. AFs were considered to be common to all isolates if they were present 
in ~95 % of isolates. AFs that were present in ~95 % of isolates of a specific lineage and in 
<5 % of the remaining isolates were classified as lineage-specific. AFs present in <95 % of all 
isolates or isolates of a specific CC were termed polymorphic. 
To measure whether the distribution of fragments between 50 to 600 bp was skewed, the 
percentage of AFs less than and greater than 300 bp within each profile were calculated. 
Skewed profiles would increase the number of fragments of a similar size decreasing the 
accuracy of AF detection. The mean percentage of the genome represented by the AFs 
generated for each isolate was calculated. The mean S. aureus genome size was taken to be the 
mean genome size of 19 WGSs obtained from the NCB! database (Appendix V: Group D). 
Hierarchical cluster analysis was performed using statistiXL software version 1.8 (Roberts & 
Withers, 2009) using the UPGMA clustering method and the Jaccard co-efficient of 
similarity. 
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2.5.2. FAFLP 
2.5.2.1. BglII+A with Csp6I+0 FAFLP analysis 
Ligation reactions were performed for all isolates as detailed above using the endonucleases 
BglU and Csp6I. FAFLP peR was performed as previously using the primers FAM-BglU+A 
and Csp6I+0 and data were analysed as described in the preliminary FAFLP analysis. FAFLP 
profiles constituted AFs between 50 to 600 bp and with a peak height of ~50 RFU. The 
presence and absence of AFs among the FAFLP profiles were recorded in a binary format. 
Isolates that generated profiles with less than 45 or greater than 100 AFs were subjected to 
identification via determining the sequence of the 16S rRNA gene. Isolates that were 
identified as S. aureus were subjected to repeat FAFLP analysis from another DNA extract. A 
subset of isolates which exhibited >70 AFs were subjected to repeat FAFLP analysis. AFs 
constituting a profile from both replicates were compared manually and the percentage 
similarity was calculated by identifying the number of AF differences. The distribution of 
fragments between 50 to 600 bp and the mean percentage of the genome represented by 
each profile was calculated as previously. 
Common and polymorphic AFs based on the definitions mentioned above were identified. 
In silico analysis of common AFs was performed using AFLP fragment predictor program, 
ALFIE (Underwood, 2008). In silico profiles were generated from 10 WGSs obtained from 
the NCBI database (Appendix V: Group E). A search was performed in ALFIE for fragments 
within ±3 bp of the expected AF size (21 bp less than that detected on the ABI 3730 
sequencer due to the absence of the adaptor sequences) and present in each of the 10 
WGSs. Sequences were obtained for the common AFs which were mapped to the WGSs 
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using the NCBI database. BlAST searches were performed of the AF sequences to identify 
features partially encoded in these regions. Multiple alignments of AF sequences from each 
of the 10 WGS were performed to calculate the percentage conservation of the sequence. 
This was calculated by observing the number of nucleotides that were conserved amongst the 
consensus sequence as compared with the number of nucleotides within the sequence. AFs 
present in ~95 % of all MRSA or MSSA isolates and <5 % of the remaining isolates were 
identified as AFs exclusive to MRSA or MSSA. In addition, AFs present in ~95 % of isolates 
from each collection were identified as common AFs whilst the remaining AFs were 
polymorphic. AFs present in ~95 % of isolates from each collection and in <5 % of the 
remaining isolates were identified as exclusive to isolates from a specific collection. 
2.5.2.2. Reproducibility studies 
The reproducibility of the FAFLP assay was evaluated on a subset of isolates by performing 
FAFLP analysis in duplicate from different DNA extracts and from the same DNA extract. 
2.5.2.3. Concordance of experimental FAFLP profiles with in silico profiles 
In silico FAFLP profiles were generated for six strains with WGS data using ALFIE. The 
percentage concordance between in silico and experimental profiles for the six reference 
strains was determined. 
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2.5.2.4. Cluster analysis 
Cluster analysis was performed on the 302 study isolates based on BglII+A with Csp6I+O 
data. A dendrogram was generated using the UPGMA method based on the Dice similarity 
coefficient. Based on MLST data, a similarity cut-off was applied to the dendrogram to 
generate clusters. To display the FAFLP·based divergence, a further similarity cut-off was 
applied to generate sub-clusters. Profiles of isolates within one cluster were compared and 
the number of polymorphic AFs was calculated. These numbers related to the percentage 
divergence exhibited within a cluster. The number of polymorphic AFs between and within 
sub-clusters was also calculated. Clusters and sub-clusters were examined for correlations 
between FAFLP data and MLST or SCCmec typing. Isolates within a cluster were also 
studied for a correlation between FAFLP data and the source (collection) of the isolates. The 
D value and 95 % Cl were calculated for FAFLP data, MLST and SCCmec data of all isolates 
(Grundmann et al, 2001; Hunter & Gaston, 1988; Simpson, 1949). 
2.5.2.5. FAFLP data correlation with lineage 
Profiles of isolates assigned to one of seven CCs: CC1, 5, 8, 22, 30, 45 and 59 were 
compared. Common AFs within a CC were identified as fragments present in ~95 % of 
isolates assigned to that CC. Conversely, polymorphic AFs within a CC were identified as 
fragments present in <95 % of isolates assigned to one CC. The FAFLP binary table was 
analysed using Stata software. Amongst isolates containing a particular AF, those AFs were 
identified where ~95 % of the isolates belonged to a specific lineage. A manual search was 
subsequently performed for lineage-specific AFs; these fragments were present in >90 % of 
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isolates assigned to one CC and <5 % of isolates assigned to the remaining CCs. The 
sequences of lineage-specific AFs were determined experimentally or in silico. 
2.5.2.6. Sequence determination of linea~e-specific amplified fra~ments (AFs) 
The identified lineage-specific AFs were sequenced. FAFLP PCRs were performed using the 
selective primers BglU+A with Csp6J+A on seven isolates (DBHT 98, 100, 198, 215, 230, 
231, and 234) which were representative of seven CCs (CC1, 5, 8, 22, 30, 45 and 59). PCR 
products (15 pI) were separated by electrophoresis on a 4 % agarose gel at 105 V for 7 h. 
Each gel lane was sliced into five segments: 50-150 bp, 150-250 bp, 250-350 bp, 350-450 bp 
and 450-600 bp. PCR products were purified from the gel slices using the Wizard® SV gel 
and PCR clean-up system (Promega, UK). The weight of each gel slice was determined and 
10 pI of membrane binding solution was added per 10 mg of gel slice. This solution was 
incubated at 80°C until the agarose dissolved. The solution was added to an SV minicolumn 
and incubated for 1 min. The solution was passed through the minicolumn, which contains 
a membrane that binds the DNA, by centrifugation at 16000 x g for 1 min. The 
flow-through was discarded and 700 pI of membrane wash solution was added to the column 
and centrifuged as previously: this step was repeated with 500 pI of membrane wash solution 
and was centrifuged for 5 min. The flow-through was discarded and centrifuged for an 
additional 1 min. DNA was eluted by adding 5 pI of water to the membrane and 
centrifuging for 1 min. 
Purified PCR products were utilised as templates in a further PCR using a BglII+A primer in 
combination with a two-base selective primer, Csp6J+AA, +AT, +AC or +AO. PCR products 
were separated by electrophoresis on a 4 % agarose gel at 105 V for 7 h. Fragments of 
124 
interest were excised from the gel using a pipette tip and transferred directly into sequencing 
reactions in a 96-well plate; sequencing was performed as mentioned previously (see 
materials and methods: section 2.3.1). Chromatograms were analysed using BioEdit software 
and sequences of lineage,specific AFs were BlAST searched against the NCBI database. A 
multiple alignment of search results was performed using BioEdit software and a consensus 
sequence was generated. PCR primers were designed from each consensus sequence using 
Primer3 software (Table 10). 
PCR was performed for lineage,gpecific AFs in a 25 J..lI reaction under standard conditions 
(see materials and methods: section 2.3.1). The annealing temperature utilised in each PCR 
varied between 50 to 55°C (Table 10). PCRs were performed on 40 isolates representative of 
CC1, 5, 8, 15, 22, 30, 45, 59, 97 and 672 (Appendix VIII). PCR products were sequenced 
using the PCR primers following the sequence determination protocol described and 
resultant chromatograms were aligned using BioEdit software. PCRs designed for 11 lineage, 
specific AFs were validated on 48 isolates assigned to the 10 CCs listed above (Appendix 
VIll). These experiments were performed as blind assays Le. the designated ST of the isolates 
were not known. Based on the lineage,gpecific sequence variations, isolates were assigned to 
a lineage. 
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Table 10. peR primer sequences of lineage-specific amplified fragments (AFs) 
Lineage- Specific Primer Annealing 
specific Primer sequence (5' to 3') temperature* 
AFe toCC
t name (OC) 
285 bp CC5 285 bp F TCTGCTGATTGcrnTGATACTAA 54 285 bp_ R AAGATGATTCAAACGTAGAACGTG 
289 bp CC8 289 bp F GAAGAAAGcrnTATTCCTGTTT 50 289 bp_ R TAACCATATCGGCTGCAGTG 
141 bp CC22 141 bp F TTGTTTTGTTTGCCTCAACA 55 141 bp R GCCTATAGGTATCAAAGTGACGAGA 
98 bp CC30 98bp F GGTTTTATCGTTTATAAAGGTGTTCG 54 98bp R TGCAATCTATGCTCTATTCCTGA 
156 bp CC30 156 bp F 
TTCGTTATGCTTTGCGGTAA 50 156 bp R GAAAGAGTAGTAACTTCAAAATCCGTA 
182 bp CC30 182 bp F 
GGTACTGATAAGCCTGTTGATTG 52 182 bp R AATGGCGTTATCCATTATGCT 
277 bp CC30 277 bp F 
GCATTTGGCAAGTTAGCTTCT 
50 277 bp R CAAAAAGACGACCTACACAACA 
307 bp CC30 307 bp F 
TGTGTTTAGGAACTGCATCTATCA 52 307 bp_ R TAACCATATCGGCTGCAGTG 
389 bp CC30 389 bp F GCCACAGCAAGACTTAGAT 50 389 bp R CGTTTGTGTGGGGAATATG 
479 bp CC30 479 bp~ F TCCAAATAATGCTGAACACTTAGC 52 479 bp_ R TCATGCTACTTAAAATACAAGCACTG 
529 bp CC30 529 bp F ACGCGCACGTATAGAGGTTT 54 529 bp_ R CGGCACCTTTAGGTAGATGTTT 
82 bp CC45 82 bp. F 
TCGTACTATACCTCACTTTATTTACGG 55 82 bp R AATCCAATAAGACAGAGTGAACG 
137 bp CC45 137 bp. F GCGTAGCGAAAGTATCTATGAAA 50 137 bp_ R TCATGCAACTAGGTCAATTCG 
85 bp CC59 85 bp F CGGAACGATACGATCATGTG 50 85 bp R TTCATGAAGCTGTTGGTGAAG 
340 bp CC59 340bp F GTACAATGGGTTGCGGTCTT 50 340bp R TCAGTTATAAGAAACGTTTTGCTG 
°Lineage-specific amplified fragments (AFs) were identified from FAFLP reactions using 
the primers BgAI+A with Gp6I+O. 
ttineages (CCs) to which AFs of a precise size were specific. 
* Annealing temperature for each PCR performed under standard conditions (see 
materials and methodss section 2.3.1). 
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2.5.2.7. In silico determination of linea~e-specific AFs 
The sequence of the lineage-specific AFs that were not obtained experimentally were 
determined in silico. The genomic loci of the AFs were determined using in silico profiles 
generated from WGSs and ALFIE. Fragment sizes in ALFIE were 21 bp less than those 
determined on the AB! 3730 Genetic Analyzer due to the absence of the adaptor sequences. 
Fragments that were ± 7 bp of the expected size in ALFIE were identified and the fragment 
closest in size to the expected was selected. Based on the locus of the fragment, the sequence 
was obtained from WGSs in the NCBI database. BlAST search results of these sequences 
from WGSs representative of 10 lineages (CC1, 5, 8, 22, 30,59,93, 151, 398 and 425) were 
aligned using BioEdit software. 
2.5.2.8. Linea~e-specific AF sequence variation 
Lineage-specific AF sequence alignments were analysed to identify lineage-specific SNPs 
(substitution), point mutations (1 bp insertion and deletion) and indels (> 1 bp). Alignments 
generated from experimental sequences were analysed for the presence of specific variations 
within the following CCs: CC1, 5, 8, 15, 22, 30, 45, 59, 97 and 672. Alternatively, 
alignments from WGSs were analysed for the presence of specific variations within CC1, 5, 
8, 22, 30, 59,93, 151,398 and 425. The number of SNPs, point mutations and indels were 
compared between each of the AF sequences. The numbers of sequence variations specific to 
isolates of one CC were identified. 
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2.5.2.9. Proteins encoded on lineage-specific AF sequence and their function 
BlAST search results were performed of the consensus sequences of lineage-specific AFs. 
Based on annotated WGSs, partial open-reading frames (ORFs) encoded in these consensus 
sequences were determined. The proteins encoded by these ORFs and their possible 
functions were researched in the literature. In addition, the translated amino acid sequence 
of these ORFs from WGSs belonging to eC1, 5, 8, 22, 30,59,93, 151, 398 and 425 were 
aligned against the lineage-specific AF sequence alignments. The SNPs or point mutations 
found in ORFs were compared against the amino acid sequences to determine whether the 
variations were synonymous (no change in amino acid sequence) or non-synonymous 
(change in amino acid sequence). 
2.5.2.10. Pyrosequencing™ 
A search was performed amongst AFs displaying lineage-specific variations as a target for a 
Pyrosequencing™ assay. AFs displaying lineage-specific variations for the maximum number 
of lineages were selected. The sequences of these AFs were compared to identify an 
approximately 100 bp region with variations specific to multiple lineages. The region 
amongst the AFs with the highest number of lineage-specific variations was selected for 
Pyrosequencing™. peR primers were designed manually using BioEdit software to amplify 
this region. A hot start peR was performed in a 25 Jll peR reaction containing Ix 
HotStarTaqTM master mix (Qiagen, UK), 0.12 JlM of unlabelled primer, 0.14 JlM of 
biotinylated primer (MWG Eurofins), 0.012 M of betaine and 75 ng of DNA The forward 
primer sequence was labelled at the 5' end with biotin. The forward primer, 307 bp_pyro_F, 
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sequence was 5'TGTGTITAGGMCTGCATCTATCA 3' and the reverse primer, 
307 bp_pyro_R, sequence was 5' ACTMGTATTCCMMATGCATGA3'. Thermocycling 
was performed on GeneAmp® PCR system 9700 (Life Technologies) and cycling conditions 
used were as follows: 95°C for 15 min; 95°C for 2 min; followed by 35 cycles of 95°C for 45 
s, 55°C for 45 s and 72°C for 1 min and a final extension at 7ZOC for 5 min with a hold 
cycle at 4°C. PCR products (2 pI) were confirmed on a 2 % agarose gel as previously 
described. 
A 60 pI solution was made up of 20 pI of PCR reaction, 3 pI of Streptavidin SepharoseTIv1 
High Performance beads (GE Healthcare Life Sciences, UK), 40 pI of PyroMark Binding 
Buffer and 17 pI of water. All reagents were obtained from Qiagen, UK unless otherwise 
stated. Each reaction was incubated for 10 min at room temperature whilst shaking at 
140 x g. The solution was aspirated using the PyroMark™ Vacuum Prep Workstation, 
resulting in the beads adhering to the vacuum tool. The tool was then transferred to a 
solution of 70 % ethanol which was aspirated for 5 s. This process was repeated for solutions 
of PyroMark Denaturation Solution and Ix PyroMark Wash Buffer sequentially. The tool 
was held vertically to ensure all liquid was drained from the tubing. Once the vacuum was 
released, the tool was placed in a PSQ 96 Thermoplate Low containing 45 pI of sequencing 
primer (0.3 pM) in PyroMark Annealing buffer. Two forward sequencing primers were used 
on PCR products from each isolate. The primer sequences were 
5' CATMMCGACMTITCA 3' for 307 bp_pyro_F1 and 
5' CATMMCMCMTITCA 3' for 307 bp_pyro_F2. The PSQ plate was incubated at 
BO°C for 2 min and allowed to cool slowly at room temperature. The vacuum tool was 
washed thoroughly by aspirating distilled water for 30 s. 
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Pyrosequencing™ was performed using PyroMark Gold Q96 reagents on the automated 
PyroMark Q96 ID system. One vial each of enzyme and substrate were reconstituted in 
620 JlI of distilled water. The PyroMark Q96 ID system was utilised with the PyroMark ID 
software version 1.0 (Biotage, UK). An SQA run was selected and the nucleotide 
dispensation order was programmed as 25 cycles of T, e, G and A The instrument 
parameters were set to a nucleotide dispensation pressure of 650 mbar, reagent dispensation 
of 400 mbar and a 65 s cycle time. The volume of enzyme, substrate and the four dNTPs 
needed for the run was calculated by the software and added to the PSQ 96 reagent 
cartridge. Reagents were automatically dispensed by the instrument according to the 
nucleotide dispensation order. Sequences were displayed as a Pyrogram TM and in text format. 
Sequences were aligned against the expected lineage-specific AF sequence using BioEdit 
software. Based on previously identified lineage-specific variations, isolates were assigned to a 
lineage. 
2.5.2.11. FAFLP comparison with spa typin~ and whole-2enome mapping <WGM) 
FAFLP data were compared with spa typing and WGM data for a subset of isolates. The 
percentage of the genome sampled by each method was compared as were the number of 
profiles or spa types exhibited with each method. The percentage similarity displayed 
amongst isolates assigned to the same lineage was calculated for each method based on 
cluster analysis using the UPGMA method. Optical maps generated a restriction fragment 
patterns across the genome, portions of these patterns were identified that were unique to 
isolates of one lineage. The number of lineage-specific AFs and restriction fragment patterns 
identified using FAFLP and WGM respectively were compared. The proportion of the 
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genome that was represented by lineage-specific regions identified using FAFLP and WOM 
were used to calculate the percentage of the genome specific to one lineage. 
2.5.3. Insertion sequence targeted FAFLP (lS-FAFLP) 
An IS targeted FAFLP (IS-FAFLP) assay was developed for S. aureus. A search of WOSs for 
an IS was performed. To ensure that the sequence is relatively conserved between lineages, 
the parameters of the target IS were that the sequence should be present in all S. aureus 
genomes but belong to one IS family. In addition, the IS should be present at variable loci 
and in a variable copy number amongst the WOSs. Firstly, the presence of ISs were 
compared amongst 15 WOSs from the NCBl database (Appendix V: Oroup F). The search 
terms 'insertion' and 'sequence' or 'transposase' were used to identify potential ISs against 
the genome annotations. Following this, a multiple alignment was performed on the 15 
WOSs using Mauve software version 2.3.1. Using the find features tool in Mauve software, 
all genomes were searched for features containing the keywords 'insertion' and 'sequence' or 
transposase'. The search results of these terms from Mauve software were BLAST searched 
against the NCBI database. Search results from Mauve software that displayed similar 
sequences in the most number of other WOSs were identified as potential FAFLP targets. 
The BlAST search results of potential FAFLP target sequences were aligned using Bioedit 
software and a consensus sequence was generated. 
Restriction endonuclease recognition sequences within the target consensus sequences were 
determined in silico using the Enzymes-Restriction Map method in OeneQuest™. The search 
was limited to those restriction endonucleases that recognise a 4 bp sequence. This method 
identified restriction endonuclease recognition sequences for up to two endonucleases per 
FAFLP target. Reverse primers were designed manually using BioEdit software; primers were 
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designed within the target sequence upstream of the restriction endonuclease site. An IS-
targeted FAFLP was developed and performed on a subset of isolates. The assay was 
performed with minor modifications to the previously described FAFLP method. Genomic 
DNA was digested with a frequent-cutting endonuclease. FAFLP peR was performed using 
the transposase-specific reverse primers on EcoRI with Msel and HindIII with HhaI ligation 
reactions performed as described previously. PCR products (10 pI) were separated by 
electrophoresis on a 2 % agarose gel (see materials and methods: section 2.3.1). FAFLP PCR 
reactions performed on HindIII with HhaI ligation reactions were separated on an ABI 3730 
sequencer and analysed using GeneMapper software. 
2.5.4. WGM 
WGM was performed on a subset of isolates by OpGen® Inc. (Gaithersburg, USA). In brief, 
bacterial cells were gently lysed using a protocol developed by OpGen® to obtain high 
molecular weight DNA fragments (250 kb or more in size). The DNA molecules were 
restricted with a rare-cutting endonuclease, Noel which recognises the following sequence: 
5' C"'CATGG 3' 
3' GGTAC"'C 5' 
As the DNA was restricted, gaps were formed between the fragments as the molecules were 
stretched taut. The fragments were fluorescently labelled and assigned a size based on the 
fluorescent intensity of each fragment. The order and number of fragments and the size of 
each fragment formed a single molecule map. The single molecule restriction maps were 
aligned to produce a consensus map covering the entire genome (optical map). Analysis of 
the generated optical maps was performed using MapSolverTM software version 3.1. The 
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maps were visualised in the software which displayed the number of restriction fragments, 
their order and location in the genome. Maps were aligned with in silica maps from 21 
WGSs obtained from the NCBI database (Appendix V: Group G). Multiple alignments were 
performed for all isolates of a specific CC, one representative from each CC and amongst 
single isolates of ST8, ST239 and ST30. Fragments unique to one map in the alignment 
were highlighted as were fragments common amongst the optical maps. The MapSolverTM 
software algorithm also highlighted fragments between optical maps, which may indicate an 
inversion event. Cluster analysis was performed on optical maps and in silico maps. 
Comparative genomics was performed to identify fragment patterns unique to each isolate 
and between isolates of a single Cc. Comparison of lineage-specific fragment patterns was 
performed against in silico maps of strains belonging to the same CC to identify possible 
genes and features encoded in these regions. 
133 
CHAPTER 3 
3. Results 
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3.1. S. aureus identification 
3.1.1. 168 rRNA gene sequence determination 
Eight isolates were identified to the species level based on the16S rRNA gene sequence. The 
peR primers amplified approximately 1500 bp of the 16S rRNA gene and each sequencing 
read ranged between 700 to 800 bp. The quality of the reads was determined by the QV20+ 
value (number of bases which have a base caller quality value of ~20), as determined by ABI 
Sequence Scanner software version 1.0 (Life Technologies). Forward and reverse sequencing 
reads were aligned into contigs which were sized between 600 to 700 bp. The eight isolates 
(DBHT 1 to 8) from SRL required confirmatory identification as DBHT 4 and 5 were 
negative for the SCCmec element whilst the other six isolates from the same patient were 
positive. All isolates were confirmed as S. aureus. All positive controls were appropriately 
identified as E. coli whilst no amplicons were detected amongst negative controls. 
3.1.2. Matrix--assisted laser desorption ionization~time-of~flight mass 
spectrometry (MALDI~TOF) 
Spectra were obtained for all 32 isolates analysed with the MALDI mass spectrometer. 
Analysis of the spectra using MALDI Biotyper software identified all isolates as S. aureus. The 
top ten matches to the database for each spectrum were S. aureUSj matches produced a score 
of 2.3 or above. All positive controls were appropriately identified as E. coli whilst no mass 
peaks were detected amongst negative controls. All 32 spectra were analysed for the presence 
and absence of 13 m/z peaks, detailed by Wolters et al (2011), for assignment to one of 15 
MALDI types. Each type corresponded to one of the CCS: CC5, 8, 22, 30 or 45. MALDI 
type assignment corresponded to MLST assignment for 30 of the 32 isolates examined. One 
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of the remaining isolates was assigned to MALDI type m002 which is indicative of ST1, 15 
or 80. However, MLST data assigned this isolate to ST59. The remaining isolate produced a 
MALDI type which was not described in the WoIters et al (2011) study: MLST data assigned 
this isolate to CC672 (Table 11). 
3.2. Characterisation of S. aureus 
3.2.1. Multilocus sequence typing (MLSTI 
Multilocus sequence typing was performed on all 302 isolates by determining the sequence 
of a region within seven housekeeping genes which ranged in size from 402 to 516 bp 
(Enright et al, 2000). Closely related STs are displayed as clusters known as CCs that 
aggregate around the 'founder' type which is the most closely related ST to all of the STs 
within the cluster. Each isolate was assigned to an allelic profile, ST and CC. The 302 
isolates belonged to one of 62 STs which were assigned to 20 CCs and eight singletons 
(Figure 20). Up to eight different STs were identified amongst CCI, 5, 8, 22, 30 and 45. The 
remaining CCs were represented by up to three STs. Of two hundred and thirty-nine isolates 
in this study, 128 were CC22 (42 %),36 were CC30 (12 %),30 were CC8 (10 %),23 were 
CC5 (8 %) and 22 were CC45 (7 %). The remaining isolates belonged to 15 CCS and eight 
Singletons. Twenty-two novel STs were identified amongst the isolates assigned to CCI, 5, 8, 
22, 30, 45 and 59. ST2042 was conferred by a novel combination of seven previously 
described alleles whilst ST2221 was conferred by a profile with four novel alleles out of 
seven. The remaining 20 novel STs displayed a unique allele at one of the seven loci (Table 
12). The gmk primers that were redesigned for this study produced contigs spanning the 
entire target region and enabled the submission of three novel ST s with a novel gmk allele. 
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Table 11. Clonal complex assignment of isolates based on matrix-assisted laser desorption ionization-time-of-flight mass spectrometry types 
m/z values· MAiDI CC/STbased MLST* Isolate typet onMAiDI 
3276 3876 4511 4641 5002 5032 5419 5437 5508 5524 6591 6612 7734 type ST CC 
DBHTl 0 1 0 0 0 1 0 1 0 1 0 1 0 NP NT 361 CC672 
DBHT4 1 1 0 0 1 0 0 1 0 1 0 1 0 moo8 CC22 22 CC22 
DBHT5 1 1 0 0 I 0 0 1 0 1 0 1 0 mOO8 CC22 22 CC22 
DBHT7 I I 0 0 1 0 0 I 0 1 0 1 0 m008 CC22 22 CC22 
DBHTI0 1 1 1 0 0 1 1 0 1 0 1 1 0 m014 CC30 30 CC30 
DBHTI5 0 1 0 0 0 1 0 1 0 1 1 1 0 m009 CCS 8 CC8 
DBHT16 0 1 0 0 0 1 0 1 0 1 1 1 0 m009 CC8 8 CCS 
DBHT17 1 0 0 0 0 1 0 1 0 1 0 I 0 mOO I CC5 5 CC5 
DBHT18 I I 0 0 I 0 0 I 0 1 0 I 0 m008 CC22 22 CC22 
DBHT19 I I 0 0 0 I 0 1 0 1 0 1 0 m002 STl, 15 or 80 1 CCI 
DBHT24 1 1 0 0 1 0 0 1 0 1 0 1 0 m008 CC22 22 CC22 
DBHT26 0 1 0 0 0 1 0 1 0 1 1 1 0 mOO9 CC8 250 CCS 
DBHT32 1 1 0 0 1 0 0 1 0 1 0 1 0 mOO8 CC22 22 CC22 
DBHT36 1 1 1 0 0 1 1 0 1 0 0 1 0 mOl3 CC30 39 CC30 
DBHT39 1 1 1 0 0 1 0 1 0 1 0 0 1 m003 CC45 2032 CC45 
DBHT43 1 0 0 0 0 1 0 1 0 1 0 1 0 mOOl CC5 5 CC5 
DBHT45 1 I 0 0 1 0 0 1 0 1 0 1 0 mOOS CC22 22 CC22 
DBHT51 1 1 1 0 0 I 1 0 I 0 0 1 0 mOl3 CC30 36 CC30 
DBHT54 I 0 0 0 0 1 0 1 0 1 0 1 0 mOO 1 CC5 5 CC5 
DBHT59 1 0 0 0 0 I 0 1 0 I 0 I 0 mOO 1 CC5 5 CC5 i 
DB HT 65 0 1 0 0 0 I 0 I 0 I 1 1 0 m009 CC8 630 CC8 I 
DBHT73 1 I 0 0 0 1 0 1 0 1 0 1 0 mOO2 STl, 15 or 80 15 CC15 ! 
DBHT76 0 1 0 0 0 1 0 1 0 1 I I 0 mOO9 CCS 239 CCS 
DBHT84 1 1 0 0 0 I 0 I 0 I 0 I 0 mOO 2 STl, 15 or 80 1 CCI 
DBHT87 1 I 1 0 0 1 0 1 0 1 0 0 1 m003 CC45 45 CC45 I 
DBHTll~ ,---L __ ~ 0 0 1 0 0 1 0 1 0 1 0 mOOS CC22 22 CC22 
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Table 11 continued. Oonal complex assignment of isolates based on matrix-assisted laser desorption ionization-time-of-flight mass spectrometry types 
m/zvalues . CC/STbased MLST* MALDI Isolate 3276 3876 4511 4641 5002 5032 5419 5437 5508 5524 6591 6612 7734 typet onMALDl ST CC 
type 
DBHT 151 1 1 0 0 1 0 0 1 0 1 0 1 0 m008 CC22 22 CC22 
DBHT204 1 1 0 0 0 1 0 1 0 1 1 1 0 mOlO CC8 8 CC8 
DBHT230 1 1 0 0 0 1 0 1 0 1 0 1 0 m002 STl, 15 or 80 59 CC59 
DBHT236 1 1 1 0 0 1 1 0 1 0 0 1 0 m013 CC30 30 CC30 . 
DBHT242 1 1 1 0 0 1 1 0 1 0 0 1 0 m013 CC30 30 CC30 
DBHT266 1 1 0 0 0 1 0 1 0 1 1 1 0 mOlO CCB 72 CC8 
-~ 
-
• m/ z values, mass to charge ratio. 
tpresence or absence of 13 m/z peaks for assignment of MALDI type (WoIters et a1., 2011). 
*MLST-based assignment to sequence type (Sn and clonal complex (CC). 
W, non-typeable. 
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Figure 20. MLST based clonal complex assignment 
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1 5 6 7 8 9 12 15 20 22 25 30 45 59 80 88 97 101 121 672 ST9 ST4 ST7 ST1 ST2 ST2 ST2 
Clonal complex 3 25 79 093 043 044 221 
. CMPHL 0 1 0 0 0 0 0 0 0 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
• BSAC 5 11 1 3 12 1 1 9 1 99 3 26 16 4 1 0 1 1 3 0 0 1 1 0 1 1 0 
• Glasgow 1 2 0 1 12 0 0 1 0 3 0 4 3 1 1 1 1 0 0 0 1 0 0 1 0 0 1 
• Reference 2 2 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
. SRL 4 7 0 0 5 0 0 0 0 17 0 5 3 3 1 1 1 0 0 2 1 0 0 0 0 0 0 
Displays clonal complex assignment, based on MLST data, amongst isolates from each of five collections. 
·S, singleton sequence type. 
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Table 12. Novel multilocus sequence types identified amongst isolates in this study 
Isolate arcC· glpF yqiL S-rt CC* SCCmec aroE gmk pta tpi 
assignment type 
DB HT 196 10 14 8 6 10 230 2 2025 CC45 N/A§ 
DBHT 211 1 4 1 4 12 231 10 2026 CC5 N/A 
DBHT 13 22 1 14 23 224 4 31 2027 CC88 IVa 
DBHT 37 3 295 1 1 4 4 3 2028 CC8 N/A 
DBHT 53 5 4 1 4 4 6 229 2029 CC7 IVh/F 
DBHT 56 1 3 1 14 11 51 230 2030 CC80 lVe 
DBHT 141 7 6 1 5 8 229 6 2031 CC22 IVh 
DBHT 39 220 14 8 6 10 3 2 2032 CC45 Ng 
DBHT 41 220 14 8 6 10 3 2 2032 CC45 lVg 
DBHT 232 6 298 6 2 7 17 19 2033 CC121 N/A 
DBHT 275 2 297 2 2 6 3 2 2034 CC30 N/A 
DBHT 261 10 14 271 6 10 3 2 2035 CC45 N/A 
DBHT200 1 4 1 4 225 1 10 2036 CC5 N/A 
DBHT 168 7 296 1 5 8 8 6 2037 CC22 IVh 
DBHT 21 7 6 1 5 8 228 6 2038 CC22 IVh 
DB HT 9 1 1 1 159 1 1 1 2039 CC1 N/A 
DBHT 248 1 4 1 161 12 1 10 2040 CC5 N/A 
DBHT 271 19 23 15 2 19 232 15 2041 CC59 N/A 
DB HT 194 8 2 2 27 6 3 2 2042 CC30 N/A 
DBHT 221 36 14 270 150 107 116 105 2043 Singleton N/A 
DBHT228 36 298 43 150 107 116 105 2044 Singleton N/A 
DBHT38 238 2 2 2 6 3 2 2220 CC30 N/A 
DBHT63 23 321 269 161 1 47 231 2221 Singleton N/A 
Novel multilocus sequence types, consisting of novel alleles (highlighted in pink) at one or 
more loci or a unique combination of previously described alleles, were submitted to the 
MLST database. 
Numbers represent allele numbers at one of seven loci (areC; aroB, gipF, gmk, pta, tpi or 
yqiL). 
tST, sequence type. 
tee, clonal complex. 
~/ A indicates isolates were MSSA whilst the remaining isolates were MRSA. 
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The 50 isolates amongst the SRL collection belonged to 20 ST s and were assigned to 11 CCs 
and one singleton; six of the STs were novel. Ninety percent of isolates belonged to one of 
the eight major lineages. The distribution of isolates to eight lineages was as follows: 17 were 
CC22 (34 %), seven were CC5 (14 %), five were CC8 (10 %), five were CC30 (10 %), four 
were CC1 (8 %), three were CC45 (6 %), three were CC59 (6 %) and one was CC80 (2 %) 
(Figure 20). The remaining 10 % of isolates belonged to three CCs and one singleton. Of 
the fifteen isolates assigned to EMRSA-15 by SRL, 13 belonged to CC22 and the remaining 
two were assigned to CC672 (Table 13). Thirty-five of the remaining 50 isolates were non-
typeable, displayed a specific pattern or displayed a distinct pattern. Those isolates where no 
data were available by bacteriophage typing and/or PFGE belonged to one of 10 CCs and a 
singleton ST. 
The Reference collection was assigned to ST1, 5, 36 or 250 and these results were 
concordant with the STs previously described from WGSs (Saunders et al, 2004). The 
Glasgow collection was assigned to 20 STs corresponding to 12 CCS and three singletons; 
three of the STs were novel. For this collection of isolates, 22 isolate (65 %) were assigned to 
one of four CCS: 12 were CC8 (35 %), four were CC30 (12 %), three were CC22 (9 %) and 
three were CC45 (9 %). The remaining isolates belonged to eight CCs and three singleton 
STs. Based on previous PFGE analysis and MLST, five non-typeable isolates belonged to 
three CCs and one singleton, two isolates exhibiting the same PFGE type belonged to CC22 
and 30, and 21 isolates exhibiting distinct PFGE types were assigned to 10 CCs and one 
singleton. Of the 34 isolates, PFGE assigned three to EMRSA-15 (belonging to CC22) and 
four to EMRSA-16 (belonging to CC30). The remaining 27 isolates belonged to 11 CCS and 
three singletons. 
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Table 13. Multilocus sequence typing (MLST) data concordance with Staphylococcal 
Reference Laboratory collection 
Isolate Bacteriophage PFGE result MLSTresult Comments 
number typing results 
DBHTl NT* EMRSA-15 CC672 
DBHT2 NT EM RSA-l5 CC672 
From single patient DBHT3 NT EMRSA-15 CC22 
DBHT4 NT Pattern A CC22 over six months with 
DBHT5 NDt ND CC22 wound abscesses and 
DBHT6 EMRSA-l5 CC22 recurrent NT bacteraemia DBHT7 EMRSA-15 EMRSA-l5 CC22 
DBHT8 EMRSA-15 EMRSA-15 CC22 
DBHT9 Distinct sttain Distinct strain CCl 
DBHT 12 NT Pattern A CC80 
DBHT 13 Distinct strain Distinct strain CC88 
DBHT20 ND EMRSA-15 CC22 
DBHT2l ND EMRSA-15 CC22 
DBHT22 ND EMRSA-15 CC22 
DBHT23 ND EMRSA-15 CC22 
DBHT24 ND EM RSA-l 5 CC22 
DBHT 31 EMRSA-l5 EMRSA-15 CC22 From same hospital DBHT 32 EMRSA-15 EMRSA-15 CC22 
DBHT 33 NT EMRSA-15 CC22 From same hospital DBHT34 NT EMRSA-15 CC22 
DBHT 35 Distinct strain ND CC30 
DBHT 36 Distinct strain ND CC30 From the same 
DBHT 37 Distinct strain ND CC8 hospital ward 
DBHT 38 Distinct strain ND CC30 
DBHT 39 Distinct strain Pattern C CC45 
DBHT40 Distinct strain Pattern A CC5 From same hospital Wide-spread DBHT41 Pattern B CC45 
sporadic strain 
DB HT 42 Distinct strain Distinct strain CC5 From same hospital DBHT43 Distinct strain Distinct strain CC5 
DBHT44 Pattern A ND CC5 From same hospital DBHT45 Pattern A ND CC20 
DBHT46 Pattern A Pattern A CC1 
DBHT47 NT ND CC97 
DBHT48 Distinct strain Distinct strain CC8 
DBHT49 Pattern A ND CC59 From same hospital DBHT50 Pattern A ND CC59 
Clonal complex (CC), based on MLST data, concordance with bacteriophage typing and 
PFGE typing results for the SRL collection which included epidemic MRSA (EMRSA). 
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Distinct strains displayed bacteriophage or PFGE profiles which were different from 
previously obtained profiles. 
ID, non-type able. 
1ND, no data. 
The BSAC collection was assigned to 44 STs which belonged to 18 CCs and four were 
singletons (Figure 20). The 99 MSSA isolates were assigned to 37 STs of which 11 were 
novel SLVs of ST5, 30 or 45. These 37 STs were assigned to 17 CCs and three singletons. 
The 103 MRSA isolates were assigned to 10 STs and two of these were novel SLVs of ST22. 
These 10 STs were assigned to CC5, 22,30,45 or 80 and one was a singleton (Table 14). Of 
the 96 and six isolates assigned to ST22 (48 %) and ST36 (3 %) respectively, the majority 
(~93 %) were MRSA 
Ten isolates, including eight from an lCU outbreak, were obtained from CMPHL. Nine 
isolates (90 %), including six from lCU, were assigned to ST22 (Figure 20). Five isolates were 
identified as EMRSA-15 by bacteriophage or PFGE typing and belonged to ST22. 
The D value for MLST data was 0.817 from the 302 isolates with a Cl of 0.773 to 0.860. 
The D values and Cl values were calculated for individual isolate collections. The Cl values 
overlapped between three collections; no overlap between the Glasgow and BSAC collection 
or the CMPHL and the remaining four collections was observed (Table 15). The D value for 
the BSAC MRSA and MSSA isolates was 0.257 and 0.990 with a Cl of 0.139 to 0.364 and 
0.972 to 1.000 respectively. The Cl values between the BSAC MRSA and MSSA did not 
overlap. 
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Table 14. Distribution of meticillin-resistant S. aureus (MRSA) and meticillin-susceptible 
S. aureus (MSSA) British Society for Antimicrobial Chemotherapy isolates within clonal 
complexes 
CC Prevalence in CC (%) MRSA prevalence (%) MSSA prevalence (%) 
CCl 2 0 5 
CC5 5 1 10 
CC6 1 0 1 
CC7 1 0 3 
CC8 6 0 12 
CC9 1 0 1 
CC 12 1 0 1 
CC15 4 0 9 
1 0 1 
CC22 48 89 8 
CC25 1 0 3 
CC30 13 7 19 
CC45 8 1 15 
CC59 2 0 4 
CC80 1 1 0 
CC97 1 0 1 
CC101 1 0 1 
CC121 1 0 3 
Singleton 2 1 3 
Total (%) 100 100 100 
The table displays prevalence of all S. aureus, MRSA and MSSA assigned to each clonal 
complex (CC) in the BSAC collection. 
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Table 15. Discriminatory power and confidence intervals based on MLST data for five 
collections 
Isolate collection Dvalue Cl value 
SRL 0.878 0.806-0.950 
Reference 0.867 0.738-0.995 
Glasgow 0.948 0.911-0.985 
BSAC 0.761 0.699-0.824 
CMPHL 0.2 0.000-0.504 
The discriminatory power (D) (Simpson, 1949) and confidence interval (Cl) (Grundmann 
et al., 2001) values were calculated based on MLST data amongst isolates obtained from 
each collection. 
3.2.2. Staphylococcal cassette chromosome mec (SCCmed typing 
3.2.2.1. SCCmec Win!: I to V 
Based on the presence of complete or partial SCCmec sequences, 184 of 302 S. aureus 
isolates (60.9 %) were identified as MRSA The majority of MRSA (n-174, 94.6 %) isolates 
belonged to SCCmec types I to V (Figure 21); 128 of these MRSA (73.6 %) were type IV, 23 
(13.2 %) were type 1I, 13 (7.5 %) were type V, six (3.4 %) were type I and four (2.3 %) were 
type Ill. 
Of the eight isolates obtained from the same patient, six belonged to SCCmec type IV and 
no element was detected in the remaining two isolates. To confirm the absence of SCCmec, 
these two isolates along with one other MRSA isolate from the same patient were subjected 
to 10 individual PCRs based on the primers pairs from the multiplex. The MRSA isolate was 
utilised as a positive control. Each of the 10 PCRs yielded no product from either isolate. 
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The positive control produced PCR products in the PCRs targeting the mecA and ccrB2; 
these corresponded to the presence of SCCmec type IV and concurred with the result 
obtained with the multiplex PCR. 
Figure 21. SCCmectype I-V determination based on size variations in SCCmecamplicon 
The figure depicts determination of SCCmec type I-V based on gel electrophoresis of 
amplicons obtained from SCCmec type I-V multiplex PCR. Lane 1, marker (lOO bp 
ladder, Life technologies); Lanes 24, 16, 20, & 24, MSSA; Lanes 5-7, 9, 12-15, 17-18, & 
25, SCCmectype IV; Lanes 8, 11, & 19, SCCmectype II; Lanes 10 & 21, SCCmectype V; 
Lane 22, SCCmec type Ill; Lane 23, SCCmec type VI; Lane 26, negative control. The 
labels on the left indicate the size in base pair (bp) for the 100 bp ladder (Lane 1). 
3.2.2.2. SCCmec IV subtype 
Of the 128 MRSA isolates which belonged to SCCmec type IV, 79 isolates (61.7 %) were 
type IVh, 19 (14.8 %) were IVa and 22 (17.2 %) were non-subtypeable. Subtypes IVb-g 
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constituted the remaining eight (6.3 %) isolates with one to three isolates assigned to each 
subtype (Figure 22). 
Figure 22. SCCmec subtype lVa-h determination based on size variations in SCCmec 
amplicon 
600 bp 
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The figure depicts determination of SCCmec subtype IVa-h based on gel electrophoresis 
of amplicons obtained from SCCmec subtype lVa-h multiplex PCR. Lane 1, marker 
(100 bp ladder, Life technologies); Lanes 2-3,9-10, 15, & 29, SCCmectype lVa; Lanes 4-7, 
11, 14, 16, & 22-23, SCCmec type lVh; Lanes 8, & 19, SCCmec type lVc; Lane 17, 
SCCmectype lVd; Lanes 24 & 25, SCCmectype lVg; Lanes 12-13, & 21, MSSA; Lanes 20 
& 28, ccrB2 positive; Lanes 26 & 27, SCCmec type VI. The labels on the left indicate the 
size in base pair (bp) for the 100 bp ladder (Lane 1). 
The isolates that could not be subtyped produced a single PCR product for the internal 
positive control (ccrB2). Amongst eight isolates from a single patient, two were 
non-subtypeable as no PCR product was obtained from the individual PCRs and the 
remaining six isolates exhibited the presence of SCCmec IVa or IVh subtypes. 
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3.2.2.3. SCCmec-orfX junction 
Sequence determination of the SCCmec-01jX junction was performed to detect the presence 
of a partial or novel SCCmec amongst eight isolates from a single patient. A 1500 bp 
consensus sequence of the orfX and left extremity of SCCmec type IV region was generated. 
PCR primers amplified approximately 1000 bp of this consensus sequence in six of the eight 
isolates and the two remaining isolates, which were non-typeable for the SCCmec type I to V 
and SCCmec type IV multiplex PCRs, produced no amplicon. Three nested primers were 
designed 100 bp into the amplicon sequence and the two reverse primers were designed 600 
and 750 bp into the amplicon sequence. The resultant sequences were assembled into 
contigs up to 814 bp in size. Greater sequence coverage was obtained in five of the six 
isolates using the nested primer pairs (Table 16). 
Table 16. Sequence coverage of SCCmeC"orf.X"junction 
Isolate number SCCmec-cnfX PCR 1 SCCmec-01j'X PCR 2 
DBHT1 399 bp 814 bp 
DBHT2 247 bp 692 bp 
DBHT3 332 bp 807 bp 
DBHT4 N/A* N/A 
DBHT5 N/A N/A 
DBHT6 663 bp 805 bp 
DBHT7 725 bp 717 bp 
DBHT8 387 bp 738 bp 
Sequence determination of the SCCmeC"orf.X"PCR 1 product was performed using PCR 
primers whilst amplicons from the SCCmeC"orf.X" PCR 2 were sequenced using nested 
primers. Greater sequence coverage was obtained in majority of the isolates using nested 
primers. 
*NI A, not applicable. 
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The contigs were aligned against the 1500 bp consensus sequence and BlAST analysis 
revealed that the contigs covered approximately 480 bp of the or/X and 520 bp of the left 
SCCmec type IV region (Figure 23). This confirmed the presence of SCCmec type IV in six of 
the eight isolates and partial or complete SCCmec elements were not identified in the two 
remaining isolates. Alignment of SCCmec-or/X junction sequences revealed this region was 
highly conserved among these six isolates. These six isolates belonged to either CC22 or 
CC672j SNPs, insertions or deletions were not observed in the sequences. 
Figure 23. Region depicting the orIX and the left extremity of SCCmec 
Obp 100bp 200 bp 300 bp 400 bp 500 bp 600 bp 700 bp BOO bp 900 bp 1000 bp 
\ 1 , I , 
or/X SCCmec 
Red arrows indicate the annealing sites and direction of amplification for three nested 
primers utilised to sequence this region. 
3.2.2.4. orfX amplification 
The presence of an intact or/X was investigated in eight isolates from a single patient. A 
consensus sequence sized 480 bp from SCCmec type I to V data were used to design primers. 
A forward primer was designed 24 bp into the consensus sequence whilst a reverse primer 
was designed at 480 bp. A PCR amplicon approximately 480 bp in length was amplified 
from the eight isolates. 
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3.2.2.5. SCCmec type VI to VIII 
The presence of SCCmec types VI to VIII was sought in three isolates from SRI.., which were 
previously non·typeable using the SCCmec type I to V and SCCmec type IV multiplex PCRs. 
The three isolates (DBHT 28, 42 and 43) generated am pi icons for mec class B, cerB4 and cer 
type 4 which corresponded to the presence of SCCmec type VI. 
3.2.2.6. SCCmec non·typeable isolates 
The SCCmec type present in thirteen isolates from this study were not identified using the 
above SCCmec typing methods. Two multiplex PCRs enabled the assignment of the cer 
complex type and mec class (Kondo et al, 2007). One isolate belonged to SCCmec type VI, a 
combination of mec class and cer complex type which did not correspond to a SCCmec type 
were identified in six isolates and a further six isolates which were negative for the presence 
of the mecA gene were assigned as MSSA (Table 17). 
3.2.2.7. SCCmec data concordance with MLST data 
The 184 MRSA isolates belonged to 12 CCs and two singleton STs. The largest number of 
different SCCmec types were identified amongst CC22 and CC8 isolates (Figure 24). One 
hundred and eighteen MRSA isolates (64 %) were assigned to CC22; 107 (91 %) of the 
CC22 MRSA isolates belonged to SCCmec type IV. Twelve (7 %) of the MRSA isolates 
belonged to CC30 and 11 (92 %) of these were assigned to SCCmec type II. A non.typeable 
SCCmec element was identified in six isolates assigned to CC8, 22 or a singleton ST. 
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SCCmee type IV non-subtypeable elements were detected in isolates belonging to CC22 and 
97. The D and Cl value was calculated for isolates assigned to the six CCs: CCl, 5,8, 22,30 
and 45 (Table 18). The calculated Cl values overlapped between CCl, 5, 8 and 45. The Cl 
values for CC22 or CC30 overlapped only with those for CCl. 
Table 17. Results of SCCmecnon-typeable isolates 
Isolate number Amplicons SCCmee assignment 
DBHT4 No amplicon MSSA 
DBHT5 No amplicon MSSA 
DBHT29 mee class B, mee internal control, ecr type 4 SCCmee type VI 
DBHT66 No amplicon MSSA 
DBHT67 meeA internal control, med, ecr type 3 and ecrC SCCmee non-type able 
DBHT81 No amplicon MSSA 
DBHT 117 ecr type 4, mee internal control SCCmee non-type able 
DBHT 157 cere, eer type 4, mee internal control SCCmee non-type able 
DBHT 163 mee internal control SCCmee non~eable 
DBHT 167 ecr type 4, mec internal control SCCmec non-typeable 
DBHT 176 ecr type 4, ccrc, mec internal control and mec SCCmec non-type able 
class C 
DBHT295 ccr type 4 MSSA 
DBHT297 ccrtype 4 MSSA 
PCR amplicons generated from a previously described multiplex PCRs (I{ondo et al., 
2007). 
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Figure 24. Distribution of SCCmec types in each clonal complex for all isolates in the study 
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The figure displays the distribution of SCCmec types amongst isolates assigned to each clonal complex (CC) or singleton sequence types (S) in relation 
to one of five isolate collections. CC assignment was based on MLST data. 
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3.2.2.8. Analysis of SRL collection 
Of the 50 SRL isolates, 41 were MRSA and nine MSSA MRSA isolates belonged to five 
types of SCCmec (I, Il and IV·VI) and those which were assigned to SCCmec type IV were 
subtyped into SCCmec type IVa, e, d, g, h or were non-subtypeable. The majority of isolates 
(n=23, 46 %) belonged to SCCmec type IV and six isolates (12 %) were assigned to type V. 
The 41 MRSA isolates belonged to 11 CCs which included CC5, 8, 22, 30 and 45. MRSA 
isolates assigned to a single CC exhibited one and eight SCCmec types (Figure 24 ). Ten 
isolates (24 % of MRSA) belonged to ST22·IVh. Majority of the remaining 31 isolates each 
belonged to a unique CC and SCCmec type combination. Twelve of the isolates from this 
collection were assigned as EMRSA-15 (ST22·MRSA-IV) and none as EMRSA-16 (ST36-
M RSA-II). Of the eight isolates from a single patient, two were assigned to ST361·MRSA-
IVa, four to ST22·MRSA-IVh and two were MSSA isolates assigned to ST22. Of the 15 
isolates assigned to EMRSA-15 by bacteriophage typing and/or PFGE, 12 were confirmed as 
EMRSA-15 by MLST and SCCmec typing, two were ST361 and one was a SLY ofST22. 
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Table 18. Discriminatory power and confidence intervals based on SCCmec data amongst 
isolates from six clonal complexes 
CC Dvalue Cl value 
eCl 0.652 0.404-0.899 
eC5 0.788 0.639-0.937 
CC8 0.886 0.815-0.956 
CC22 0.530 0.433-0.627 
CC30 0.167 0.000-0.433 
eC45 0.933 0.805·1.000 
The discriminatory power (D) (Simpson, 1949) and confidence interval (Cl) (Grundmann 
et al., 2001) values were calculated based on SCCmecdata amongst isolates obtained from 
six clonal complexes (CC). 
3.2.2.9. Analysis of Reference collection 
Five of the six reference strains were confirmed as MRSA and one was an MSSA The COL 
strain was assigned to ST250·MRSA-l, the strains N315 and Mu50 were ST5·MRSA-Il, 
MRSA252 belonged to ST36-MRSA-ll (EMRSA-16), MW2 was ST1·MRSA·lVa and 
MSSA476 belonged to ST1·MSSA (Kuroda et al, 2001; Baba et al, 2002; Holden et al, 
2004; Gill et aL, 2005). 
3.2.2.10. Analysis of Glas~ow collection 
From the Glasgow collection of 34 isolates, 27 were MRSA and seven MSSA The MRSA 
and MSSA assignment was concordant with previously performed MlCs for oxacillin and 
mecA PCR (performed by SRL). SCCmec was not identified amongst four isolates which were 
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meticillin resistant, based on oxacillin MICs or mecA PCR. Twenty-seven MRSA isolates 
were assigned to four SCCmec types (II to V) and one non-type able element. The majority of 
MRSA isolates (n= 12, 35 %) belonged to SCCmec type IV whilst five (15 %) isolates 
belonged to SCCmec type II and V each. The 12 isolates assigned to SCCmec type IV were 
subtyped as IVa-c, IVe, IVh or were non-subtypeable. The three isolates assigned as EMRSA-
15 by PFGE were ST22-MRSA-IV. Of the four isolates assigned as EMRSA-16 by PFGE, 
three were ST36-MRSA-II. The remaining isolate was assigned to ST36 but no SCCmec was 
detected. Amongst MRSA isolates assigned to a single CC, between one and five SCCmec 
types were identified (Figure 24). The remaining isolates (74 %) belonged to a unique CC 
and SCCmec type combination. 
3.2.2.11. Analysis of British Society for Antimicrobial Chemotherapy collection 
The BSAC collection constituted 99 MSSA isolates and 103 MRSA isolates based on 
SCCmec typing. These results were concordant with previously performed MICs 
determinations for oxacillin and the mecA PCR (BSAC, 2010). The MRSA isolates belonged 
to one of three SCCmec types (12 isolates belonged to type n, 85 were type IV and one was 
type V) or five were non-typeable. The 85 SCCmec type IV isolates were subtyped as IVa 
(na 7), IVh (nc 66) or were non-subtypeable (no: 12). The MRSA isolates belonged to five CCs 
and one singleton ST. Sixty-six MRSA belonged to ST22-IVh and majority of the remaining 
37 isolates each belonged to a unique CC and SCCmec type combination (Figure 24). The 
presence of an SCCmec type II element was significantly associated withCC30 isolates as 
compared to CC22 isolates whilst SCCmec type IV was significantly associated withCC22 
isolates as compared to CC5, 30 and 45. 
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Of 87 BSAC isolates from 2009, 81 (79 %) isolates were assigned to EMRSA-15 whilst six 
(6 %) were EMRSA-16. Sixty-four (79 %) EMRSA-15 isolates were assigned to SCCmec IVh 
whilst the remaining isolates belonged to subtype IVa (five isolates) or were non-sub-typeable 
(12 isolates). Of the 16 (15 %) MRSA isolates not assigned to EMRSA-15 or -16, eight were 
ST22 (with SCCmec type lI, V or was non-type able) and three were SLVs of ST22 (ST954, 
ST2031 and ST2037 with SCCmec type IVa or IVh). Amongst five of the remaining 16 
isolates, one was ST5 (with SCCmec II), one isolate was ST80 (with SCCmec Na) and one 
was ST45 (with SCCmec II), one was ST779 (with a non-type able SCCmec) and one was a 
SLY ofST30 (ST1621 with SCCmec II). 
A higher percentage (~95 % confidence) of CC22 isolates displayed resistance to 
ciprofloxacin, oxacillin and piperacillin-tazobactam as compared to isolates assigned to CC5, 
8 and 15. Resistance to ciprofioxacin, erythromycin and piperacillin-tazobactam was 
common amongst the EMRSA-15 and ·16 isolates as previously described (Ellington et 
al,2010; Hope et aL, 2008). Statistical analysis based upon antimicrobial resistance and 
SCCmec data were performed on one representative of a specific lineage from each centre to 
reduce the association between isolates. Antimicrobial resistance and SCCmec data were 
compared between lineages and 95 % Cls were calculated using Stata software using the 
Clopper·Pearson method (Clopper & Pearson, 1934). However, this reduced the number of 
isolates belonging to each CC. In addition, one isolate from this subset was chosen at 
random as a representative of a specific lineage; the results were therefore variable and 
dependent on the isolate selected. Significant differences could not be identified amongst 
the other lineages due to broad 95 % CIs owing to the low number of isolates. Resistance to 
glycopeptides (teicoplanin and vancomycin) was not identified amongst isolates in this study 
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3.2.2.12. Analysis of Clinical Microbiology and Public Health Laboratory collection 
Of the ten isolates from CMPHL, eight were MRSA and two MSSA Of the nine ST22 
isolates, seven belonged to SCCmec type IV, one belonged to SCCmec type V and one isolate 
was MSSA The single ST5 isolate was an MSSA Of the eight isolates from the leU 
outbreak, one belonged to ST5 and the remaining seven isolates were EMRSA-15. 
The D value was 0.772 for SCCmec data from all isolates with a Cl value of 0.720 to 0.823. 
The D value and Cl for isolates from five collections were calculated. The Cl values 
overlapped between the SRL, Reference and Glasgow collection. The Cl values also 
overlapped between the Reference, BSAC and CMPHL collections. The Cl values of the 
SRL and Glasgow collection did not overlap with the Cl values of the BSAC and CMPHL 
collection (Table 19). 
Table 19. Discriminatory power and confidence interval based on SCCmec data amongst 
isolates from five isolate collections 
Isolate collection Dvalue Cl value 
SRL 0.871 0.821-0.920 
Reference 0.700 0.349·1.000 
Glasgow 0.892 0.847-0.936 
BSAC 0.563 0.458.Q.667 
CMPHL 0.250 0.000-0.600 
The discriminatory power (D) (Simpson, 1949) and confidence interval (Cl) (Grundmann 
et al., 2001) values were calculated based on SCCmecdata amongst isolates obtained from 
each collection. 
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3.2.3. spa typing 
Seventy-four MRSA isolates from three collections (SRL, Reference and Glasgow) were 
investigated using spa typing. Only a subset of the isolates were analysed to indicate the level 
of heterogeneity at this locus and to determine its concordance with MLST data. spa 
amplicons ranging in size from 250 to 900 bp were obtained from 73 isolates which were 
assigned to 39 spa types; the remaining isolate was non-type able (Figure 25). The most 
common spa types were t032 and t037. Six and five isolates were assigned to spa type t032, 
containing 16 repeats and t037, with seven repeats respectively. The number of repeats in 
each spa type varied from 3 (in t026) to 16 (in t032). Three isolates were assigned to two 
novel spa types; two were t9238 whilst one was t9239 (Appendix VI). 
The 73 spa-type able isolates were assigned to 12 CCS and one singleton including CC5, 8, 
22, 30 and 45. Forty-three isolates (59 %) belonged to CC5, 8 and 22. Isolates of CC5 and 
22 exhibited diverse spa types (Figure 26). CC8 and 45 isolates exhibited five and four 
different spa types respectively whilst CC1 and 30 isolates exhibited three different spa types 
each. Isolates assigned to the remaining lineages belonged to up to two different spa types. 
Isolates assigned to the novel spa types t9238 and t9239 belonged to CC22 and 30 
respectively. Cluster analysis was performed on spa sequences using the UPGMA method. 
Based on MLST data, a 90 % similarity cut-off was applied to the spa dendrogram. Twelve 
spa clusters were identified among 69 MRSA isolates and the remaining four isolates 
exhibited divergent spa sequences (> 10 % difference) (Figure 26). 
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Figure 25. spa type as determined by size variations in spa amplicon 
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The figure depicts determination of spa type based on gel electrophoresis of amplicons 
obtained from spa typing peR. Lane 1, 100 bp ladder; Lane 2, spa type tl86; Lane 3,spa 
type t032; Lane 4, spa type t026; Lane 5, spa type t026; Lane 6, spa type t037; Lane 7, spa 
type t032; Lane 8, spa type t008; Lane 9, spa type t032; Lane 10, spa non.typeable; Lane 
11, spa type tOO8; Lane 12, spa type tl08t. 
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Figure 26. Dendrogram derived from spa data using Unweighted Pair Group Method 
with Arithmetic mean (UPGMA) cluster analysis 
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Based on 90 % similarity cut-off (shown as a vertical black line), 12 spa clusters were 
identified (shown as black numbers 1 to 12). The clonal complex and spa type of isolates is 
shown on the right of the cluster number. Isolates with identical spa profiles and CCs are 
boxed together. 
Cluster 1 grouped six isolates which belonged to CC672, 5 and 30 and exhibited five 
different spa types. The two isolates in cluster 2 and cluster 8 were assigned to CC45 and 5 
respectively; each isolate belonged to unique spa types. Of the nine isolates in cluster 3, five 
belonged to CC8 and exhibited spa type t037 and four isolates belonged to CC30 and 
exhibited spa type t018. Cluster 4 consisted of five isolates; two belonged to CCl and 
exhibited spa type t128, one to CC30 exhibited spa type t019, and two to the singleton ST93 
exhibited spa type tZ02. The isolates within cluster 5 belonged to five CCS, two CC97 
isolates belonged to spa type t267 and t1236 whilst isolates assigned to the four CCs 
exhibited four spa types. Clusters 6, 9 and 10 consisted of isolates belonging to CC22 which 
exhibited six distinct spa types. Of the six isolates within cluster 7, three isolates were CC59 
and exhibited spa type t3l6 whilst the remaining three isolates (CC8 or CC80) exhibited 
individual spa types. The seven isolates in cluster 11 belonged to diverse CCs (CCl, 8, 45 
and 80). The two CCl isolates had spa type t127 and the three CC8 isolates belonged to 
t190; the individual isolates belonging to CC45 and 80 exhibited individual spa types. The 
three isolates in cluster 12 were assigned to CC5 or 45 and belonged to the spa type t026. 
Four isolates belonging to CCl, 5,22 and 88 exhibited divergent spa sequences. 
The D and Cl values based on spa data were calculated for isolates from six CC; Cl values 
overlapped between the six CCs (Table 20). 
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Table 20. Discriminatory power and confidence intervals of spa data from isolates of six 
clonal complexes 
CC Dvalue Cl value 
CC1 O.BOO 0.657.().943 
CC5 0.B91 0.733-1.000 
CCB 0.791 0.689.().B92 
CC22 0.B43 0.744'().941 
CC30 0.600 0.215.().985 
CC45 0.900 0.724-1.000 
The discriminatory power (D) (Simpson, 1949) and confidence interval (Cl) (Grundmann 
et al., 2001) values were calculated based on spa data amongst isolates obtained from six 
clonal complexes (CC). 
3.3. Genetic diversity in the whole genome 
3.3.1. Preliminary fluorescent amplified fragment length polymorphism 
(FAFLP) analysis 
FAFLP was utilised to assess the degree of genetic diversity between isolates belonging to the 
same CC. DBHT 1 to 30 were analysed using four endonuclease combinations: EcoRI with 
Msel, HindlII with HhaI, EcoRI with HhaI and BglIl with Csp61. Various selective and 
non-selective primer combinations were utilised for amplification of the restricted fragments. 
FAFLP analysis using the primer combinations HindIII+A and HhaI+T, EcoRI+O and 
HhaI+A, BglII+O and Csp6I+T, and BglIl+O and Csp6I+C was successful for all isolates 
analysed. FAFLP using the remaining three primer combinations (EcoRI+O and Msel+C, 
BglIl+O and Csp61+A, and BglIl+O and Csp61+G) was successful for up to 26 of the 30 
isolates. The remaining isolates generated profiles with less than 34 AFs which indicated a 
162 
failure in FAFLP digestion, ligation or in the PCR reaction. Therefore FAFLP using these 
three primer combinations was not successful for all isolates. 
The number of AFs in each profile indicated the number of loci sampled in the genome. 
Chi-squared analysis of the total number of AF markers, the number of markers common to 
all profiles and the number of polymorphic markers amongst profiles differed significantly 
amongst each of the primer combinations (99.99 % confidence). Among the profiles 
generated with the different primer combinations, profiles produced with EcoRI +0 and 
MseI +C were composed of the least number of polymorphic or total AF markers. This 
primer combination sampled fewer loci and therefore was likely to display less 
discriminatory power. The largest number of AFs and those that were common or 
polymorphic were generated using the primers EcoRI+O and HhaI+A Although the 
discriminatory power of a technique increases as the number of loci sampled increases the 
possibility of errors due to factors such as homoplasy and collision also increase (Gort and 
van Eeuwijk, 2012). Therefore a primer combination that generated profiles displaying 
sufficient discriminatory power was sought. All profiles generated with each of the primer 
combinations displayed a greater number of fragments between 50 to 300 bp than between 
300 to 600 bp and each FAFLP profile covered between 0.40 to 1.33 % of the genome 
(Table 21). Profiles were required which displayed an approximately uniform spread of a 
large number of AFs to reduce the chances of errors due to homoplasy and collision. 
Comparative analysis of AFs generated from each of the different primer combinations was 
performed amongst isolates belonging to one of seven major CCs (CC1, 5, 8,22,30,45 and 
59). The presence of each AF was classified as follows: a) AFs present in all isolates, b) AFs 
present in all isolates of one or more lineages, c) AFs present exclusively in isolates of a 
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specific lineage or d) AFs polymorphic amongst isolates of one or more lineages (Table 22). 
Factors relating to the success of a particular lineage may be encoded on regions which 
generated lineage-specific AFs. Lineage-specific AFs were defined as AFs present in ~95 % of 
isolates of a single lineage and present in <5 % of the isolates of other lineages. Using these 
criteria, lineage-specific AFs were identified using all primer combinations with the 
exception of EcoRJ+O with MseJ+C. The primer combinations BglU+O with Csp6J+T and 
BgllI+O with Csp6J+C identified the greatest number of CC1-specific AFs. Profiles generated 
with the primer set BglII +0 with Csp6J +C displayed the largest number of CC5 and 
22-specific AFs. BglII+O with Csp6I+A profiles generated the largest number of 
lineage-specific AFs amongst CCB isolates. From this initial analysis it was concluded the 
BglII + X and Csp6J + X primer combination displayed reasonable discriminatory power 
between lineages whilst reducing the possibility of errors to homoplasy and collision. 
However as multiple BglII +0 and Csp6J + X primer combinations displayed reduced 
typeability a larger set of isolates were examined using numerous BglU+X and Csp6I+0 
primer combinations. 
Isolates 1 to 50 from SRL were examined with the BglU+X and Csp6I+0 primer combination. 
FAFLP with the primer combinations BglII+T with Csp6J+0 and BglII+A with Csp6J+0 was 
successful for all isolates analysed. Of the 50 isolates analysed using the primers BglU +C with 
Csp6J+0 and BglU+G with Csp6J+O, 14 and 20 isolates respectively produced profiles with 
peaks of low signal intensity and were eliminated from further analysis. Profiles generated 
using the primers BglII+A and Csp6J+0 displayed an approximately uniform spread of AFs 
between 50 to 600 bp. Conversely, majority of the AFs (84 %) within profiles generated 
using the primers BglII+C and Csp6I+0 were <300 bp (Table 21). 
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Table 21. FAFLP profile characteristics with different primer combinations 
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Bgl1I+O and 66 to 94 71 29 20 228 248 0.69% Csp6I+A 
Bglll+O and 53 to 105 65 35 19 277 296 0.62% Csp6I+C 
BglU+O and 55 to 99 73 27 16 254 270 0.67% Csp6I+G 
BglU+O and 64 to 119 61 39 20 294 314 0.94% Csp6I+T 
BglU+Aand 47 to 123 56 44 14 256 270 0.56% Csp6I+0 
BglU+C and 50 to 147 84 16 7 307 314 0.56% Csp6I+0 
Bgl1I+G and 40 to 85 67 33 9 255 264 0.46% Csp6I+0 
Bglll+Tand 59 to 131 74 26 24 285 309 0.61 % Csp6I+0 
EcoRI+O and 106 to 159 57 43 35 335 370 1.33 % HhaI+A 
EcoRI+O and 30 to 56 63 37 11 126 137 0.40% MseI+C 
HindIII+A 68 to 137 58 42 19 335 354 0.96% 
and HhaI+T 
'Multiple primer combinations were used in preliminary FAFLP experiments to assess the 
suitability of the endonuclease and primer pair on all study isolates. 
trndicates number of amplified fragments (AFs) and the distribution of AFs in FAFLP 
profiles generated from one of eleven primer combinations. 
*The total number of AFs and the number of these which were common (present ~95 % 
of isolates) or polymorphic (present <5 % of isolates) amongst all isolates. 
%e percentage of the genome sampled using each primer combination. 
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Table 22. Number of AFs identified for each primer combination amongst seven clonal 
complexes 
Clonal complex 
FAFLP 
0 0 0 0 0 0 0 PCR 0 0 0 0 0 0 0 N 1..;.1 ....,. I..rt 
...... I..rt co N 0 I..rt \0 
CommonAFs 
- -
60(20) 48(20) 
- - -
BglII+O Lineage-specific 3 4 
and - - · · -AFs 
Csp6I+A Polymorphic 47 99 
-
. 
· · · AFs 
CommonAFs 45(19) 51(19) 44(19) 43(19) 
· · -
BglU+O Lineage-specific 
4 3 1 9 
· · · and AFs 
Csp6I+C Polymorphic 38 65 80 141 
- - · AFs 
CommonAFs 
-
52(16) 60(16) 48(16) 
- · · 
BglII+O Lineage-specific 2 2 4 
and - · - -AFs 
Csp61+G Polymorphic 59 56 85 
· - - -AFs 
CommonAFs 80(20) 76(20) 67(20) 61(20) 
- · · 
BglII+O Lineage-specific 
4 2 1 4 
- · · and AFs 
Csp61+T Polymorphic 38 64 59 90 
- · · AFs 
CommonAFs 22(14) 19(14) 20(14) 19(14) 16(14) 19(14) 29(14) 
BglII+A Lineage-specific 0 1 1 1 3 6 6 
and AFs 
Csp6I+0 Polymorphic 9 26 61 18 24 14 7 AFs 
CommonAF"s 39(7) 32(7) 28(7) 30(7) 35(7) 36(7) 
-
BglU+C Lineage-specific 1 0 1 5 1 1 
-and AFs 
Csp6I+0 Polymorphic 61 140 133 185 112 99 
· AFs 
CommonAFs 34(9) 26(9) 32(9) 30(9) 28(9) 
- -
BglU+G Lineage-specific 2 1 0 6 5 
and - · AFs 
Csp6I+0 Polymorphic 41 87 88 88 48 
- -AFs 
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Table 22 continued. Number of AFs identified for each primer combination amongst 
seven clonal complexes 
Clonal complex 
FAFLP (') (') (') () () () () 
PCR () (') () () (') () () N \j.) ~ \Jl 
-
\Jl 00 N 0 \Jl \0 
CommonAFs 58(24) 48(24) 39(24) 45(24) 56(24) 
-
62(24) 
BglII+T Lineage-specific 1 1 0 4 2 2 
and AFs -
Csp6I+0 Polymorphic 
49 67 119 97 59 19 AFs -
CommonAFs 97(35} 90(35) 107(3 86(35) 5) - - -EcoRI+O 
Lineage-specific 
and 2 2 1 5 
· - -
HhaI+A AFs 
Polymorphic 48 82 57 158 
- - -AFs 
CommonAFs 16(11) 18(11) 
-
26(11} 
· - · 
EcoRI+O Lineage-specific 0 0 0 
and - · - -AFs 
Msel+C Polymorphic 62 47 88 . 
· · · AFs 
CommonAFs 62(19} 56(19} 62(19} 55(19) 
· - · 
HindIIl+ Lineage-specific 0 1 0 4 
· · · A and AFs 
HhaI+T Polymorphic 72 89 81 185 AFs - · · 
Number of amplified fragments (AFs) common to isolates of each lineage, polymorphic 
amongst isolates of each lineage and specific to isolates of each lineage identified amongst 
profiles from each of eleven FAFLP primer combinations are displayed. Numbers in 
brackets indicate the number of AFs common to ~95 % of all isolates. 
The greatest number of lineage-specific AFs were identified amongst profiles generated using 
the primers Bgm+A and Csp6I+O (n-18), although Bgm+G with Csp6J+O profiles generated 
the largest number of lineage-specific AFs (n-5) amongst CC30 isolates. Amongst those 
isolates assigned to CC45 and 59, the greatest number of lineage-specific AFs (n-6) were 
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identified from BglII+A with Csp6I+0 profiles. Of alllineage-specific AFs identified with each 
primer combination, the largest proportion of AFs (up to 80 %) were specific to CC22 in 
the majority of combinations (Table 22). These findings indicated the BglU+A and Csp6I+0 
primer combination identified the greatest degree of heterogeneity between lineages. 
3.3.1.1. Cluster analysis 
Eleven dendrograms were generated for data from each of the primer combinations (data 
not shown). Based on FAFLP data from each primer combination with the exception of 
BglU+A and Csp6I+0 data, each isolate exhibited a unique profile. Based on MLST data, a 
70 % similarity cut~ff was applied to the dendrograms (Table 23). 
Table 23. Summary of FAFLP dendrograms based on 11 primer combinations 
No. of 
Clonal complex 
FAFLP No. of divergent n n n n n peR clusters n n n () n () n n profiles n n n N I.H ..;.. Vl 0\ 
-
Vl 00 N 0 Vl \0 -.,J N 
EcoRI+O 
and 8 4 N/A· N/A N/A N/A N/A N/A N/A N/A 
Msel+C 
EcoRI+O 
and 5 12 26 37 28 N/A 36 42.5 N/A 17 
HhaI+A 
HindIII+A 
and 5 20 N/A 50 49 59 52 N/A N/A 46 
HhaI+T 
BglII+O 
and 4 10 19 42 36 51 40 N/A N/A 21 
Csp6I+A 
BglII+O 
and 5 13 24 36 40 50 38 N/A N/A 21 
Csp6I+T 
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Table 23 continued. Summary of FAFLP dendrograms based on 11 primer combinations 
No. of 
Clonal complex 
FAFLP No. of divergent () () () () () PCR clusters () () () () profiles () () g () () () () 0\ N VJ ~ \J\ 
-
\J\ N 0 \J\ \0 -.J N 
BglII+O 
and 5 17 41 45 28 48 47 N/A N/A 24 
Csp6I+C 
Bglll+O 
and 3 16 27 42 37 35 33 N/A N/A 42 
Csp6J+G 
Bglll+T 
and 8 16 33 39 30 45 33 31 18 43 
Csp6J+0 
BglII+C 
and 3 30 47.5 59 N/A 58 58 61 55 N/A 
Csp6I+0 
BglII+G 
and 1 26 44 44 N/A 52 51 52 N/A 31 
Csp6I+O 
BglII+A 
and 11 8 20 36 33 29 34 35 18 0 
Csp6I+0 
Based on a 70 % similarity cut-off, the numbers of clusters and divergent profiles amongst 
dendrograms generated from one of 11 primer combinations is displayed. In addition, the 
percentage divergences displayed amongst isolates of each of eight clonal complexes are 
shown. 
NI A indicates only single representative of a clonal complex present or isolates of the 
same clonal complex not found in a single cluster. 
Dendrograms based on data from primer combinations BglII+A with Csp6I+0 and BglU+T 
with Csp6I+0 grouped isolates belonging to each of the major lineages. Therefore the 
divergence between each of these lineages was identified based on these two dendrograms. In 
addition, the dendrogram based on BglII+A and Csp6I+0 data exhibited the greatest number 
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of clusters and the least number of divergent profiles (>30 %). Based on the findings of 
cluster analysis and the initial results of FAFLP profiles, FAFLP analysis was performed on 
all isolates using the primer combination BglII+A and Csp6I+O. 
3.3.2. FAFLP analysis 
3.3.2.1. BglII+A and Csp6I+0 FAFLP analysis 
FAFLP analysis using the primers BglU+A with Csp6I+0 was performed on all isolates in this 
study. FAFLP profiles of the 302 isolates exhibited between 35 and 123 AFs. Based on 
reprodUcibility studies, profiles from the same isolate displayed >98 % similarity. Of the AFs 
in each profile, 59 % of the AFs were less than 300 bp in size and 41 % were between 300 
and 600 bp based on the mean. The mean genome size calculated from 19 WOSs was 
2849090 bp; based on this, each profile covered approximately 0.54 % of the genome. 
Amongst the 302 isolates in this study, a total of 512 precisely-sized AFs were identified. The 
majority of AFs (500 AFs, 98 %) were polymorphic among the profiles from 302 isolates. 
The remaining 12 AFs (CI-C12) were common to ~95 % isolates (Table 24). Fragments 
similar in size to the common AFs were identified via in silico analysis of WGSs. Three of the 
common AFs (Cl, C6 and C12) could not be mapped to WGSs due to the presence of 
multiple AFs within ±3 bp of the expected AF size amongst in silico profiles. In silico analysis 
of one other AF (F9) revealed the absence of AFs sized within ±3 bp of the expected size. 
Therefore the sequence and function of these four AFs could not be discerned. The 
sequences and putative functions of the remaining eight common AFs were determined via 
in silico analysis. BIAST search results of these eight sequences revealed they encoded 
essential cell functions. The sequence for fragment C2 partially encoded the codY gene which 
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acts as a transcriptional repressor. Fragment C3 encoded an enzyme involved in the 
catabolism of glycerol whilst C10 encoded an enzyme required for the metabolism of 
pyruvate. The sequence of C7 encoded a protein essential for the transfer of a phosphate 
group to and from adenosine triphosphate. C4 and CB encoded enzymes required for cell 
division or nitrogen fixation in other species of bacteria. 
The percentage similarity of each of the eight AF sequences (C2-C5, C7-C8, C1Q..C11) was 
calculated amongst 10 WGSs. Seven of the eight sequences displayed 97 % to 100 % 
conservation. One sequence (C5) displayed 77 % similarity amongst the 10 WGSs and 
represented the region between two ORFs. With the exception of this sequence, the 
remaining seven sequences were within an ORF. 
A search was performed for AFs present in ~95 % of all MRSA or MSSA isolates and <5 % 
of the remaining MSSA or MRSA isolates respectively. However, no AFs were exclusive to all 
FAFLP profiles of MRSA or MSSA isolates. AFs present in FAFLP profiles of the majority of 
isolates (~95 %) from each collection were identified as common AFs. Those AFs which 
were present in the majority of isolates from one collection and in <5 % of the remaining 
isolates were identified as AFs exclusive to a specific isolate collection. The remaining AFs 
amongst isolates from each collection were termed polymorphic as differences in the 
presence or absence of these AFs are due to sequence variations. Amongst isolates obtained 
from the five collections 19, 12, 13,21 and 16 common AFs (including the 12 AFs common 
to all S. aureus) were identified within isolates obtained from SRL, BSAC, Glasgow, 
Reference and CMPHL collection respectively. No AFs were exclusive to isolates from a 
single collection. 
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Table 24. AFs common amongst the 302 isolates in this study 
AF" Size of Presence in In silico BlAST search result of sequence of AP 
number AF (bp)" isolates (%)t AF size* 
Cl 65 99.01 N/AII N/A 
C2 79 99.01 58 Transcriptional repressor CodY 
C3 114 98.01 92 Dihydroxyacetone kinase subunit DhaK 
C4 152 99.34 129 DNA translocase (FtsK/SpoIIIE family) 
C5 160 97.35 140 Region between two open reading frames 
C6 189 99.01 N/A N/A 
C7 227 98.01 204 Phosphoglycerate kinase pgk 
C8 254 99.01 231 Aminotransferase N ifS 
C9 281 98.34 N/A N/A 
ClO 313 96.36 292 2-oxoisovalerate dehydrogenase 
C11 314 98.68 294 Hypothetical protein 
C12 392 95.03 N/A N/A 
·Size of amplified fragments (AFs), generated using FAFLP analysis with primers BgllI+A 
and Dp6I+O, common to ~95 % of isolates. 
Trevalence of common AF amongst all isolates. 
*Size of AF detected via in silico analysis in ALFIE 
(http://www.hpa-bioinformatics.org.uklcgi-bin/ALFIE/index.cgi). 
§BLAST search result of common AF sequences in the NCBI database 
(http://www.ncbi.nlm.nih.govj). 
I IN/ A., not applicable. 
3.3.2.2. ReprodUcibility srudies 
The reproducibility of the assay was evaluated by performing FAFLP analysis in duplicate on 
18 isolates. FAFLP analysis was performed from the same DNA preparation and from two 
different DNA preparations. FAFLP profiles generated from the same DNA preparation 
displayed 100 % identity. FAFLP profiles from different DNA preparations of the same 
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isolate exhibited ~98 % similarity. Based on these results, FAFLP profiles were considered to 
be indistinguishable when <3 AF differences (~98 % similarity) were exhibited. Based on this 
criterion, 281 profiles were identified amongst the 302 isolates. 
3.3.2.3. Concordance of experimental FAFLP profiles with in silico profiles 
The percentage concordance between in silico profiles and the six reference strains was 
calculated. Between 55 and 70 AFs were exhibited within profiles generated from in silico 
analysis whilst 46 to 59 AFs were identified within experimental profiles. The isolates 
displayed between 84 and 89 % concordance with in silico profiles (Table 25). In each of the 
six comparisons, an absence of a subset of AFs expected from in silico analysis in the 
experimental profiles accounted for the dissimilarity between profiles. 
3.3.2.4. Cluster analysis 
A dendrogram was generated of all 302 S. aureus isolates based on BglII+A and Csp6I+O 
FAFLP data (Appendix VII). Two hundred and eighty-one profiles were identified amongst 
the isolates. Based on MLST data, a 65 % similarity cut-off was applied to the dendrogram. 
T wenty-one clusters were exhibited amongst 288 isolates and the remaining 14 isolates 
displayed divergent profiles (>35 % difference) (Table 26). Cluster 1 consisted of two isolates 
displaying unique profiles or 17.5 % divergence. The two isolates exhibited 59 AFs, 42 AFs 
were common whilst 17 were polymorphic. The two MSSA isolates represented two 
singleton ST s. 
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Table 25. Concordance of experimental FAFLP profiles with in silico profiles 
Strain name Isolate number No. of AFs· absent in Similarity (%) 
experimental profiles 
MRSA252 DBHT 51 7 89 
N315 DBHT54 8 87 
Mu50 DBHT59 11 84 
COL DBHT 75 8 86 
MW2 DBHT79 9 84 
MSSA476 DBHT84 9 84 
Concordance of experimental FAFLP profiles generated using primers BgllI + A and 
Gp6I+0 with in silico profiles generated in ALFlE 
(httpl/ /www.hpa-bioinformatics.org.uk/cgi-bin/ALFlE/index.cgi). 
OAF, amplified fragments. 
The nine isolates grouped in cluster 2 exhibited distinct profiles with between 14.5 and 
34.5 % divergence. A total of 203 AFs were identified; 45 were common in all isolates whilst 
158 were variable amongst isolates. Of the nine isolates in cluster 2, three were MSSA and a 
non-subtypeable SCCmec type IV was identified in six isolates. Cluster 2 represented 7 % of 
ce22 isolates in this study (Figure 27). 
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Table 26. Characteristics of Unweighted Pair Group Method with Arithmetic mean-
derived dendrogram based on Bgll1+A and 0'1'61+0 FAFLP data 
Cluster 
Divergence No. No. No. 
no. (no. of common polymorphic CCs in cluster* MSSA 
isolates) (%)" AFst AFst isolates 
1 (nz 2) 17.5 42 17 0(2 singleton STs) 2 
2 (n-9) 34.5 45 158 CC22 3 
3 (n-117) 33.0 42 136 CC22 6 
4 (n-18) 35.0 39 110 CC5 9 
5 (n-3) 22.0 44 25 CC5 0 
6 (n=10) 28.5 30 53 CC1 6 
7 (n-6) 33.5 28 62 CC1 and 25 (and one 4 
singleton sn 
8 (n-2) 32.0 36 33 CC6and 101 2 
9 (n=4) 26.5 30 30 CC7 3 
10 (n=16) 28.0 38 87 CC8 13 
11 (n-2) 0.0 50 0 CC672 0 
12 (n-3) 33.5 39 40 CC80 0 
13 (n-12) 33.0 24 97 CC8 1 
14 (n-2) 35.0 46 37 o (one singleton ST) 0 
15 (n=8) 25.5 39 47 CC59 5 
16 (n-35) 30.5 31 135 CC30 23 
17 (n-3) 31.5 38 37 CC97 1 
18 (n-3) 30.5 37 40 CC45 1 
19 (n=17) 28.0 37 88 CC45 13 
20 (n-2) 38.0 59 57 CC45 2 
21 (n-14) 33.0 32 62 CC9, 15,20 and 121 14 
The table displays characteristics for clusters (based on 65 % similarity cut-off) generated 
from a dendrogram based on Bgll1 + A and Cs-p61 +0 FAFLP data. 
"The percentage divergence exhibited between profiles within each cluster is displayed. 
'tJ'he number of amplified fragments (AFs) common to ~95 % of isolates and <95 % of 
isolates (polymorphic) within each cluster are displayed. 
*The clonal complex (CC) assignment of isolates within each cluster is displayed and those 
assigned to singleton sequence types (STs) are shown in brackets. 
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Figure 27. Cluster 2 of UPGMA-derived dendrogram based on BgII.I+A and wp6I+0 FAFLP data 
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Cluster 2 was based on 65 % similarity cut-off (shown as vertical black line). The dashed line represents 85 % similarity cut-off. The clonal complex 
(CC) and SCCmectype of each isolate is shown on the right. 
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One hundred and seventeen isolates constituting cluster 3 showed one of 98 profiles which 
exhibited between 0 to 33.0 % divergence. Forty-two AFs were conserved amongst the 
profiles and 136 AFs were different. Ninety-one percent (n= 117) of the CC22 isolates in this 
study were grouped in Cluster 3. Of these isolates, 111 belonged to one of five SCCmec types 
and six isolates were MSSA (Figure 28). 
Cluster 4 was composed of 18 isolates which were assigned to 17 profiles which exhibited 
between 1 to 35 % divergence. Thirty-nine of the 149 AFs were common to profiles of all 
isolates in this cluster and 110 AFs were polymorphic. Seventy-eight percent (n-18) of CC5 
isolates constituted cluster 4; nine isolates were assigned to one of four SCCmec types and 
the remaining nine were MSSA (Figure 29). Three isolates amongst cluster 5 had unique 
profiles which exhibited up to 22 % divergence. The isolates displayed 44 common AFs and 
25 variable AFs. Cluster 5 consisted of 13 % of CC5 isolates which belonged to SCCmec 
type II or IVa (Figure 29). 
Cluster 6 comprised 10 isolates displaying distinct profiles with ~28.5 % divergence. Thirty 
AFs were conserved amongst the isolates whilst 53 were polymorphic. Eighty-three percent 
(n"1O) of CC1 isolates constituted cluster 6, four isolates exhibited one of three SCCmec 
types and six were MSSA (Figure 30). Each of the six isolates in cluster 7 displayed a unique 
profile with up to 33.5 % divergence. Profiles shared 28 AFs whilst 62 AFs were variable. 
Two isolates amongst cluster 7 were assigned to CC1, three to CC25 and one was a 
singleton ST. One CC1 and the CC25 isolates were MSSA and an SCCmec type V or a non-
type able element were identified in the remaining two isolates (Figure 30). 
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Figure 28. Cluster 3 of UPGMA-derived dendrogram based on BglI.l+A and CSp61+0 FAFLP data 
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Figure 28 continued. Cluster 3 of UPGMA-derived dendrogram based on BgAI+A and C5p6I+O FAFLP data 
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Cluster 3 was based on 65 % similarity cut-off (shown as vertical black line). The dashed line represents 85 % similarity cut-off. The clonal complex 
(CC) and SCCmectype of each isolate is shown on the right. 
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Figure 29. Clusters 4 and 5 of UPGMA-derived dendrogram based on Bglll+A and 0'1'61+0 FAFLP data 
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Clusters 4 and 5 were based on 65 % similarity cut-off (shown as vertical black line). The dashed line represents 85 % similarity cut-off. The clonal 
complex (CC) and SCCmectype of each isolate is shown on the right. 
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Figure 30. Clusters 6 and 7 of UPGMA-derived dendrogram based on BgAI + A and Cs-p61 +0 FAFLP data 
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Clusters 6 and 7 were based on 65 % similarity cut-off (shown as vertical black line). The dashed line represents 85 % similarity cut-off. The clonal 
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Cluster 8 consisted of two isolates which exhibited individual profiles which were 32 % 
divergent. Thirty-six AFs were common amongst the two isolates whilst 33 AFs were 
polymorphic. Both MSSA isolates were assigned to CC6 and CC10l. Four isolates amongst 
cluster 9 presented individual profiles with up to 26.5 % difference. Thirty similar AFs were 
identified amongst the isolates and another 30 AFs were variable. Cluster 9 isolates belonged 
to CC7, one isolate belonged to SCCmec type IV whilst the remaining three isolates were 
MSSA. 
Sixteen isolates constituting cluster 10 displayed distinct profiles and ~28 % difference. 
Profiles shared 38 AFs whilst 87 AFs were different. Fifty-three percent (n-16) of all CC8 
isolates constituted cluster 10 and 13 isolates were MSSA The presence of SCCmec type I 
and IV was exhibited amongst three isolates (Figure 31). 
Each of the 12 isolates within cluster 13 displayed individual profiles and up to 33 % 
divergence. Isolates displayed 24 similar AFs and 97 variable AFs. Cluster 13 consisted of 
40 % of CC8 isolates, 11 isolates belonged to one of six SCCmec types and one isolate was 
MSSA (Figure 32). 
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Figure 31. Cluster 10 of UPGMA-derived dendrogram based on BgllI+A and Csp6I+O FAFLP data 
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Cluster 10 was based on 65 % similarity cut-off (shown as vertical black line). The dashed line represents 85 % similarity cut-off. The clonal complex 
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Figure 32. Cluster 13 of UPGMA-derived dendrogram based on BglII+A and Q-p61+0 FAFLP data 
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Two isolates belonging to cluster 11 exhibited indistinguishable profiles and displayed 50 
similar AFs. Isolates were assigned to CC672 and were assigned to SCCmec type IVa. Cluster 
12 was composed of three CC80 isolates which displayed unique profiles and up to 33.5 % 
divergence. These profiles displayed 39 conserved AFs and 40 polymorphic AFs. Cluster 14 
grouped two isolates which exhibited individual profiles and 35 % difference. Forty-six AFs 
were common amongst the two isolates whilst 37 AFs were variable. Both isolates were 
assigned to ST93 and belonged to SCCmec type IVa. Cluster 15 had eight isolates which 
displayed distinct profiles and between 4 and 25.5 % divergence. Thirty-nine similar AFs 
and 47 different AFs were identified amongst profiles. Cluster 15 isolates constituted all 
CC59 isolates in this study; three isolates exhibited SCCmec type V and the remaining five 
isolates were MSSA (Figure 33). 
Cluster 16 comprised of 35 isolates, each of which displayed individual profiles. Between 3.5 
to 30.5 % divergence was exhibited amongst the isolates. Profiles shared 31 AFs and 
displayed 135 variable AFs. Ninety-seven percent of CC30 isolates constituted cluster 16; 12 
were assigned to SCCmec type II or IV and 23 were MSSA (Figure 34). Three isolates 
amongst cluster 17 displayed unique profiles and up to 31.5 % divergence. Isolates displayed 
38 common AFs and 37 different AFs. Of the three CC97 isolates of cluster 17, two isolates 
belonged to SCCmec type IV and V and one isolate was MSSA. 
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Figure 33. Cluster 15 of UPGMA-derived dendrogram based on Bg111 + A and Qp61 +0 FAFLP data 
0 ~ 0 (fj [Jl 
~ 0 ~ 0 C ~ 0 0 (JJ PJ ::; 
rt rt (D (D PJ 3 
~ ~ ~ ~ () n 
65 75 85 90 95 100 70 80 
C 0 ~ a s u ~ (D 
(D ~ 
~ (D 
>< 
I DBllr i9 CC59 v DBHT50 CC59 V 
I DBHrI I CC\9 ~ISSA 
I 
• 
15 DBHr 111 CC59 
~ISS:\ 
DBHl m CC59 ~ISSA 
DBHI1JO CC59 ~ISSA 
DBH117l CC59 ~ISSA 
DBHI80 CC59 V 
Cluster 15 was based on 65 % similarity cut-off (shown as vertical black line). The dashed line represents 85 % similarity cut-off. The clonal complex 
(CC) and SCCmectype of each isolate is shown on the right. 
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Figure 34. Cluster 16 of UPGMA-derived dendrogram based on BglIl+A and CSp6I+0 FAFLP data 
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Figure 34 continued. Cluster 16 of UPGMA-derived dendrogram based on Bglll+A and C5p61+0 FAFLP data 
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Cluster 18 consisted of three isolates displaying distinct profiles and up to 30.5 % difference. 
Thirty-seven AFs were conserved and 40 variable AFs were identified amongst profiles. The 
isolates constituted 14 % of CC45; one isolate each belonged to SCCmec type IV, V or was 
MSSA The 17 isolates within cluster 19 exhibited individual profiles and up to 28 % 
divergence. Profiles displayed 37 similar AFs and 88 polymorphic AFs. Cluster 19 was 
composed of 77 % of CC45 isolates; four CC45 isolates exhibited one of three SCCmec 
types and 13 were MSSA Both isolates within cluster 20 displayed individual profiles and 
38 % divergence. Profiles shared 59 common AFs and 57 different AFs. The two MSSA 
isolates constituted 9 % of CC45 isolates (Figure 35). 
Fourteen isolates amongst cluster 21 displayed individual profiles and 33 % divergence. 
Thirty-two conserved AFs and 62 variable AFs were identified amongst profiles. Isolates were 
assigned to CC9, 15, 20 and 121 and were MSSA One CC15 isolate displayed >35 % 
divergence (Figure 36). 
The majority of the 21 clusters exhibited isolates from a single CC. Clusters 2 and 3 
harboured seven and 91 % of CC22 isolates. Isolates constituting cluster 2 displayed up to 
40.5 % divergence from the 117 isolates of cluster 3. CC5 isolates were grouped within 
cluster 4 (78 %) and 5 (13 %) and exhibited up to 37.5 % divergence. Eighty-three percent 
and 17 % of CC1 isolates were assigned to clusters 6 and 7 respectively, and they differed by 
up to 42.5 %. Clusters 10 and 13 harboured 53 % and 40 % of CC8 isolates respectively, 
and isolates displayed up to 52.5 % difference between the two clusters. CC45 isolates 
belonging to clusters 18 (14 %), 19 (77 %) and 20 (9 %) displayed up to 38 % divergence. 
The fourteen divergent profiles were assigned to seven CCs (CC5, 8, 12, 15, 22,30 and 88) 
and three singleton STs. 
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Figure 35. Clusters 18, 19 and 20 of UPGMA-derived dendrogram based on Bglf.I+A and wp61+0 FAFLP data 
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Clusters 18, 19 and 20 were based on 65 % similarity cut-off (shown as vertical black line). The dashed line represents 85 % similarity cut-off. The 
clonal complex (CC) and SCCmec type of each isolate is shown on the right. 
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Figure 36. Cluster 21 of UPGMA-derived dendrogram based on Bglll + A and Qp61 +0 FAFLP data 
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Cluster 21 was based on 65 % similarity cut-off (shown as vertical black line). The dashed line represents 85 % similarity cut-off. The clonal complex 
(CC) and SCCmec type of each isolate is shown on the right. The different colour lines represent a CC: a grey line represents CC9, a purple line 
represents CC1S, a dark pink line represents CC20 and a Light pink line represents CC12t. 
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To reflect the FAFLP-based divergence between the isolates, a ~85 % similarity cut-off was 
further applied to the dendrogram. Five sub-clusters were identified amongst the isolates in 
clusters 2 and 3. Zero to 32 AF differences were observed within each sub-cluster; conversely 
five to 94 polymorphic AFs were observed between sub-clusters. Each sub-cluster consisted of 
CC22 isolates; two sub-clusters harboured MRSA isolates whilst three harboured both 
MRSA and MSSA isolates. Three sub-clusters were identified amongst CC5 isolates of 
cluster 4. Up to 16 variable AFs were identified within each sub-cluster whilst up to 28 
polymorphic AFs were observed between sub-clusters. One sub-cluster was composed of 
MSSA isolates and the remaining two harboured MRSA isolates. The CC1 isolates within 
cluster 6 exhibited three sub-clusters. Up to seven AF differences were observed within each 
sub-cluster and up to 28 polymorphic AFs were identified between sub-clusters. MSSA 
isolates constituted one sub-cluster and two sub-clusters were composed of MRSA and 
MSSA One sub-cluster each consisting of CC7 and CC25 MSSA were identified amongst 
cluster 9 and cluster 7 respectively. 
Three sub-clusters were displayed amongst cluster 10 and 13 isolates. Up to 15 AF 
differences were identified within sub-clusters whilst up to 35 polymorphic AFs were 
observed between sub-clusters. One sub-cluster was composed of MRSA, one of MSSA, and 
one of MRSA and MSSA. CC59 isolates within cluster 15 exhibited two sub-clusters. Up to 
nine variable AFs were identified within sub-clusters whilst up to 21 polymorphic AFs were 
observed between sub-clusters. MSSA isolates constituted one sub-cluster whilst the second 
was composed of MRSA and MSSA CC30 isolates within cluster 16 exhibited five 
sub-clusters. Up to 19 polymorphic AFs were displayed within sub-clusters and up to 39 AF 
differences were observed between sub-clusters. Two sub-clusters were composed of MRSA 
isolates which belonged to SCCmec type II, and all isolates within these sub-clusters 
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excluding one were assigned to EMRSA16. The three remaining sub-clusters were formed of 
MSSA isolates. Six sub·dusters were exhibited amongst CC45 isolates of cluster 18 and 19. 
Up to 18 polymorphic AFs were observed within each sub-cluster; conversely up to 47 
variable AFs were observed between sub-clusters. Four sub-clusters harboured MSSA, one 
MRSA, and one MRSA and MSSA One sub-cluster was identified within cluster 21 which 
harboured eight MSSA isolates assigned to CC15 and CC121. 
3.3.2.5. Correlation of FAFLP data within isolate collections 
All isolates within clusters 1,8, 11, 18, 20 or 21 belonged to the same isolate collection. The 
remaining fifteen clusters consisted of isolates obtained from two or more collections. 
Isolates within each of the identified sub-clusters belonged to the same isolate collection. 
Cluster 4 isolates (n=18) belonging to CC5 were obtained from three collections whilst those 
belonging to cluster 5 (n-3) were obtained from the Glasgow or Reference collection. The 
CC8 isolates in cluster 10 (n-16) belonged to the SRL, Glasgow and BSAC collections. 
However, 11 CC8 isolates within cluster 13 (92 %) were from the Glasgow collection. Of the 
cluster 2 isolates assigned to CC22 (n~9), seven (78 %) were obtained from CMPHL 
collection and the remaining two (22 %) from BSAC collection. On the other contrary, 
cluster 3 isolates belonging to CC22 (n-117) consisted of isolates from four collections. 
Cluster 18 isolates belonging to CC45 (n-3) were from the Glasgow collection. Cluster 19 
isolates (n-17) were from SRL and BSAC collections and cluster 20 isolates (n-2) were from 
BSAC collection. Clusters harbouring CC1, 30 and 59 isolates were assigned to three or 
four collections. 
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Eight of the 50 isolates from SRL were from a single patient. Six (cluster 3) of these were 
CC22 and exhibited ~98 % similarity whilst the remaining two were CC672 isolates 
(cluster 11) and exhibited indistinguishable profiles. Multiple isolates within SRL collection 
which were obtained from the same hospital or ward were assigned to the same lineage and 
exhibited ~84.5 % similarity. The reference strains clustered with other isolates of the same 
lineage. CC8 and 45 isolates from the Glasgow collection grouped in clusters 13 and 18; the 
CC8 isolates exhibited up to 52.5 % difference from the remaining CC8 isolates in the 
study. Profiles from the BSAC collection displayed no correlation with the centre of 
isolation. A majority of the CMPHL isolates (n-7; 70 %) were assigned to cluster 2; ~65.5 % 
similarity was exhibited amongst these isolates. 
3.3.2.6. Discriminatory power and confidence interval values 
The D and Cl values for FAFLP data were calculated for all isolates. Both values were also 
calculated for isolates from each of the five collections and for the eight major CCs: CC1, 5, 
8, 15, 22, 30, 45 and 59. The D value for all FAFLP data was 0.999 with a Cl of 0.999 to 
1.000. The calculated D values for isolates from the same collection was 1.0 in each case 
except for those from SRL (D==0.997) and BSAC (D=0.999) collections. The calculated D 
values for isolates from the eight CCs were 1.0 except for those from CC22 (D=0.999). 
3.3.2.7. Correlation of FAFLP amplified fra~ments (AFs) with linea~es 
Initially FAFLP profiles within isolates assigned to one of seven major lineages (CC1, 5, 8, 
22, 3D, 45 and 59) were compared in Stata software. Of the 500 polymorphic AFs amongst 
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all isolates, 73 fragments were exclusive to isolates assigned to one of the seven lineages. One 
AF was specific to CCl, nine AFs to CC5, 28 AFs to CC8, 24 AFs to CC22, six AFs to 
CC30, three AFs to CC45 and two AFs to CC59. Seventy-two of these AFs were present in 
up to three isolates of a specific lineage and the one remaining AF was present in 90 % of 
CC22 isolates (data not shown). Therefore although these AFs were lineage-specific, they 
were not present in all or the majority of isolates of a particular lineage. Fragments which 
were common, polymorphic and specific to isolates of each lineage were subsequently 
identified manually (Table 27). Relative to the number of isolates assigned to each CC, the 
largest number of common AFs was demonstrated within CCl followed by CC59 and 
isolates within CC5 and 8 displayed the maximum numbers of polymorphic AFs. A total of 
50 lineage-specific AFs were identified. The largest numbers of lineage-specific AFs were 
exhibited amongst CC30, 45 and 59 isolates. 
Table 27. Analysis of FAFLP profiles with primers BglII+A and G-p6I+O 
CC CCl CC5 CC8 CC22 CC30 CC45 CC59 Total 
CommonAFs 28 31 23 34 31 29 36 212 
Lineage-specific 1 4 2 6 13 11 13 50 AFs 
Polymorphic AFs 69 181 209 292 165 145 50 1111 
Number of amplified fragments (AFs) common to all isolates of one of seven clonal 
complexes (CCS), polymorphic amongst isolates of a particular CC and specific to a 
particular CC are shown. 
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3.3.2.8. Lineage-specific AFs 
Fifty lineage-specific AFs were identified and the sequences of 15 of these AFs were 
determined experimentally from isolates representative of one of seven CCS: CCl, 5, 8, 22, 
30,45 and 59. Of the 50 AFs, the remaining 35 AFs comigrated on agarose gels with AFs of 
a similar size and were hence difficult to sequence. Alignments based on BIAST search 
results (from up to 27 WGSs) of the lineage-specific AF sequences were performed. These 
AFs were found for CC30 (n=8), CC45 (n=2), CC59 (nc 2), CC5 (na l), CC8 (n=1) and 
CC22 (n= I) (Table 28). PCR primers designed for these 15 AFs were evaluated on 48 
isolates. Sequences of each AF were obtained in seven or more CCs. Therefore although the 
size of these AFs were lineage-specific, similar sequences were identified in majority of the 
lineages. This indicated these sequences harboured lineage-specific variations, therefore these 
sequences were compared between lineages. 
Of the remaining 35 lineage-specific AFs, sequences for 34 were obtained via in silico analysis 
of WGSs; one AF size was not detected in silico and was not investigated further. Of the 34 
AFs, 11 AFs were specific to CC59, eight to CC45, five each to CC22 and 30, three to CC5 
and one each to CCl and 8. Six of the 34 AF sequences were detected in up to four CCs. 
The remaining 28 sequences were detected in isolates assigned to six to 10 different CCs 
(Table 29). Although the sizes of these AFs were lineage-specific, experimental data obtained 
from determining the sequence of these AFs showed the presence of these sequences in the 
majority of other lineages. This indicated that the AF sequences also harboured lineage-
specific variations which was analysed further. 
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Table 28. Sequence determination results of lineage-specific AFs 
Lineage-specific Size of AF Lineage Presence in lineage t AF (bp)" specificity· 
F1 286 CC5 CC1,5, 15,22,30,45 and 97 
F2 289 CC8 CC1, 5, 8, 15, 22, 30, 45, 59 and 97 
F3 141 CC22 CC1, 5, 8, 15, 22, 30, 45, 59,97 and 672 
F4 97 CC30 CC1, 5, 8, 15, 22, 30, 45, 59 and 97 
F5 156 CC30 CC1, 5, 15, 22, 30, 59, 97 and 672 
F6 182 CC30 CC1, 5, 8, 15, 22, 30, 45, 59, 97 and 672 
F7 277 CC30 CC1, 5, 8, 15, 22, 30, 45, 59,97 and 672 
F8 307 CC30 CC1, 5, 8, 15, 22, 30, 45, 59 and 97 
F9 389 CC30 CC1, 5, 8, 15, 22, 30, 45, 59 and 97 
F10 479 CC30 CC1, 5, 8, 15, 22,30, 45, 59 and 97 
Fll 528 CC30 CC1, 5, 8, 15, 22, 30, 45, 59 and 97 
F12 82 CC45 CCI, 5, 8, 15, 22, 30, 45, 59, 97 and 672 
F13 137 CC45 CC1, 5, 8, 15, 22, 30, 45, 59, 97 and 672 
F14 85 CC59 CC1, 5, 8, 15, 22, 30, 45, 59 and 97 
F15 340 CC59 CC1, 5, 8, 15, 22, 30, 45, 59 and 97 
·Sizes of amplified fragments (AFs), generated using FAFLP analysis with primers Bglll+A 
and (Sp61 +0, which were identified in isolates of a particular lineage. 
ttineages within which sequences of lineage-specific AFs were identified. 
3.3.2.9. Seguence variation amon~st lineage-specific AFs 
Sequence variation was observed amongst fragments of a precise size specific to a particular 
lineage. Sequence variation was observed amongst 39 of the 50 lineage-specific AFs. Of these 
AFs, 12 were sequences obtained experimentally whilst 27 were obtained via in silico analysis. 
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Table 29_ Lineage-specific AF sequences obtained via in sHico analysis 
Lineage-
Size of Lineage Accession 
specific Loci of AP' AF present in lineages§ 
AF- AF (bp)" specificity- number* 
F16 355 CC1 6051~ NC_003923 CC1, 5, 8, 22, 30, 93 60839 and 398 
F17 368 CC5 2352726- NC_009782 CC1, 5, 8, 22, 30, 59, 2353073 93, 151,398 and 425 
F18 388 CC5 2353068- NC_009782 CC1, 5, 8, 22, 30,59, 2353431 93, 151,398 and 425 
F19 414 CC5 485187- NC_009782 
CC1, 5, 8, 22,30, 59, 
485577 93, 151,398 and 425 
F20 353 CC8 2293146- NC_007795 CC1, 5, 8, 22, 30, 59, 2293474 93, 151,398 and 425 
F21 107 CC22 2682498- HE681097 CC22 2682584 
F22 117 CC22 432061· HE681097 
CC5, 8, 22,93, 151 
432157 and 398 
F23 270 CC22 2440502· HE681097 CC22, 30, 59 and 425 2440749 
F24 331 CC22 2306520- HE681097 CC1, 5, 8, 22, 30, 59, 2306830 93, 151,398 and 425 
F25 411 CC22 1555575· HE681097 CC1, 8, 22, 30, 93, 105 1555960 and 398 
F26 124 CC30 2703901· NC_002952 
CC1, 5, 8, 22,30,59, 
2704002 93, 151,398 and 425 
F27 247 CC30 2765286- NC_002952 CC1, 5, 8, 22,30,59, 2765506 93, 151,398 and 425 
F28 251 CC30 1314761· NC_002952 CC1, 5, 8, 22,30,59, 1314890 93, 151,398 and 425 
F29 295 CC30 92666- NC_002952 CC30 and 239 92936 
F30 296 CC30 1373018- NC_002952 CC1, 5, 8, 22,30, 59, 1373289 93, 151,398 and 425 
F31 102 CC45 1144078- NC_017349 CC1, 5, 8, 22,30,59, 1144159 93, 151,398 and 425 
F32 299 CC45 45394- NC_002951 CC1, 5, 8 and 30 45668 
F33 317 CC45 1166118- NC_009782 CC1, 5, 8, 22, 30, 59, 1166412 93, 151,398 and 425 
F34 347 CC45 2326879· NC_007795 CC1, 5, 8, 22, 30, 59, 2327203 93, 151,398 and 425 
F35 354 CC45 2611039· NC_017338 CC1, 5, 8, 22, 30, 59, 2611372 93, 151,398 and 425 
F36 363 CC45 347212- NC_009641 CC8 and 425 347552 
199 
Table 29 continued. Lineage-specific AF sequences obtained via in siJico analysis 
Lineage# 
Size of Lineage Accession 
specific Loci of A~ AF present in lineages§ 
AF· AF (bp)" specificity· number* 
F37 496 CC45 N/A" N/A N/A 
F38 573 CC45 1105871# CP003166 CC1, 5, 8, 22, 30, 59, 1106421 93, 151,398 and 425 
F39 585 CC45 718453# NC_009632 CC5, 8 and 93 719016 
F40 212 CC59 1887952# CP003166 CC1, 5, 8, 22, 30, 59, 1888142 93, 151,398 and 425 
F41 222 CC59 701113# CP003166 CC1, 5, 8, 22, 30, 59, 701312 93, 151, 398 and 425 
F42 304 CC59 155473~ CP003166 CC1, 5, 8, 22, 30, 59 1555018 and 93 
F43 350 CC59 227717~ CP003166 CC1, 5, 8, 22, 30, 59, 2277500 93, 151,398 and 425 
F44 389 CC59 290065# CP003166 CC1, 5, 8, 22, 30, 59, 290430 93, 151,398 and 425 
F45 429 CC59 1663979# CP003166 CC1, 5, 8, 22, 30, 59, 1664389 93, 151,398 and 425 
F46 447 CC59 2245902# CP003166 CC1, 5, 8, 22, 30, 59, 2246327 93, 151,398 and 425 
F47 537 CC59 2424067# CP003166 CC1, 5, 8, 22,30,59, 2424581 93,151,398 and 425 
F48 551 CC59 44712~ CP003166 CC1, 5,8, 22,30,59, 447646 93, 151,398 and 425 
F49 571 CC59 1105871# CP003166 CC1, 5, 8, 22, 30, 59, 1106421 93, 151,398 and 425 
F50 599 CC59 1835#2410 CP003166 CC1, 5, 8, 22,30,59, 93, 151,398 and 425 
·Sizes of amplified fragments (AFs) generated using FAFLP analysis with primers Bglll+A 
and Csp61 +0 which were identified in isolates of a particular lineage. 
twcus of AF based on whole-genome sequences (WGSs). 
* NCBI database accession number of WGSs used for analysis. 
§Lineages within which sequences of lineage-specific AFs were identified based on WGSs. 
"NI A, not applicable as lineage-specific AF was not detected in silico. 
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The sequences of six (F21, 23, 29, 32, 36 and 39) of the 50 AFs were amplified in four CCs 
or less, therefore sequence comparisons of these AFs could not be performed between 
lineages (Table 29). BLAST search results of these six AF sequences detected in four CCs 
revealed these partially encoded (did not encompass an entire ORF from a start to stop 
codon) SCCmec proteins, a transposase, a bacteriophage tape measure protein, an ABC 
transporter permease protein and a protein involved in the biosynthesis of cobalamin 
(vitamin B12). Four AFs (F4, 11, 14 and 25) displayed no sequence variation; three of these 
were obtained experimentally whilst one was obtained by in silico analysis. BLAST search 
results of these four AF sequences revealed that these partly encoded an UDP-N-
acetylmuramoylalanine-D-glutamate ligase, transposase within the SCCmec, zinc-binding 
dehydrogenase and a bacteriophage DNA-directed DNA polymerase. One AF sequence 
(F37) could not be obtained experimentally or through in silico analysis as no AFs within 
± 7 bp of the expected AF size were detected (Table 28). 
The sequence variations amongst the 39 AFs included SNPs, point mutations and indels 
specific to isolates of one lineage (Table 30). The point mutations included nine 1 bp 
insertions and 163 deletions. Four insertions between three to 24 bp and 25 deletions 
between three to 67 bp were also identified. All four insertions> 1 bp and eight of the 25 
deletions were multiples of three indicating the ORF is restored after the mutation. A total 
of 1204 SNPs, point mutations and indels were identified amongst the 39 AFs. Of these, 
1003 were SNPs and 201 were insertions or deletions of 1 bp or greater. Between one and 
111 variations were identified in each of the AF sequences. The maximum number of 
variations or SNPs were exhibited amongst the CC59-specific AF sized 551 bp (F48, na 111) 
whilst the least variations were identified in CC3Q. and CC45-specific AFs of 277 bp (F7, 
n-l) and 137 bp (F13, n-l). The CC8-specific 353 bp AF (F20) exhibited the greatest 
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number of indels (n=34). Twenty AF sequences exhibited no indels larger than 1 bp. The 
mean number of variations amongst all AFs specific to one lineage was identified. The 
maximum number of variations was identified amongst AFs specific to CC8 (n=188) whilst 
the minimum number was obtained within CC45 (n=95). 
202 
Table 30. Sequence variation in lineage-specific AFs 
No. SNPs* within CC 
Variations Lineage- Size of AF (bp) No. SNPst 
specific to no. ! 
specificAF in CC· perAF () () () () () () () () () en () () () () () () ~ ofCCs§ () () () N Vl ~ Vt \() 0\ \() I 
-
Vt ~ N 0 Vt \() -..J -..J Vl N 
! 
F16 355 (CCl) 40 (14) 8 (2) 6 6 4 (2) 6 (1) 
- - - -
10 (9) 6 
Fl 286 (CC5) 16 (8) 3 (1) 10 (6) 
- -
2 1 (1) 
- - - -
4 
F17 368 (CC5) 47 (13, 1) 13 (1) 5 (2) 5(1) 9 (6, 5 (1) 3 7 (2) 7 1) · · -
F18 388 (CC5) 92(27,2) 22 (5) 16 17 8 (4) 9 12 (1) 8 (3) 7 (10) (5, 1) - - · I 
F19 414 (CC5) 34 (1) 1 1 1 3 (1) 17 
· 
4 
- · 
7 7 ! 
F2 289 (CC8) 96 (30, 1) 8 13 (7) 2 (1) 15 (9) 7 (1) 27 14 (2) 10 8 
I (10) (1) -
. 
F20 353 (CCB) 92 (33, 1) 25 (5) 11 (7) 16 14 9 11 (1) 6 (1) 7 
I 
(6) (14) - · · I 
F22 117 (CC22) 63 (0) 
· 
18 22 18 
· -
. 
· · 
5 4 
F3 14l(CC22) 34 (2) 
· 
1 
-
. 16 12 (1) 4 (1) 1 
-
. 5 
F24 331 (CC22) 54 (16,1) 12 4 4 19 6 (1) 5 4 (1) 7 (14, 1) · - -
F26 124 (CC30) 41 (3) 1 
· · -
1 
· 
. 
- -
39 (3) 3 
F5 156 (CC30) 8 (0) 1 
· · 
. 
· · -
5 2 
-
3 
F6 182 (CC30) 27 (0) 
· · -
1 2 24 
- · - -
3 
F27 247 (CC30) ___ § (1) 
-
4 
· 
2 (1) 
· · '----L_ · - 1 4 ---- - -------- -- - --- - L-____ ~----
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Table 30 continued. Sequence variation in lineage-specific AFs 
No. SNPs* within CC 
Lineage~ Size of AF (bp) No. SNPst Variations () () () () () () () () () ~ specific to no. specific AF in CC· perAF () () () () () () () Q () N \oH 4>- Vl 0\ '-0 ofCCs§ 
-
Vl (J) N 0 \Jl '-0 -..] -.,J \oH N 
F28 251 (CC30) 2 (0) ~ ~ ~ ~ ~ ~ 1 ~ ~ 1 2 
F7 277 (CC30) 1 (0) ~ 1 ~ ~ ~ ~ ~ ~ ~ ~ 1 . 
F30 296 (CC30) 23 (1) 2 6 (1) 2 ~ ~ ~ 4 ~ ~ 9 5 I 
F8 307 (CC30) 68 (17) 8 (1) 5 (2) 2 (2) 15 (7) 4 (1) 20 (3) 9 (1) 5 ~ ~ 8 I 
F9 389 (CC30) 28 (5) ~ 14 (3) ~ ~ ~ 7 (1) ~ 7 (1) ~ ~ 3 I 
FlO 479 (CC30) 16 (2) 1 2 ~ 1 6 (1) ~ 5 1 (1) ~ ~ 6 I 
F12 82 (CC45) 18 (0) ~ ~ ~ ~ 2 4 ~ 12 ~ ~ 3 I 
F31 102 (CC45) 9 (0) 1 ~ ~ 2 3 ~ 3 ~ ~ ~ 4 
F13 137 (CC45) 1(0) ~ ~ 1 ~ ~ ~ ~ ~ ~ ~ 1 
F33 317 (CC45) 3 (0) 1 ~ ~ 1 ~ ~ ~ ~ ~ 1 3 
F34 347 (CC45) 22 (0) 4 4 1 1 4 ~ 2 ~ ~ 6 7 
F35 354 (CC45) 26 (0) 4 1 4 2 2 ~ 1 ~ ~ 12 7 
F38 573 (CC45) 16 (1) 1 ~ ~ 2 3 ~ 5 (1) ~ ~ 5 5 
F40 212 (CC59) 15 (0) ~ 1 2 2 5 ~ 1 ~ ~ 4 6 
F41 222 (CC59) 12 (0) ~ ~ 1 7 3 ~ 1 ~ ~ ~ 4 
F42 304 (CC59) 3 (0) ~ ~ ~ ~ ~ ~ 3 ~ ~ ~ 1 
F15 340 (CC59) 12 (0) 2 ~ 1 3 2 ~ 3 ~ ~ 1 6 
F43 350 (CC59) 21 (0) 4 4 1 1 4 ~ 2 ~ ~ 5 7 
F44 389 (CC59) 6 (0) 1 1 ~ 1 ~ ~ 2 ~ ~ 1 5 
F45 429 (CC59) 17 (0) 1 _i __ 3 3 2 ~ 1 ~ ~ 3 7 
-
- ----_._-
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Table 30 continued. Sequence variation in lineage-specific AFs 
No. SNPs* within CC 
Lineage- Size of AF (bp) No. SNPst Variations () () () () () () () () () C/) specific to no. 
specific AF in CC' perAF () () () () () () () () () -1 N \.J.J ~ \Jl \D 0\ \D ofCCs§ ~ \Jl 00 N 0 \Jl \D -.J -.J \.J.J N 
F46 447 (CC59) 48 (12, 3) 10 (1) 7 4 (1) 14 6 (1) 2 5(0 7 (11) - - -
F47 537 (CC59) 43 (0) 
-
3 2 34 2 
-
2 
- - -
5 
F48 551 (CC59) 111 (2, 3) 10 83 (3) 1(1) 4 (1) 5 
-
2 
- -
6 7 
F49 571 (CC59) 19 (1) 1 - - 2 6 - 5 (1) - - 5 5 
F50 599 (CC59) 12 (0) - 6 - 2 1 - 1 - . 2 5 
No.ofSNPs* 1204 145 231 98 190 140 95 109 41 2 (0) 153 per CC (16) (41) (18) (72) (7) (16) (8) (3) (20) 
'Size of amplified fragments (AFs) generated using FAFLP analysis with primers BgllI+A and 0"1'61+0 specific to one clonal complex (CC; shown in 
brackets). 
~umber includes number of single-nucleotide polymorphisms (SNPs), point mutations and indels in each AF. 
*'me number of SNPs, point mutations and indels in each AF specific to one of 10 CC are shown. Numbers in brackets indicate the number of point 
mutations (1 bp insertions or deletions) and/ or> 1 bp indels. Black numbers in brackets indicate deletions and red numbers indicate insertions. 
'Number of lineages for which specific variations were identified in each AF. 
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Each of the sequences exhibited variations specific to one of eight CCs. All four 
CC5-specific AF sizes displayed variations specific to CCl, 5 and 30. Both AFs specific to 
CC8 isolates displayed variations for at least six CCs. Amongst those AFs specific to CC22, 
30 or 45 isolates, variations that were specific to nine or 10 CCs were identified. All AFs 
specific to CC59 displayed variations specific to this lineage. Amongst the 39 sequences, the 
total number of variations specific to isolates of one lineage varied from two (CC672) to 231 
(CC5). The majority of variations were specific to isolates assigned to CC5 (19 %) followed 
by CC22 (16 %) and ST93 (13 %). Isolates belonging to CC5 (19 %) also exhibited the 
greatest number of SNPs, followed by CC30 (13 %) and ST93 (13 %) isolates. The 
maximum number of insertions and deletions that were ~ 1 bp were exhibited amongst 
CC22 (36 %), CC5 (20 %) and ST93 (10 %) isolates. 
Table 31. Results of PCRs targeting lineage-specific AF sequences 
Lineage-specific AF Size of AF (bp) No. of isolates 
assigned to a CC 
Fl 286 24 
F2 289 45 
F3 141 22 
F5 156 7 
F6 182 10 
F7 277 3 
F8 307 46 
F9 389 11 
F10 479 27 
F12 82 13 
F13 137 7 
Assignment of a collection of 48 blind isolates to a single clonal complex (CC) based on 
lineage-specific variations amongst one of 11 amplified fragment (AF) sequences. The 
remaining isolates were identified to belong to a subset of lineages or failed to amplify an 
amplicon. 
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A blind study was performed on 48 isolates to evaluate the specificity of lineage-specific 
variations amongst 11 of the 39 AF sequences. Based on these results, the isolates were 
assigned to a CC; some isolates could not be assigned to a single CC (Table 31). This 
indicated that these variations were relatively stable amongst a specific lineage. 
3.3.2.10. Proteins encoded on linea~e-specific AFs 
Partial ORFs (a proportion of the region between a start and stop codon) and the proteins 
encoded by each of the 39 AF sequences were identified using sequences from the NCBI 
database which were aligned using BioEdit software (Table 32). Three AF sequences partially 
encoded a transposase enzyme (FI, F5 and Fl6). One of these (F5) also encoded, in part, a 
sodium transport protein. Eleven AF sequences encoded proteins required for the 
biosynthesis of essential cell components. Eight AFs (F2, F8, F9, F17, F18, F20, F24 and 
F46) partly encoded acetolactate synthase, a protein required for the biosynthesis of amino 
acids. Of these eight AFs, six also partially encoded an RNA-directed DNA polymerase 
(reverse transcriptase). Fragments F38, F45 and F49 encoded three additional proteins that 
play a role in the biosynthesis of haem. Proteins relating to the repair of damaged DNA were 
encoded on two AF sequences (F3 and F12). Proteins associated with DNA replication and 
recombination, such as a single-stranded DNA~binding protein, were encoded on eight AFs 
(F2, F7, F8, F9, F17, FI8, F20 and F50). 
Functions of a further five AF sequences were related to antimicrobial resistance. Two of 
these AFs encoded a multidrug efflux system protein (F34 and F43) and one encoded a 
protein implicated in the metabolism of a herbicide (Fl5). F41 partially encoded a protein 
which conferred bacitracin resistance and F44 partly encoded a protein which altered their 
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antimicrobial tolerance. Bacteriophage proteins were encoded on two ORFs; one partly 
encoded a capsid morphogenesis protein (F30) whilst the other for a portal protein (F42). 
Two AFs (FI0 and F13) harboured ORFs relating to proteins with homology to proteins 
involved in programmed cell death (apoptosis) in eukaryotes. Lipoproteins were encoded on 
three AF sequences (FI9, 22 and 48); these proteins have a structural function or are 
enzymes or toxins. Four AF sequences (F26, F27, F28 and F47) encoded proteins which are 
essential for the respiration, growth or cell division of S. aureus. Of the remaining five 
fragment sequences, four (F6, F31, F35 and F40) encoded enzymes such as hydrolases, 
proteases and methyltransferases and one AF (F33) encoded a hypothetical protein. 
Alignment of the 39 AF sequences and the translated amino acid sequences identified one 
to 95 SNPs amongst ORFs of 37 sequences {Table 32). The remaining AFs did not harbour 
SNPs within ORFs. One to 41 synonymous SNPs were identified in ORFs and one to 62 
SNPs were non-synonymous. Eighteen (49 %) of the 37 AFs exhibited a greater proportion 
of synonymous SNPs as compared to non-synonymous SNPs amongst ORFs. Of the 
remaining 19 AFs, 18 displayed more non-synonymous SNPs than synonymous SNPs and 
one AF displayed an equal proportion of synonymous and non-synonymous SNPs. 
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Table 32. Proteins and singl~nucleotide polymorphisms encoded on lineag~pecific AF sequences 
No. SNPs No. synonymous and non-synonymous SNPs in coding No. of Lineage~ Size of perAF regions* synonymous and 
specific AF (bp) (no. in () () () Cl Cl () () Cl ~ non-synonymous ORFs within AF sequence" AF in CC· () () () Cl Cl () () g ORFs)t ~ Vt 00 N ~ ~ Vt ~ SNPs§ N 0 Vt \0 -.J 
355 1 1 1 0 1 0 0 0 1 5 F16 (CCl) 40 (37) T ransposase 4 5 5 4 5 0 0 0 9 32 
286 0 2 0 0 1 1 0 0 0 4 F1 (CC5) 16 (14) T ransposase 2 7 0 0 1 0 0 0 0 10 
368 2 0 1 0 0 0 1 0 0 4 Acetolactate synthase and F17 (CC5) 47 (25) RNA-directed DNA polymerase 11 1 3 0 3 0 1 0 2 21 (Reverse transcriptase) 
388 0 1 1 1 1 0 4 0 0 8 Acetolactate synthase and F18 (CC5) 92 (38) RNA-directed DNA polymerase 8 4 6 4 3 0 2 0 3 30 (Reverse transcriptase) 
414 0 1 1 3 6 0 2 0 4 17 Staphylococcus tandem F19 34 (34) (CC5) 1 0 0 0 11 0 2 0 3 17 lipoprotein 
289 0 4 0 0 0 0 3 4 0 8 Acetolactate synthase and F2 (CCB) 96 (73) RNA-directed DNA polymerase 7 7 2 13 5 20 3 5 0 62 (Reverse transcriptase) 
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Table 32 continued. Proteins and single-nucleotide polymorphisms encoded on lineage-specific AF sequences 
No. SNPs No. synonymous and non-synonymous SNPs in coding No. of Lineage# Size of perAF regions* synonymous and 
specific AF (bp) (no. in () () () () () () () () (f) non-synonymous ORFs within AF sequence 11 AF in CC· () () () () () () () () ~ ORFs)t ...... Vl 00 N \,;.) ~ Vl \0 \,;.) SNPs§ N 0 Vl \0 -..J 
353 1 0 2 4 1 0 4 0 0 12 Acetolactate synthase and F20 (CC8) 92 (52) RNA.-directed DNA polymerase 11 8 4 8 4 0 2 0 3 40 (Reverse transcriptase) 
117 0 8 6 4 0 0 0 0 2 20 Staphylococcus tandem F22 (CC22) 63 (63) lipoprotein 0 10 16 14 0 0 0 0 3 43 
141 0 0 0 0 0 0 0 0 0 0 F3 (CC22) 34 (0) Recombination protein RecR 0 0 0 0 0 0 0 0 0 0 
331 1 1 0 3 1 0 2 0 1 9 F24 (CC22) 54 (45) Acetolactate synthase 11 1 3 14 3 0 2 0 2 36 
124 1 0 0 0 1 0 0 0 0 2 Pyruvate oxidase or thiamine F26 (CC30) 41 (2) pyrophosphate#requiring 0 0 0 0 0 0 0 0 0 0 enzyme 
156 0 0 0 0 0 0 0 0 0 0 Sodium transport protein and F5 (CC30) 8 (1) 0 0 0 0 0 0 0 1 0 1 transposase 
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Table 32 continued. Proteins and single-nucleotide polymorphisms encoded on lineage-specmc AF sequences 
No. synonymous and non-synonymous SNPs in coding i No. SNPs No. of I Lineage~ Size of perAF regions* synonymous and 
specific AF (bp) (no. in 0 0 0 0 0 0 0 0 (J) ORFs within AF sequence I I AF in CC· 0 0 0 () () 0 0 g ~ non-synonymous ORFs)t 
-
Vl (XI N ~ ~ I.Jl ~ SNPs§ N 0 Vl \0 -..] 
182 0 0 0 0 1 20 0 0 0 21 Zinc-dependent F6 27 (27) (CC30) 0 0 0 1 1 4 0 0 0 6 metalloprotease 
247 0 1 0 1 0 0 0 0 0 2 F27 (CC30) 8 (3) l.,.lactate dehydrogenase 2 0 1 0 0 0 0 0 0 0 1 
251 0 0 0 0 0 0 1 0 1 2 DNA translocase FtsK (cell F28 2 (2) (CC30) 0 0 0 0 0 0 0 0 0 0 division protein) 
277 0 0 0 0 0 0 0 0 0 0 Single-stranded DNA-binding F7 1 (0) (CC30) 0 0 0 0 0 0 0 0 0 0 protein 
I 
1 0 1 0 0 0 2 0 2 6 I 
F30 296 23 (22) Bacteriophage putative capsid (CC30) 1 5 1 0 0 0 2 0 7 16 morphogenesis protein 
0 1 0 2 0 1 1 3 0 8 Acetolactate synthase and 
F8 307 68 (49) RNA-directed DNA (CC30) 7 4 2 11 2 13 0 2 0 38 polymerase (Reverse 
transcriptase) 
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Table 32 continued. Proteins and single-nucleotide polymorphisms encoded on lineage-specific AF sequences 
No. SNPs No. synonymous and non-synonymous SNPs in coding No. of I Lineage- Size of perAF regions* synonymous and 
specific AF (bp) (no. in () () () () () () () () (J) ORFs within AF sequence" AF in CC· () () () () () () () Q ~ non-synonymous ORFs)t 
-
Vl 00 N <..N ~ Vl '-D SNPs§ N 0 Vl '-D -J <..N 
0 0 0 0 0 1 0 0 0 1 Acetolactate synthase and 
F9 389 28 (4) RNA.Jirected DNA (CC30) 0 3 0 0 0 0 0 0 0 3 polymerase (Reverse 
transcriptase) 
1 0 0 0 1 0 2 0 0 4 Addiction module toxin, 
FI0 479 16 (10) Txe/YoeB family and (CC30) 0 1 0 1 3 0 1 0 0 6 addiction module antitoxin, 
Axe family 
82 0 0 0 0 1 2 0 8 0 11 F12 (CC45) 18 (15) DNA Photo lyase 0 0 0 0 1 0 0 3 0 4 
102 0 0 0 2 3 0 2 0 0 7 F31 (CC45) 9 (9) rRNA methyltransferase ! 1 0 0 0 0 0 1 0 0 2 \ 
137 0 0 0 0 0 0 0 0 0 0 Abortive infection 
, 
F13 (CC45) 1 (1) bacteriophage resistance 0 0 1 0 0 0 0 0 0 1 protein 
317 0 0 0 0 0 0 0 0 0 0 Conserved hypothetical F33 3 (2) (CC45) 1 0 0 0 0 0 0 0 1 2 protein 
- ~ -~---~- -~~--- -- --- - --- ~- - -----~--.~-- ------- ---
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Table 32 continued. Proteins and single-nucleotide polymorphisms encoded on lineage-specific AF sequences 
No. SNPs No. synonymous and non-synonymous SNPs in coding No. of Lineage, Size of perAF regions* synonymous and 
specific AF (bp) (no. in 0 0 0 0 0 0 0 () ~ non-synonymous o RFs within AF sequence 11 AF in CC· ORFs)t 0 0 0 () 0 () () g SNPs§ ~ Vl 00 N \,j.) -"'" In \,j.) N 0 In \0 -J 
347 2 3 1 0 3 0 1 0 3 13 Acriflavin resistance transport F34 22 (14) (CC45) 0 0 0 0 0 0 0 0 1 1 protein 
354 4 0 3 1 1 0 0 0 7 16 F35 (CC45) 26 (22) Hydrolase (Esterase/Lipase) 0 1 0 1 1 0 0 0 3 6 
573 1 0 0 0 3 0 2 0 2 8 Haem biosynthesis related F38 (CC45) 16 (10) protein and Allergen 0 0 0 2 0 0 0 0 0 2 V5ff px,l related protein 
212 0 0 1 2 2 0 1 0 1 7 Dipeptidyl F40 (CC59) 15 (13) aminopeptidase/ acylaminoacyl 0 1 1 0 3 0 0 0 1 6 ,peptidase 
222 0 0 1 7 3 0 1 0 0 12 T wocomponent response F41 12 (12) (CC59) 0 0 0 0 0 0 0 0 0 0 regulator BceR 
304 0 0 0 0 0 0 2 0 0 2 F42 (CC59) 3 (3) Bacteriophage portal protein 0 0 0 0 0 0 1 0 0 1 
~--
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Table 32 continued. Proteins and single-nucleotide polymorphisms encoded on lineage-specific AF sequences 
No. SNPs No. synonymous and non-synonymous SNPs in coding No. of Lineage- Size of perAF regions* synonymous and 
specific AF (bp) (no. in 0 0 0 () 0 0 () () U) ORFs within AF sequence I I AF in CC· 0 Q 0 () 0 Q () 0 ~ non-synonymous ORFsl N l..>l lJ1 \0 SNPs§ I 
-
00 N 0 lJ1 \0 -..J l..>l I 
340 1 0 0 2 2 0 0 0 0 5 Allophanate hydrolase 2 F15 12 (12) (CC59) 1 0 1 1 0 0 3 0 1 7 subunit 2 
2 3 1 1 3 0 1 0 3 14 Hypothetical protein and 
F43 350 21 (14) RND multidrug efflux (CC59) 0 0 0 0 0 0 0 0 0 0 transporter, 
Acriflavinresistance protein 
389 1 1 0 1 0 0 2 0 1 6 Murein hydrolase regulator F44 (CC59) 6 (6) LrgA and antiholin-like 0 0 0 0 0 0 0 0 0 0 protein LrgB 
429 1 3 1 2 2 0 0 0 2 11 Coproporphyrinogen III I F45 17 (15) (CC59) 0 0 2 1 0 0 0 0 1 4 oxidase 
447 0 4 0 1 0 0 1 0 0 6 F46 (CC59) 48 (18) Acetolactate synthase 9 1 1 0 0 0 0 0 1 12 
537 0 3 2 30 1 0 2 0 0 38 F47 (CC59) 43 (43) Nitrite reductase 0 0 0 4 1 0 0 0 0 5 
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Table 32 continued. Proteins and single-nucleotide polymorphisrns encoded on lineage-specmc AF sequences 
No. SNPs No. synonymous and non-synonymous SNPs in coding No. of Lineage~ Size of perAF regions* synonymous and 
specific AF(bp) (no. in () () () () () () () () ~ ORFs within AF sequence I I AF in CC· () () () () () () () Q non-synonymous ORFs)t ...... V'l 00 N lH ~ V'l lH SNPs§ N 0 V'l \D -.J 
551 6 28 0 3 2 0 1 0 1 41 , F48 (CC59) 111 (95) Lipoprotein 4 41 0 1 3 0 1 0 4 54 
571 1 0 0 0 3 0 2 0 2 8 Haem biosynthesis related I F49 (CC59) 19 (10) protein and Allergen I 0 0 0 2 0 0 0 0 0 2 V5rrpx~1 related protein I 
599 0 2 0 1 0 0 1 0 2 6 Chromosomal replication F50 (CC59) 12 (6) initiator DnaA and DNA 0 0 0 0 0 0 0 0 0 0 polymerase Ill, beta chain 
~.-- -- -- .. - -- --
- - - -- - - - - -- - - -----
·Size of amplified fragments (AFs) generated using FAFLP analysis with primers BglIl+A and CSp61+0 specific to one clonal complex (CC; shown in 
brackets). 
'Number of single-nucleotide polymorphisrns (SNPs), point mutations and indels in each AF. Numbers in brackets indicate the number of variations 
in ORFs of each AF. 
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*Number of synonymous (top row) and non-synonymous (bottom row) variations, specific to one of nine CCs, in open reading frames (ORFs) of each 
AF. 
~umber of synonymous and non-synonymous variations in ORFs of each AF. 
"Proteins encoded on ORFs of each AF identified via BlAST searches against the NCBI database (http://www.ncbi.nlm.nih.gov/). 
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3.3.2.11. Pyroseguencin~TM 
The 307 bp (F8) fragment specific to CC30 isolates was identified as a Pyrosequencing™ 
target with variations for eight lineages (Table 30). A 97 bp region within this AF was 
selected as a target for pyrosequencing. This region exhibited SNPs and point mutations 
specific to isolates assigned to one of seven lineages (CC1, 5, 22, 30, 45, 59 and 97). 
Pyrosequencing™ was performed on 23 isolates which were assigned to CC1, 5, 8, 15, 22, 
30, 45, 59 and 672. Pyrosequencing™ amplified an amplicon in 18 of the 23 isolates (78 %). 
Alignment of these 18 sequences to the expected sequence revealed three sequences were 
less than 28 bp and could not be assigned to a lineage based on SNPs and point mutations 
(Appendix IX). The remaining 15 isolates were assigned to a lineage based on lineage-specific 
variations. The lineage assignment of these isolates correlated with MIST data (Figure 37). 
3.3.2.12. Correlation of FAFLP data with spa typin~ and whole1:enome mappin~ (wGM) 
FAFLP data were compared amongst 18 and 74 isolates analysed using WGM and spa typing 
respectively. FAFLP profiles sampled between 0.53 % to 0.55 % of the genome amongst 
these isolates. WGM encompassed the entire genome and spa typing sampled approximately 
0.02 % of the genome. Seventeen FAFLP profiles and 12 distinct optical maps were 
exhibited amongst the subset of 18 isolates and 69 FAFLP profiles were exhibited amongst 
the subset of 74 isolates which belonged to 39 spa types. The D and Cl values based on 
FAFLP, spa, and WGM data were calculated for both subsets of isolates (Table 33). 
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Figure 37. Pyrosequencing™ region depicting single-nucleotide polymorphisms and point mutations 
DBHT 79_CCl 
DBHT 247_CC15 
DBHT 40_CC5 
DBHT l6_CC8 
DBHT 88_CC239 
DBHT l30_CC22 -
DBHT 222_CC30 
DBHT 121_CC45 
DBHT 49_CC59 
DBHT4LCC97 
;COCCA TTGACT AA. 
ICOCCA TTOACT AA.! 
eOCC.-\. TTGACT AA, 
ICOCCA TTGACT AA 
ICGCCA TTGACT AA 
ICGCCA TTGACT Ai 
COTCA TTGACT Ai 
:CGCCA TCGACT AM 
ICOTCA TTGACT AA. 
'cACCA TCGACTAi 
TCA.CTCCCT~C~-\'AA.TCTAC 
ICAAAA TCT AT 
,CA.-\..-\..-\. TCTAC 
C.-\'AA.."'-T CT A T 
AAA..--\, T CT AT 
'CA.-\..-\..-\. TCT AC 
iCAAA..-\. TCT AC 
ICA.-\..-\..-\. TCT AC 
'cAAAATCTAC 
!CA.-\.A..",-TCTAC 
Target region (97 bp) of Pyrosequencing™ assay was selected based on 307 bp region of a CC30-specific amplified fragment generated using FAFLP 
analysis with primers BgllI+A and Csp6I+O. Highlighted nucleotide positions display SNPs and point mutations specific to one of eight clonal 
complexes (CC). The combination of sequence variations highlighted in each colour were utilised to assign isolates to one of eight CCs. Positions in 
pink harbour CCI- or CC15-specific variations, grey harbour CC97, light green harbour CC45, light blue harbour CC30, orange harbour CCS, yellow 
harbour CC59 and light purple is CC22. 
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Table 33. Discriminatory power and confidence intervals amongst isolates analysed using 
FAFLP, spa typing and whole-genome mapping (WGM) 
Analysis method Dvalue Cl value 
FAFLP of isolate set A· 0.993 0.977 to 1.000 
WGM of isolate set A* 0.922 0.833 to 1.000 
FAFLP of isolate set Bt 0.998 0.995 to 1.000 
spa typing of isolate set Bt 0.975 0.965 to 0.986 
The discriminatory power (D) (Simpson, 1949) and confidence interval (Cl) (Grundmann 
et al., 2001) values were calculated based on FAFLP, spa typing and whole-genome 
mapping (WGM) data amongst two sets of isolates. 
·Calculations were based on 18 isolates (set A) analysed using FAFLP and WGM. 
tCalculations were based on 74 isolates (set B) analysed using FAFLP and spa typing. 
Comparison of dendrograms based on FAFLP and spa typing data revealed isolates in each 
cluster were assigned to the same lineage. FAFLP identified greater heterogeneity (percentage 
difference) between isolates assigned to the same lineage as compared to spa typing. Based on 
a 90 % similarity cut-off applied to the dendrograms, 5 % of isolates (n-4) displayed 
divergent spa profiles (Figure 26) whilst 74 % of isolates (n-70) exhibited divergent FAFLP 
profiles (Figure 38). Cluster analysis based on FAFLP and WGM data grouped isolates 
assigned to CC22, 30 and 45 in distinct clusters (see WGM: section 3.4.4). However, the 
heterogeneity identified amongst these isolates varied between the two analysis methods. 
FAFLP analysis identified 31.0 %, 57.0 % and 63.0 % divergence whilst WGM identified 
6 %, 7.5 % and 13.0 % difference amongst CC22, 30 and 45 isolates respectively. 
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Figure 38. Cluster analysis using UPGMA on FAFLP data 
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The dendrogram was derived from FAFLP data for 73 isolates using UPGMA cluster 
analysis. Based on 90 % similarity cut-off (shown as vertical black line), seven FAFLP 
clusters were identified (shown as black numbers). The clonal complex (CC) and spa type 
of isolates is shown on the right of the cluster number. FAFLP identified the 
heterogeneity between isolates of each lineage. 
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The number of lineage-specific fragments identified using FAFLP and WGM were compared 
(Table 34). Lineage-specific fragments identified using WGM covered a larger percentage of 
the genome than FAFLP. Fragments specific to CCl, 5 and 8 were identified using FAFLP 
whilst WGM identified fragments specific to CC239. In both cases the second method 
(FAFLP or WGM) failed to identify fragments specific to those respective lineages. 
3.3.3. Insertion sequence targeted fluorescent amplified fragment length 
polymorphism (lS-FAFLP) 
Searches for an IS present within WGSs of S. aureus was performed. Initial searches based on 
NCBI database annotations of 15 WGSs did not identify any ISs from the same family 
present in all sequences. Comparisons of these 15 sequences using Mauve sequence 
alignment software revealed no sequences that met the search terms 'insertion' and 
'sequence' amongst 11 of the 15 WGSs. Two regions (131 bp and 783 bp sequences) were 
identified within the strain MRSA252 which encoded putative IS proteins but were probable 
pseudogenes whilst the tnp gene which encodes for the transposase (1319 bp) associated with 
IS1181 was identified in three strains (Mu3, Mu50 and N315). Search results using the 
keyword 'transposase' yielded between seven and 46 sequences amongst each of the 15 
genomes (Appendix X). BlAST search results of these transposase sequences revealed similar 
sequences were present in up to 12 WGSs. However, no transposase sequence displayed 
similar sequences in each of the 15 genomes. The transposase sequence (T!) from the strain 
ED98 (981105 to 982280 bp) was selected as a FAFLP target as similar sequences were 
identified in 12 of the 15 genomes. The consensus sequence (1320 bp) of this region was 
conserved (99.16 %). However, no similar sequences were identified amongst three strains 
(MSSA476, MW2 and RFI22). 
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Table 34. Lineage-specific fragments identified using FAFLP and WGM 
FAFLP WGM 
CC· No. lineage-specific Size of genome Size of genome No. lineage-specific Size of genome Size of genome 
fragmentst represented (bp)* represented (%)* fragments t represented (bp)* represented (%)* 
CC1 1 355 0.01 % N/A§ N/A N/A 
CC5 4 1456 0.05% N/A N/A N/A 
CC8 2 642 0.02% N/A N/A N/A 
CC239 N/A N/A N/A 3 (1) 30000 1.05 % 
CC22 6 1377 0.05% 14 (3) 212500 7.46% 
CC30 13 3628 0.13% 7 (2) 140000 4.91 % 
CC45 11 3655 0.13% 5 (1) 119000 4.18% 
CC59 13 5036 0.18% 15 (1) 245000 8.60% 
·CC, clonal complex. 
iLineage-specific fragments identified using FAFLP and whole-genome mapping (WGM). Brackets indicate number of lineage-specific regions. 
*1'he size of the genome represented by the lineage-specific fragments identified using F AFLP or WGM are shown in base pairs and as a percentage of 
the genome. 
~/ A, not applicable as fragments specific to the lineage were not identified using FAFLP or WGM. 
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A second search was performed for an additional FAFLP target which may enable the 
application of this assay to the majority of S. aureus isolates. The transposase sequence (T2) 
from the strain MRSA252 (2306521 to 2307052 bp) was selected as similar sequences were 
identified amongst eight strains which included MSSA47 6 and MW2. This consensus 
sequence (534 bp) was also relatively conserved (84.63 %). Sequences similar to Tl and/or 
T2 were identified in 14 WGSs. However, sequences similar to Tl and T2 were not 
identified within the strain RF122. 
Restriction endonuclease recognition sequences within the transposase sequences (Tl and 
T2) were analysed using GeneQuestlM• This identified a recognition sequence for the 
endonucleases MseI and Csp61 within the Tl sequence and a Csp61 recognition sequence 
within the T2 sequence. Reverse primers were designed manually upstream of the restriction 
endonuclease recognition sequences (Figure 39) (Figure 40). The primer sequences were 
5'CACGTATAATGATGATTTTCAGCTT 
5' GAATGAATACCGTMTAAAAAAGGA 3' 
3' for 
for and 
5' TCITGGCITATACATGACTAlTITC 3' for T2_Csp6I. The primer name represents 
the transposase sequence (TI or T2) targeted by the reverse primer and the restriction 
endonuclease utilised in FAFLP. An IS-FAFLP assay targeting Tl was initially performed on 
DBHT 1 to 24 from SRL using the endonuclease Msel for DNA digestion. Fragments were 
amplified using the MseI+O (Table 9) and TI_MseI primers and resolved on a 2 % agarose 
gel. Between one to three fragments less than 200 bp in size were amplified amongst these 
isolates. 
Further IS-FAFLP assays targeting TI and T2 were performed on isolates DBHT 1 to 24 
from SRL using the endonuclease Csp61 for DNA digestion. Fragments were amplified using 
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the Csp6I+O (Table 9) and either the T1_Csp61 or T 2_Csp61 primer and resolved on a 2 % 
agarose gel. All isolates excluding one (DBHT 7 which yielded 16 fragments) amplified a 
large number of fragments which could not be accurately differentiated . 
Figure 39. 1nsertion-sequence FAFLP target transposase sequence 1 
TTAGGCGGCCAGTCCATTATTGGGCTTGGTTGTCTTCTTTTTTTCTCCTTTGTANAAGCTGAAAATCATCATTATACGT ) 
G GTTGTTGAM TTTCTGTAACCAAMGAM TTCNCTTGA TT AA TTTTATCTTA TTA TTAA TTCCTTCTATAGCA 
CCATTATTAAATGCTGGGTAATAAATTGTATTTCTTAACATCCTTTGATGTTTTCTATAATATTTAACCNCTTTCCATACA 
CCNTTACTCACAGACTTTTTACTAACTGAATTTAAACGATTMTAAATTTAGGCCAATTACATAACCTTAGNTCTTTTCN 
TMTCCTTGGACAAGTTCGTAGGAGNGTCGTAGTATATCGTCTTTTGAAAGCATGAATTCTACAATGTCAGATGAGCT 
TTATAAGCCTTAAAAGATTTATTCCATCTGTATTTACTAAATATGGTTTTACTAGTATCCATCAATAGNACTTTCCAGTA 
TTCTTAAAAATTGTATMTNAGI ATAA CGATACTTATTAAGTTCNCTA 
( 
TTTAAATGTTGMCGATATGGAATCTGTCAAMATMTAGCTGCATTAGGAAATAGGTCGCGAAATMTCGGACATAG 
GGTTCATACATGTCAATAGTMCCGTCTTMCTTGTTGTCGATTTTTTAAATCGAATCGCTCGAAATAGOCACGCAAGA 
ATCTTGTAGTTCTATTTTCTAAAATATCTATAACATCATGAGTATCATTATCTATMAAATGAAACTCATTGATCCAGTTA 
CATTTTTAACGCTTTTAAATTCATCCATAGCGATGTGTTCTGGCAMCAATTAAANGGTTTM TTCGTAATGAATTAGCC 
GCTTTAGTTCTMTACGACTTACAGTAGATGGAGAGATACAGTTATCTTCTGCAGTATCAATCTCTGTTTTM CTTTAGT 
AGCTTCTTCTATMCTTTTTGAGTAACACATCTTGAGATAAAACACGACTCATCAACAATTGACGTTTTAGCAGTAAAA 
GTGCCATTGCATTCTMGCATTTAAAACGTTGTTTAGCTMGTTGAGGTATGTGTTATACCCTTGAGTTTTAAGTAMG 
TMTACGAGAAACACGCTTACCATGTTTATGMTTTGTCCTTCATTTTTM CTCCACAACAATM CAGGCCGMGGCTT 
ATACGTTAGTACAGCATTMCCACTGTTGCTTTTTTTCCTTTGATMTGACGTCAATTTCTTGGTTTATATATTTTATATT 
TTCATCTTTTATTCTTAGTMTTCTMGGTATCATTACACAT 
Consensus sequence of the transposase 1 (Tl) target utilised in an insertion-sequence 
targeted FAFLP assay. Highlighted nucleotides in purple and blue indicate ~e1 and 
Csp61 restriction endonuclease recognition sequences respectively. Nucleotides 
highlighted in grey and green indicate the TC~e1 and TC 0'P61 reverse primer 
annealing sequences respectively. Arrows indicate the orientation of the reverse primer. 
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Figure 40. lnsertion-sequence FAFLP target transposase sequence 2 
AAGAGNAANCGTCAGTCTATTATTGANAAGTATTATCCNATCNTCNAAAANTTACTTTCAGACNCTAGTGAANAANANTTNTACTATAA 
NNNTNTNNTTTGNCAATATTNGAANGNNAAACNTNGATTAACCTGTGNNTATTNTNCATTTAGAGCTIATNTNCTIAANCATGNTGNA 
TTTANTCNTTATNTTATGAAANGTTATCAANNGNTGTCGCCTAAAGNNANAACNAGANTCGAGACAAAANCNNNTCATCAAGCACAGT 
TTGACTGGAAAGAANGCATTAACTTTAAAACGAANGATAATCAAANNNTTNCACTANATATAGGNGTGNTACTACTITNTTANTCNCG 
TTTTNTAATCATGNAAGTNACAATGANTAAATCNAGTGATGNNTTATTTAATTNATTNACACAANCGTTTGAGCTAATNNNAGNTGTNN 
NTNATGNACTIGTAACNGATAAcnj ________ IAAAG""" ... Ul,"""GTGGTCGAATAAATCGTAGATTTAAA 
TAA ( 
Consensus sequence of the transposase 2 (T2) target utilised in an insertion-sequence 
targeted FAFLP assay. Highlighted nucleotides in blue indicate a Csp61 restriction 
endonuclease recognition sequence. Nucleotides highlighted in green indicate the 
T2_ Csp61 reverse primer annealing sequence. Arrows indicate the orientation of the 
reverse primer. 
IS-FAFLP PCRs were performed on DBHT 9 to 16 from SRL using the transpo a e-specific 
reverse primers (TLCsp61 and T2_Csp6I) on EcoRI with Msel- and HindUI with 
HhaI-digested DNA. As the reverse primers Tl_Csp6I and T2_Csp6I were 
transposase-specific the FAFLP AFs should harbour partial Tl or T2 sequences. In addition, 
the use of a double digest reaction generated less fragments as compared to when a single 
frequent-cutting endonuclease was utilised. Isolates analysed with the majority of IS-FAFLP 
assays yielded less than five fragments when resolved on a 2 % agarose gel. However, AFs 
generated using the primer T2_Csp61 on HindIU with HhaI digested DNA yielded a range of 
fragments between 50 to 600 bp which could be discriminated on an agarose gel. This IS-
FAFLP peR was repeated for DB HT 1 to 15. Isolates analysed using the T1 _Csp61 primer 
amplified no fragments. Each of the 15 profiles generated using the primer T2_Csp6I 
displayed background fluorescence of greater than 100 RFU, therefore the number of 
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fragments were not distinguishable. Therefore no IS-FAFLP assay produced FAFLP profiles 
which could distinguish between isolates. 
3.3.4. WGM 
Of the 18 isolates analysed using WGM, six were MSSA and were representative of CC8, 15, 
22 and 30. The remaining 12 isolates were MRSA and were assigned to CC1, 5, 8, 22, 30, 
45 and 59. A single isolate represented the majority of CCS with the exception of CC8 (n-3) 
and CC45 (n=2). MRSA isolates belonged to SCCmec types I to VI which included four 
SCCmec type IV subtypes and one non-subtypeable element. Each optical map was 
composed of 192 to 227 fragments, each of which was between 1174·94098 bp in size 
(Table 35). 
Cluster analysis was performed using the UPGMA method on WGM data for 18 isolates 
and in silico data for 21 strains obtained from the NCBI database. Optical maps were 
concordant with MLST data. Based on MLST CCs, a 90 % similarity cut-off was applied to 
the dendrogram (Figure 41). The 39 entries were grouped into six clusters and six maps 
displayed greater than 10 % divergence. Cluster 1 isolates (CC22) displayed up to 18.4 % 
difference compared to isolates from other clusters. Isolates belonging to CC30 (cluster 4) 
displayed up to 23.9 % divergence from other isolates. Cluster 6 isolates (CC59) displayed 
the greatest diversity (up to 36.9 %) with isolates of other lineages. 
Cluster 1 was composed of seven CC22 entries, one of which was an in silico optical map 
based on a preliminarily annotated EMRSA-15 strain. WGM identified heterogeneity within 
the CC22 isolates. DBHT 18 (CC22.II) displayed the greatest similarity with EMRSA-15. 
The remaining isolates displayed up to 5.3 % divergence from this strain and other CC22 
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maps. DBHT 4 and 5 were MSSA and displayed indistinguishable optical maps. The 
remaining four CC22 MRSA isolates displayed different spa types. WGM identified 
heterogeneity between all optical maps. 
Table 35. Characteristics of optical maps generated using WGM 
Isolate number Minimum fragment Maximum fragment No. of 
size (bp)" size (bp)" fragments t 
DBHT4 1756 70027 212 
DBHT5 1625 70417 216 
DBHTI0 1487 63863 215 
DBHT 15 1174 90716 227 
DBHT18 1275 69646 217 
DBHT19 1595 94098 219 
DBHT24 1818 81560 205 
DB HT 32 1480 70631 218 
DBHT36 1549 63137 201 
DBHT39 1237 67788 201 
DB HT 43 1487 89174 212 
DBHT45 1576 68682 205 
DBHT61 1536 53268 227 
DBHT65 1454 92276 211 
DBHT73 1500 90852 205 
DBHT87 1434 62595 220 
DBHT78 1638 81474 192 
DBHT88 1657 83210 215 
·Display minimum and maximum size of fragments amongst 18 optical maps generated 
using whole-genome mapping (WGM) with the endonuclease Nod. 
~umber of fragments constituting each optical map. 
227 
Figure 41. Cluster analysis using UPGMA on WGM data 
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The dendrogram was derived from whole-genome mapping (WGM) data using the 
restriction endonuclease Nod for 18 isolates. Based on a 90 % similarity cut-off (shown as 
vertical black line), six WGM clusters were identified (shown as black numbers). The 
clonal complex (CC) assignment of isolates and isolate number are shown on the right. 
Isolates assigned to each CC are highlighted in a single colour. 
·Isolate assigned to a singleton ST. 
Cluster 2 consisted of 16 entries assigned to eC1, 5, 8 and 15. Based on a further 95 % 
similarity cut-off the isolates composed four sub-clusters and a single isolate. One sub-cluster 
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consisted of six CC5 entries, five of which were in silico optical maps. DBHT 43 was most 
closely related (3.1 % difference) to the strain ED98 and exhibited up to 5.1 % divergence 
from the remaining CC5 WGSs. A second sub·duster was composed of a CC15 and three 
CCl entries two of which were generated from WGSs. DBHT 73 (CC15) displayed up to 
4.1 % divergence from the remaining CC1 entries. One CCl isolate (DBHT 19) displayed 
an optical map indistinguishable to the strain MW2. The remaining two sub-clusters were 
composed of WGSs assigned to CC8. Indistinguishable maps were generated for two 
USA300 strains which exhibited 3.6 % divergence from the strain NCTC 8325. Optical 
maps based on strains COL and Newman revealed 4.6 % difference. Isolate DBHT 15 
(CC8) was divergent from the remaining isolates in the cluster and exhibited up to 8.4 % 
difference from the other entries. 
The two ST239 (CC8) isolates constituting cluster 3 exhibited 6.6 % difference from each 
other. Cluster 4 was composed of four CC30 isolates and one MRSA252 (EMRSA-16) 
strain. DBHT 61 exhibited 99.4 % similarity with MRSA252. The other two MSSA CC30 
isolates (DBHT 10 & 36) exhibited up to 6.2 % divergence from the other entries. Cluster 5 
consisted of two whole-genome sequenced strains which exhibited up to 9.1 % difference. 
One of these strains was a bovine strain whilst the other was an Australian CA-MRSA clone. 
Two CC59 entries formed cluster 6 and DBHT 78 exhibited up to 5.8 % difference as 
compared to the whole-genome sequenced strain M013. 
Of the six optical maps which displayed greater than 10 % divergence from the remaining 
isolates, two were assigned to CC45 and two belonged to clones associated with live-stock. 
The two remaining isolates, DBHT 65 and the strain N3l5, belonged to CC8 and 5 
respectively but displayed divergence from other isolates assigned to the same CC. 
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Multiple alignment on the 39 optical maps revealed insertions, deletions and an inversion 
between genomes. Optical maps d isplayed greater similarity between isolates assigned to the 
same CC. Fragment patterns unique to isolates from a single CC were identified and one 
inversion was identified among the maps. The inversion consisted of a region (34000 to 
37500 bp) displaying six or seven fragments which were present in all isolates. However, the 
optical map for isolate DBHT 24 (CC22) displayed this fragment pattern in a reverse 
orientation . Four fragments immediately to the left of this inverted region in DBHT 24 
fo rmed a similar pattern to those of the first four fragments of this inverted region in all 
other isolates (Figure 42). Comparison to in silico W GSs revealed this inverted region 
encoded numerous membrane and cell surface proteins including the spa gene. 
Figure 42. Optical maps displaying inversion between CC22 isolates 
, IO-?'e be> , OO-?'e be> , 1()o:"l':' be> , " 0:"1':' be> , 120:"1':' be> , n0:"l':' be> , 100:"1':' be> , 15O,,!,,!, be> , 160:"1':' be> , "0:"1':' be> , l00.opo be> , lOO;,!,? be> , 200:"1':' be> ) 210, 
DD_14, DBHT 45 (CC22); DD_9, DBHT 24 (CC22). The figure depicts optical maps 
with Nod restriction endonuclease recognition sites (vertical bars). Highlighted region in 
red displays a restriction fragment pattern in the reverse orientation in DBHT 24 as 
compared to other isolates such as DBHT 45 indicating an inversion has occurred in this 
region in isolate DBHT 24. Highlighted region in blue indicate regions similar between 
the optical maps whilst those in grey are unique to each map. 
Restriction fragment patterns unique to isolates assigned to a single CC were identified. 
Patterns unique to isolates assigned to CC22, 30, 45, 59 and ST239 were also identified. 
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Lineage-specific restriction fragment patterns exclusive to isolates assigned to CCl, 5 or 8 
were not found. Of the six CC22 isolates, four isolates (DBHT 4, 5, 18 and 32) displayed 
three unique regions. The first CC22-specific region was identified 1360 kb into the 
sequence and was composed of a single fragment approximately 19 kb in size, comparison of 
this region to the in silica map of the strain H050960412 revealed this region contained 
genes encoding proteins involved in the repair of damaged DNA, an ion channel and an IS 
protein (Figure 43). 
Figure 43. Multiple alignment of optical maps displaying CC22-specific fragment patterns 
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DBHT 32 (CC22); DD _5, DBHT 10 (CC30); DD _20, DBHT 88 (CC8); DD _12, DBHT 
39 (CC45); DD_17, DBHT 73 (CC15); DD_19, DBHT 78 (CC59). The figure depicts 
optical maps with Nod restriction endonuclease recognition sites (vertical bars). 
Highlighted regions in red indicate regions of similarity between multiple optical maps. 
Highlighted regions in blue with yellow bars indicate regions specific to a subset of CC22 
isolates. 
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A second unique region was located 1600 kb into the sequence and was formed of seven 
fragments ranging in size from 2 to 18 kb. Features within this region included 
bacteriophage proteins, a transposase and integrase/recombinase (Figure 43). The final 
fragment pattern consisted of six fragments found at the end of the map which covered 144 
kb. This region harboured genes encoding for surface proteins, a transposase and conserved 
proteins. 
A single region unique to ST239 approximately 30 kb in size was identified and was formed 
of three fragments 20 kb into the genome. Comparison with the in silico optical map of the 
strain TW20 revealed that this region encodes for proteins associated with the SCCmec such 
as ccrc, IS431 and the mercury resistance operon (Figure 44). Two fragment patterns unique 
to isolates of CC30, in addition to ST239, were also identified. The first of these regions 
consisted of two fragments 67 kb into the genome and were approximately 40 kb in size. 
Comparison of this region with in silico optical maps from strains MRSA252 and TW20 
revealed this region encoded a cadmium efflux system, restriction endonuclease and a partial 
SCCmec region which included the transposon Tn554, ccrA and ecrB genes (Figure 44). Five 
fragments at the end of the optical maps were also unique to CC30 and ST239 isolates. This 
region covered over 100 kb and encoded numerous surface proteins, membrane transporters 
and a transposase. 
Lineage-specific restriction fragment patterns unique to CC45 and 59 were identified at the 
terminal end of optical maps. These regions covered up to 245 kb and were formed of 5 to 
15 fragments (Figure 45). The CC45 optical map could not be compared with a was 
representative of CC45. The CC59-specific region was compared against the strain M013 
and encoded features similar to those found at the terminal end of CC22 and 30 isolates. In 
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add ition, numerous transposases with homology to IS1272 and IS605/1S200, holin-like 
prote in cidA, exotoxin G, antimicrobial transport proteins, numerous surface-associated 
proteins and a biofilm operon were encoded in this region. 
Figure 44. Multiple alignment of optical maps showing lineage-specific regions at the 
beginning of maps 
DD_13, DBHT 43 (CC5); DD_8, DBHT 19 (CCl); DD_6, DBHT 15 (CC8); DD_10, 
DBHT 32 (CC22); DD _5, DBHT 10 (CC30); DD_20, DBHT 88 (CC8); DD _12, DBHT 
39 (CC45); DD_17, DBHT 73 (CC15); DD_19, DBHT 78 (CC59). The figure depicts 
optical maps with Nod restriction endonuclease recognition sites (vertical bars). 
Highlighted regions in red indicate regions of similarity between multiple optical maps. 
Highlighted regions in blue indicate regions of similarity between two optical maps. 
Highlighted regions in grey indicate regions unique to a single optical map. Highlighted 
regions in light blue bars indicate regions specific to ST239 and dark blue bars indicate 
regions specific to CC30 and ST239 isolates. 
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Figure 45. Multiple alignment of optical maps showing lineage-specific regions at terminal 
end of maps 
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DD_13, DBHT 43 (CC5); DD_8, DBHT 19 (CCl); DD_6, DBHT 15 (CC8); DD_10, 
DBHT 32 (CC22); DD_5, DBHT 10 (CC30); DD_20, DBHT 88 (CC8); DD_12, DBHT 
39 (CC45); DD_17, DBHT 73 (CC15); DD_19, DBHT 78 (CC59). The figure depicts 
optical maps with Nod restriction endonuclease recognition sites (vertical bars). 
Highlighted regions in red indicate regions of similarity between multiple optical maps. 
Highlighted regions in blue indicate regions of similarity between two optical maps. 
Highlighted regions in grey indicate regions unique to a single optical map. Highlighted 
regions in dark blue bars indicate regions specific to CC30 and ST239 isolates. 
Highlighted regions in yellow bars indicate regions specific to CC22 isolates. Highlighted 
regions in green bars indicate regions specific to CC45 isolates. Highlighted regions in 
purple bars indicate regions specific to CC59 isolates. 
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WGM also identified the heterogeneity within isolates of a single Cc. Multiple alignment of 
optical maps revealed fragment patterns unique to a single isolate. These restriction patterns 
could not be compared to in silico optical maps, therefore the features encoded in these 
regions were difficult to ascertain. However, these fragments and possible features encoded 
in these regions were noted (Table 36). The majority of unique regions were identified in 
CC8 isolates. In addition, the majority of isolate-specific regions were identified at the start 
and end of the optical maps. 
A multiple alignment between an ST8, ST239 and ST30 isolate revealed 240 kb near the 
beginning of the ST239 optical map and the final 160 kb (13 %) displayed restriction 
fragment patterns similar to those found in ST30. The central 2280 kb region (76 %) 
displays restriction fragment patterns similar to ST8 isolates of which 1690 kb was also 
similar to ST30. The remainder of the ST239 optical map (up to 240 kb) was unique and 
did not display similarity to ST8 or ST30 (Figure 46). 
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Table 36. Isolate-specific fragments identified using WGM 
Isolate No. of Loci of Compared to CC· isolate-specific isolate·specific Notes§ 
number 
fragmentst fragments (bp)* strain* 
First two 
DBHT restriction-sites in 
45 CC22 4 148918 H050960412 purA and "cl, 
second two differ 
from other isolates 
DBHT NoCC15WGS CC15 4 1·37672 N/A" available for 73 
comparison 
NCfCB325, 
USA300, Fragment not DB HT CCB 1 1777763·1791 USA300_TC found in any in 15 951 H1516, COL, 
Newman, silico optical map 
TW20 
Fragment may 
NCTCB325, encode bacteriophage USA300, 
DBHT 2051BB~2094 USA300_TC phiNM 1 proteins 
15 CCB 1 702 H1516, COL, including PVLlike 
Newman, protein. Restriction-site in TW20 bacteriophage 
integrase sequence 
NGfC8325, 
USA300, 
DBHT CCB 2 1·39049 USA300_TC 
Two restriction-sites 
65 H1516, COL, in purA and "cl 
Newman, 
TW20 
NCTCB325, 
USA300, Fragments not DBHT CCB 1 170746-19196 USA300_TC found in any in 65 4 H1516, COL, 
Newman, silico optical map 
TW20 
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Table 36 continued. Isolate-specific fragments identified using WGM 
Isolate No. of Loci of Compared to CC· isolate-specific isola te-specific Notes§ 
number strain* fragmentst fragments (bp)* 
NCfC8325, 
USA300, Fragments not DBHT 269783+2830 USA300_TC 
65 CC8 3 865 H1516, COL, found in any in 
Newman, silico optical map 
TW20 
DBHT 182091·21121 
Fragments not 
36 CC30 3 1 MRSA252 found in any in 
silico optical map 
Two restriction-sites 
DBHT in yycl and sasH 
61 CC30 8 1·17161 MRSA252 replaced with one, 
two cut-sites in ccrB 
replaced with one 
DBHT 532369·55262 Fragment may 
61 CC30 1 2 MRSA252 encoderibosomal proteins 
Three fragments 
DBHT unlike in silico 
88 CC8 9 1.88704 TW20 optical map this 
region included the 
SCCmec 
Region includes 
membrane proteins 
DBHT CC8 2 48158549853 TW20 and two less 88 1 restriction-sites 
compared to in silico 
optical map 
DBHT 2468284·2566 Fragments not 
78 CC59 4 381 MO 13 found in any in 
silico oPtical map 
DBHT No CC45WGS 
39 CC45 3 148649 N/A available for 
comparison 
DBHT No CC45WGS 
87 CC45 5 1.62262 N/A available for 
comparison 
DBHT 2241108.-2242 No CC45WGS 
87 CC45 1 542 N/A available for 
comparison 
DBHT 245841 +2564 NoCC45WGS 
87 CC45 6 531 N/A available for 
comparison 
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Table 36 continued. Isolate-specific fragments identified using WGM 
Isolate No. of Loci of Compared to CC isolate-specific isolate-specific Notes§ 
number strain; fragments t fragments (bp); 
DBHT 2761176-2844 NoCC45WGS 
87 CC45 7 901 N/A available for 
comparison 
·CC, clonal complex. 
"Number of fragments specific to a particular isolate. 
*Loci of isolate-specific fragments relative to the whole-genome sequence (WGS) of the 
strain displayed. 
§Features encoded in these regions relative to the WGS of the strain displayed. 
I 1Nl A, not applicable. 
Figure 46. Multiple alignment of optical maps from ST8, ST30 and ST239 isolates 
DD_5, DBHT 10 (CC30); DD_20, DBHT 88 (CC8); DD_6, DBHT 15 (CC8). 
Highlighted regions in red indicate regions of similarity between multiple optical maps. 
Highlighted regions in blue indicate regions of similarity between two optical maps. 
Highlighted regions in grey indicate regions unique to a single optical map. 
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CHAPTER 4 
4. Discussion 
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Molecular methods are useful in microbial diagnostics, epidemiology and research. In 
particular, well-established molecular methods such as MLST and SCCmec typing have been 
invaluable in understanding the population structure and evolution of S. aureus, a human 
pathogen. The bacterium is a common cause of HA infection in immunocompromised 
patients, individuals with open wounds and the elderly. However, infections affecting the 
healthy and young have increased in the past few decades and are a rising clinical concern. 
Understanding the genetic diversity of S. aureus can therefore result in a better 
understanding of the pathogenesis, spread and evolution of S. aureus, which in turn can lead 
to the development of effective infection control measures. In the present study, molecular 
methods were utilised to investigate differences in the distribution and variability of bacterial 
genes present between successful and unsuccessful lineages of MRSA Furthermore, this 
study explored these genetic differences in relation to functional differences within the 
bacterium, which could provide a selective advantage in successful lineages, for example, by 
altering their virulence or pathogenicity. 
The BSAC collection provided a wel1-<:haracterised set of isolates with data for MIC (for six 
antimicrobials), mecA and mupA PCR and the number of isolates collected from each centre 
available. As MIC testing for all isolates was performed by a single laboratory, this eliminated 
the inter-laboratory variability of these data. Since bacteraemia is a systemic infection, 
analysing bacteraemia isolates provided an advantage as compared to isolates from other sites 
of infection where it may be difficult to differentiate between those isolates causing infection 
and colonising isolates. Studying bacteraemia isolates could help us understand S. aureus 
infections at other sites. However, bacteraemia isolates may not be representative of the 
entire S. aureus population; they may represent a subset such as those resistant to treatment 
at the initial site of infection. The BSAC isolates were also selected as they were 
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representative of urban and rural settings, with a range of deprivation scores which can be 
used as a measure of the standard of living in an area. This may help reduce sample bias, 
however, it should be noted data on the geographical locations throughout England and 
Ireland from which the isolates were collected was not available. As isolates were collected 
consecutively as opposed to randomly throughout the year, and due to the infectious nature 
of bacteria, the independence of each isolate was reduced, although duplicate isolates from 
the same patient were not collected (Reynoids et al, 2008; 2009). Statistically significant and 
meaningful results in this study were drawn from results obtained using this collection of 
isolates. 
The SRL collection was representative of different centres however, their geographic 
locations were unavailable. Although the epidemiological data for this collection was limited, 
it included multiple isolates from the same centre including those obtained from a single 
patient. Preliminary FAFLP analysis of this collection determined FAFLP as a molecular tool 
to highlight small-scale sequence variations (point mutations and indels) within isolates from 
a single patient. Furthermore, this collection assisted the development and optimisation of a 
novel FAFLP method which was subsequently applied to all isolates in this study. WGS data 
were available for six strains which facilitated in silieo analysis on strains and a direct 
comparison with experimental data for the same strains. The Glasgow collection represented 
a well-characterised isolate collection for which MIC, nuc, mecA and mupA PCR and PFGE 
information was available. In addition, inclusion of this collection from Scotland ensured 
that the study represented isolates from different regions of the UK. The CMPHL collection 
included isolates involved in an outbreak and isolates which colonised patients and staff 
during this period. FAFLP analysis of this collection enabled the author to assess the genetic 
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diversity between outbreak and colonising isolates and the ability of FAFLP to differentiate 
between these groups of isolates. 
4.1. Epidemiology of study isolates 
The proportion of cases of S. aureus bacteraemia caused by MRSA peaked and subsequently 
declined during the 2000s (43 % in 2001, 23 % in 2009 and 14 % in 2011) (Hope et al., 
2008). During the period 1998 to 2007, the majority of MRSA bacteraemia was attributable 
to two strains (ST22-MRSA-IV or EMRSA-15 and ST36-MRSA-II or EMRSA-16). This study 
has built on that previous molecular epidemiological surveillance of MRSA causing 
bacteraemia by using conventional typing tools and has developed new tools to probe the 
genetic diversity of M RSA in greater depth. 
The current study identified that the majority of cases of MRSA bacteraemia in 2009 
continued to be attributed to these two highly successful strains. Cases due to EMRSA-15 
and EMRSA-16 continued to fall from 31 % and 3 % in 2007 to 18 % and 1 % of the 
S. aureus bacteraemia collection in 2009 respectively (Figure 47). This suggested that against a 
backdrop of a MRSA bacteraemia rate that has peaked and is now falling, the prevalence of 
EMRSA-15 amongst MRSA causing bacteraemia also reached its epidemic peak and was 
declining by the end of the first decade of this century. EMRSA-16 has also continued to 
decline since 2007 and this decline appears to have started naturally, prior to the overall 
MRSA bacteraemia decrease (Ellington et al, 2010; Pearson et al., 2009). 
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Figure 47. Trends in meticillin-resistant S. aureus(MRSA) bacteraemia from 1998 to 2009 
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The chart depicts trends in total proportion of S. aureus bacteraemia attributed to MRSA 
(blue line) and proportion of MRSA bacteraemia attributed to EMRSA-15 {red line}, 
EMRSA-16 (green line) and other clones (purple line) in the UK. The dotted line 
represents proportions gained from the European Antimicrobial Resistance Surveillance 
System (EARSS) and the EMRSA-15 and EMRSA-16 strains were identified using 
bacteriophage typing (Johnson et al., 2001), The solid line represents proportions gained 
from the BSAC and EMRSA-15 and EMRSA-16 were identified using PCRs which target 
R-M genes and SCCmec typing (Ellington et al., 2010). The dashed line represents 
proportions identified in this study and EMRSA-15 and EMRSA-16 were identified using 
MLST and SCCmec typing. 
This displays certain features of the perceived epidemic cycle where strains can undergo 
clonal expansion, followed by a relatively stable and successful period before they 
subsequently decline in the population (Wyllie et al., 2011). It is unknown whether these 
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strains decline due to displacement by novel strains, environmental factors (infection control 
measures and antimicrobial therapy) and/or biological factors (host immune responses and 
the activity of bacteriophages) (Hibbing et al, 2010; Rao et al., 2011). 
The case of EMRSA-15 and EMRSA-16 in the UK displays how the prevalence of epidemic 
MRSA clones can decline in the population. This decline may enable the opportunity for 
novel or less prevalent clones to emerge. Monitoring such trends could therefore provide 
insights into the success of certain S. aureus clones and enable us to determine the trends in 
prevalence of MRSA clones in the future. During the period 1998 to 2007, the proportion 
of MRSA bacteraemia isolates assigned to clones other than EMRSA-15 and -16 remained 
relatively constant. However, an increase was observed from 2007 to 2009 (Figure 47). This 
may indicate that the rapid decline of EMRSA-15 and ·16 enables the population of low 
prevalent clones to increase as they are able to occupy niches previously dominated by these 
two strains. The CC22 and 30 lineages appear to be highly successful in the UK as they 
represented a large proportion of BSAC isolates (63 %). Although, sample bias may also 
account for the large proportion of CC22 and 30 isolates. Significant antimicrobial 
susceptibility differences were identified between CC22 and the other lineages which may 
explain, in part, the success of CC22 under conditions of selection due to antimicrobial 
therapy. 
Low prevalence clones may represent rare or sporadic clones that have emerged recently or 
are less adapted to the hospital environment. These included ST5·MRSA-II, a clone thought 
to have a polyphyletic origin (multiple independent insertions of SCCmec type II) (Nobel et 
al., 2008). MRSA clones also included ST45·MRSA-II which is rarely identified outside of 
the USA, the ST80-MRSA-IV clone which is often PVL-positive and an ST779 isolate which 
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is a sporadic lineage in the UK The mecA gene but no recombinases were identified within 
the ST779 isolate and may indicate a combination of SCCmec and SCCfus elements 
(Monecke et at, 2011). As the MRSA isolates assigned to clones other than EMRSA-15 
and -16 belonged to individual MRSA lineages (CC5, 45, 80 and a singleton ST), this study 
did not provide evidence that these represented emerging MRSA clones. However, this study 
established the clones present at a lower frequency in 2009 which can be used as a baseline 
for future studies to monitor changes in the proportion of these clones in the UK 
MRSA isolates within the remaining collections in this study represented a diverse range of 
lineages. Although this study did not include representatives for the entire diversity of 
MRSA identified in the literature, the collection identified lineages which have given rise to 
numerous widespread HA and CA-M RSA strains through to sporadic strains (those that are 
identified at irregular intervals) in the UK The few representatives of an ancestral MRSA 
clone (ST250-MRSA-I) indicated the continued state of decline of this clone, although the 
reasons for this remain unknown. SCCmec type III elements were restricted to ST239 
isolates. These isolates also represented an ancestral clone which displays divergent 
hybridisation patterns as compared to other CC8 isolates as it was formed by a large-scale 
recombination event between isolates of CC8 and 30 (Monecke et at, 2011; Robinson and 
Enright, 2004). This clone displays resistance to multiple antimicrobial classes and heavy 
metals which may explain its success in the UK and worldwide. Non-typeable SCCmec 
elements have been described in MRSA clones belonging to lineages such as CC8 (Monecke 
et aL, 2011). This may indicate the presence of composite and irregular SCCmec types that 
harbour novel virulence factors or antimicrobial resistance determinants that could play a 
role in the emergence of these clones. MRSA assigned to CC5 belonged to clones such as 
ST5-MRSA-II, the success of which may be driven by glycopeptide-resistant strains (Niibel et 
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al, 2008). CC45 MRSA included representatives of the sporadic CC45-MRSAV clone and 
a ST45-MRSA-VI isolate, which to the best of the author's knowledge is a novel observation. 
This indicated the diversity amongst ST 45 MRSA clones is increasing, although the reasons 
for this are unknown. Other clones such as ST1-MRSA-IVa, ST8-MRSA-IVa and 
ST97-MRSA-V have been associated with the arginine catabolic mobile element which may 
play a role in the virulence and/or fitness and hence the success of these clones (Diep et al, 
2008; Ellington et al, 2008). MRSA isolates belonging to CC7, CC97 and ST361 are 
generally thought to be rare (Monecke et al, 2011), whilst novel genotypes were identified 
amongst pandemic and sporadic lineages (CC7, 22,45,80 and 88). Therefore MRSA clones 
amongst the remaining collections included a range of diverse MRSA clones. 
The CA-M RSA in this study were genetically diverse (CCI, 30, 59, 80, 88 and ST93) and 
have been associated with PVI. (Monecke et al, 2011). This may indicate these isolates are 
associated with severe disease (Gillet et al, 2002). Despite being previously reported in the 
UK, clones assigned to ST93 are rarely identified in the UK. Monitoring the emergence of 
PVI.....positive strains is vital as although the role of PVL in virulence is controversial, such 
strains are often able to infect individuals not associated with HA risk factors (Diep and 
Otto, 2008). 
MSSA isolates were assigned to a greater number of lineages as compared to MRSA isolates 
and hence the isolates in this study represented a smaller proportion of the entire MSSA 
diversity than MRSA isolates described to date. The MSSA isolates belonged to diverse 
lineages which included those associated with major HA and CA-MRSA lineages, in 
addition to lineages that contain MSSA predominantly. Amongst MSSA, the greatest 
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proportion of isolates belonged to CC30 which correlates with studies indicating that this 
lineage is particularly successful in the UK (Ellington et al., 2010; Johnson et aL, 2005). 
Majority of the MSSA isolates were assigned to lineages similar to MRSA bacteraemia 
isolates (CC1, 8, 5, 22, 30, 45 and 59). This indicated that lineages have given rise to 
multiple successful MSSA and MRSA clones. Those isolates assigned to CC5 included an 
ST6 isolate which is a DLV of ST5. A large-scale chromosomal replacement between a CC5 
isolate and a representative from another lineage is thought to have occurred to form ST6; 
approximately half of the ST6 genome is thought to originate from CC5. MSSA assigned to 
CC1 and 8 included an ST573 and ST72 isolate respectively, which based on microarray 
hybridisation patterns and MLST, indicates previous recombination events may have 
occurred to form these genotypes. The presence of multiple STs in these CCs demonstrated 
that indicated MSSA displayed considerable diversity amongst each lineage. The remaining 
MSSA isolates were composed of predominantly MSSA-specific lineages (CC9, 12, 15, 20, 
25,97, 101 and 121). CC15, for example, is a successful MSSA lineage which is a common 
colonising strain (Monecke et al., 2011). The three remaining STs belonged to a lineage 
(ST425) associated with livestock, thus indicating the prevalence of infections associated 
with livestock-associated lineages remains rare at present. The presence of novel genotypes in 
MRSAassociated lineages (CC1, 5, 8, 30, 45 and 59), the predominantly MSSA CC121 and 
three singleton STs (ST2043, ST2044 and ST2221) identified in this study indicated these 
genotypes have emerged recently. Therefore this shows the diversity of MSSA continues to 
increase in a similar manner to that of MRSA These findings are in accordance with 
previous findings which state MSSA isolates display greater genetic diversity than MRSA 
isolates. This is probably due to the limited SCCmec insertion events that have occurred in a 
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subset of genetic lineages to form a small number of MRSA clones which have spread 
globally (Fitzgerald et aL, 2001; Musser and Kapur, 1992; Robinson & Enright, 2003). 
Five SCCmee types or subtypes and at least five non-typeable or non-subtypeable SCCmee 
elements identified in CC22 isolates indicated that this locus displayed considerable 
diversity within this lineage. Isolates with a SCCmee type IV non-subtypeable element 
revealed that these isolates may display variations in the virulence factors within the J regions 
of the element. Determining the sequence of these regions may be of value as it may identify 
the presence of SCCmec elements with novel virulence factors. SCCmee type IV and in 
particular, SCCmec IVh was overrepresented in CC22 which indicated EMRSA-15 was 
abundant and continued to be a significant cause of MRSA bacteraemia. Further 
investigation may identify whether this SCCmec subtype is directly associated with the 
prevalence of this strain in the UK The ST22-MRSA-V clone identified amongst MRSA 
bacteraemia has been sporadically isolated in a few countries including the UK. Although 
the low prevalence of this clone indicates that it is not particularly successful, at present it is 
of value to monitor its emergence as PVL-positive versions of this clone have been identified 
(Boakes et aL, 2011; Monecke et aL, 2011). SCCmee non-type able elements which consisted 
of cer complex 4 and mecA indicated that SCCmee types VI and VII variants may be present 
in these isolates. Nevertheless, the presence of two eer complexes in other non-type able 
elements may indicate the presence of a composite SCCmee. However, further investigation 
would be required via determining the sequence of the SCCmee locus to confirm whether 
these findings indicate the presence of novel or variant SCCmee types which have not been 
previously described within this lineage. The diversity observed at this locus and within the 
housekeeping genes of the S. aureus MLST scheme demonstrates the concordance of this 
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study with previous studies that displayed divergence in this lineage across the genome as 
compared to other lineages (Monecke et aL, 2011). 
A previous study has suggested the presence of multiple SCCmec IV subtypes amongst 
MRSA clones has arisen via independent SCCmec insertion events rather than conversion 
between subtypes via insertions or deletions. Therefore the presence of different SCCmec 
types and subtypes identified in the present and previous study indicated that insertion of 
different SCCmec cassettes has occurred on at least seven occasions (Boakes et aL, 2011; 
Mammina et aL, 2012). The identification of multiple ST22·MRSA-Il isolates indicated one 
of these insertion events included the HOT of SCCmec type II into ST22, which to the best 
of the author's knowledge is a unique observation. Furthermore, as the replacement of an 
SCCmec type within an MRSA isolate is unfavourable, this indicates these insertion events 
have occurred into ST22·MSSA (Robinson & Enright, 2003). In some cases, the 
ST22-MSSA progenitor clones were PVL-positive which have given rise to PVL-positive 
MRSA clones. Further work is needed to identify whether ST22·MRSA-1I encoded PVL. 
Nonetheless, these results have provided insights into the diversity and evolution of MRSA 
amongst CC22 (Figure 48). 
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Figure 48. Hypothetical insertions of SCCmec types and sub types into ST22 
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The figure depicts seven hypothetical insertions into STZZ,MSSA progenitors. In some 
cases, the progenitor clones were PVL-positive which gave rise to PVL-positive MRSA 
clones. MRSA clones illustrated in dashed circles were not identified in this study but 
have been identified in previous studies (Boakes et al., ZOll; Mammina et al., 201Z). 
MRSA clones in solid circles were represented in this study and STZ2-MRSA·ll is a novel 
clone identified only in this study. 
The relationship of EMRSA-15 to the remaining STZ2 isolates with SCCmec type Il, V and 
other cassettes requires further investigation . If the insertion of alternative SCCmec types has 
occurred prior to the emergence of EMRSA-15 it poses the question as to why the ST22· 
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MRSA-IV combination is particularly successful. Conversely, insertion of alternative 
SCCmec types may have occurred after the emergence of EMRSA-15. The presence of novel 
or unusual MRSA clones such as ST2z..MRSA-II may indicate they have emerged recently. 
Further SCCmec insertion events in this lineage may be driven or allowed to emerge by 
changes in selective pressure due to the continued decline of EMRSA-15. However, 
ST22·MRSA-II may not have been previously identified if it displayed low prevalence. 
Lineages such as CC22 which indicate multiple SCCmec insertion events support a previous 
study which suggested the insertion of SCCmec occurs on numerous occassions in the same 
lineage but each clone is limited in their geographic spread (Niibel et al, 2008). This is in 
contrast to the theory that a limited number of MRSA clones have emerged and spread 
globally. Due to the limited discriminatory power of current molecular methods to 
discriminate between lineages, techniques such as NOS are needed to provide further 
insights into the emergence and spread of MRSA 
4.2. Genetic homogeneity between S. aureus lineages 
This study identified twelve regions of genetic homogeneity amongst the MRSA lineages 
examined, of which a subset were mapped to WOSs. FAFLP identified the size of an AF, its 
sequence is unknown. Hence, we assume AFs of the same size originate from the same 
genomic locus. Thus, AFs present in all S. aureus isolates were taken as an indication that 
they originated from conserved regions of the genome which may encode important cell 
functions. The presence of AFs with a distinct sequence of the same size in the same isolate 
(collision) or in different isolates (homoplasy) may be a factor in the FAFLP profiles observed 
(Gort and van Eeuwijk, 2012). 
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Mapping one of the homogeneous regions to WGSs identified that it encoded the 
noncoding region between a recombination protein and the 16S rRNA gene. Despite not 
containing an ORF, this region may play a role in functions such as the regulation of 
neighbouring genes (Niibel et aL, 2008). The sequences of the remaining core regions were 
relatively conserved amongst lineages (98 to 100 %), and mapping to WGSs confirmed these 
regions harboured ORFs. Thus the presence of a specific AF in each lineage could identify 
the presence of highly conserved regions associated with essential cell functions. The 
presence of minor genetic variations agreed with previous findings which suggested 
variations within these regions were associated with significant phenotypic changes that 
affected strain growth and metabolism and may contribute to the SUrvival, fitness and 
success of S. aureus (Table 37). 
4.3. Genetic diversity between S. aureus lineages 
This study utilised molecular methods to identify regions which display genetic variation 
which may confer a fitness advantage in major MRSA lineages by altering traits such as 
virulence or pathogenicity. 
The presence of a unique combination of genetic variation in each lineage was confirmed by 
the clusters based on FAFLP data, which were concordant with MLST data, and the level of 
heterogeneity between lineages which was variable. The most successful lineage within the 
UK is CC22. The CC22 genome was highly divergent (~4 7 % detected using FAFLP) from 
the remaining lineages, which is in accordance with previous studies (Monecke et aL, 2011). 
A proportionately high fraction of variations were indels (over 40 %) rather than SNPs. The 
majority of these indels were identified in regions encoding for lipoproteins or proteins 
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involved in the biosynthesis of amino acids. SNPs indicated regions which are associated 
with functions which may confer a selective advantage in this lineage and explain why this 
lineage predominates within the UK. CC22 isolates displayed distinct sequences for proteins 
which may alter the virulence and antimicrobial resistance. Additionally certain loci showed 
similarity with CC30 isolates, which may indicate cell growth, formation of the 
small-colony variant (SCV) phenotype and antimicrobial resistance may play a role in the 
success of these two lineages (Table 38). 
The maximum heterogeneity was observed amongst CC8 as ST239 displayed considerable 
diversity from the remaining CC8 isolates, which is in accordance with previous findings 
(Monecke et al, 2011). Alternatively, CC59 isolates displayed the greatest homogeneity, 
indicating few MRSA clones have emerged from this lineage. HA-MRSA lineages (CC5, 8, 
22,30 and 45) displayed greater divergence than a,MRSA lineages (CCI and 59). Further 
work on larger isolate sets would be required to determine whether this is due to differences 
in the relative ages of HA- versus CA- lineages or another factor such as differential 
antimicrobial selective pressure or their ability to spread in the nosocomial and community 
settings. 
Based on FAFLP data, CC22 genome exhibited the greatest similarity with CCl, 5 and 8 
genomes. CCI and 5 genomes displayed the greatest homogeneity with each other. 
Genomes from other major lineages (CC30, 45, 59, and 97) displayed greater divergence 
from CCl, 5, 8 and 22. Based on loci throughout the genome, this study identified lineages 
which may be closely related to other lineages. Therefore further investigation of these loci 
may provide valuable insights into the evolution of MRSA lineages. 
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Table 37. Function of homogeneous regions amongst S. aureus lineages 
Protein Function Phenotype of Reference 
mutant 
Regulation of genes 
Transcriptional involved in nitrogen Display (Majerczyk et aL, 2010; 
metabolism, amino acid reduced rate 
repressor (Cody) biosynthesis, nucleotide of cell growth Pohl et aL, 2009) 
metabolism and virulence 
Catabolism of glycerol an Lack of cell Dihydroxyacetone intermediate of glycolysis, growth on (Erni et aL, 2006; kinase (DhaK) the metabolic pathway glycerol Pulsen et aL, 2000) 
which generates ATP 
Alters their 
Phosphoglycerate Role in glycolysis growth under (Nakano et aL, 1999; kinase (PGK) anaerobic Watson et aL, 1982) 
conditions 
FtsKlSpoIIIE Segregation of Prevent cell (Begg et al, 1995; Lyer 
ATPase family chromosomes during cell division et al, 2004) division 
2-oxoisovalerate Catabolism of 
dehydrogenase branched-chain amino Unknown (Aevarsson et al, 1999) 
acids 
Aminotransferase Mobility of sulphur for the 
(NifS) formation of Unknown (Zheng et aL, 1993) 
metalloenzymes 
Previous studies demonstrate the function of proteins identified in homogeneous regions 
amongst all S. aureus lineages and the effect of mutations within these protein coding 
regions. 
WGM identified restriction fragment patterns specific to CC30, 45 and 59. Lineage-specific 
patterns may have been generated due to polymorph isms within regions harbouring the 
restriction endonuclease recognition sequence or insertion or deletion of acquired DNA 
elements. WGM alignments performed using ST8, ST30 and ST239 optical maps identified 
the regions of these genomes that were homogeneous between lineages. This supported the 
finding that ST239 was formed by a large recombination event (Robinson and Enright, 
2003; 2004). The majority of the ST239 genome (76 %) was similar to the ST8 genome. Of 
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76 % of the ST239 genome, 74 % also displayed similarity to the ST30 genome, indicating 
that the remaining region (26 %) represents variable regions of the ST8 genome. The 
remaining 24 % of the ST239 genome was equally composed of ST30-specific regions or 
regions unique to ST239. The SCCmec region in ST239 did not show similarity with either 
ST8 or ST30 and hence this study confirms the origin of this element in ST239 remains 
unknown and requires further investigation (Holden et al., 2010). Regions unique to ST239 
indicated genetic variations or genetic events such as point mutations or HOT have arisen 
within these regions since the formation of ST239. Furthermore, unique fragment patterns 
were also identified within the former ST8 portion of the ST239 genome. This indicated the 
presence of genetic variations within these regions that have arisen after the recombination 
event between these lineages. Therefore genomic regions displaying lineage-specific 
heterogeneity require further investigation using NOS as they may provide insights into the 
survival and virulence of S. aureus lineages. 
Where heterogeneous regions were identified between lineages, the regions were mapped to 
WOSs in order to identify whether these were attributed to differences in the distribution of 
these regions or whether they have been identified as a result of sequence variation. This 
study revealed the presence and absence of these AFs were due to sequence variation within 
the AF sequences in the form of SNPs, point mutations and small-scale indels at the loci 
identified. This is in accordance with a previous study which identified AFs specific to 
particular FAFLP dusters that are due to point mutations rather than the presence or 
absence of loci and these AFs are spread throughout the genome (Melles et al., 2004). 
Regions identified in each lineage may encode essential cell functions and we expect these 
loci to be maintained via purifying selection, as minor variations in these sequences could 
result in significant phenotypic differences. As the majority of variations amongst these 
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sequences were specific to isolates of a specific lineage including MRSA and MSSA, this may 
indicate these variations arose prior to the insertion of SCCmec types in a common ancestor 
of each lineage. Conversely, these variations may have arisen via random mutations in a 
subset of the lineage and subsequently spread through the lineage via genetic transfer. 
Further analysis of these variations identified whether they altered the amino acid sequences 
of the encoded proteins which are now discussed below. The proteins included are those 
involved in functions which may provide a selective advantage. 
The identification of lineage-specific variations could be utilised to develop assays which 
enable the rapid differentiation between lineages. Based on a single heterogeneous region, a 
pyrosequencing assay which could differentiate between major S. aureus lineages was 
developed. The assay was able to identify lineages for the majority of the isolates. Such assays 
would prove to be invaluable high,throughput and rapid tools, economical for the majority 
of resource'poor laboratories. However, further optimisation is required to improve the 
typeability of this assay. Further validation of the assay with a larger set of isolates may help 
to identify novel primer sequences. Such assays can help in outbreak situations to determine 
antimicrobial patterns and the genetic relatedness of the isolates. Furthermore, it can help us 
monitor trends in the emergence and spread of particular lineages. 
A proportion of heterogeneous regions partly encoded proteins with a role in essential cell 
functions. These include proteins involved in aerobic and anaerobic respiration, biosynthesis 
of essential cell components, and DNA replication, repair and recombination. Other regions 
encoded proteins involved in nonessential functions such as antimicrobial resistance, 
virulence and pathogenicity (Table 38). Previous studies have revealed sequence variations 
within these regions can influence the growth, virulence, pathogenicity or antimicrobial 
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resistance of S. aureus. Specific regions were exclusive to isolates of one lineage or a subset of 
lineages indicating they represented accessory genomic regions. However, in the majority of 
cases, heterogeneous regions were identified in each lineage. 
The majority of variations associated with regions encoding respiratory functions were 
restricted to non-coding regions, which can affect gene regulation (Gottesman, 2005). On 
the contrary, those encoded on ORFs were synonymous, indicating the conservation of 
protein sequence and function between lineages, in the main. The AF sequence for F47, 
nitrite reductase involved in the anaerobic conversion of nitrite to ammonia, was conserved 
amongst the majority of lineages but displayed numerous CC22-specific SNPs of which most 
were non-synonymous. With regards to the mutations in the non-coding regions of the AF, 
considering the effect of mutations in the regulatory systems which control the transcription 
of the nitrite operon is useful. Mutations in these loci result in decreased nitrite reductase 
activity and formation of a SCV phenotype under anaerobic conditions (Schlag et aL, 2008). 
SCVs show an increase in antimicrobial resistance and persistence in the host (Tuchscherr et 
al., 2011). Further investigation would be required to identify whether the non-synonymous 
CC22-specific SNPs alter the function of nitrite reductase, and lor whether the synonymous 
SNPs alter the translation efficiency of the protein. If either hypothesis (above) is correct, 
then this region may alter the growth and survival of CC22 isolates under anaerobic 
conditions. 
Haem is the prosthetic group of a number of proteins including the cytochromes involved in 
the respiratory electron transport chain (Lee, 1995; Tien & White, 1968). Multiple 
heterogeneous regions (F38, F45 and F49) which encoded proteins involved in haem 
biosynthesis were identified in this study. These proteins were conserved amongst the 
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majority of lineages except two major lineages CC8 and 22, in addition to ST93 where 
variations occurred. Mutations in proteins with a role in haem biosynthesis can result in a 
SCV phenotype which can also be associated with repressed levels of virulence factors such 
as a-haemolysins (Kohler et al, 2003). Such factors may aid in evasion of the host immune 
system and variations within this region may affect the growth and virulence. Another 
protein (F21) involved in the biosynthesis of cobalamin was specific to CC22. Cobalamin is 
a coenzyme required for multiple metabolic processes, and the biosynthesis of cobalamin can 
occur via multiple pathways under aerobic and anerobic conditions (Raux et al, 2000). 
Further work is required to establish the function of cobalamin in providing a selective 
advantage for this succesful lineage and to determine whether variations in haem 
biosynthesis associated regions aid the evasion of the host immune response in CC8, 22 and 
ST93. 
Proteases were encoded on multiple heterogeneous regions, one of which included 
dipeptidyl aminopeptidase (F40) which cleaves the terminus of peptides with an alanine or 
proline as the penultimate amino acid. Aminopeptidases have a role in virulence, nitrogen 
metabolism and the activation or degradation of various proteins (Gonzales and 
Robert-Baudouy, 1996). The disruption of genes encoding for aminopeptidases have been 
shown to reduce the severity of an S. aureus infection (Carroll et al, 2012). The greater 
proportion of SNPs specific to CC22 and 59 were synonymous whilst those specific to CC5 
and 30 were non-synonymous. This indicated the function of this protein is conserved in 
certain lineages such as CC22 to a greater extent than in others such as CC30. Cell 
functions such as replication, repair and recombination of DNA were encoded on multiple 
heterogeneous regions. SNPs at these loci were restricted to non-coding regions or were 
synonymous, indicating the essentiality and conservation of the amino acid sequence and 
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may indicate that these loci are under the action of purifying selection. The non-coding 
region displayed sequence divergence particularly in CC30 and 45 isolates as compared to 
other lineages and further investigation is required to identify whether these SNPs alter the 
regulation of DNA repair and whether this affects strain success. 
One heterogeneous region encoded a protein (F13) which interferes with the development 
of bacteriophages after their DNA has penetrated the cell (Duckworth et al, 1981). This 
mechanism often results in cell death as the infection has progressed sufficiently to damage 
cell functions or host DNA (Garvey et al, 1995). The one non-synonymous SNP identified 
within this region was specific to CC8. Whilst further work is necessary to investigate the 
significance of the SNP, mutations within proteins displaying abortive infectivity domains 
are known to affect the quantity of protein A and a subset of other surface proteins. In 
addition, this alters the abundance and shape of the cros~walls forming the peptidoglycan. 
Therefore mutations in these proteins may affect cell division, cell separation and virulence 
(Frankel et al, 2010). 
A number of proteins encoded on heterogeneous regions play a role in the efflux or 
degradation of antimicrobials. A partial ABC transporter protein (F23) required for the 
efflux of multiple antimicrobials was identified in CC22, 3D, 59 and ST425. Previous studies 
have identified mutations in these proteins result in an increased sensitivity to the 
antimicrobial bacitracin (Ohki et al, 2003). Multiple regions encoded lipoproteins, one of 
which (F22) was present in the majority of lineages excluding CC1, 30 and 59. This protein 
displayed a unique sequence in CC5, 8, 22 and ST93 isolates. Lipoproteins play numerous 
roles in S. aureus which include immune evasion and antimicrobial resistance. The absence 
of this protein in certain CA-MRSA lineages and the unique protein sequence displayed 
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amongst other lineages may explain, in part, differences in antimicrobial resistance or 
virulence between lineages. Two lipoproteins displayed a divergent amino acid sequence in 
CC30 (F19) and CC5 (F48) respectively. Post-translational modification of lipoproteins has 
been shown to play an important role in pathogen recognition via the innate immune 
system (Wardenburg et aL, 2006). Lipoproteins are also essential to maintain intermediate 
glycopeptide resistance (Jousselin et aL, 2012). Variations amongst these proteins could alter 
the ability of this organism to resist antimicrobial therapy and cause infection. It appears 
that these regions may be under greater selective pressure in CC5 and 30 as compared to 
other lineages. Further to antimicrobial resistance, herbicidal resistance could affect 
environmental resistance or persistence for S. aureus. Herbicides may affect bacterial growth 
and hence genes which confer resistance to herbicides may provide a selective advantage 
where herbicides are used. An enzyme involved in the degradation of herbicides (F15j 
allophanate hydrolase) was identified in one region (Cheng et aL, 2005). The majority of 
SNPs in this region specific to CC22 and 30 were synonymous whilst those specific to CC8, 
59 and ST93 were non-synonymous. These proteins are found throughout bacteria and 
display a region of conserved residues of up to 130 amino acids. Mutations within the 
codons of these amino acids have not been documented in S. aureus. However, in 
Granulibacter bethesdensis, a Gram-positive environmental bacterium, mutations within this 
protein severely reduce the catalytic activity of the protein (Un and St Maurice, 2013). 
Variation of the protein A sequence was concordant with MLST, indicating this region 
displayed lineage-specific variation. Furthermore, the presence of the spa gene in all S. aureus 
lineages indicated it is essential for the survival of S. aureus. Lineage-specific variation has 
been identified in the spa gene and certain domains of the protein A, particularly those at 
the host-interface, display a higher level of interline age variation compared to other domains 
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(McCarthy and Lindsay, 2010). VNTRs are thought to aid the organism to adapt to 
environmental factors by accumulating variation providing a selective advantage (van 
Belkum et al., 1998). Therefore, conserved regions of the spa gene amongst each lineage 
indicates that each lineage may have adapted differently to evade the host immune response 
(McCarthyand Lindsay, 2010). Therefore further studies may indicate whether this variation 
plays a role in the success of a particular lineage. 
Further acquired regions for which variable AFs were found included FlO, which partially 
encoded proteins with homology to an addiction toxin/antitoxin module. This particular 
system showed homology to the T xe toxin from Enterococcus faecium, which when the toxin is 
bound to the antitoxin, leaves the cell unaffected. However, the toxin is freed once the' 
antitoxin is degraded, resulting in cell damage under conditions of selection due to 
nutritional or environmental stress; moreover this system has been shown to affect cell 
growth and division (Engelberg-Kulka and Glaser, 1999; Grady and Hayes, 2003). The 
majority of SNPs amongst this sequence specific to CCl and 59 were synonymous whilst the 
majority specific to CC5, 22 and 30 were non-synonymous. Further analysis would be 
required to confirm whether CC5, 22 and 30 isolates encode a functional addiction module 
and whether these variations cause differences in the ability of each lineage to adapt or 
survive in certain environments. A further fragment (F29) from isolates in CC30 also 
mapped to a region in ST239 indicating this region represents a region that recombined 
from ST30 to form ST239 (Robins on and Enright, 2003; 2004) and may represent the 
SCCmec chromosomal junction, although this would require further analysis. 
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Table 38. Variations in function of proteins between lineages 
KEGG protein Clonal complex 
functional Specific function 0 0 0 0 0 en Effect of mutations References 0 0 0 group 0 0 0 0 0 0 0 0 .....j N Vl ~ lJl \0 \J:) 
-
lJl a:J N 0 lJl \0 -.J Vl 
Carbohydrate Conversion of pyruvate to Reduced enzyme activity, (Patton et aL, 2005; 
metabolism acetate or lactate and N Y N N N N N N N increase in pH, reduced Richardson et aL, 2008) 
virulence factor virulence 
Decreased nitrite reductase 
Nitrogen Conversion of nitrate to N N N Y Y N N N N activity, formation of a (Schlag et al, 2008; 
metabolism ammonia small-colony variant Tuchscherr et al, 2011) 
phenotype 
Metabolism of Formation of small-colony 
cofactors and Synthesis of the prosthetic N N Y Y N N N N Y variant phenotype and (Kohler et aL, 2003) group of a no. of proteins exhibition of repressed 
vitamins levels of virulence factors 
Biosynthesis of Biosynthesis of Lack of growth when 
amino acids branched-chain amino Y Y Y Y Y Y Y Y Y acetate is the only carbon (Dailey & Cronan, 1986) 
acids source 
DNA Reduced rate and (Honda et aL, 2008; Inoue 
replication and Repair of damaged DNA N N N N Y N N N Y 
efficiency of DNA repair et aL, 2008; Liu et aL, 2011; 
repair Marceau, 2012;) 
- ---- --- --- -- ------
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Table 38 continued. Variations in function of proteins between lineages 
Clonal complex 
KEGG protein 
functional Specific function 0 0 0 0 0 ~ Effect of mutations References 0 0 0 group 0 0 Q 0 0 0 0 0 N V.) 
""'" 
Vl \0 \0 
...... Vl N 0 Vl \0 -.J V.) 
Cell division Unlink and segregate N N N N N N N N N Forms multi-chambered (Begg et al., 1995; Geissler 
chromosomes chains and Margolin, 2005) 
Proteolysis Cleaves the terminus of N y Y Y Y Y Y N Y Reduced enzyme activity (Kumagai et al., 2000) 
certain peptides and virulence 
Bacteriophage Interferes with the Effects cell division, cell development of N N Y N N N N N N (Frankel et al., 2010) 
resistance bacteriophages separation and virulence 
Increased sensitivity to 
(Butler et al., 2002; 
Regulation of cell wall Dintner et al., 2011; bacitracin and penicillin, 
Signal growth, initiation of DNA altered resistance to Groicher et al., 2000; 
transduction replication and efflux of Y N N N N N Y N N multiple antimicrobials Inoue et al., 2001; bacitracin. Transfer of a 
and no DNA replication at Kawada-Matsuo et al., 
methyl group to rRNA higher temperatures 2011; Long et al., 2006; 
Ohki et al., 2003) 
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Table 38 continued. Variations in function of proteins between lineages 
Clonal complex 
KEGG protein 
functional Specific function () () () () () en Effect of mutations References () () () 
group () () () () () () () Q ~ 
...... \Jl 00 N V.) .j::o. \Jl V.) N 0 \Jl \0 -..J 
Increased meticillin Oousselin et al., 2012; Un Active efflux or resistance, enables evasion 
Drug resistance degradation of multiple Y Y Y Y Y N Y Y Y of an immune response and St Maurice, 2013; 
antimicrobial molecules. and altered oxacillin and Sieradzki et al., 2008; 
glycopeptide resistance Wardenburg et al., 2006) 
Genome Factors involved in y y y y y N Y N Y Lack of formation of small (Damle et al., 2012; 
stability factors integration or loss of DNA capsids Poliakov et al., 2008) 
___ L-____ 
-
Displays KEGG functional group (obtained from UniProt database; http://www.uniprot.org) and function of proteins encoded in regions which 
displayed lineage-specific variation. Displays whether protein function is altered (Y) or conserved (N) in each lineage and the effect variations within 
these proteins may have in each lineage based on previous studies (see references). 
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Sequences which encoded proteins that play a role in essential cell functions such as haem 
biosynthesis, DNA repair and cell division displayed a greater number of synonymous SNPs. 
Proteins which were associated with resistance of the organism to certain antimicrobials or 
drugs also displayed a bias of synonymous SNPs. Alternatively, proteins such as transposases, 
lipoproteins, bacteriophage.related proteins or those with homology to those with a role in 
apoptosis in eukaryotes displayed more non-synonymous SNPs. However, most AF 
sequences only partially encoded an ORF, it was difficult to deduce whether purifying 
selection may be acting on particular regions. 
The number of synonymous versus non-synonymous mutations can indicate the level of 
amino acid sequence conservation between lineages. However, as dN/dS ratios could not be 
calculated, the number of synonymous and non-synonymous SNPs could not be taken as a 
definite indicator of selective pressure within these regions. Synonymous mutations can alter 
the translation accuracy and efficiency of the protein which may, in turn, affect the function 
of the protein. Where non-synonymous mutations occur, selection for codon bias is likely to 
occur as certain codons are translated more accurately or efficiently (Hershberg and Petrov, 
2008). Non-synonymous mutations result in an amino acid change, the effect of this 
substitution is dependent on numerous factors. If the biochemical properties of the 
substituted amino acid are similar to the original, the effect of this substitution may be 
minimal. Also the position of the amino acid in relation to the protein structure is 
significant as changes to particular residues in the active site of proteins may have a 
profound effect on the function of the protein as compared to those in other regions. This 
study identified regions of variation which may alter the regulation or function of proteins 
between lineages. However, further work would be needed to confirm whether differences in 
the expression or function of these proteins could provide a selective advantage in certain 
265 
MRSA lineages which contribute to their success. 
4.4. Genetic diversity within S. aureus lineages 
Current molecular methods such as MLST and spa typing were able to identify the 
heterogeneity between lineages. However, limited genetic variation was identified within 
lineages. Hence techniques which are able to identify the heterogeneity within lineages are 
needed. Although in outbreak situations the relatedness of isolates may be indicated with 
current methods, a limited number of lineages often circulate in a given hospital. Therefore 
methods which can distinguish between strains such as EMRSA-15 and the remaining CC22 
isolates are required. This could help us identify whether predominant MRSA strains 
represent a distinct subset of these lineages. From this information we may be able to 
identify regions which play a role in the success of these strains. 
The SCCmec types or subtypes identified in each lineage indicated the minimum number of 
insertions which have occurred in each lineage. As SCCmec types are rarely replaced by 
another, this indicated each SCCmec insertion is likely to have occurred into an MSSA 
representative of each lineage (Robinson & Enright, 2003). Major HA-MRSA lineages such 
as CC5, 8, 22 and 45 displayed five or more SCCmec types/subtypes whilst CA-MRSA such 
as CCl, 59, 80 and ST93 displayed up to three SCCmec types/subtypes. This indicated 
HA-MRSA displayed greater genetic heterogeneity at this locus as compared to CA-MRSA 
The SCCmec region harbours multiple antimicrobial resistance determinants; this variation 
may reflect how this pathogen has adapted to the greater antimicrobial selective pressure in 
hospitals as compared to the community. However, a greater number of isolates represented 
HA-MRSA lineages as compared to CA-M RSA lineages. Hence further investigation is 
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required to identify whether a significant difference is present between HA and CA-MRSA. 
Similar to the SCCmec locus, HA-MRSA lineages displayed greater heterogeneity at the spa 
locus as compared to CA-M RSA. Variations in VNTRs can affect virulence (van Belkum et 
aL, 1998). Therefore further investigation of differences within lineages at this locus may 
identify whether lineages have adapted differentially to the host. Novel spa types identified 
amongst CC22 and 30 isolates indicated these lineages are continuing to evolve at this locus. 
As multiple spa types were identified in the same lineage, this also indicated that this locus 
evolves at a different rate to that of the core genome (van Belkum et al, 1998). These data 
may help ascertain whether certain lineages are under greater selective pressure at this locus 
and whether these variations alter the virulence of these lineages. 
4.4.1. Genetic diversity within lineages across the genome 
The heterogeneity within lineages was identified using FAFLP. Subsets of isolates in each 
lineage displayed greater similarity to each other than the remaining isolates of that lineage, 
indicating these isolates were closely related and may have arisen from a recent common 
ancestor. The majority of isolates displayed unique FAFLP profiles which indicated 
heterogeneous regions unique to a single isolate. This heterogeneity may have arisen via 
point mutations. However, as these variations were restricted to a particular lineage, this may 
indicate these variations have arisen recently or that these variations may not be beneficial 
and hence are not under the influence of natural selection. Heterogeneous regions unique 
to a subset of isolates of one lineage were identified in CCI, 8, 22 and 80. This indicated 
these regions displayed variation which was either present in a recent common ancestor of 
these isolates or this variation has emerged and spread amongst a subset of the lineage. 
Further investigation of these regions may identify whether within ccn, for example, these 
heterogeneous regions were unique to EMRSA-15 and whether they may play a role in the 
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predominance of this strain. 
The level of heterogeneity identified within lineages was variable. Despite the fact that CC22 
isolates were overrepresented in this study these isolates displayed the greatest homogeneity. 
This indicates the majority of MRSA isolates assigned to CC22 have emerged from clones 
formed from a relatively few number of SCCmec insertion events. CC22 isolates formed two 
distinct genetic groups; one consisted of the majority of isolates from CMPHL whilst the 
remaining cluster grouped CC22 isolates from the remaining collections. Therefore isolates 
from the same lineage were genetically diverse, based on their geographic location which 
indicated these groups are likely to have arisen via independent SCCmec insertion events. 
Further work is therefore needed to identify whether regions of genetic heterogeneity 
between these two clusters provide insights into how isolates adapt differentially to their 
environment. CCB isolates formed two clusters; one had the majority of MSSA isolates 
whilst the remaining cluster predominantly had MRSA isolates. This indicated CCB MRSA 
display considerable divergence from MSSA isolates of the same lineage. The remaining 
lineages formed single genetic groups composed of MRSA and MSSA isolates, thus 
indicating MRSA isolates are genetically similar to MSSA isolates of the same lineage. Each 
lineage displayed a variable level of heterogeneity; however as the number of isolates assigned 
to each lineage was variable, further work would be needed to confirm which lineages 
displayed greater genetic diversity as compared to other lineages. 
Restriction fragment patterns unique to a subset of isolates amongst those assigned to ST8, 
ST22 and ST239 were identified, thus indicating the presence of variation specific to those 
isolates. Mapping of these regions to WGSs indicated that these regions may harbour surface 
proteins such as SasH which exhibit intralineage variation. Furthermore, MGEs such as 
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SCCmec, bacteriophage proteins and the blaZ operon, which show transposition activity in 
t'itro, were identified in these regions indicating HGT of this MGEs may have occurred into 
ST239 (Griffin et al, 1999; McCarthy and Lindsay, 2010). Variations within such regions 
may alter the virulence or antimicrobial resistance of these subsets of isolates contributing to 
their success (Butler et al, 2002;Richardson et al., 2008). 
Restriction fragment patterns also identified heterogeneity within CC22 isolates. With the 
exception ofNGS, more than one molecular method is often required to identify regions of 
genetic diversity within this lineage (Shore et al., 2010). One region of the CC22 genome 
revealed an isolate-specific inversion. Part of the restriction fragment pattern exhibited 
within the inverted region was repeated adjacent to the inverted region. The repeated region 
encoded genes for surface--associated proteins such as protein A, capsular polysaccharide 
synthesis protein and lipoproteins. This inversion also harboured two transposases, thus 
indicating that the inverted region was formed by a transposition event. However, this 
inversion may also be the result of site-specific recombination or double-strand break repair. 
The stability of inversions and their effect on cell fitness is variable (Cam po et al, 2004). 
Furthermore, inversions can alter the expression of genes (Henderson et al., 1999). 
Therefore, further studies would provide an insight into the effect of this inversion on the 
virulence and cell fitness of this isolate. 
The presence of restriction fragment patterns unique to a subset of isolates within a lineage 
indicate the presence of intralineage variation. Surface proteins within such regions have 
been shown to display intra~lineage variation. The level of variation is greater amongst 
lineages than within lineages which shows that these proteins are relatively conserved within 
a lineage. However, levels of intralineage variation differed between lineages which may 
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correspond to differences within each lineage to adapt to the host or evade an immune 
response (McCarthy and Lindsay, 2010). Techniques such as MLST are limited in their 
ability to identify differences between STs. Therefore tools such as FAFLP and WGM can 
help identify regions of the genome which display variation within lineages. Further 
investigation by determining the sequence of these regions could identify which proteins 
display intralineage variation and whether the function of these proteins differ between 
variants. This may help us identify differences which contribute to the success of epidemic 
strains such as EMRSA-15. 
4.5. Conclusions 
This study investigated the genetic diversity amongst predominant HA-MRSA lineages. 
Distinct genetic differences were identified between successful and unsuccessful lineages of 
MRSA Regions of genetic variation were identified between and within lineages. Greater 
diversity was exhibited between than within these lineages. In part, genetic differences 
between lineages were attributed to regions distributed exclusively amongst a particular 
lineage. Regions unique to each of three CCs (CCB, 22 and 30) were identified, which may 
alter the virulence or antimicrobial resistance amongst each lineage and contribute to their 
success. The majority of the heterogeneity observed within the cultures tested, however, was 
due to lineage-specific sequence variation at loci throughout the genome. The proteins 
encoded at these loci indicated they play a role in the emergence and prevalence (or spread) of 
dominant genetic lineages by altering features such as virulence or antimicrobial resistance. 
The CC22 genome was highly divergent from the remaining lineages and the presence of 
novel genotypes indicates the level of this diversity continues to increase. Regions of 
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heterogeneity were associated with virulence and antimicrobial resistance which may confer 
a selective advantage in this lineage and explain why this lineage predominates within the 
UK Additionally certain loci showed similarity with CC30 isolates, which indicated cell 
growth, formation of the SCV phenotype and antimicrobial resistance may play a role in the 
success of these two lineages. 
Factors with a role in carbohydrate metabolism are unlikely to contribute to the success of 
any particular lineage as these proteins appear conserved between lineages. However, 
proteins which are involved in aerobic or anaerobic respiration may reduce the virulence 
exhibited by CC5. The virulence of CC22 and 30 appear to be altered due to variations 
identified in proteins with a role in nitrogen metabolism, which may explain in part the 
success of these lineages in the UK. Heterogeneity amongst proteins with a role in the 
metabolism of cofactors and vitamins may contribute to changes in the virulence of CCB, 22 
and ST93. The predominance of multiple lineages may be attributed to variations in 
proteins involved in the biosynthesis of amino acids, as such variations may hamper the 
ability of isolates of certain lineages to grow and survive. CC30 and ST93 isolates displayed 
variations amongst proteins with a role in DNA repair. Therefore variations in these regions 
may alter the ability of the cell to repair damaged DNA which may provide a selective 
disadvantage amongst these lineages. Proteins required for essential cell functions such as 
cell division are unlikely to contribute to the success of any particular lineage as these 
proteins are relatively conserved between lineages. The diversity amongst proteases was 
identified to alter virulence and play a role in the success of multiple lineages. The 
heterogeneity amongst bacteriophage resistance proteins was also identified to contribute to 
the success of CCB by causing changes in virulence in this lineage. The predominance of a 
subset of lineages may be attributed in part to diversity amongst proteins with a role in signal 
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transduction or drug resistance; heterogeneity within these regions may alter the resistance 
of these lineages to multiple antimicrobials, thus aiding their survival under conditions of 
selection due to antimicrobial pressure. This study also identified the success of multiple 
lineages is partially attributed to heterogeneity within proteins with a role in genome stability 
as this may affect genomic transfer in these lineages. Therefore it appears as though no single 
factor contributes to the success of an MRSA lineage. Multiple contributing factors which 
alter features such as virulence, antimicrobial resistance and HOT play an important role in 
the success of predominant MRSA lineages. 
The ability of a pathogen to cause infections depends on multiple interactions between the 
host and pathogen. Therefore a combination of host and pathogen factors is important to 
cause disease. However, this study focused only on factors relating to the predominance of 
particular lineages encoded on the bacterial genome. The genome of the host has been 
shown to be associated with the genotype of S. aU'I'eus. Therefore factors relating to the 
predominance of particular lineages may in part be related to host factors (Emonts et al, 
2008). Furthermore, although the bacteraemia collection provided a well characterised and 
representative isolate collection, these results are unable to provide many insights into 
isolates associated with carriage or other types of infection. Particularly as the predominant 
S. aU'I'eus genotypes may be variable depending on the site of infection or isolates associated 
with different infections may exhibit different phenotypes such as antimicrobial resistance 
(Reynolds, 2009). Although the findings from this study may not be extrapolated to isolates 
from other infection sites, a similar approach could be used to analyse such isolates in the 
future. 
Various molecular methodologies in this study have been demonstrated as useful tools to 
272 
investigate the genetic diversity between and within MRSA lineages. In addition to 
identifying regions of genetic homogeneity these tools enabled the detection of heterogeneity 
between lineages. It was shown that FAFLP analysed conserved regions in a similar manner 
to MLST and could be utilised to infer the macro-evolution of MRSA lineages (Lindsay & 
Holden, 2004). Moreover, whilst FAFLP probably underestimated the level of genetic 
diversity in accessory regions, it sampled variable regions thus facilitating understanding of 
the micro-evolution of S. aureus and the diversity of MGEs amongst lineages (Melles et al., 
2004; van Leeuwen et aL, 2005). 
4.6. Future direction 
A subset of proteins encoded in heterogeneous regions remained unidentified. Further work 
such as gene knockout studies and transcriptional studies using microarrays would be 
needed to identify the functions of these proteins and the effect of the amino acid changes 
to its function and phenotype of the bacterium. This study identified regions unique to a 
subset of lineages which may alter the regulation or function of proteins between lineages. 
However, further work would be needed to confirm whether differences in protein function 
could provide a selective advantage to certain MRSA lineages which contribute to their 
success. Furthermore, regions identified in a limited number of lineages are found to be 
associated with MGEs such as the SCCmec. MGEs may be restricted to certain lineages by 
mechanisms such as R-M systems which limit the exchange of genetic information between 
lineages. Further work would be needed to identify whether a unique combination of 
MGEs, which may harbour antimicrobial resistance determinants or virulence factors, are 
present in each lineage. The diversity of MGEs may explain in part the success of particular 
lineages under certain conditions such as antimicrobial therapy. The acquired SCCmec type 
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IV element was found in almost every lineage, indicating that combinations of this SCCmec 
type and the MRSA lineages were stable and often gave rise to successful MRSA clones. 
However, SCCmec type IV is highly variable with at least eight sub-types known to exist. The 
overall success of SCCmec type IV and the diversity of sub-types are thought to be associated 
with a lower fitness cost and higher mobility for the relatively small SCCmec type IV element 
(Ma et al., 2002). 
Existing molecular typing techniques for MRSA may not detect minor variation throughout 
the genome. NOS provides the ultimate resolution for detecting genetic diversity as it can 
distinguish between isolates with variations at a single nucleotide position. NOS has been 
useful for the development of microarrays which have been utilised for comparative 
genomics, identification of new genes and functions in S. aureus, and has been applied in 
outbreak situations. Since the advent of NOS, the cost and time to sequence a genome have 
fallen dramatically. These improvements could lead to NOS being utilised in laboratories as 
a routine procedure in the near future. At present however, it is not yet feasible for the 
majority of laboratories to resource the technique. 
NOS can be utilised to monitor the emergence, spread and evolution of clones (Koser et al., 
2012). CC22 has been shown to acquire a wide-range of MOEs associated with antimicrobial 
resistance; however, these MOEs are not accumulated. NOS could aid the monitoring of the 
acquisition and loss of such elements which are thought to be the key to the success of this 
lineage (Lindsay et al., 2012). The greatest hurdle to introduce NOS into routine practice is 
the lack of bioinformatics tools required to analyse the large volume of NOS data generated. 
The development of databases for comparisons and an automated analysis method are 
required to identify rapidly whether isolates are associated with an outbreak and how the 
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emergence of variations play a role in the evolution of clones. 
NOS can also be useful in systems biology to model complex biological networks and 
pathways which could be utilised to determine the effect of individual genes on the 
bacterium (Holden et al, 2008). Such analysis requires a complete view of the pan-genome of 
s. aureus. The pan-genome consists of all genes identified in members of a species. Each 
whole-genome sequenced strain identifies novel genes which continuously expands our 
knowledge of the S. aureus pan-genome which indicates this pan-genome is affectively 
open-ended (Holden et al, 2008; Mira et al, 2010). In this situation, techniques such as 
FAFLP may provide a feasible alternative to study the pan-genome until the cost and analysis 
of WOSs are further improved. FAFLP could be utilised to identify rapidly regions of 
heterogeneity which have not been previously described enabling the sequence 
determination of regions of interest or WOSs of the subset of isolates which display 
heterogeneity. 
Bacterial cells have complex systems of biochemical pathways. Each gene is not necessarily 
transcribed into a protein and each protein does not necessarily have a single function. 
Hence from this study, it is clear further work is needed to identify whether heterogeneity is 
present across the entire protein coding sequences of interest. Future studies would require 
gene knockout studies of these regions to confirm the effect of this heterogeneity on the 
function of these proteins. Previous studies have shown resistance to certain antimicrobials 
contribute to the success of certain lineages. Lineages such as CC22 have been shown to 
display significant diversity of MOEs which is thought to contribute to the fitness of this 
clone (Lindsay et al, 2012). Therefore further work would also be required to identify 
whether changes in the functions of interest identified in this study alter the fitness of 
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particular lineages. Understanding the genetic diversity amongst lineages can provide 
insights into the population genetics of MRSA and the evolution of successful lineages. This 
study indicates a combination of factors play a role in the success of major MRSA lineages. 
The genetic diversity amongst core regions and MOEs appear to alter antimicrobial 
resistance and virulence factors which are vital to their success as they enable the rapid 
adaption of lineages to their environment. 
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Appendix 1. Characteristics of the 34 S. aureus isolates from the Glasgow collection at PHE, London 
Isolate number Bacteriophage type PFGE type Oxacillin Mupirocin nuc gene mecAgene mupA Comments gene 
OBHT52 932/29/52/52J\180/95/77Uh+ PF111a R* Sf P* P N§ 
OB HT 53 29/80/54/75/77/81+ PF121a R S P P N 
OBHT55 83C/75w/83Aw PF016p R S NOli NO NO EMRSA-16' 
OBHT 56 Nr PF116a B** S P P N 
OBHT 57 83CUh/9 3 2ih/29ih/5 2ih/ 5 2Aih/79ih/8 PF140a R S NO P NO Oih/47ih/54ih/75ih/83J\184/85ih+ 
OBHT 58 NO ND NO NO NO NO NO 
OBHT60 932w/29w/52w/3Cw/6w/88J\19Ow/94 PF118a B HLtt P P P 
w 
OBHT61 75w PF016b R S NO NO ND EMRSA-16 
OBHT62 83C/29ih/75w/77w/83Aw PF016a R S P P N EMRSA-16 
OBHT63 29w/79w/54w/84w/81w PF137a S S P N N 
OBHT64 NO PF155b R S ND NO NO 
OBHT65 NT PF132a B S P N N 
OBHT66 52ih/75w PF016d R LL** ND NO NO EMRSA-16 
OBHT67 29ih/75 ih/77w/84ih/85 ih PFI09a R S ND P ND 
OBHT68 NT PF015b R S ND NO ND EMRSA-15 
OBHT69 6w PF145a R S P P N 
DBHT70 83C/932w/52Aw/6/42Ew/47w/53w/5 PF147a R S ND P ND 4w/75w/83Aw/9Ow/81w 
DBHT71 932/29/52/52J\180/95/6ih/47ih/75ih PF134a B S P P N /77/83Aih/84/88Aih/20ih+ 
-----
~~- ... -
--- -- --
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Appendix I continued. Characteristics of the 34 S. aureU5 isolates from the Glasgow collection at PHE, London 
Isolate number Bacteriophage type PFGEtype Oxacillin Mupirocin nuc gene mecAgene mupA Comments gene 
DBHT72 932w/52w/52Aw/79w/8Ow/95w/6w/4 PF135a B S P P N 2Ew/47w/54w/83Aw/84w/9Ow/81w 
DBHT73 52Aw/3Aw/3Cw/55/71 PFl27a S S P N N 
DBHT74 93 2ih/ 6ih/ 47 ih/7 5ih/84ih/88Aih PFOOlb R S ND P ND 
DBHT76 932/47 ih/75ih/84ih/85 ih+ PFl41a R S ND P ND 
DBHT77 ND PFl53a R S P P N 
DBHT78 NT PF015d R S ND ND ND EMRSA-15 
DBHT80 42Eih/47w/54w/75w/81w PFl26a ND HL P P P 
DBHT 81 83C/932/52A/79/42Eih/47/53/54/75 PF098a R S ND P ND /77/84/85/88A/90/81/94+ 
DBHT82 75w PF015a R S P P N EMRSA-15 
DBHT83 83C/6/42E/54/75/77/83A/81+ PFlO5a B S ND P ND 
DBHT85 932/6/47/54ih/75/85/90+ PF1l7a R S P P N 
DBHT86 NT PFI07a R S P N P 
DBHT87 ND PF151a B S P P N 
DBHT88 ND PF149a R S P P N 
DBHT89 ND PF157a R S ND P ND 
DBHT90 ND PF156a R S ND P ND 
--- -- - --- --- -- ---
--~-~ 
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Bacteriophage typing, PFGE, oxacillin and mupirocin minimum inhibitory concentrations, nue, mecA and mupA PCRs were performed on a subset 
of the isolates by Staphylococcal Reference Laboratory (PHE, London). Oxacillin susceptibility tested by disk diffusion and Etest. PFGE, number 
indicates PFGE type and letter in lower case or number after indicates subtype. Sub types differ by a few bands and are part of the same clone. 
"R, Resistant. 
ts, susceptible. 
fp, Positive. 
~, Negative. 
IIND, No data. 
'E:MRSA, Epidemic MRSA. 
'NT, non~typeable. 
""B, Borderline. 
11JIL, High level. 
**LL, Low level. 
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Appendix H. Two hundred and two S. aureus isolates obtained from the 2009 British Society for Antimicrobial Chemotherapy bacteraemia resistance 
surveillance programme 
Isolate Ciprofloxa Erythromycin Oxacillin Piperacillin.T azobactam T eicoplanin Vancomycin mecA mupA Centre Comments 
number cin gene gene 
DBHT91 128 >128 128 128 1 1 p. Nt 32 HA* 
DBHT92 64 0.25 >128 128 1 1 P N 32 HA 
DBHT93 128 >128 64 64 1 1 P N 32 HA 
DBHT94 128 >128 64 128 1 1 P N 32 HA 
DBHT95 64 >128 >128 128 1 1 P N 32 HA 
DBHT96 128 >128 64 64 1 1 P N 32 HA 
DBHT97 64 >128 8 4 0.5 1 P N 32 CA§ 
DBHT98 128 >128 >128 >128 2 1 P P 2 HA 
DBHT99 >128 0.5 >128 >128 4 2 P N 2 HA 
DBHT 100 32 >128 >128 64 1 2 P N 3 HA 
DBHT 101 64 >128 >128 128 1 1 P N 3 CA 
DBHT 102 128 >128 128 128 1 1 P N 3 CA 
DBHT 103 >128 >128 >128 128 2 1 P N 3 HA 
DBHT 104 128 >128 >128 128 1 1 P N 3 HA 
DBHT 105 64 >128 128 128 1 1 P N 3 HA 
DBHT 106 128 >128 128 128 1 2 P N 4 HA 
DBHT 107 >128 0.5 128 128 1 1 P N 4 CA 
DBHT 108 >128 >128 >128 >128 1 2 P P 4 HA 
DBHT 109 >128 >128 >128 128 1 2 P N 4 HA 
DBHT 110 128 0.5 64 64 1 1 P N 5 HA 
DBHT 111 '-- _>12~_ 0.25 >128 32 1 1 P N 12 HA 
~-
-
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Appendix 1I continued. Two hundred and two S. aureus isolates obtained from the 2009 British Society for Antimicrobial Chemotherapy 
bacteraemia resistance surveillance programme 
Isolate Ciprofloxacin Erythromycin Oxacillin Piperacillin-T azobactam T eicoplanin Vancomycin mecA mupA Centre Comments 
number gene gene 
DB HT 112 64 >128 >128 >128 1 2 P N 12 HA 
DB HT 113 16 0.5 128 128 1 1 P N 8 CA 
DBHT 114 16 0.25 128 64 1 1 P N 8 CA 
DB HT 115 128 >128 >128 128 1 1 P N 8 CA 
DBHT 116 64 >128 >128 128 0.5 <=0.5 P N 8 CA 
DBHT 117 16 0.5 >128 128 0.5 1 P N 8 CA 
DB HT 118 64 >128 128 128 0.5 1 P N 8 ND" 
DBHT 119 128 0.25 128 128 1 1 P N 8 CA 
DBHT 120 64 >128 128 64 1 1 P N 10 CA 
DBHT 121 128 >128 128 1 2 2 P N 10 CA 
DBHT 122 128 >128 128 64 1 1 P N 10 CA 
DBHT 123 128 >128 >128 >128 1 1 P N 33 CA 
DBHT 124 16 >128 >128 >128 1 1 P N 33 HA 
DBHT 125 64 >128 128 128 1 1 P N 33 HA 
DBHT 126 128 >128 >128 >128 1 2 P N 33 HA 
DBHT 127 128 >128 >128 128 4 2 P N 33 HA 
DBHT 128 >128 0.5 128 64 0.5 1 P N 13 HA 
DBHT 129 128 0.5 >128 >128 1 2 P N 13 HA 
DBHT 130 16 >128 >128 128 1 1 P N 13 CA 
DBHT 131 64 >128 >128 128 1 1 P N 34 CA 
DBHT 132 128 >128 >128 128 2 2 P N 34 HA 
DBHT 133 64 >128 >128 128 1 2 P N 34 CA 
-
- ~~- ------- --~-
---- --- - - - -- --
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Appendix II continued. Two hundred and two S. aureus isolates obtained from the 2009 British Society for Antimicrobial Chemotherapy 
bacteraemia resistance surveillance programme 
Isolate Ciprofloxacin Erythromycin Oxacillin Piperacillin-Tazobactam T eicoplanin Vancomycin mecA mupA Centre Comments 
number gene gene 
DBHT 134 128 >128 >128 128 2 1 P N 34 HA 
DBHT 135 64 >128 >128 128 1 1 P N 34 HA 
DBHT 136 16 0.5 64 64 1 2 P P 34 HA 
DBHT 137 128 >128 >128 128 1 1 P N 30 HA 
DBHT 138 >128 >128 >128 128 1 1 P N 30 CA 
DBHT 139 >128 >128 64 64 1 1 P N 15 HA 
DBHT 140 128 >128 >128 128 1 1 P N 15 CA 
DBHT 141 128 >128 128 128 1 1 P N 15 HA I 
DBHT 142 128 >128 128 128 1 1 P N 15 HA 
DBHT 143 64 >128 128 128 1 1 P N 15 HA 
DBHT 144 0.5 0.5 16 2 1 2 P N 15 HA 
DBHT 145 128 0.25 128 32 1 1 P N 15 CA 
DBHT 146 >128 0.5 128 128 1 1 P N 15 HA 
DBHT 147 16 0.5 128 128 1 1 P N 15 HA 
DBHT 148 0.5 0.5 32 16 1 1 P N 20 HA 
DBHT 149 32 >128 >128 128 1 1 P N 20 HA 
DBHT 150 128 0.5 >128 128 1 1 P N 20 HA 
DBHT 151 16 0.25 128 64 1 1 P N 20 CA 
DBHT 152 128 >128 >128 128 1 1 P N 21 CA 
DBHT 153 64 >128 >128 128 1 1 P N 22 HA 
DBHT 154 64 >128 128 64 1 1 P N 22 CA 
DBHT 155 128 0.5 >128 >128 1 1 P N 7 CA 
- - - - --
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Appendix II continued. Two hundred and two S. aureus isolates obtained from the 2009 British Society for Antimicrobial Chemotherapy 
bacteraemia resistance surveillance programme 
Isolate Ciprofloxacin Erythromycin Oxacillin Piperacillin-T azobactam T eicoplanin Vancomycin mecA mupA Centre Comments 
number gene gene 
DBHT 156 128 0.25 8 4 1 1 P N 5 CA 
DBHT 157 128 >128 >128 128 1 1 P N 26 CA I 
DBHT 158 >128 0.25 >128 128 0.5 1 P N 26 CA 
DBHT 159 128 0.25 128 128 1 1 P N 7 HA 
DBHT 160 128 0.5 >128 128 1 1 P N 5 HA 
DBHT 161 >128 >128 128 32 0.5 1 P P 26 CA 
DBHT 162 >128 >128 >128 128 1 1 P N 7 CA 
DBHT 163 0.5 0.5 64 8 2 2 P N 5 HA 
DBHT 164 128 >128 128 64 1 1 P N 26 HA 
DBHT 165 128 0.25 >128 128 1 1 P N 7 CA 
DBHT 166 128 0.5 128 128 1 1 P N 26 HA 
DBHT 167 128 0.5 >128 128 1 1 P N 26 HA 
DBHT 168 32 >128 128 64 1 1 P N 10 CA 
DBHT 169 >128 >128 >128 128 1 1 P N 11 HA 
DBHT 170 64 0.25 >128 64 1 1 P N 11 HA 
DBHT 171 128 0.5 >128 128 1 1 P N 11 HA 
DBHT 172 128 >128 >128 128 1 1 P N 11 CA 
DBHT 173 1 0.5 32 8 1 2 P N 11 HA 
DBHT 174 128 0.25 >128 >128 1 1 P N 12 HA 
DBHT 175 128 >128 128 64 0.5 <cO.5 P N 11 HA 
DBHT 176 128 >128 4 4 1 1 P N 12 CA 
DBHTI77 128 >128 128 128 1 1 
'------
P 
- .... -- -
N 12 HA 
~- -~-
--
-~- ---- ~~ -
-
-
-- ---
~-
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Appendix 11 continued. Two hundred and two S. aureus isolates obtained from the 2009 British Society for Antimicrobial Chemotherapy 
bacteraemia resistance surveillance programme 
Isolate Ciprofloxacin Erythromycin Oxacillin Piperacillin.T azobactam T eicoplanin Vancomycin mecA mupA Centre Comments 
number gene gene 
DBHT 178 128 >128 128 64 0.5 1 P N 12 CA 
DBHT 179 64 0.5 64 32 0.5 1 P N 22 CA 
DBHT 180 128 >128 >128 128 2 1 P N 22 HA 
DBHT 181 128 0.25 >128 >128 1 1 P N 23 CA 
DBHT 182 128 >128 >128 128 0.5 1 P N 28 HA 
DBHT 183 16 >128 >128 128 1 1 P N 28 CA 
DBHT 184 16 >128 >128 128 0.5 1 P N 28 HA 
DBHT 185 128 >128 128 64 0.5 1 P N 28 HA 
DBHT 186 128 >128 >128 64 4 2 P N 28 CA 
DB HT 187 128 >128 128 32 1 1 P N 28 HA 
DBHT 188 64 >128 64 64 1 1 P N 24 CA 
DBHT 189 64 >128 >128 128 1 1 P N 35 HA 
DBHT 190 64 0.5 128 128 1 1 P N 35 HA 
DBHT 191 128 >128 >128 128 1 2 P N 35 HA 
DBHT 192 128 0.5 128 128 1 2 P N 29 HA 
DBHT 193 64 0.5 128 128 1 2 P N 29 HA 
DB HT 194 0.5 0.25 0.25 1 1 1 N N 32 HA 
DBHT 195 0.5 0.5 0.25 2 2 2 N N 32 HA 
DBHT 196 0.25 0.5 0.25 4 1 2 N N 32 CA 
DBHT 197 1 >128 1 4 1 2 N N 32 HA I 
DBHT 198 0.5 0.25 0.25 2 1 1 N N 2 HA 
DBHT 199 ... 64 0.25 0.5 4 1 1 N N 2 CA 
-
L-. 
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Appendix II continued. Two hundred and two S. aureus isolates obtained from the 2009 British Society for Antimicrobial Chemotherapy 
bacteraemia resistance surveillance programme 
Isolate Ciprofloxacin Erythromycin Oxacillin Piperacillin#T azobactam Teicoplanin Vancomycin mecA mupA Centre Comments 
number gene gene 
DBHT200 1 0.5 0.125 0.5 1 2 N N 2 HA 
DBHT 201 0.5 0.5 0.25 2 2 2 N N 2 CA 
DBHT202 0.5 0.5 0.25 2 2 2 N N 2 CA 
DBHT203 0.5 0.25 0.125 1 1 1 N N 3 CA 
DBHT204 0.5 64 0.5 2 2 2 N N 3 CA 
DBHT205 0.25 0.25 0.25 2 1 2 N N 3 HA 
DBHT206 1 0.5 0.125 0.5 2 2 N N 3 CA 
DBHT207 1 0.5 0.25 4 2 2 N N 4 HA 
DBHT208 0.5 0.5 0.25 1 2 2 N N 4 HA 
DBHT209 0.5 0.5 0.5 1 1 2 N N 4 HA 
DBHT210 1 0.5 0.25 2 1 2 N N 4 HA 
DBHT 211 0.5 0.5 0.25 1 1 1 N N 5 CA I 
DBHT212 1 64 0.5 4 1 1 N N 5 HA 
DBHT213 64 >128 0.25 2 1 1 N N 5 CA 
DBHT214 0.25 0.25 0.25 2 0.5 1 N N 5 CA 
DBHT 215 0.25 8 0.5 2 1 2 N N 6 HA 
DBHT 216 0.25 0.5 0.25 0.5 1 2 N N 6 CA 
DBHT 217 1 0.5 0.25 2 1 2 N N 6 CA 
DBHT 218 0.5 0.5 0.25 4 1 2 N N 6 CA 
DBHT219 0.5 0.5 0.25 2 1 1 N N 7 HA 
DBHT220 0.5 0.25 0.25 2 1 1 N N 7 CA 
DBHT 221 0.5 0.5 0.25 2 2 2 N N 7 CA 
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Appendix II continued. Two hundred and two S. aureus isolates obtained from the 2009 British Society for Antimicrobial Chemotherapy 
bacteraemia resistance surveillance programme 
Isolate Ciprofloxacin Erythromycin Oxacillin Piperacillin-T azobactam T eicoplanin Vancomycin mecA mupA Centre Comments 
number gene gene 
DBHT222 1 0.5 0.25 1 1 1 N N 7 CA 
DBHT223 0.25 0.5 0.25 2 1 1 N N 26 CA 
DBHT224 2 0.5 0.5 1 0.5 1 N N 26 HA 
DBHT225 1 0.25 0.5 2 1 1 N N 26 CA 
DBHT226 0.5 0.25 0.25 1 1 1 N N 26 HA 
DBHT227 1 0.5 0.25 1 1 2 N N 8 CA 
DBHT228 1 0.25 0.5 2 2 2 N N 8 CA 
DB HT 229 0.5 0.5 0.25 0.5 1 1 N N 8 HA 
DBHT230 1 0.25 0.25 1 1 1 N N 8 CA 
DBHT231 0.5 0.5 0.25 2 1 2 N N 10 CA 
DBHT232 1 >128 0.5 2 1 1 N N 10 CA 
DBHT233 1 0.5 0.25 0.5 1 1 N N 10 CA 
DBHT234 0.25 0.5 0.125 1 1 2 N N 10 CA 
DBHT235 128 0.25 0.25 1 1 2 N N 11 CA 
DB HT 236 0.25 0.5 0.25 1 1 1 N N 11 CA 
DBHT237 1 0.5 0.25 0.5 1 1 N N 11 HA 
DBHT238 1 0.5 0.25 2 1 2 N N 11 HA 
DBHT239 1 0.25 0.25 1 1 2 N N 12 CA 
DBHT240 0.5 0.5 0.5 2 1 2 N N 12 HA 
DBHT 241 0.25 0.5 2 2 1 1 N N 12 HA 
DBHT242 1 0.25 0.25 1 1 1 N N 12 CA 
DBHT243 4 0.25 0.25 1 2 2 N N 33 HA 
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Appendix II continued. Two hundred and two S. aureus isolates obtained from the 2009 British Society for Antimicrobial Chemotherapy 
bacteraemia resistance surveillance programme 
Isolate C' fl . Eh' Ox '11' p' '11' T b T' I . V . mecA mupA Ce C 
be lpro oxacm ryt romyc1O aCl m lperaCl m- azo actam elCOp amn ancomyc1O ntre omments num r gene gene 
DBHT 244 1 0.5 0.5 1 2 2 N N 33 CA 
DBHT 245 1 0.5 0.5 1 1 2 N N 33 CA 
DBHT 246 0.5 0.5 0.25 1 2 2 N N 33 CA 
DBHT 247 0.5 0.5 0.5 2 1 1 N N 13 CA 
DBHT 248 1 0.5 0.25 0.5 1 2 N N 13 CA 
DBHT 249 0.5 0.5 0.25 0.5 1 2 N N 13 CA 
DBHT 250 0.5 8 0.25 1 1 1 N N 13 HA 
DBHT 251 4 0.5 0.25 0.5 2 2 N N 34 CA 
DBHT 252 0.25 0.5 0.5 1 2 2 N N 34 CA 
DBHT 253 0.5 0.5 0.25 1 2 2 N N 34 HA 
DBHT 254 0.5 0.5 0.5 1 1 2 N N 34 HA 
DBHT 255 0.5 0.5 0.25 2 1 2 N N 30 CA I 
DBHT 256 0.5 0.5 0.25 1 1 1 N N 30 HA 
DBHT 257 1 0.5 0.25 1 1 2 N N 30 CA 
DBHT 258 0.5 0.5 0.25 1 0.5 1 N N 30 CA 
DBHT 259 0.125 0.25 0.25 1 2 1 N N 15 CA 
DBHT 260 0.25 0.5 0.25 2 1 2 N N 15 HA 
DBHT 261 0.5 0.5 0.125 1 1 1 N N 15 HA 
DBHT 262 1 0.5 0.5 4 1 2 N N 15 HA 
DBHT 263 0.25 0.5 0.125 0.5 2 2 N N 20 HA 
DBHT 264 0.5 0.5 0.25 1 2 1 N N 20 HA 
DBHT 26?_ ~ 0.5 0.25 2 0.5 1 N N 20 CA 
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Appendix II continued. Two hundred and two S. aureus isolates obtained from the 2009 British Society for Antimicrobial Chemotherapy 
bacteraemia resistance surveillance programme 
Isolate Ciprofloxacin Erythromycin Oxacillin Piperacillin-T azobactam T eicoplanin Vancomycin mecA mupA Centre Comments 
number gene gene 
DBHT266 0.5 0.5 0.5 2 2 2 N N 20 HA J 
DBHT267 1 0.5 0.25 4 1 2 N N 21 HA I 
DBHT268 0.5 4 0.5 2 1 2 N N 21 HA 
DBHT269 1 2 0.25 2 1 2 N N 21 CA i 
DBHT270 8 32 0.5 2 1 1 N N 21 HA 
DBHT271 1 >128 0.5 4 1 1 N N 22 HA 
DBHT272 0.5 0.5 0.25 0.5 1 1 N N 22 CA 
DBHT 273 0.5 0.5 0.5 2 2 2 N N 22 HA 
DBHT274 0.5 0.5 0.25 2 1 1 N N 22 CA 
DBHT 275 0.5 0.5 0.25 1 1 2 N N 22 CA 
DBHT276 1 0.5 0.125 1 1 2 N N 23 HA 
DBHT277 0.5 0.5 0.25 4 1 2 N N 23 HA 
DBHT278 1 0.5 0.25 0.5 1 2 N N 23 CA 
DBHT279 0.5 0.5 0.5 4 2 2 N N 23 CA 
DBHT280 1 0.5 0.25 2 2 2 N N 28 HA 
DBHT 281 0.5 0.5 0.5 2 1 2 N N 28 CA 
DBHT282 0.25 0.5 0.25 0.5 1 1 N N 28 HA 
DBHT283 0.25 0.5 0.125 0.5 1 2 N N 28 CA 
DBHT284 0.5 0.5 0.5 2 1 2 N N 24 CA 
DBHT285 1 0.5 0.25 4 2 1 N N 24 HA 
DBHT286 0.5 0.5 0.25 2 1 2 N N 24 HA 
DBHT287 0.25 0.5 0.125 0.25 1 2 N N 24 CA 
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Appendix II continued. Two hundred and two S. aureus isolates obtained from the 2009 British Society for Antimicrobial Chemotherapy 
bacteraemia resistance surveillance programme 
Isolate Ciprofloxacin Erythromycin Oxacillin Piperacillin,T azobactam T eicoplanin Vancomycin mecA mupA Centre Comments 
number gene gene 
DBHT288 1 0.5 0.125 0.5 1 2 N N 35 HA 
DBHT289 64 >128 0.25 2 1 1 N N 35 HA 
DBHT290 128 >128 0.25 2 1 1 N N 35 HA 
DBHT291 1 0.5 0.5 1 1 2 N N 35 HA 
DBHT292 1 0.5 0.125 1 1 2 N N 29 HA 
Antimicrobial susceptibilities to six antimicrobials and mecA and mupA PCRs were performed on the isolates by Antimicrobial Resistance and 
Healthcare Associated Infections Reference Unit, PHE, London. 
"F, positive. 
~, negative. 
*HA, hospital~sociated. 
§CA, community~sociated. 
IIND, no data. 
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Appendix Ill. Antimicrobial susceptibilities to eight antimicrobials for six S. aureus isolates obtained from the Clinical Microbiology and Public 
Health Laboratory 
Isolate Oxacillin Ciprofloxacin Erythromycin Fusidic acid Gentamicin Mupirocin Neomycin Rifampicin 
number 
DBHT293 RO R R st R R S S 
DBHT294 R R R S R R S S 
DBHT296 R R R S R R R S 
DBHT300 R R R S R R S S 
DBHT 301 R R R S R R R S 
L- DBHT 302 ..... _ R R R S 
.-
R R S S 
.-
--- ---
--
---- --- --
._-
- --- -
-
._-
OR, Resistant. 
ts, Susceptible. 
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Appendix IV. Sequences of peR primers used in this study 
PCR Primer Primer sequence (5' to 3') Reference 
name 
(Edwards 
ANTIF AGAGTTTGATCCTGGCTCAG et aL, 
16S rRNA 1989) (Lane et gene PCR 
1392R ACGGGCGGTGTGTACAAG al,1985) (Lane, 
1991) 
16SrRNA 357F CTCCTACGGGAGGCAGCAG (Lane, gene 1991) 
sequence (Coenye et determinat 3R GTTGCGCTCGTTGCGGGACT 
ion al, 1999) 
arcC arcGF TTGATTCACCAGCGCGTATTGTC 
arcGR AGGTATCTGCTTCAATCAGCG 
aroE aroE-F ATCGGAMTCCTATTTCACATTC 
aroE-R GGTGTTGTATTAATAACGATATC 
glpF glpF.F CTAGGAACTGCAATCTTAATCC 
glpF·R TGGTAAAATCGCATGTCCAATTC 
gmk gmk-F ATCGTTTTATCGGGACCATC (Enright et 
gmk·R TCATTAACTACAACGTAATCGTA aL,2000) 
pta-F GTTAAAATCGTATTACCTGAAGG pta 
pta·R GACCCIIIIGTTGAAAAGCTTAA 
tpi.F TCGTTCATTCTGAACGTCGTGAA 
tpi 
tpi·R TTTGCACCTTCTAACAATTGTAC 
yqiL yqiL-F CAGCATACAGGACACCTATTGGC yqiL-R CGTTGAGGAATCGATACTGGAAC 
SCCmec-or SCCmec-o CATGAAAATCACCATTTTAGCTG This study 
rfXF JX SCCmec-o junction 
rfXR ATAGTTCCCAGTAGCAACCT This study 
SCCmec-o TCCAGACGAAAAAGCACCAGAAAA This study SCCmec-or rfX2F 
JX SCCmec-o TTGAMTGAMGACTGCGGAGGCT This study junction rfX2R 
nested SCCmec-o ACATTATTGGTACGTITCTCITTA This study 
rfX3R 
orjX orfXF CGCATAATCTTAMTGCCT This study 
orfXR ATGAAAATCACCATTTTAGC This study 
IS1272J-F GAAGCTTTGGGCGATAAAGA 
SCCmec IS1272J-R GCACTGTCTCGTTTAGACCAATC (Chen et 
type VI ccrB4-F CGAAGTATAGACACTGGAGCGATA al,2009) 
ccrB4-R GCGACTCTCTTGGCGTTTA 
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Appendix IV continued. Sequences of peR primers used in this study 
PCR Primer Primer sequence (5' to 3') Reference 
name 
ccrC2-F2 ATAAGTTAAAAGCACGACTCA 
ccrC2-R2 TTCAATCCTAII I IICTTTGTG 
SCCmec ccrC8-F GCATGGGTACTCAATCCA (Higuchi et 
type VII ccrC8-R GGTTGTAATGGCTTTGAGG aL,2008) 
mecC2-F ATCAGTTCATTGCTCACGATATGTGTA 
mecC2-R CAATACGCCATTTGTAATAAGCIIII 
mecl-F CCCI I I I I ATACAA TCTCGTT 
mecl-R ATATCATCTGCAGAATGGG 
SCCmec ccr4-Fd ATCGCTCATTATGGATACYGC (McClure 
type VIII ccr4-R2 CAAAACAACCIIIICTATAACG et aL, 
VIII-F3 CAATATTGATTTCCTTCATCGTTTACCTCC 2010) 
VIII-R3 GAGCATCATAAGAAGCAATTTTATGTTAC GC 
mAl TGCTATCCACCCTCAAACAGG 
mA2 AACGTTGTAACCACCCCAAGA 
al AACCTATATCATCAATCAGTACGT 
a2 TAAAGGCATCAATGCACAAACACT 
a3 AGCTCAAAAGCAAGCAATAGAAT 
SCCmec J3c ATTGCCTTGATAATAGCCITCT 
non-typeab a4.2 GTATCAATGCACCAGAACTT (Kondo et 
le p4.2 TTGCGACTCTCTTGGCGTTT aL,2007) 
'YR CCTTTATAGACTGGATTATTCAAAATAT 
yF CGTCTATTACAAGATGTTAAGGATAAT 
mI6 CATAACTTCCCATTCTGCAGATG 
IS7 ATGCTTAATGATAGCATCCGAATG 
IS2(iS-2) TGAGGTTATTCAGATATTTCGATGT 
mA7 ATATACCAAACCCGACAACTACA 
Forward and reverse primer sequences used in peR and sequence determination assays in 
this study. 
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Appendix V. Sequences obtained from the NCB! database used in this study 
Accession no. Strain name Group 
NC 002745 N315 A, D, E, F,G 
NC 009782 Mu3 A, D, F, G 
NC 002758 Mu50 A, D, E, F, G 
NC 007622 RF122 A, D, E, F, G 
NC 010079 USA300 TCH1516 A, D, F, G 
NC 003923 MW2 A. D, E, F, G 
NC 013450 ED98 A. D, F, G 
NC 009641 Newman A. D, F, G 
NC 007793 USA300 FPR3 757 A. D, E, F,G 
NC 002951 COL A. D, E, F, G 
NC 002953 MSSA476 A, D, E, F, G 
NC 002952 MRSA252 A, D, E, F, G 
NC 009632 JH1 A. D, F, G 
NC 009487 JH9 A, D, E, F, G 
NC 007795 NCTC8325 A. D, E, F,G 
AB425824 JCSC6670 B 
CPOO0255 USA300 FPR3757 B 
AB425823 JCSC6668 B 
BAOOO033 MW2 B 
CPOO0730 USA300 TCH1516 B 
AB121219 ]CSC3624 C 
AB033763 NCTC 10442 C 
D86934 N315 C 
AB425427 V14 C 
AB063172 CA05 C 
AB063173 lCSC1978 C 
NC 017331 TW20 D,G 
NC 017338 JKD6159 D,G 
CP003166 M013 D,G 
HE681097 H050960412 D,G 
NC 017349 LGA251 G 
NC 017333 ST398 G 
Group A, used to design gmk PCR primers; Group B, used to design SCCmt'£"orf.XPCR 
primers; Group C, used to design orf.XPCR primers; Group D, used to calculate mean 
size of S. aureus genome; Group E, used to generate in silieo FAFLP profiles; Group F, 
used to search for presence of insertion sequences; Group G, used to generate in silieo 
optical maps. 
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Appendix VI. Results of spa typing 
Isolate number spa type spa repeats 
DBHTl t315 26-22·17·20-17·12·17·17·16 
DBHT2 t315 26-22-17·20-17·12-17·17·16 
DB HT 3 t8530 26-23·23·13·23·31·29·16-31.29·17·25.17·25·16-28 
DBHT6 t8530 26-23·23·13·23·31·29·16-31·29·17·25·17·25·16-28 
DBHT7 t8530 26-23·23·13·23·31·29·16-31.29·17·25·17·25·16-28 
DBHT8 t8530 26-23·23·13·23·31·29·16-31·29·17·25·17·25·16-28 
DBHT 12 t131 07·23·12-34-33·34 
DBHT 13 t186 07·12·21·17·13·13·34·34-33·34 
DBHT14 t202 11·17·23·17·17·16-16-25 
DBHT 15 t190 11·17·34-24-34-22·25 
DBHT16 t190 11·17·34-24-34-22-25 
DBHT 17 tOOl 26-3()"17·34-17·2()"17·12·17·16 
DBHT18 t065 09-02·16-34-13·17·34-16-34 
DB HT 19 t128 07·23·23·21·16-34-33.13 
DBHT20 t022 26-23·13·23·31·29·17·31·29·17·25·17·25.16-28 
DBHT21 t032 26-23·23·13·23·31.29·17·31·29·17·25·17·25·16-28 
DBHT22 t005 26-23·13·23·31-05·17·25·17·25·16-28 
DBHT23 t032 26-23·23·13·23·31·29·17·31·29·17·25·17·25·16-28 
DBHT24 t005 26-23·13·23.31-05.17·25·17·25·16-28 
DBHT25 t002 26-23·17·34-17·2()"17·12·17·16 
DBHT26 t008 11·19·12·21·17·34-24·34-22-25 
DBHT27 t127 07·23·21·16-34-33·13 
DBHT28 t311 26-23·17·34-20-17·12·17·16 
DBHT29 t004 09-02-16-13.13.17·34-16-34 
DBHT30 t019 08-16-02.16-02·25·17·24 
DBHT31 t9238 26-23.31.31.29.17·31·29·17·25·17·25·16-28 
DBHT 32 t9238 26-23·31·31·29·17·31.29·17·25·17·25·16-28 
DBHT33 t032 26-23.23.13.23·31·29·17·31·29·17·25.17·25·16-28 
DBHT 34 t032 26-23·23·13·23·31·29·17·31·29·17·25·17·25·16-28 
DBHT 39 t630 08-16-02·16-34-17·34·16-34 
DBHT40 t640 26-23·17·12·16 
DBHT 41 t026 08-16-34 
DBHT42 t548 26-23·17·34-17·20-17·12·16 
DBHT43 t5490 26-23·17·34-17·2()"17·12·17·274 
DBHT44 t026 08-16-34 
DBHT45 t474 26-23·13·23·31-05·17·25.16-28 
DBHT46 t127 07·23·21·16-34-33·13 
DBHT47 t267 07·23.12.21·17·34-34-34-33.34 
DBHT49 t316 04-2()..17·31·16-34 
DB HT 50 t316 04-2()"17·31.16-34 
DBHT 51 t018 15·12·16-02·16-02·25·17·24-24-24 
DBHT52 t026 08-16-34 
DBHT53 t091 07·23·21·17·34-12·23-02.12·23 
DBHT54 tOO 2 26-23·17·34-17·20-17·12-17·16 
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Appendix VI continued. Results of spa typing 
Isolate number spa type spa repeats 
DBHT 55 t9239 15·21·1001-25·17·24·24-24 
DB HT 56 t044 07·23·12-34·34-33·34 
DBHT 57 t037 15·12·1002·25·17·24 
DBHT 58 t450 26-23·17·34-16 
DBHT 59 t002 26-23·17·34-17·20-17·12-17·16 
DBHT60 t3209 04-34-24-34-22·25 
DBHT61 t018 15·12·1002·1002·25·17·24-24-24 
DB HT 62 t018 15·12·16-02·16-02·25·17·24-24-24 
DBHT64 t037 15·12·1001-25·17·24 
DBHT66 t018 15·12.16-02.16-02·25·17·24-24-24 
DBHT67 t037 15·12-1002·25.17·24 
DBHT68 t032 26-23·23·13·23·31·29·17·31·29·17·25·17·25·16-28 
DBHT69 t2311 07·12·12.21·17·13.13.34-34-33.34 
DB HT 70 tl236 26-23·12·21·17·34-34·34-33·34 
DBHT71 tl90 11·17·34-24·34-22·25 
DBHT72 tS073 26-23·13·21·17·34-34·34-33"()2"()2·34 
DBHT74 t037 15·12·1002·25·17·24 
DB HT 75 t008 11·19·12·21·17·34-24·34·22·25 
DBHT76 t037 15·12·1002·25·17·24 
DBHT77 t008 11·19·12·21·17·34-24-34-22·25 
DB HT 78 t032 26-23·23·13·23·31·29·17·31·29·17·25·17·25·16-28 
DBHT79 t128 07·23·23·21·16-34·33·13 
DBHT80 t316 04-20-17·31·16-34 
DBHT82 t022 26-23·13·23·31·29·17·31·29·17·25·17·25·16-28 
DBHT83 t002 26-23·17·34-17·20-17·12-17·16 
DBHT85 t008 11·19·12·21·17·34-24·34-22·25 
DBHT87 tl081 08-16-02-43·34·17·34 
DBHT88 t138 08-16..02·25·17·24 
DBHT90 t202 11·17·23·17·17·16-16-25 
spa type and spa repeats for 73 isolates. spa repeats represent the size and number of 
repeating units which are found in the polymorphic X region of the spa gene. The size 
and number of repeating units constitute a specific spa type. 
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Appendix VII. Cluster analysis of UPGMA-derived dendrogram based on Bg/lI + A and Csp61 +0 FAFLP data 
Percentage similarity 
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The dendrogram was derived for all 302 study isolates and an E. coli strain. FAFLP clusters were designated as clusters 1 to 21 {shown as black 
numbers}, based on 65 % similarity cut-off {shown as solid vertical black line}. Sub-clusters were based on an 85 % similarity cut-off {shown as dashed 
vertical black line}. The clonal complex and SCCmec type of isolates is shown on the right of the cluster number. Isolates assigned to the same clonal 
complex were highlighted in a single colour. 
'Indicate SCCmec non-typeable. 
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Appendix VIII. Isolates utilised in lineage-specific amplified fragment PCRs and blind study 
Isolates utilised in lineage-specific AFo PCRs Isolates utilised in blind study Clonal complex 
DBHT 19, DBHT 79, DBHT 233 DBHT 19, DBHT 46, DBHT 233, DBHT 257 CC1 
DB HT 25, DBHT 40, DBHT 59, DBHT 206, DBHT 272, DBHT 28, DBHT 54, DBHT 59, DBHT 272, DBHT 288 CC5 DBHT290 
DBHT 16, DBHT 67, DBHT 76, DBHT 88, DBHT 201, DBHT 16, DBHT 48, DBHT 67, DBHT 76, DBHT 85, DBHT CC8 
DBHT259 88, DB HT 202, DBHT 231 
DBHT 205, DBHT 247, DBHT 279 DBHT 205, DBHT 277, DBHT 279, DBHT 285 CC15 
DBHT 18, DBHT 94, DBHT 130, DBHT 181, DBHT 235 DBHT 7, DBHT 91, DBHT 130, DBHT 140, DBHT 172, CC22 DBHT 199, DBHT 213, DBHT 235, DB HT 297 
DBHT 30, DBHT 66, DBHT 161, DBHT 222, DBHT 239, DBHT 132, DBHT 161, DBHT 222, DBHT 239, DBHT 254, CC30 
DBHT 252, DBHT 287 DBHT 281, DBHT 287 
DBHT 87, DBHT 121, DBHT 255 DBHT 121, DBHT 210, DBHT 255, DBHT 273 CC45 
DBHT 49, DB HT 212, DBHT 225 DBHT 11, DBHT 80, DBHT 212, DBHT 230 CC59 
DBHT 47, DBHT 70, DBHT 278 DBHT 70, DB HT 278 CC97 
DBHT1 DBHT2 CC672 
~--
--
"AF, amplified fragment 
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Appendix IX. Isolates utilised in Pyrosequencing™ assay 
Isolate number MLST 
DBHT72 CC1 
DBHT 19S" CC1 
DBHT 5S" CC5 
DBHT lOO" CC5 
DBHT204 CCS 
DBHT226 CCS 
DBHT 207 CC15 
DBHT 22" CC22 
DBHT3f CC22 
DBHT45" CC22 
DBHT96" CC22 
DBHT lIS" CC22 
DBHT 13S" CC22 
DBHT 173" CC22 
DBHT21f CC22 
DBHT 302 CC22 
DB HT 55" CC30 
DBHT 236" CC30 
DBHT29 CC45 
DBHT 196 CC45 
DBHT 260' CC45 
DBHT 50· CC59 
DBHT2 CC672 
·Isolates assigned to a lineage based on lineage-specific SNPs and point mutations. 
Isolates utilised in Pyrosequencing™ assay targeting 95 bp of lineage-specific 307 bp 
amplified fragment. 
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Appendix X. Loci amongst 15 whole-genome sequences which encode a transposase 
Strain 
No. of T ransposase regions 
regions 
36353·37027,42958-44481,467453-467725, 
COL 7 1436659·1436955, 1894859·1895344, 
193292()"1934239, 1972991·1974310 
53099·53590,53556-54062,399312·399584,981105. 
982280,982249·982425, 1093058·1094377, 1151848-
1153167, 1408479·1408661, 1421603·1422922, 
1713665·1714984, 1746451·1746771, 1746902-
ED98 24 1747414, 1862395·1862559, 1862998-1863681, 
1877982-1878551, 1879582-1880082, 193741~ 
1938763, 197677s..1977281, 1977349·1977798, 
2140965·2142284, 222329()"2223460, 2223453· 
2223611,2303723.2304049,2738091~739410 
51535·51912,64441-64794,64779-65093, 718701· 
720020, 753283·754602,972729·974048, 1263536-
JHl 13 1264855, 1812284·1812661, 196339()"1964073, 
2023726-2025045,2038447·2039766,2240636-
2241955,2478139·2479458 
473451-473723, 718825·720144, 753407·754726, 
972854-974173, 1263662.1264981, 152018()" 
JH9 11 1520476, 1980101·1980601,2023851·2025170, 
2038572·2039891,2240761.2242080,2478263. 
2479582 
36403·37077,41749-42423,5768()"58057, 
58064-59956,59953-61038, 70097·70939, 
70924-71238,89496-89795,89837·90643,91351· 
92298,449607-449954, 733183·764882,734448-
735122, 742098-743744, 758443·760089, 763228-
763605,76370()"764374,973598-975244,998073· 
999020,1004249·1005037,1006111·1007757, 
1029169·1029300, 1182701·1184347, 1215677· 
MRSA252 46 1216624, 1351329·1352349, 1367414-1368361, 
1409057·1409845, 1431432·1433078, 1493459· 
1494406, 1798303·1798680, 1798687·1800579, 
1800576-1801661, 1909322-1910764, 1972462-
1972606, 1993384-1993590,2119976-2121622, 
2175406-2175627,2245178-2245861, 2304037· 
2305684, 2306521.2307052, 2325364·2327010, 
2392632·2393420,2543734-2545380,2690769· 
2691193,2797873.2798820,2890689·2891645 
58948-59577,59745·59855, 140437·140921, 
1204084-1204269, 14 2609s..14 26391, 
MSSA476 12 1442115·1442596, 1459026-1459604, 1872598-
1872807, 1872849·1873153, 2011686-2011897, 
2205996-2206527, 235981()"2360145 
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Appendix X continued. Loci amongst 15 whole-genome sequences which encode a 
transposase 
36436-37110,42007-42456,57753·58130, 
58137-60029,60026-61111,70170-70547,70659· 
71012,426640-427959,460237-461427,463952· 
464248,70399+705313,97163+972953,1216813· 
1218132, 1252941·1253153, 1473328-1473624, 
Mu3 31 1765447·1765824, 1765831·1767723, 1767720-1768805, 1815037·1816356, 1841027·1842346, 
1918797·1919147, 1919323·1919571, 1919490-
1920269, 1934570-1935139, 193516~1935415, 
1936170-1936670, 1993998-1995317,2071108-
2071281, 2212484-2213803, 2506985.2508304, 
2638860-2640179 
36436-37110,41782-42456,57753.58130, 
58137-60029,60026-61111,70170-70547,70659· 
71012, 70997·71311,426637-427956,460233. 
461423,463948-464244, 702549·703868,970190-
971509,1215412-1216731,1251541.1251753, 
Mu50 32 1471928-1472224, 1764047·1764424, 1764431· 1766323, 1766320-1767405, 1813637·1814956, 
1839628-1840947,1917398-1917748,191792+ 
1918172, 1918091·1918870, 1933171·1933740, 
1933762·1934016, 1934771·1935271, 1992601· 
1993920,2069711.2069884,2210846-2212165, 
2505347·2506666,2637221.2638540 
36432-37106,60241-60870,61038-61148, 
1175411·1175596, 1397643·1397837, 1413561· 
MW2 12 1413755, 1413773·1414165, 1430664-1431050, 
1893263.1893472, 1893675·1893818,2032439· 
2032612,2380849·2381163 
36435·37109,41781-42455,57792·58169, 
58176-60068,60065-61150, 70209·70586, 70698-
71051,426680-427999,438190-438486,678300-
679619,867008-868093,868090-869982,869989· 
870366,893906-895225, 113908+1140403, 
N315 30 1175212·1175424, 1395599·1395895, 1687654· 1688031, 1688038-1689930, 1689927· 
1691012,1761714-1763033, 1839605·1839955, 
1840131·1840379, 1840298-1841077, 1855378-
1855947, 1855969·1856223, 1914806-1916125, 
1991916-1992089,2134414-2135733,2566795. 
2568114 
344 
Appendix X continued. Loci amongst 15 whole-genome sequences which encode a 
transposase 
115867·116088,264380-264784,1111031·1111240, 
1332886-1333182, 1348900-1349016, 
1349111·1349503, 1705674-1706480, 1706498-
NCTC8325 16 1707325,1813964-1814788,1814821.1815429, 
1820862.1821347, 1832051.1832260, 1832463· 
1832606, 1897329·1898531,2237284-2238486, 
2425635·2425991 
115844-116065,433128-433400, 1210988-1211197, 
1432841.1433137, 1448855.1449049, 
1449067·1449459, 1762474-1763280, 1763298-
Newman 20 1764125, 1852428-1852919, 187080~1871626, 1871659·1872267, 1877700-1878185, 1889301· 
1889444, 1954178-1955497,2294897·2296135, 
2322168-2322968,2322965·2323285,2323433· 
2323792,2436373·2436687,2483472·2483828 
775800-776813,812335·812604,922627·923943, 
979690-980364, 1268707·1269489, 
RF122 14 1269528·1270028, 1421380-1422054, 1721534-1722850,2020407·2020628,2184629·2185453, 
2185450-2185950, 2309331·2309831, 2309828-
2310652,2341147~342463 
35877·36551,42442-43953,67966-68790, 
USA300_FPR3757 11 78432-79445,318970-319374, 1443183·1443668, 1917170-1917571, 1993601·1994956,2290382. 
2291620,2431859·2432173,2478538-2478894 
35877·36551,42442-43965,67885-68736, 
USA300_TCHI516 11 78378-79391,318865·319269,443428-443700, 1443035·1443427, 1457130-1457615, 1917920-
1918321, 1994386-1995747,229081~2292014 
Number of regions amongst each of 15 whole-genome sequences (WGSs) which encoded a 
transposase. Regions were identified using Mauve software based on the search for the 
term 'transposase' amongst annotations available on the NCBI database 
(http://www.ncbi.nlm.nih.gov). 
~ucleotide positions of regions which encoded a transposase amongst the 15 WGSs. 
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